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ABSTRACT 
This thesis examines the relationship between obesity and health and health service 
use, and whether or not this relationship varies by socioeconomic status (SES). We 
start by generating hypotheses for this relationship based on a human capital model 
for health. We conduct a literature review on the topic and generate econometric 
models to be tested. We then provide an analysis of socioeconomic variation in the 
relationship between obesity and Health Related Quality of Life (HRQL). The results 
show that obesity is negatively associated with HRQL and that the negative association 
is more pronounced in lower SES individuals than higher SES individuals. We then 
conduct an analysis of socioeconomic variation in the association between obesity and 
HRQL in individuals with obesity-related comorbidities. The results show that the 
association between obesity and HRQL is more negative in individuals with these 
comorbidities than individuals without. Furthermore, it shows that obesity-related 
comorbidities are associated with greater reductions in HRQL in lower SES groups than 
in higher SES groups. We also examine SES variation in the impact of obesity on life 
expectancy and find that obesity increases mortality and reduces life expectancy. We 
find that the impact of obesity on mortality is more negative in lower SES women than 
in higher SES women. Mortality does not vary by SES groups in men. We then conduct 
an analysis of SES variation in the association between obesity and health service use. 
We use a range of health service indicators and find that obesity is associated with 
increased use. We also find that obesity will lead to greater use of some services in 
lower SES groups compared with higher SES groups. The main implication of this thesis 
is to illustrate that obesity can constitute different challenges across SES groups. 
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CHAPTER 1 
 
Introduction 
 
In this chapter we start by explaining the background and motivation for the work in 
this thesis. We then go through the research aims and discuss the approaches we will 
use to reach these aims.  
 
1.1 Background 
In this thesis we examine the relationships between obesity and health, and obesity 
and health service use. Then we examine if these relationships vary by socioeconomic 
status (SES). We start by describing obesity and SES separately, before we discuss their 
relationship and how they might interact. 
 
1.1.1 Obesity 
Overweight and obesity are clinical terms used to describe excess body fat 
(Department of Health, 2011). Obesity is a state of being seriously overweight to the 
stage where it becomes a risk factor for poor health and the most common method of 
measuring obesity is Body Mass Index (BMI), measured as weight in kilogrammes 
divided by height in metres squared (kg/m2). We use BMI and have grouped the BMI 
 13 
 
categories according to World Health Organization guidelines (WHO, 1995), which is 
shown in Table 1.1.  
 
Table 1.1: WHO BMI classification 
Classification BMI (kg/m2) cut points 
Underweight <18.5 
Normal weight 18.5-24.99 
Overweight (pre-obese) 25-29.99 
Obese Class I 30-34.99 
Obese Class II 35-39.99 
Obese Class III >40 
Note 
In the following analysis we pool some of the classes to ensure an adequate number of individuals in 
each class when we stratify by SES.   
 
BMI has been criticised, e.g., because it does not incorporate body fat, which is an 
independent predictor of ill health (Burkhauser & Cawley, 2008). There are a range of 
other measures available: total body fat; percent body fat; waist circumference; and 
waist-to-hip ratio. Each of these measures has their strengths and weaknesses, and 
there is no consensus which measure of fatness is the best (Freedman & Perry, 2000; 
Burkhauser & Cawley, 2008). We have chosen to focus on BMI as it is the preferred 
measure by the WHO and is most widely used in social science research related to 
obesity (Burkhauser & Cawley, 2008). In our case this is relevant as we seek to 
compare our results to other studies. 
 
We define obesity as a lifestyle related risk factor for poor health. By doing this we 
follow both public health traditions (Butland et al., 2007; Marmot, 2010; WHO, 2011) 
and health economics traditions (Contoyannis & Jones, 2004; Balia & Jones, 2008). 
Other harmful lifestyle related factors are smoking, excess drinking and drug use 
 14 
 
(Marmot, 2010). However, the complicated nature of obesity distinguishes it from the 
other risk factors; it is a consequence of sedentary behaviour and excess energy 
consumption, it is not a description of the behaviour in itself. Not only is obesity a risk 
factor, it can be seen as an intermediate indicator of health. In the following we 
recognise that obesity has two effects on health. The first is the direct effect, which is, 
for example, reduced mobility. The second effect is the (indirect) risk factor effect. This 
is the increased risk of diabetes and other comorbidities caused by obesity, which then 
again harms health.  
 
Rising obesity levels are a major issue in the UK. In England in 1993 15% of adults aged 
16 years and over were obese (13% of men, 16% of women); by 2008 this figure had 
risen to 25% (24% of men, 25% of women) (National Centre for Social Research and 
Department of Epidemiology and Public Health, (UCL), 2009). The British government’s 
Foresight programme shows that over half of the British adult population could be 
obese by 2050 (McPherson, Marsh, & Brown, 2007). This trend is worrying because 
obesity is, as mentioned, an important risk factor for a number of diseases including 
coronary heart disease, type II diabetes, hypertension and stroke (NHLBI, 1998). In 
England 7% of all deaths are attributable to obesity (House of Commons Health 
Committee, 2004). Obesity is also associated with decreased life expectancy. For 
instance, in the UK a 30-year old non-smoking man with a BMI of 35 kg/m2 is projected 
to lose five years of life compared to a similar person with a BMI of 24 kg/m2 (Mayhew, 
Richardson, & Rickayzen, 2009). The analogous result for women is a loss of two years. 
Results of a similar order of magnitude have been found in other countries (see, e.g., 
Peeters et al., 2003). As well as affecting premature mortality and life expectancy there 
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is also increasing evidence that obesity is associated with a loss in health related 
quality of life (HRQL) (see, e.g., Sach et al., 2007). Hence, obesity is a major public 
health problem presenting a direct and indirect burden on individuals and is also 
proven to have major implications for health service expenditures (National Audit 
Office, 2001). In 2002 the House of Commons Health Select Committee estimated that 
the total cost of obesity was close to £7 billion per year (including both direct and 
indirect costs) and that the direct health care costs of obesity constituted between 
2.3% and 2.6% of the total annual NHS expenditure (House of Commons Health Select 
Committee, 2004). To generate sustainable responses to this problem we need 
evidence based, cost-effective solutions.  
 
1.1.2 Socioeconomic status 
The Acheson report (1998) highlights socioeconomic position as the most fundamental 
of the social determinants of health. In addition, socioeconomic disadvantage has been 
identified as a major reason for why other groups like some ethnic minorities have 
higher rates of poor health (Graham, 2004). 
 
Monitoring and understanding socioeconomic conditions requires conceptual clarity 
about what socioeconomic parameters we are measuring, and why (NICE, 2008). A 
range of terms has been used (social class, social stratification, socio-economic 
position, socio-economic circumstances, deprivation), to describe variations in the 
living and working conditions of individuals, households or the areas. We base the 
definition of SES on a definition by Krieger (1997, p.345) of socioeconomic position: 
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“An aggregate concept that includes both resource-based and prestige-based 
measures, as linked to both childhood and adult social class position. Resource-based 
measures refer to material and social resources and assets, including income, wealth, 
educational credentials; terms used to describe inadequate resources include “poverty” 
and “deprivation”. Prestige-based measures refer to individual’s rank or status in a 
social hierarchy, typically evaluated with reference to people’s access to and 
consumption of goods, services, and knowledge, as linked to their occupational 
prestige, income, and education level”  
 
Strictly speaking this is a definition of socioeconomic position. The difference between 
socioeconomic status and socioeconomic position lies in the word “status”. Some 
prefer not to use “status” as it refers to prestige and rank related characteristics, while 
“position” refers to actual resources (Krieger, Williams, & Moss, 1997). However, they 
are measuring the same thing and it will be referred to as socioeconomic status (SES) 
in the following text as this is more common in economic literature.  
 
1.1.3 Obesity and socioeconomic status 
Lifestyles that lead to obesity are becoming increasingly concentrated among lower 
SES groups (See, e.g., McLaren, 2007). Figure 1.1 and Figure 1.2 show the development 
of obesity across SES groups in England for men and women. We can see that obesity 
is steadily increasing across all social classes, however the share of obese individuals is 
higher in the lower social classes compared with the higher social classes. The social 
class gradient is more pronounced for women where professional women had an 
obesity prevalence of less than 15% in 2008 compared with almost 35% in the 
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unskilled manual classes. We can also see that the social gradient in the prevalence of 
obesity is consistent across time and appears to be increasing.  
 
Figure 1.1: Prevalence of obesity in men (aged 16 and over) by social class, 1997-2008 
 
Figure 1.2: Prevalence of obesity in women (aged 16 and over) by social class, 1997-
2008 
 
Source: National Obesity Observatory, based on the Health Survey for England 
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Tackling inequalities in health is a primary aim in the English National Health Service 
(NHS). Hence, the socioeconomic pattern in the prevalence of obesity and other 
lifestyles has lead to a focus counteracting these lifestyles in lower SES groups. Many 
of the social policies implemented to address inequalities over recent years have been 
targeted at the most disadvantaged groups or areas (Marmot, 2010). For example, 
there has been a focus on increasing life expectancy in the so called spearhead group1. 
A similar concept to targeting is proportionate universalism (Marmot, 2010). This is 
universal interventions; however there is a social gradient in the distribution of 
resources, so that the resource use is proportionate to level of disadvantage. 
Furthermore, the Department of Health’s White Paper (2010) suggests “A radical new 
approach” to increase the population health and decrease inequalities. In this 
approach they suggest that “the Government will consider different approaches for 
different groups of the population, taking account of the significant barriers that some 
people face” (Department of Health, p. 28, 2010). They continue to argue that local 
areas should develop tailored approaches that particularly target at risk groups and 
Directors of Public Health should be responsible for addressing inequalities in health by 
addressing the wider determinants of health through interventions aimed at smoking, 
alcohol consumption and obesity.  
 
Based on the reasoning of the Department of Health (2010) and Marmot (2010), 
obesity may well be an area where it could be recommended to introduce 
                                                     
1
 Spearhead PCTs are the most health deprived areas of England. They are areas in the bottom fifth 
nationally for three or more indicators relating to life expectancy at birth, cancer and CVD mortality and 
the index of multiple deprivation. 
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interventions targeted at lower SES groups or spend proportionally more resources in 
lower SES groups. Furthermore, the Foresight report mentions as one of their “top five 
policy responses to obesity” was targeting health interventions for those at increased 
risk, such as low income groups (Butland et al., 2007). 
 
By using interventions targeted at vulnerable groups to tackle inequalities in health 
one makes assumptions about a homogenous condition across heterogeneous groups. 
If the prevalence of a problem is concentrated to a defined group, and we aim to 
target this group, the evidence required to inform decision makers should be from this 
group. Traditionally, it has been assumed that determinants of health (such as obesity, 
smoking and SES) are separate entities in their contribution to health and health 
service use. Limited evidence exists on if, and if so how, these determinants are 
combined and interact with each other. However, there is little reason to believe that 
unhealthy lifestyles are equally associated with health in high and low SES groups, and 
that this would have equal consequences for health service use. For example, low SES 
individuals may be less harmed from unhealthy lifestyles because, given the general 
health risk produced by limited resources, they have less to lose from damaging 
lifestyles. Conversely, low SES individuals might experience greater harm from poor 
lifestyles because poor material circumstances increase the health problems 
experienced from poor lifestyles. In other words there might be an interaction 
between poor lifestyle and SES in their relationship with health/health service use2.  
 
                                                     
2
 This will be discussed further in Chapter 2, where we will present theories and discuss previous 
literature. 
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While the impacts of obesity on health and health service use have been investigated 
both in the UK (See, e.g., Macran, 2004; Sach et al., 2007; and, the Counterweight 
Project Team, 2005b) and in other countries (Jia & Lubetkin, 2005; and, Reidpath, 
2002), little attention has been given to variations in these impacts across 
socioeconomic groups. Although we have information about prevalence of obesity 
across SES groups, see for example Figure 1.1 and 1.2, there is a need for information 
of the consequences of obesity across SES groups. Even if an obesity intervention was 
equally effective in terms of the change in obesity prevalence across SES groups the 
outcomes in terms of health might differ. Hence, previous studies not taking account 
of these interactions may fail to reflect the underlying reality of the relationship 
between various determinants and health/health service use when stratified by SES. 
This is important as it might have implications for how resources are distributed to 
improve efficiency of the health care system and tackle socioeconomic equity in 
health.  
 
The Acheson Report (1998) highlighted as one of its key recommendations “that as 
part of health impact assessment, all policies likely to have a direct or indirect effect on 
health should be evaluated in terms of their impact on health inequalities, and should 
be formulated in such a way that by favouring the less well-off they will, wherever 
possible, reduce such inequalities”. Assessing the impact of interventions (both 
targeted and universal) on health inequalities depends on clarity about how 
determinants link up to influence overall health and its unequal distribution. Public 
health interventions to reduce harmful lifestyles might be associated with increasing 
the overall health of the population, but have unknown effect on the overall 
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distribution of health across SES groups within the population. Furthermore, in 
economic evaluation of obesity interventions we might base our assumptions on 
biased measures of costs and effects, which could compromise economic efficiency in 
the health care system. 
 
In summary obesity is a major concern in the UK, which continues to increase. 
Furthermore, obesity has a socioeconomic gradient and is identified as a determinant 
of health inequalities (Department of Health, 2010; Marmot, 2010). In counteracting 
health inequalities current government reports (e.g., the White Paper and Marmot 
review) recommend focusing on the lower SES groups either through targeting or 
spending proportionally more on lower SES groups. Furthermore, obesity specific 
reports recommend SES targeted interventions as means of tackling obesity in general. 
Little attention has been given to possible interactions. If one assume independence 
between health determinants like obesity and SES one may fail to reflect the 
underlying reality of production of health in populations, hence misinforming policy 
makers and misallocating resources (Birch et al., 2000). However, as will be shown in a 
literature review, in the following Chapter 2, little is known about heterogeneities 
between the determinants of health. In an attempt to add to this topic we analyse SES 
variation in the impact of obesity on health and health service use.  
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1.2 Aims and overview of thesis 
 
1.2.1 Aims 
In this thesis we want to investigate the consequences of obesity, in terms of health 
and health serviced use, and whether or not these consequences vary by SES groups. 
More specifically there are two general aims of this thesis: 
 
1. Examine the relationships between obesity and health outcome; and obesity 
and health service use in the UK  
 
2. Investigate whether or not there are socioeconomic variations in these 
relationships 
 
In the thesis we focus on obesity and socioeconomic status. We have chosen to focus 
on adults (age>16) throughout this thesis. For individuals under the age of 16 we 
would need to apply a different set of socioeconomic measures (e.g., parent’s 
education and income) and obesity measures (percentage above 95th BMI percentiles 
in the specific age group) which are less frequently available. Furthermore, we do not 
have measures of HRQL (since only individuals over the age of 16 are requested such 
information) and life expectancy (limited data where the follow up period is long 
enough) for this group.  
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1.2.2 Overview of thesis 
Before a thorough empirical analysis, we construct a framework for examining the 
impact of obesity on health and health service use and how this varies by SES. We 
present the Commission on Social Determinants of Health (CSDH) framework for 
determinants of health and present a human capital model for health (the Grossman 
model). We use these models to analyse the impact of lifestyle related risk factors (like 
obesity) on health, and how they might vary by SES. We conduct a literature review on 
SES variation in the association between lifestyle related risk factors and health. The 
review shows that few studies have explored the manner in which SES and behavioural 
risk factors influence health and are characterised by inconsistent findings. In addition, 
limited research has been done on obesity and there is a complete absence of UK 
research investigating heterogeneities in the impact of obesity on health by SES 
groups. We then present a model for the relationship between obesity and health 
service use and how this relationship might vary by SES. Based on the models we 
develop econometric models for testing. 
 
The preferred measure of health effects in the NICE public health reference case is 
Quality Adjusted Life Years (QALYs) (NICE, 2008). QALYs are essentially a composite 
measure consisting of HRQL and life expectancy; hence it takes into account both the 
quality and the quantity of life across health states. We have chosen to use HRQL (EQ-
5D) and life expectancy as our measures of health in this thesis. Hence, we want to 
analyse the relationship between obesity and HRQL and how this varies by SES. We 
then also want to analyse the relationship between obesity and life expectancy and 
how this varies by SES. 
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Chapter 3, 4, 5 and 6 provide the empirical analysis of SES variation in the 
consequences of obesity. Chapter 3 investigates the relationship between HRQL and 
obesity, and whether or not this relationship varies by SES. Data is taken from four 
rounds of the Health Survey for England (2003–2006) for persons aged 16 and above. 
Banded total annual household income is regressed against a comprehensive set of SES 
indicators using interval regression. We use the equivalised predicted values from this 
model, categorised into quartiles, as our measure of SES. We regress HRQL (EQ-5D 
scores) against interactions between BMI and SES categories controlling for a range of 
covariates and generate predictions of mean EQ-5D scores. Obesity is negatively 
correlated with HRQL. The negative association between obesity and HRQL is greater 
in people from lower SES groups. Overweight and obese people in lower SES groups 
have lower HRQL than those of normal weight in the same SES group, and have lower 
HRQL than those in higher SES groups of the same weight. This trend is also observed 
after controlling for individual and household characteristics, although the statistical 
significance and magnitude of effects is diminished. 
 
In Chapter 4 we investigate how obesity-related comorbidities modify the association 
between obesity and HRQL, and then how socioeconomic status influences this. We 
use the same dataset and SES groups as in Chapter 3. We regress HRQL (EQ-5D score) 
against interactions between BMI groups and obesity-related comorbidities, 
controlling for a range of covariates. We then include and interact with SES groups. We 
generate predictions of mean EQ-5D scores for each BMI/comorbidity/SES 
combination. The findings from this chapter suggest that the association between 
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obesity and HRQL is more pronounced in individuals suffering from obesity-related 
comorbidities. This chapter also finds that the relationship between obesity-related 
comorbidities and HRQL is more pronounced in lower SES groups.  
 
In Chapter 5 we analyse the relationship between obesity and life expectancy. We use 
data from the British Health and Lifestyle Survey (1984-1985) and the longitudinal 
follow-up in June 2009 to investigate the impact of obesity on life expectancy for 
persons aged 40 and above. Our measure of SES is based on a prediction of income as 
in previous studies. We use both parametric and semi-parametric duration models and 
account for unobservable heterogeneity. We use a range of statistical tests to identify 
the parametric survival distribution that best fits our data. We look at both mortality 
and predicted life expectancy. Obesity increase mortality and is negatively correlated 
with life expectancy in men and younger women. In older women obesity is associated 
with increased life expectancy. The negative impact of obesity on mortality varies by 
SES groups in women, but not in men. The impact of obesity on life expectancy is more 
negative in lower SES women than in higher. This trend is also observed after 
controlling for longstanding illnesses, although the statistical significance and 
magnitude of effects is diminished. 
 
Although we do not focus on a specific intervention and cannot calculate the cost of an 
intervention to the NHS we can calculate the general association between obesity and 
services provided by the NHS. This is done by analysing the association between 
obesity and health service use and how this varies by SES. We use data from ten 
rounds of the Health Survey for England (HSE: 1999-2008) and two rounds of the 
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British Household Panel Survey (BHPS: wave 14 (2004 - 2005) and wave 16 (2006 - 
2007)) to investigate the association between obesity and a range of health services 
including medication categories based on the British National Formula (BNF) in Great 
Britain and how this varies by SES. Total annual household income is regressed against 
a comprehensive set of SES indicators in both datasets using panel and cross sectional 
regression methods. As in earlier chapters, we use the equivalised predicted values 
from these models, categorised into quartiles, as our measure of SES. We use a range 
of statistical methods including interval regression, nonlinear binary choice and count 
models to investigate the relationship between obesity and use. We make predictions 
of use based on the models. The methods and predictions are adjusted for data being 
either panel or cross sectional. We find that obesity is associated with increased use of 
a range of health services and medications. Furthermore, obesity in lower SES groups 
is associated with a greater increase in use than obesity in higher SES groups. However, 
the SES gradient was not identified for all health services. The findings are consistent 
across the datasets. 
 
Chapter 7 concludes by pulling together the findings of the first six chapters. We 
discuss implications for policy and research. Furthermore, we discuss limitations and 
offer some suggestions for further research.  
 
1.3 Summary 
Obesity is a major public health problem that needs evidence based, cost-effective 
responses. Obesity is more prevalent in lower social classes and this social gradient has 
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persisted over time. This has led to a focus on counteracting obesity in lower SES 
groups. We argue that there is no reason to believe that obesity affects individuals 
across SES groups in the same way. The consequences of obesity might vary by SES 
groups and therefore so too might the outputs in terms of health and health service 
use. Furthermore, we summarise the methods we will use in meeting the general aims 
of this thesis. The following chapter will go into detail on earlier literature, theories 
and models mapping socioeconomic variation in the relationship between obesity and 
health/health service use.  
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CHAPTER 2 
 
Modelling socioeconomic variation in the impact of 
obesity on health and health service use  
 
2.1 Introduction  
Generally health economic research and modelling assumes a production relationship 
between health and the determinants of health, i.e. an improvement in the 
determinants of health is seen to produce better health. Determinants of health can 
be lifestyle related risk factors, like smoking, diet and exercise, and it is also 
increasingly recognised that social, cultural and economic factors are associated with 
health status (see, e.g., Marmot, 2010). Traditionally little attention has been given to 
interactions between these determinants and it is assumed that health is produced 
from a number of determinants that all have a separate impact on health. However, 
the impact of one determinant might depend on other determinants.  
 
The aim of the following chapter is to present a conceptual framework for the 
following analysis using a theoretical model. In addition, to construct hypotheses for 
SES variation in the impact of obesity on health and health service use based on this 
framework. This framework will form the basis for empirical models for testing.  
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To illustrate how SES and obesity affect health we build on earlier literature from both 
health economics and public health traditions. We start by explaining a conceptual 
framework for social determinants of health. We then build a theoretical model to 
illustrate socioeconomic variation in the impact of obesity on health. The theoretical 
model will be based on the Grossman model, which has been (and still is) the most 
influential economic model for understanding how variables such as age and lifestyle 
influence the demand for health. Further, we show a framework first presented by 
Birch et al. (1997) for socioeconomic variation in the impact of risk factors on health. 
We then generate hypotheses for how SES and lifestyle related risk factors interact and 
its consequences for health and discuss the hypotheses in light of a literature review. 
Last, we generate a model to illustrate socioeconomic variation on the impact of 
obesity on health service use and generate hypotheses for this relationship. 
 
2.2 A conceptual framework for the social determinants of health 
The Commission for Social Determinants of Health (CSDH) was a commission lead by 
Prof. Sir Michael Marmot set up by the WHO and was tasked to collect, collate, and 
synthesize evidence on the social determinants of health and their impact on health 
inequity, and to make recommendations for action to address that inequity (CSDH, 
2008). The CSDH has developed a framework for the pathways and mechanism 
through which social determinants of health influences health (Solar and Irvin, 2007). 
This framework has three main elements consisting of different factors and is shown in 
Figure 2.1.  
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The first element is socio-economic and political context. These are factors that cannot 
be directly measured at the individual level. The factors are related to the function and 
the structure of the social system that influence people’s health opportunities and the 
social gradient in health. Like a country’s governance and social policy.  
 
The second element of the framework consists of structural determinants and 
socioeconomic status3. Structural determinants are those who generate stratification 
and social class diversion in the society. They identify the most important structural 
stratifiers as: income, education, occupation, social class, gender and ethnicity.  
 
The third element is the intermediate determinants. The main categories are material 
circumstances (e.g., housing quality and consumption potential), psychosocial 
circumstances (e.g., stressful living and social support), behavioural and biological 
factors (e.g., obesity and smoking).  
 
 
 
 
 
 
 
 
                                                     
3
 They use the term socioeconomic position, however we refer to this as socioeconomic status for 
consistency 
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Figure 2.1: The Commission on Social Determinants of Health conceptual framework 
 
 
 
 
 
 
 
 
Source: Amended from Solar & Irwin, 2007 
 
Figure 2.1 illustrates the main process in the CSDH framework. Moving from the left to 
right we see that the social and political context generates the socioeconomic 
positions and social classes. The socioeconomic position will then affect intermediate 
determinants which then affects health. The diagram also illustrates the reversed 
effects through which illness might affect socioeconomic position and widely prevalent 
diseases might affect social and political institutions. 
 
The health care system is modelled as a separate element. The reason for this is that 
the health care system can influence health directly and it can alter the prevalence of 
intermediate determinants (for example, the GP might help a patient to quit smoking). 
  
This framework is interesting as it illustrates that it is not SES in itself that influences 
health but it is behaviour and possibilities resulting from SES. For instance, income 
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increase material circumstances and education improves choice of diet, while it is the 
material circumstances and the diet which has an impact on health. In addition, it 
emphasises the importance of country specific data by including the political context in 
addition to the health care system. In the following we will use the Grossman model to 
focus on a part of this framework, which is the relationship between socioeconomic 
status, intermediate determinants and health. By using the Grossman model we will 
use economic theory to explain in detail how the determinants link up and 
heterogeneities between them. 
 
2.3 A human capital model for health 
We have now briefly discussed a framework that provides a basis for how health can 
be influenced by its separate determinants. In economic theory the Grossman model 
(Grossman, 2000) has been especially influential in understanding the impact various 
determinants on general health have. Not only has this model provided considerable 
insight into the allocation of resources (like time and money) into activities that 
generate health. It has also crossed academic fields and it is backed by empirical 
results, see Grossman (2000) for a discussion of empirical evidence. We will start by 
explaining the Grossman model framework. We will then use this framework to 
analyse how obesity and SES might influence health. 
 
The Grossman model is a model derived from human capital theory where individuals 
increase their health capital by investments in health. The main contribution of the 
Grossman model is that the demand for health care is derived from its ability to 
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produce health capital and not for the direct utility. This means that one does not gain 
utility directly from antibiotics. One will gain utility from the increased health capital 
(reduced duration/impact of illness) resulting from taking this drug. In this way this 
model introduces a production relationship between health capital and multiple 
influences on health. Hence, health capital is both demanded and produced by 
individuals. We start with a simple representation of a utility function:  
 
),( OHUU            (2.1) 
 
Equation 2.1 illustrates that people gain utility from two goods: health capital (H), 
which in this case is measured as the sum of the number of healthy days over a 
lifetime, and consumption of all other goods (O). The number of healthy days is 
derived from the individuals health stock (HS) (H=f(HS)). The health stock at time t is 
determined by health stock in the previous period (HSt-1), the depreciation in the 
health stock (dt) and investments in health (It). 
 
tttt IdHSHS  1          (2.2) 
 
Health stock depreciates over time because of effects like aging and poor lifestyles. 
Depreciation can be seen as “wear and tear” of health and can be offset by 
investments in health through, for example, eating more fruit or consuming health 
care. The larger the depreciation is, the larger investment is needed to offset this 
depreciation. Both It and Ot are produced in the household and have a similar pattern: 
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),( Httt TMII           (2.3) 
),( Ottt TXOO           (2.4) 
 
Production of It uses medical care (Mt) and Ot uses other market goods (Xt). Both It and 
Ot are affected by time spent on their production THt and TOt.  
 
Individuals maximise their utility within two constraints, time budget and monetary 
budget. The time budget is the total time available (365 days per year) and it can be 
distributed on four time consuming activities. The time spent on producing health (THt) 
and other goods (TOt), the time spent working (TWt) and the time spent being sick (TSt).  
 
WtStOtHtt TTTTT          (2.5) 
 
The monetary budget depends on the income from work, the wage rate (W), the 
market goods and their prices (Pm, PX)
4.  
 
WTXPMP WXM ***          (2.6) 
 
This equation represents the present value of each of its components. Hence, it is 
discounted with the discount rate (r).  
 
                                                     
4
 In England the NHS is free of charge hence in this case PM=0. However, Mt does not only represent 
health services provided by the NHS but also other goods that contribute to increased health.   
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Maximising utility gained from health means that the individual sets the marginal 
benefit of health capital equal to its marginal costs. Marginal benefit of health capital 
consists of two parts. The first is what Grossman calls the investment benefit, which is 
based on the fact that healthy days can be used to work and this generates income. 
The marginal benefit of this monetary benefit is denoted MBMt. The investment benefit 
consists of the marginal product of health (the number of healthy days generated from 
one unit increase in health stock) denoted as MPH and wage. 
 
 tHtMt WMPMB *          (2.7) 
 
The second benefit is what Grossman has called the consumption benefit. This is the 
utility gained directly from health and is the value of the marginal product of health 
multiplied by the value of a healthy day. The marginal product of healthy days is 
measured as the ratio of the undiscounted marginal utility of healthy days (MUH) to 
the marginal utility of wealth (MUW).  
 
)/(*)1(* WtHt
t
HtHt MUMUrMPMB        (2.8) 
 
As mentioned we maximise utility when marginal benefit is equal to marginal costs. 
The marginal benefit consists of the investment benefit and the consumption benefit 
(MBMt + MBHt). The marginal costs consists of the marginal cost of investment (MCI) 
multiplied with the opportunity cost of investment (the interest rate (r) minus the 
change over time in MCI (ΔMCI)) and the depreciation rate. 
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])[( 11 tttHtMt dMCIrMCIMBMB         (2.9) 
 
This equation fully determines the optimal quantity of health at any time. Hence, 
people will invest in health up until the point where the marginal benefit from an 
investment (the consumption benefit and the investment benefit) is equal to the 
marginal costs incurred by the investment. If we divide both sides of equation 2.9 on 
MCI we get:  
 
])[( 1
1
tt
t
HtMt dMCIr
MCI
MBMB




       (2.10) 
 
On the left hand side we have what we call the total rate of return on an investment in 
health and the term of the right hand side is from now on referred to as the user cost 
of health capital. In equilibrium the total rate of return on an investment in health 
must equal the user cost of health capital. 
 
We will now demonstrate the equilibrium health in a figure which later will be used to 
make predictions. Due to the complicated relationship between the consumption 
benefit and the investment benefit we cannot estimate both in one model. To 
demonstrate some of the predictions of the model we focus on the investment model. 
The advantage of using this model compared with the consumption model is that it 
allows more easy interpretation in form of graphs. Although some predictions differ in 
the investment and the consumption model, it will not have consequences for the 
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predictions of how obesity and SES we influence health. For example, we will later 
illustrate how obesity reduces health in the investment model, but the same would 
have happened if we had used the consumption model, although a different 
mechanism would have worked.  
 
So when we use the investment model the utility gained from health is in terms 
monetary units. This is illustrated in Figure 2.2 using the concept MEC (marginal 
efficiency of capital) which shows the relationship between the stock of health (HS) 
and the rate of return on an investment in health. It is assumed a diminishing marginal 
productivity of health as the health stock increases (Grossman, 2000), hence the 
convex shape of the MEC curve. The horizontal line (supply) shows the relationship 
between the stock of health and the cost of health capital (C= (r-∆MCI)+d). Since, the 
cost of capital is independent of the stock; the supply curve is a straight line. We can 
now see the equilibrium health stock (HS) which is where the MEC curve crosses the 
supply curve. We will later use this result to illustrate predictions about changes in 
equilibrium health based on changes in the determinants.  
 
 38 
 
Figure 2.2: Equilibrium health 
 
 
The Grossman model has been widely used as a basis for empirical testing and there is 
a range of evidence supporting the predictions made by the model. However, some of 
its assumptions have been heavily criticised. One of the main critiques it receives is 
that the model assumes that individuals have perfect information and make rational 
well informed choices about the time of death. In addition, it does not take into 
account uncertainty (such as the effect of health care on health). An extended model 
has taken account of this criticism by making the model probabilistic and assuming 
that individuals face a probability distribution of depreciation rates (Grossman, 2000). 
In our case this implies that lifestyle related risk factors increase the risk of a negative 
health outcome. However, as we discussed in the introduction, obesity works both by 
a direct effect and by an indirect (risk factor) effect. We discuss this further below.  
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We have now presented the Grossman model framework. In the following part we will 
go into detail on how obesity and SES influence health in this framework. 
 
2.3.1 Lifestyles, SES and demand for health  
We start by explaining how lifestyle related risk factors influence health capital. We 
then explain how the model can be modified to take into account SES variation in the 
impact of risk factors on health capital. 
 
2.3.1.1 Lifestyle related risk factors in the Grossman model 
When we want to include lifestyle related risk factors in the model we have two 
options. Either we can include lifestyle related risk factors as part of the investment in 
health or we can include them as part of the depreciation rate. Traditionally lifestyle 
related risk factors have been included as a part of the investment in health alongside 
medical care. However, it has been argued that this is not satisfactory as it extends the 
vector of medical care to a range of variables with widely different interpretations. 
Furthermore, it is assumed that investments in health is non-negative (Grossman, 
2000), which makes it difficult to handle disinvestments in health. Muurinen (1982) 
suggests, however, that some behaviours such as smoking might cause use-related 
deterioration of health and that these should be modelled as a part of the health 
depreciation rate. Hence, in modified versions of the Grossman model the 
depreciation rate has also been a function of other factors like lifestyle related risk 
factors in addition to age (Muurinen, 1982; Reid, 1996; Grossman, 2000; Bolin et al., 
2006). This means that the depreciation rate is defined as a function of both “the age 
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of the stock” and “the intensity of the use of the stock”. To model this we denote the 
depreciation rate as a product of t (age), lifestyle (Lt) and all other variables (Xt), like 
environmental factors (such as pollution). 
 
),,( ttt XLtdd           (2.11) 
 
Following Grossmans (2000) extension of the model we consider the depreciation rate 
effect to be probabilistic. In the introduction we explained that we have two effects of 
obesity, the direct and indirect effect (risk factor effect). The direct effect increases 
depreciation in the same way as the direct effect of age. While age reduces physical 
strength obesity may reduce mobility, for example. Hence, the probability that an 
individual experiences a negative health impact from the direct effect is close to or 
equal to 1. The indirect effects increase the probability of longstanding illnesses and 
health shocks. Hence, there is uncertainty surrounding whether or not individuals 
experience this effect and which of these effects the individual experiences. Hence, the 
risk factor effect has a range of probabilities <1. The depreciation rate is therefore the 
expected depreciation rate based on age, lifestyle and other variables.   
 
2.3.1.2 SES in the Grossman model 
In the original Grossman model (1972) there were two SES factors included: wage and 
education. These work to alter health in two ways. Higher wages increase the 
opportunity to purchase health care, i.e. high income individuals can purchase more 
expensive health care goods (this is more relevant in countries with a private health 
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care system). Education increases the efficiency of an investment in health care, which 
raises the optimal stock of health. For example, individuals with a university degree 
will gain more in terms of health from a GP visit than individuals with no education. 
Based on both these factors the Grossman model predicts that high SES individuals will 
have a higher health stock on average across the population. 
 
It has later been argued that this approach does not deal with SES in a satisfactory way 
and in extended versions of the Grossman model it has been argued that SES factors 
like education should be a part of the depreciation rate (Muurinen, 1982; van 
Doorslaer, 1987; and, McGuire, Henderson & Mooney, 1994). The results of doing this 
conform to the original Grossmans model, but the justification is different. In the latter 
SES is positively associated with health because it increases the general health 
productivity of an individual, and therefore reduces the marginal cost of investment in 
health. However, by including SES as a part of the depreciation rate it is seen as 
operating by redirecting the choice of different production processes in a way which 
leads to a lifestyle which is less use intensive in terms of health (Muurinen, 1982). For 
example, low SES individuals are more likely to make lifestyle choices that lead to a 
poorer health outcome. This is consistent with the CSDH framework, which also 
predicts that high SES individuals have a higher average health “level”, as they have 
lower prevalence of negative health determinants. 
 
We illustrate this in the Figure 2.3 below. SES works indirectly in two ways. SES has an 
impact on the prevalence of risk factors, illustrated by arrow 1. In addition, SES has an 
indirect impact on health through other intermediate determinants from the CSDH 
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framework (see Figure 2.1), which is illustrated by arrow 2. These other intermediate 
determinants could be material circumstances (e.g., housing quality and consumption 
potential), psychosocial circumstances (e.g., stressful living and social support) (CSDH, 
2008).  
 
Figure 2.3: Impact of lifestyle and SES on health 
 
 
We also introduce a third way that SES might influence health. This is by modifying the 
impact of lifestyle related risk factors on health. We illustrate this in Figure 2.4 below. 
The third way will work so that it modifies the negative impact of risk factors on 
health, which is showed by arrow 3.  
 
Figure 2.4: SES modified the impact of lifestyle on health 
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If SES modifies the effect of lifestyle related risk factors we assume that SES influences 
the impact of lifestyle related risk factors on the health depreciation rate5. In equation 
2.12 the depreciation rate has been altered to take into account this SES effect: 
 
);,,( tttt SESXLtdd           (2.12) 
 
The semicolon (;) in front of SESt illustrates that SES modifies the impact of the other 
variables (like lifestyle related risk factors) on the depreciation rate. We substitute 2.12 
into equation 2.9: 
 
)];,,()[( 11 tttttHtMt SESXLtdMCIrMCIMBMB       (2.13) 
 
Equation 2.13 shows that the level of health capital depends on lifestyle related risk 
factors however; a homogenous risk factor will have unequal consequences for the 
depreciation rate depending on SES.  
 
2.3.2 Predictions of the model 
We will now use Grossman’s investment model to illustrate how a homogenous 
lifestyle related risk factor can have heterogeneous consequences for equilibrium 
health. Let’s assume that we have two equal individuals who are both normal weight. 
They do both have the same health stock HS and the cost of health capital C. This is 
                                                     
5
 We will later present and discuss a range of theories for why, and if so how, health SES might modify 
the health depreciation rate.  
 44 
 
shown in Figure 2.5. Now assume that they both become obese, but that individual 2 
has more health problems related to obesity. This could be a result of, for example, 
individual 1 has more knowledge and resources available to tackle either the direct or 
indirect effect (or both) of obesity. Then obesity will result in a higher depreciation 
rate in individual 2 compared to individual 1 (although the obesity status is the same). 
That would mean that the user cost of health capital is higher for individual 2 (C**= (r-
∆MCI)+d**) than individual 1 (C*= (r-∆MCI)+d*). Hence, equilibrium health will 
decrease more for individual 2 (HS**) than for individual 1 (HS*) when they become 
obese.   
 
Figure 2.5: Variation in equilibrium health due to shift in health depreciation 
 
 
Figure 2.6 below shows individual 1 and 2 in a framwork where we have health, which 
is produced by health stock (H=f(HS)), on the vertical axis and BMI on the horizontal 
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axis. Both start out with the same health, however individual 2 has a higher 
depreciation rate when BMI increases. For the sake of the presentation we present a 
linear relationship between BMI and health. As illustrated in Figure 2.5 a higher 
depreciation rate when BMI increases will lead to more negative impact on equilibrium 
health stock, which then again reduces health. As a result we can see the disparities in 
health between individual 1 and 2 increase when BMI increase. So BMI excerts a more 
negative effect in individual 2 than in individual 1. 
 
Figure 2.6: Relationship between equilibrium health and BMI 
 
 
Using the Grossman model we have shown how a separate impact of lifestyle related 
risk factors on the health depreciation rate will generate disparities in health when 
individuals have a ‘poor’ lifestyle compared to having a ‘good’ lifestyle. We will later in 
this chapter discuss why there might be a heterogeneous impact of obesity on health.  
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2.3.3 Empirical testing of heterogeneities in the impact of lifestyle on health 
We have presented a detailed outline of the structure for SES variation in the impact of 
obesity on health. This model has provided hypotheses for how our relevant 
determinants link up. Based on this we will now develop an econometric model 
suitable for empirical testing. 
 
We illustrated that equilibrium level of health depends on the marginal investment 
and consumption benefits (MBMt + MBHt), the marginal costs of an investment in heath 
(MCI) and the user cost of health capital (C= (r-∆MCI)+d). Based on Grossman (2000) 
we include the depreciation rate as a separate element and we write the empirical 
formulation of the demand function for health capital (Ht) as: 
 
ttHtMtt udMCIMBMBH  )1())(1()( 3210      (2.14) 
 
The ε’s are parameters to be estimated. The depreciation rate depends indirectly on 
SES (based on literature by, for instance, CSDH (2008) we know that SES is positively 
associated with health through material circumstances). In addition, we let the 
depreciation vary by lifestyle (Lt) and other variables (Zt) like age: 
 
ttttt uZaSESaLaad  3210                    (2.15) 
 
The a’s are parameters to be estimated. We swap 2.15 into 2.14: 
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tttttHtMtt uuZaSESaLaaMCIMBMBH  ))(1())(1()( 32103210 
  
(2.16) 
 
We want to look at the impact of a change in lifestyle related risk factors on health. In 
our model lifestyle and SES influences health stock (Ht) through the health 
depreciation rate. We have included the health depreciation rate as a separate 
element in the function for health capital. Based on reasoning by, for example, 
Muurinen, we let lifestyle and SES work only through the depreciation rate. Hence, we 
keep both marginal benefit and marginal costs of an investment constant when risk 
factors change. So to investigate the impact of behavioural risk factors on health, we 
model the impact of the depreciation rate on health capital:  
 
ttttt
tttttt
eZbSESbLbbH
uuZaSESaLaaH


3210
3332313030 ))1(()1()1()1())1(( 
           (2.17) 
 
To let the impact of risk factors vary by SES we include an interaction between risk 
factors and SES. 
 
ttttt eZbSESLbSESbLbbH  43210 *      (2.18) 
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To test for a SES variation in the impact of lifestyle we can test the hypothesis H0: 
b3=0. If b3 ≠ 0 it means that H0 is rejected and the impact of lifestyle on health is not 
equal across SES groups.   
 
In Figure 2.7 we draw the relationship between BMI and health based on equation 
2.18, with and without an interaction. For the sake of presentation we show a linear 
relationship6 between BMI and health7. We now see the implications of rejecting H0. 
The solid lines present an equal relationship between BMI across SES groups (i.e. b3=0). 
The dotted lines in the two graphs represents relationships where b3 ≠ 0. In the first 
graph b3 < 0 and in the second graph b3 > 0. 
                                                     
6
 It has been showed that this relationship is concave as both underweight and overweight/obesity has a 
negative impact on health. 
7
 For the sake of presentation we have drawn the figures so that the high SES group always lies above 
the low SES group, however in the real relationship they might cross each other at some point.  
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Figure 2.7: SES variation in the impact of BMI on health 
 
 
We have now discussed the mechanism behind a heterogeneous impact of obesity on 
health and how we can test for it. However, we have not discussed why there might be 
an interaction. To begin to answer this we have conducted a literature review to 
analyse theories and empirical evidence on heterogeneities in the relationship 
between lifestyle related risk factors and health. However, before we discuss these 
theories we present an earlier model developed by Birch et al. (1997) to illustrate SES 
variation in the impact of lifestyles on health. This is a useful supplement to our model 
because it takes a different perspective. While our framework looks at individual level 
variations in health, their framework looks at the consequences for the whole 
community in terms of a community’s resource expenditures. 
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2.4 Overview of pathways to health in the population 
In this chapter we presented an individual level model based on the Grossman model 
to explain heterogeneities in the impact of obesity on health. Birch, Jerret and Eyles 
(1997 & 2000) have presented a similar framework that takes account of 
socioeconomic variation in the association between lifestyle related risk factors and 
health. However, the main distinction between the previous and the “Birch 
framework” is that the “Birch framework” takes the perspective of the society, while 
the Grossman model is an individual level model. In this way the “Birch model” 
combines the CSDH framework presented earlier and our modified Grossman model. 
The aim is to illustrate that the demand for health improvements compete for the 
resources of the society with other utility generating activities. In addition, demand for 
health care competes with other health improving activities. It then illustrates how 
heterogeneities in the pathways to health can influence how the resources should be 
distributed to maximise the well being of the population.  
 
In Figure 2.8 we see the framework presented by Birch, Jerret and Eyles (1997 & 2000). 
This framework illustrates that society can distribute it resources to maximise its well 
being. Well being consists of population health and other determinants of well being. 
Health is determined by lifestyle, health care and other determinants of health. Other 
determinants of health are considered to be environmental and socioeconomic 
factors. This framework shows that other determinants of health can influence health 
in two ways. Firstly, there is the direct effect in terms of the impact of the adverse 
effect of poor socioeconomic conditions on health. Second, socioeconomic factors can 
influence health indirectly as a moderator of other health determinants such as 
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lifestyle on health (represented by the dashed line). For example, the health risk of 
smoking or obesity might be related to socioeconomic status.  
 
Figure 2.8: SES variation in the impact of lifestyle related risk factors on health 
 
 
 
 
 
 
 
 
 
 
 
As we can see from this model the determinants of well being compete for limited 
resources and one must chose the interventions that maximise the well being of the 
society. Hence, if resources are devoted to counteracting lifestyle related risk factors, 
we need to know how these influence health. Birch, Jerret and Eyles (1997 & 2000) 
argue that reducing the prevalence of lifestyle related risk factors are likely to have 
systematically different health effects among social groups, and resource allocation 
based on average population values could lead to misallocation of resources. If one 
does not take into account the interaction between health determinants one may fail 
to reflect the reality of production of health in populations. 
Other 
determinants of 
health 
Population 
health 
Lifestyle 
Health care 
The total 
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2.5 Hypothesis on pathways to health 
We have discussed various frameworks for socioeconomic variation in the impact of 
lifestyle on health. However, we have not discussed why we might reject H0, and if so 
the direction of the relationship. We assumed that lifestyle related risk factors would 
affect health through the health depreciation rate. We also suggested including SES as 
a part of the depreciation rate. In Figure 2.7 we illustrated three hypotheses on the 
relationship which are; (a) a more pronounced impact in the high SES groups (b3 < 0), 
(b) more pronounced impact in the lowest SES groups (b3 > 0) and (c) SES does not 
modify the relationship (b3 = 0)  (similar effect).  
 
There are some theories that support the first hypothesis (a), which is that high SES 
worsens and low SES limits the negative influence of lifestyle related risk factors on 
health. Blaxter (1990) argued that lifestyle factors were important determinants of 
health among those who were well off and not among those who were less well off in 
terms of occupation status. Blaxter argues that individuals in low SES groups have so 
many other factors around them that worsen health, so improving lifestyle will not 
make much difference. High SES individuals on the other hand, who have few factors 
around them that worsen health, will be able to achieve the full benefits from 
improving their lifestyle. Also some economists that use a rationale choice framework 
support this hypothesis either directly or indirectly. They assume that individuals with 
long lives have more to lose by increasing the probability of death at any point in time 
(Adda & Lechene, 2001; Carbone, Kverndokk & Røgeberg, 2003). As individuals with a 
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low SES have a shorter life expectancy on average they experience less harm from poor 
lifestyles and therefore are more likely to have a poor life style (like smoking and being 
obese). Individuals in high SES groups have a longer life expectancy; hence they have 
more incentives to invest in healthy behaviours. In this argument lies the assumption 
that high SES individuals have a higher impact on their absolute life expectancy than 
low SES individuals.  
 
The second hypothesis (b) is that high SES limits and low SES worsens the negative 
influence of lifestyle related risk factors. Birch, Jerret and Eyles (2000) suggest that the 
effect is opposite of Blaxter (1990). The idea is that given the economic resources and 
favourable social circumstances, high SES individuals are more capable of tackling the 
harm of unhealthy lifestyles. While low SES groups are already weak and are more 
likely to suffer the comorbidities of unhealthy lifestyles. They also suggest that the 
underlying cause of the poor lifestyle (in their case smoking) might differ between SES 
groups and that the reason for the lifestyle might interact with the lifestyle to increase 
the health consequences. This can also be thought of as a “ceiling effect” where high 
SES groups have reached their potential health and improvements in lifestyles makes 
little difference. Low SES groups have not reached their full potential health and have 
more room for improvements (Pampel & Rogers, 2004). Higher SES groups might 
develop a better resistance to comorbidities since they have better medical care and 
more comfortable living conditions.  
 
Finally, the third hypothesis (c), which is a similar relationship between BMI and 
health, means that there is no SES variation in the impact of lifestyle related risk 
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factors on health. This suggests that SES and risk factors contribute independently to 
health such that there is no interaction between them.  
 
We have now presented three hypotheses on the association between lifestyles and 
health. In the following section we will present a literature review on this topic to 
investigate the empirical evidence.   
 
2.5.1 Literature review on SES variation in the association between lifestyle 
related risk factors and health 
The aim of this review is to identify studies that investigate SES variation in the 
relationship between lifestyle related risk factors and health.  
 
2.5.1.1 Search strategy 
We used three search strategies. First, we searched the databases MEDLINE and 
EMBASE using controlled vocabulary terms. In this review we choose to focus on the 
four main lifestyle related risk factors identified in Marmot (2010), which were obesity, 
smoking, alcohol and drug use8. Search terms and number of identified studies in each 
stage can be found in Appendix 2.1. 
 
We included all papers that could be related to smoking, obesity, alcohol or drug 
consumption either directly or indirectly. We included only papers examining variation 
in the impact/association of the lifestyle related risk factors on health by variables 
                                                     
8
 These have been chosen as they were identified as the most important lifestyle related determinants 
of socioeconomic inequalities in health by Marmot (2010).  
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related to our definition of socioeconomic status (see Chapter 1). Hence, we do not 
include papers looking at the association between lifestyle related risk factors and 
health controlling for SES variables. In addition, we focus on SES variation hence we 
excluded papers looking at heterogeneities based on other groups, e.g., gender and 
ethnicity. We restricted the search to papers written in English. We did not have any 
restrictions on years, geographical area or population. 
 
We screened titles and abstracts and identified a total of 7 papers in the first stage. In 
the second stage we searched the references of the papers identified in the first stage. 
In the third stage we used the citation search “referenced by” in Google Scholar to 
identify papers that had referenced our identified papers. We identified another 7 
papers based on the reference searches. Hence, we found a total of 14 papers. A 
summary of the country, year, methods and results of identified papers can be found 
in Table 2.1.  
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Table 2.1: Summary of identified studies on SES variation in the association between 
lifestyle related risk factors and health 
Author, country, 
year 
Dataset Method Results 
Marang-van de 
Mheen, Davey 
Smith, & Hart, 
Scotland, 1999 
Renfrew and 
Paisley study 
(1972-1976) 
and the NHS 
central register, 
Men: n=7045 
women: 
n=8348,  age 
20+ 
Used Cox models to investigate the impact of 
smoking on mortality interacting smoking and SES 
(measured by social class and area deprivation). 
They fitted three models depending on the 
covariates (the most advanced model controlled 
for age, cholesterol, diastolic BP, BMI, adjusted 
FEVI, deprivation, angina, ECG ischemia and 
bronchitis.  
Did not find significant 
interactions, hence they 
concluded that the impact is 
similar across SES groups.  
Thrane, Norway, 
2006 
National 
Screening 
program (1998-
1999), n=19741, 
age 40-43 
Used logistic regression techniques to investigate 
the impact of lifestyle (BMI, smoking, physical 
activity and diet) interacted with education on self-
rated health controlling for gender, employment 
status, welfare support and loneliness  
Find significant interactions 
between different lifestyles 
and education 
Schafer, Ferraro, & 
Williams, USA, 2011 
National Social 
Life, Health and 
Aging Project 
(2005-2006), 
n=3005, age 57-
85 
Fit models with interactions between BMI and low 
SES on C-reactive protein levels 
Find significant interactions 
between BMI and low SES 
and conclude that BMI has a 
more negative effect in 
lower SES groups 
Makela & Paljarvi, 
Finland, 2008 
Finish Drinking 
Habit Survey 
(1969, 1976, 
1984) , n=8199, 
age 15-69 
Used Cox models to investigate the impact of 
alcohol and SES (based on occupation) and their 
interactions on mortality or hospitalisation 
controlling for gender, period, age, and marital 
status.  
They did not find significant 
interactions between SES 
and alcohol consumption.  
Pampel & Rogers, 
USA, 2004 
National Health 
Interview 
Survey (1990), 
n= 41,104, age 
18+ 
Use tobit, logit and Cox models to investigate the 
impact of smoking and SES (measured by 
education and occupation) and its interactions on 
morbidity, self-rated ill health and mortality. 
Controlling for age, gender, ethnicity, marital 
status and family income.  
Find significant effect of the 
interactions between SES 
and smoking for men and 
women on morbidity and 
self-rated ill health but not 
on mortality.  
Krueger & Chang, 
USA, 2008 
National Health 
Interview 
Survey (1990) 
linked to 
mortality data 
in 1997, 
n=43335, age 
18+ 
Used Gompertz models to investigate the impact 
of stress and lifestyle (smoking, alcohol, physical 
activity) on mortality. Fitted separate models for 
three SES (based on family income and education) 
groups. Controlled for age, gender, race/ethnicity, 
and marital status. 
High baseline levels of 
former smoking and physical 
inactivity increased the 
impact of stress on mortality 
in the general population as 
well as among those of low 
socioeconomic status (SES), 
but not middle or high SES 
Birch, Jerret, 
Wilson, Law, Elliot, 
& Eyles, Canada, 
2005 
Telephone 
survey of four 
neighbourhoods 
where 300 
households  
were selected in 
each 
neighbourhood. 
(1996)  
Used logistic regression to investigate the impact 
of smoking and SES (neighbourhoods) and their 
interactions on self-rated health. Controlling for 
age, gender and marital status. 
They find a significant 
interaction between smoking 
and the deprived downtown 
neighbourhood. Smoking 
had less impact. 
Birch, Jerret, & 
Eyles, Canada, 2000 
Sante Quebec 
Survey (1992-
1993), 
n=23,564, age 
15+ 
Used logistic regressions to investigate the impact 
of smoking and SES (income, education and 
occupation) and their interactions on self-rated 
poor health. Controlling for age, gender and 
marital status. 
The difference between 
smokers and non-smokers 
was significantly greater 
among groups of the 
population with low incomes 
and without employment, 
but significantly less among 
sub-groups with lower levels 
of education. 
Davey Smith & 
Shipley, England, 
1991 
Whitehall Study 
(1967-1969), 
Men: n=16930, 
age 40-64. 
Note: only civil 
servants  
Calculated mortality percentage for different 
smoking and occupation categories. 
Found that mortality was 
higher for low SES smokers 
than high SES smoker and 
that the increase from non 
smokers to smokers was 
higher.  
Singh-Manoux, 
Britton, Kivimaki, 
Whitehall II 
(1985), 
Fitted separate regressions by SES groups 
(measured by employment) and used MANCOVA 
There was only a significant 
negative impact of IMT on 
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Gueguen, Halcox & 
Marmot, England, 
2008 
n=10308, age 
35-55. Note: 
only civil 
servants 
with interactions between SES and IMT controlling 
for age gender. The dependent variable was 
cognitive functioning. 
cognitive functioning in the 
lowest SES group.   
Laaksonen, Sarlio-
Lahteenkorva, 
Leino-Arjas, 
Martikainen, & 
Lahelma, Finland, 
2005 
Finish cross 
sectional 
surveys (2000, 
2001, 2002),  
men: n=1799 
women: 
n=7148, age 40-
60 
Use linear regression methods to investigate the 
impact of BMI and SES (working conditions and 
occupation) and their interactions on the physical 
and mental scale of SF-36. Control for Smoking, 
alcohol use, marital status, and menopausal status 
(for women). 
Socioeconomic position did 
not modify the association 
between BMI and health. 
However, there were some 
significant interactions 
between working conditions 
and BMI. 
Kooiker, 
Christiansen, The 
Netherlands and 
Denmark, 1995 
Two datasets. 
Dutch National 
Survey of 
General Practice 
(1987/88), 
n=11038, age. 
Danish Health 
Survey (1983), 
n=3149, age 25-
64 
Use MANOVA to test for significant interactions 
between lifestyle (BMI>27, smoking, drinking and 
no sports) and SES (social class, urbanisation, 
tenure status, health insurance, living 
arrangements, and daily activities) on five 
dependent variables (subjective health, number of 
health complaints, days with complaints, presence 
of one or more chronic diseases, GHQ score). 
Controlling of age and gender.  
Neither the Dutch nor the 
Danish study finds 
interactions between 
lifestyles and SES on any of 
the measures of health.  
Marmot, Rose, 
Shipley & Hamilton, 
England, 1978 
Whitehall Study 
(1967-1969), 
Men: n=18403, 
age 40-64. 
Note: only civil 
servants 
Used logistic models to investigate the impact of 
smoking on coronary heart disease mortality. 
Control for age. Fitted separate models by 
occupation groups.  
Find a higher prevalence of 
smoking related diseases in 
the lower SES groups. These 
diseases appear to be not 
only related to more 
smokers, but also a higher 
impact of smoking in the 
lower SES groups.  
Williamson, Canada, 
2000 
National 
Population 
Health Survey 
(1994-1995), 
n=11941, age 
20-64 
Used OLS to investigate the interaction between 
smoking status and five income groups on self 
rated health and number chronic conditions. 
Controlling for age, education, gender and marital 
status. 
Did not find that the effect of 
smoking and physical activity 
depends on income 
 
2.5.1.2 Results 
We identified 14 studies, which were all from Europe or North America. Of the three 
UK studies identified (Marmot, Shipley & Hamilton, 1978; Davey Smith & Shipley, 
1991; Singh-Manoux et al., 2008) none had investigated SES variation in the 
association between obesity and health. 
 
Smoking is the risk factor that has received the most attention. Blaxter (1990) 
hypothesised that harmful habits like smoking has a greater impact on health in non-
manual than in manual social classes. Their findings support this hypothesis when 
using a composite measure of physiological indices as the outcome measure. However, 
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this study has later been criticised for not providing confidence intervals or any formal 
statistical tests for differences between the groups (Marang-van de Mheen et al., 
1999). In addition, it has been replicated using mortality as an outcome measure 
(Marang-van de Mheen et al., 1999) and the authors do not find significant differences 
in mortality and conclude that the association is equal across SES groups. On the 
contrary to Blaxter (1990), Birch, Jerret & Eyles (2000) argue that the association 
between smoking and health decrease in higher SES groups compared with lower. 
They find support for this by modelling interactions between SES variables and 
smoking on self-rated health. Pampel & Rogers (2004) find a significant effect of the 
interactions between SES and smoking for men and women on morbidity and self 
rated ill health but not on mortality. Their analysis supports the results by Birch, Jerret 
& Eyles (2000) by showing a stronger association in the low SES groups. Similar findings 
were found by Marmot, Shipley & Hamilton (1978) and Davey Smith & Shipley (1991) 
who find a more pronounced association between smoking and smoking related 
diseases in the lower SES groups. However, there are also some studies that show no 
interactions between smoking and SES and its association with subjective health 
measures (Kooiker & Christiansen, 1995; Williamson, 2000; Thrane, 2006).  
 
Some studies have investigated SES variation in the association between health and 
BMI. Kooiker & Christiansen (1995) interacted a dummy for BMI>27 with a composite 
SES measure and tested if this interaction was significant using MANOVA tests. The 
dependent variables were a range of subjective and physiological health measures. 
They do not find significant interactions. This is similar to the findings of Thrane (2006) 
who interact BMI as a linear term with education. Laaksonen, Sarlio-Lahteenkorva, 
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Leino-Arjas, Martikainen, & Lahelma (2005) investigated the association between BMI 
(in three groups) interacted with working conditions and occupational status and SF-36 
score. They do not find significant interactions for occupational class however; they do 
find significant interactions for working conditions.  
 
Thrane (2006) also investigate interactions between SES and physical activity and diet 
and find some indications of an interaction with physical activity. This is contradicted 
by Williamson (2000) who does not find an interaction between SES and physical 
activity on self-rated health. Kooiker & Christiansen (1995) have looked at interactions 
between SES and drinking and exercise. They do no find significant interactions. 
Similarly, Makela & Paljarvi (2008) interacted alcohol use and occupation and looked at 
it association with mortality. They also do not find significant interactions.  
 
We can see that the direction of this relationship might depend on the type of risk 
factor that is studied. For instance, the relationship might differ for smoking and 
obesity. In addition, it might be that this relationship differs depending on the type of 
health measure used. For example it looks like there is more support for an impact on 
health related quality of life and less support for an impact on mortality. In addition, 
the results might be sensitive to the country of origin. 
 
The results are also sensitive to the underlying regression model. Most of these studies 
are based on nonlinear models like logit and survival models. These models look at 
multiplicative interactions and they do not quantify the implications of the 
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interactions. There is a general lack of clarity regarding what these studies actually 
investigates as they do not quantify the consequences.  
 
To conclude, there is little evidence to support the hypothesis of a more negative 
impact of lifestyle related risk factors on health in the highest SES groups as originally 
suggested and tested by Blaxter (1990). However, numerous studies provide support 
of the hypothesis of a more negative impact lifestyle related risk factors on health in 
the lower SES groups. In addition, there is support of the hypothesis of an equal impact 
of lifestyle on health across SES groups. Although most of the evidence is on smoking, 
some studies investigate BMI/obesity and provide inconsistent results. In general, 
more research is needed to establish if and how socioeconomic variation in the impact 
of lifestyle related risk factors on health transpires.  
 
2.6 Health service use 
We have illustrated, using the Grossman model, how lifestyle related risk factors 
increase the health depreciation rate, which is negatively correlated with equilibrium 
health capital. We also included the possibility of SES variation in the impact of risk 
factors on the health depreciation rate. A further interest in our research is the 
consequences this has for health service use. 
 
When health depreciation increases, equilibrium health will decrease, this means that 
a lower health capital is demanded. However, a lower demand for health capital does 
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not mean a lower demand for health care. As health depreciates individuals invest 
more in health care to augment their declining health stock.  
 
When analysing demand for health care it is common to take into the consideration 
the concept of need. Need is a set of factors that is believed to determine use. We do 
take into consideration need in the following model of health service use, which is 
based on an economic model by Sutton et al. (2002). Need is an unobserved variable 
and the standard assumption is that need depends on current health status.  
 
Health service use is however not a direct measure of need and there are other non-
need variables affecting use (Sutton et al., 2002). Non-need variables are variables like 
ethnicity, gender and income. Although, Sutton et al. (2002) include SES as a part of 
need, we consider SES to be a non-need variable. For example, health service use may 
also depend on propensity to use across socioeconomic groups, but propensity to use 
should not increase actual need. Hence, it is only the current health status that decides 
how much one needs health care.  
 
We would also expect supply variables like waiting times and number of GP’s in an 
area to have an effect on use. Such supply variables are affected by past decisions of 
allocation of resources (which are affected by need) and failure to include these could 
lead to endogeneity issues (omitted variable bias).  
 
We model utilisation of health services (U) as a function of need (N), non-need (NN) 
and supply factors (S).  
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),,( tttt SNNNfU           (2.19) 
  
Need is a function of health (Ht). We consider SES to be a non-need variable in addition 
to other non-need variables (Xt).  
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Health is affected by lifestyle and SES. And as we see below, SES influences need 
indirectly by its indirect impact on health through intermediate determinants. So you 
do not need more health care because of low SES in itself. But you need more health 
care because of the reduced health you have as a result of reduced material 
circumstances, for example.    
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Hence, we believe lifestyle, SES, supply, and other non-need variables to affect health 
service use. 
  
),,,(5 ttttt XSSESLfU          (2.22) 
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The model is illustrated in Figure 2.9. As we can see this model is an extended version 
of the model presented for the impact of lifestyle on health in Figure 2.4. So health 
service use is determined by need, non-need and supply factors. Need depends on 
health, which again is determined by SES, lifestyle and its interaction. So by controlling 
for supply and other non-need variables we can determine the effect of lifestyles on 
health and then again on health service use. We can also investigate SES variation in 
the impact of lifestyle on use. 
 
Figure 2.9: Impact of lifestyle and SES on health service use 
 
 
 
 
 
 
In figure 2.9 we also illustrate that health service use can affect lifestyle. For instance, 
the GP might help an individual to stop smoking or improve diet. Hence, there are 
potential endogeneity issues, if this is not accounted for in the analysis.  
 
2.6.1 Empirical testing of heterogeneities in the impact of lifestyle on health 
service use  
Based on the Grossman model we hypothesise that obesity increases the health 
depreciation rate, which will reduce the equilibrium health. We used a model to 
illustrate that health affects need for health services. We also showed that use might 
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not be determined only by need but also by other factors, non-need variables and 
supply. Based on this model we present the following econometric specification for 
health service use (mt). 
 
tttttt uXSSESHm  43210        (2.23) 
 
Where the amount of health service used by an individual depends on the SES of the 
individual, health (Ht), the supply (St) of health care and other non-need variables (Xt). 
The ε’s are parameters to be estimated. Earlier we modelled health at time t a function 
of obesity (Lt), SES and other covariates like age (Zt). 
 
ttttt eZbSESLbSESbLbbH  43210 *      (2.24) 
 
The b’s are parameters to be estimated. As we can see we have included an interaction 
between lifestyle and SES. Hence, if the impact of lifestyle on health differs by SES, we 
would also expect the impact of lifestyle on health service use to differ by SES. We 
swap equation 2.24 into equation 2.23 to illustrate how lifestyle will affect health 
service use: 
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tttttttt
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

543210
13413122111010
324321010
*
)(*))1(()(
)1()*(


           (2.25) 
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To test for a SES variation in the impact of lifestyle on health service use we can test 
the hypothesis H0: a3=0. If a3 ≠ 0 it means that H0 is rejected and the impact of lifestyle 
on health service use is not equal across SES groups.  
 
We have posed three hypotheses for how lifestyle might affect health status. Similar 
hypotheses can be illustrated for health service use. Hence hypothesis (a) illustrates a 
more negative impact of lifestyle related risk factors on health in the higher SES 
groups. Hence, high SES individuals will have a more pronounced impact of increased 
BMI on primary care use, which would mean that a3 > 0.  
 
Hypothesis (b) is when low SES individuals have a more negative impact of risk factors 
on health. Hence, this means that when BMI increases the slope is steeper for the low 
SES groups and a3 > 0. Therefore, increased BMI leads to larger disparities in health 
service use between lower and higher SES groups. 
 
The third hypothesis is when we do not reject H0 and a3 = 0, which means a similar 
effect of lifestyles on depreciation across SES groups. Hence, in scenario (c) BMI has an 
equal impact across SES groups on health service use.  
 
There might be variations in the sign of a2, i.e. whether or not the high or the low SES 
groups use most of the service at baseline. There are indications of lower SES groups 
using more primary care services than higher SES individuals both with and without 
controlling for need (Morris, Sutton, & Gravelle, 2005). For other services there might 
be a different relationship at baseline and it might be that for some services higher SES 
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individuals have more use at baseline (normal weight). There are evidence to suggest 
that high SES individuals have a higher use of specialist/secondary care services when 
need is controlled for (Morris, Sutton, & Gravelle, 2005). However, the implications of 
the interactions are similar.    
 
We do not have a literature review of SES variation in the impact of obesity on use in 
this chapter. However, we do have a review in Chapter 6 looking at obesity and health 
service use. 
 
2.7 Summary 
In this chapter we have presented a framework for analysis in the following chapters in 
this thesis.  
 
We showed the CSDH framework for how the pathways and mechanism through which 
social determinants of health influences health. The idea is that socioeconomic status 
has an impact on intermediate determinants (e.g., material circumstances and lifestyle 
related risk factors). This again will have an impact on health.  
 
We presented a human capital model for health (the Grossman model) and use this 
model to analyse how the impact of lifestyle related risk factors might vary by SES. In 
this model risk factors like obesity affect the health depreciation rate. An increased 
user cost of health capital will decrease the consumption of health capital and 
individuals who are obese will have a lower equilibrium health. We modified the model 
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to take into account SES variation in the impact of obesity and its consequences for 
equilibrium health. We then show how this framework has been modelled earlier by 
Birch et al. (1997) in a “macro” perspective and how this has consequences for 
distributing the resources in the society to maximise well being.   
 
Three hypotheses on the relationship between risk factors and health are presented 
and discussed. These are: (a) high SES worsens and low SES limits the negative 
influence of lifestyle related risk factors on health; (b) high SES limits and low SES 
worsens the negative influence of lifestyle related risk factors on health; and, (c) the 
impact of lifestyle related risk factors on health is equal across SES groups (similar 
effect).  
 
We presented a review of the literature investigating SES variation in the impact of 
lifestyle related risk factors on health. We find that there is limited evidence in support 
of hypotheses “(a) high SES worsens and low SES limits the negative influence of 
lifestyle related risk factors on health”, which originally was found by Blaxter. 
However, more support of the hypotheses (b) and (c), meaning that the current debate 
is between these two hypotheses. Although most of the evidence is on smoking, some 
studies investigate BMI/obesity and provide inconsistent results. 
 
We further analyse how SES variation in the impact of lifestyle related risk factors on 
health depreciation might have consequences for health service use. We use a 
framework where health influences need, which then again influences health service 
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use. We show that supply could influence each of these parts. Based on this 
framework we present three hypotheses for health service use.  
 
In the following four empirical chapters we will test these three hypotheses. To find 
which of these has support using British data.  
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CHAPTER 3 
 
Socioeconomic variation in the association between 
obesity and health related quality of life 
 
3.1 Introduction 
In Chapter 2 we built an economic model for the relationship between lifestyle and 
health and how this might vary by socioeconomic status. In this chapter we want to 
test this hypothesis. We presented an econometric specification for empirical testing: 
 
tttttt eXbSESLbSESbLbbH  43210 *      (3.1) 
 
Where health status (Ht) is determined by lifestyle (Lt), SES and other variables (Xt), 
which are variables like age and gender. The lifestyle variable in our case is obesity. To 
test for a SES variation in the impact of obesity we can test the hypothesis H0: b3=0. If 
b3≠0 it means that H0 is rejected and the association between obesity and health is not 
equal across SES groups.  
 
In this chapter we measure health status with Health Related Quality of Life (HRQL). 
HRQL aims to capture the multidimensional concept of health and both clinicians and 
policymakers are recognising the importance of this to inform patient management 
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and policy decisions. For example, it is used in assessing Patient Reported Outcome 
Measures (PROMs). PROMs are measures of health gain and the collection is co-
ordinated by the department of health (The Health and Social Care Information Centre, 
2011). They are used for assessing the clinical quality of providers and supporting the 
reduction of health inequalities. In addition, the National Institute for Health and 
Clinical Excellence in England use cost-effectiveness analysis in economic evaluation of 
public health interventions and the preferred measure of benefit is quality-adjusted 
life years based on HRQL.  
 
The aims of this chapter are to investigate the relationship between HRQL and obesity, 
and to investigate whether or not this relationship varies by SES. We start with a 
review of the literature of the relationship between obesity and HRQL. We then 
undertake the analysis using data from a large individual-level health survey, which 
includes interviewer-measured rather than self-reported height and weight and, a 
comprehensive set of individual and household characteristics that allows us to control 
for factors that affect the relationship between obesity and HRQL.  
 
3.2 Literature review of the association between obesity and 
HRQL  
The objective of the review was to identify studies that investigate the relationship 
between obesity and HRQL.  
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3.2.1 Search strategy 
The literature was searched in three stages9: First, we searched the journals: Obesity 
Reviews; Social Science & Medicine; Health Economics; and, Journal of Health 
Economics. Obesity Reviews is the highest ranked obesity journal by impact factor 
(Thompson ISI, 2010). Health Economics and Journal of Health Economics were chosen 
as they are the two top ranked journals in the field of health economics in the 
Thomson Reuters Journal Citation Reports. Social Science & Medicine is the world’s 
most cited social science journal (Thomson ISI, 2010) and it has a focus on health 
economics. The search term used was:  
 
(obesity OR obese OR overweight OR weight loss) AND (quality of life OR health status 
OR health outcome OR rated health OR health index)  
 
From this search we identified 5 papers. We then searched the references of the 
papers identified. In the third stage we used the “cited by” option in Google scholar to 
identify papers that had referenced the papers identified in the two first stages. We 
ended up with a total of 21 studies.  
 
We included all papers that investigated the associations between a measure of 
obesity/overweight and HRQL (e.g., EQ-5D, self-rated health, SF-36 and HUI). We 
excluded papers that looked at physical status in other ways (e.g., blood pressure or 
diabetes status). We exclude all studies not in the English language. 
 
                                                     
9
 We initially used the search term ((("Obesity"[Mesh]) OR "Body Mass Index"[Mesh]) AND "Health 
Status Indicators"[Mesh]) OR "Quality of Life"[Mesh] in PubMed and got 93 754 results.  
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From each paper we extracted the year, country, methods and results, which can be 
found in Table 3.1. 
 
Table 3.1: Literature review of studies describing the relationship between obesity 
and HRQL  
Author, country, 
year 
Dataset Methodology Key results 
Wiczinski, Doring, 
John, & von 
Lengerke, 
Germany, 2009 
General 
population 
survey in the 
Augsburg region, 
n=2732, age 35-
74 
Used linear regression techniques to 
investigate the impact of 4 BMI groups 
(excluding underweight) on the mental and 
physical scale of SF-12 controlling for age, 
education, family status, kind of health 
insurance, and place of residence 
Obesity was associated 
with the physical but not 
the mental scale of SF-12 
Brown, Dobson, & 
Mishra, Australia, 
1998 
Australian 
Longitudinal 
Survey for 
Women’s Health, 
Women: 
n=13431, age 45-
49 
Calculated mean SF-36 score for 5 BMI 
groups adjusted for area of residence, 
education, smoking, exercise and 
menopausal status for women. 
Increased BMI was 
associated with a 
significant reduction in 
the score of the physical 
component of the SF-36 
but not the mental 
component 
Han, Tijhuis, Lean, 
& Seidell, The 
Netherlands, 1998 
Monitoring Risk 
Factors in Health 
in The 
Netherlands 
(1995), men: 
n=1885 women: 
n=2156, age 20-
59 
Used logistic regression to estimate the risk 
of poor health (a score below 66.7% of the 
standardised score on SF-36). Adjusted for 
age, smoking, alcohol consumption, 
physical activity, education, marital status, 
employment, household composition, 
intimate contact, and parity. 
Higher BMI increased the 
probability of having poor 
health 
Lean, Han, & 
Seidell, The 
Netherlands, 1998 
Monitoring Risk 
Factors in Health 
in The 
Netherlands 
(1993-1995), 
men: n=5887 
women: n=7018, 
age 20-59 
Used logistic regression analysis to 
investigate the odds for poor quality of life 
(a score below 66.7% of the standardised 
score on SF-36), by waist circumference. 
Adjusted for age, smoking, education, 
alcohol consumption, physical activity, 
employment status, household 
composition, discussion of personal 
matters with other people, and parity 
Higher waist 
circumference was 
related to higher 
probability of having poor 
health 
Le Pen, Levy, Loos, 
Banzet, & 
Basdevant, 
France, 1998 
SOFRES, n=1000 
(500 obese; 500 
non-obese), age 
18+ 
Compares the association between obesity 
(BMI>30) and SF-36 and OSQOL. Using a 
cross-sectional survey with a control group 
matched based on sex, age, and 
employment status 
The quality of life of 
patients with severe 
obesity is impaired, but it 
mainly affects the 
physical consequences of 
the disease. Comparison 
of the specific OSQOL 
with the generic SF-36 
shows clearly that the 
two kinds of scales 
correspond to different 
objectives and could be 
considered as 
complementary. 
Fine et al., USA, 
1999 
Nurses Health 
Study (1992-
1996), women: 
n=40098, age 46-
71 
Used OLS to investigate the impact of 
weight change (in three groups: losers, 
maintainers, gainers) on SF-36 score 
controlling for age, cigarette smoking, 
levels of physical  activity, alcohol 
consumption, and self reported comorbid 
Weight gain was 
associated with 
decreased SF-36 scores 
while the association with 
weight loss was opposite.  
 73 
 
conditions 
Lean, Han, & 
Seidell, The 
Netherlands, 1999 
Monitoring Risk 
Factors in Health 
in The 
Netherlands 
(1993-1995), 
men: n=5887 
women: n=7018, 
age 20-59 
Used logistic regression methods to 
measure the impact of BMI in three 
categories on the probability of low SF-36 
score (less than 66.7% of the standardised 
score). Adjusted for age, smoking, 
education, alcohol consumption, physical 
activity, employment status, household 
composition, discussion of personal 
matters with other people, and parity 
Individuals with higher 
BMI had a higher 
probability of having  a 
low SF-36 score 
Doll, Petersen, & 
Stewart-Brown, 
UK, 2000 
Postal survey 
within hte old 
Oxford Regional 
Health Authority 
(1997), n=8889, 
age 18-64 
ANOVA models looking at the impact of 
BMI (measured as 5 BMI groups) on SF-36 
score, controlling for age, gender and 
frequency of health service utilisation 
Overweight and obesity 
are associated with poor 
levels of subjective health 
status, particularly in 
terms of physical well-
being 
Ford, Moriarty, 
Zack, Mokdad, & 
Chapman, USA, 
2001 
Behavioural Risk 
Factor 
Surveillance 
System (1996), 
n=109076, age 
18+ 
Used logistic regression to investigate the 
impact of 6 BMI groups on binary quality of 
life measures, adjusting for age, gender, 
race or ethnicity, educational attainment, 
employment status, smoking status, and 
physical activity status 
Participants with a self-
reported BMI>18.5 and 
participants with a self-
reported BMI>30 
reported impaired quality 
of life 
Larsson, Karlsson, 
& Sullivan, 
Sweden, 2002 
Swedish cross 
sectional survey, 
n=5633, age 16-
64 
Used regressions to look at the impact of 
BMI on SF-36 scores controlling for age, 
sex, physical activity and disability. Used 
ANOVA test to control for the impact of 
three BMI groups on SF-36 scores.  
Find a relationship 
between BMI and 
physical but not mental 
health 
Heo, Allison, Faith, 
Zhu, & Fontaine, 
USA, 2003 
Behavioural Risk 
Factor 
Surveillance 
System (1999), 
n=155989, age 
18+ 
Created a binary self-rated health variable 
and use logistic regression methods to look 
at the impact of BMI (as continuous and as 
six categories) controlling for age, sex, 
marital status, educational attainment, 
annual income, smoking status, and 
employment status. They also control for 
comorbidities 
Associations between 
BMI and HRQL indices 
were J-shaped. Joint pain 
and comorbidities may 
mediate BMI-HRQL 
associations 
Groessl, Kaplan, 
Barrett-Connor, & 
Ganiats, USA, 
2004 
Longitudinal 
cohort study 
(1992-1995), 
n=1326, mean 
age 72 
Used ANOVA and ANCOVA methods to 
investigate if there was a significant 
association between BMI (in four groups) 
on quality of well being scale in individuals 
with a mean age of 72. Controlling for age, 
gender, smoking history, and exercise 
Obese older adults tend 
to have lower HRQOL 
than those who are 
overweight or of normal 
BMI. Overweight did not 
have a significant impact. 
Yan et al., USA, 
2004 
Cross sectional 
survey in Chicago 
(1996), men: 
n=3981 women: 
n=3099, age 65+ 
Used generalised linear models and logistic 
regressions to investigate the impact of 
four BMI groups on HSQ-12 domains 
controlling for age, race, education, 
smoking, and alcohol intake.  Separate 
analysis by gender in a population aged 65 
and older 
Obesity was associated 
with lower health 
perception and poorer 
physical and social 
functioning (women only) 
but not impaired mental 
health 
Macran, UK, 2004 Health Survey for 
England (1996), 
n=11783, 18+ 
Used OLS and MANOVA to investigate the 
impact of BMI (three and five groups) on 
EQ-5D controlling for age gender and 
comorbidities.  
Most of the apparent 
relationship between BMI 
and HRQL could be 
accounted for by age and 
the presence of long-
standing illness. However 
women’s 
HRQL did appear to be 
sensitive to their weight. 
Jia & Lubetkin, 
USA, 2005 
Medical 
Expenditure 
Panel Survey 
(2000), n=15438, 
age 18+ 
Used linear and spline regression methods 
to investigate the impact of obesity (five 
groups) on SF-12 and EQ-5D scores 
controlling for smoking, physical activity, 
clinical conditions, age, race/ethnicity, sex, 
and income 
Persons with obesity had 
significantly lower HRQL 
than those who were 
normal weight and such 
lower scores were seen 
even for persons without 
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chronic diseases known 
to be linked to obesity. 
Kortt, & Clarke, 
Australia, 2005 
Australian 
National Health 
Survey (1995), 
n=19301, age 
18+ 
Separate regression analyses for males 
and females to model the association 
between utility (measured by SF-36), BMI 
(three groups, excluding underweight), 
controlling for obesity-related medical 
conditions, age, smoking status, age left 
school, and income 
Results suggest that BMI 
is negatively associated 
with utility 
Laaksonen, Sarlio-
Lahteenkorva, 
Leino-Arjas, 
Martikainen & 
Lahelma, 
Finnland, 2005 
Finish cross 
sectional surveys 
(2000, 2001, 
2002),  men: 
n=1799 women: 
n=7148, age 40-
60 
ANOVA was used to assess differences in 
SF-36 of three BMI groups controlling for 
age. The effect of SES and working 
conditions on the associations between 
body weight and SF-36 was examined with 
multiple regression analysis. Included 
interactions between BMI as a continuous 
variable and SES groups as categorical 
variables. 
Body weight was 
associated with physical 
health only.  
Socioeconomic position 
did not modify the 
association between BMI 
and health. However, 
they found an effect of 
working conditions. 
Sach et al., UK, 
2007 
Patients at one 
UK general 
practice (2004), 
n=1865, age 45+ 
Used linear regression methods to 
investigate the impact of six BMI groups on 
EQ-5D, EQ-VAS and SF-6D controlling for 
age, sex, smoking status, and presence of 
the 10 co-morbidities. In addition, they 
used logistic regression methods to 
investigate the impact of probabilities of 
reporting at being at level one in each of 
the domains in the respective HRQL 
measure. 
The EQ-5D, EQ-VAS and 
SF-6D were in agreement 
that, relative to a normal 
BMI, obesity is associated 
with a lower HRQL, even 
after controlling for 
patient characteristics 
and comorbidity. 
Wee et al., 
Singapore, 2008 
Recruited 
Primary Care 
patients (), 
n=411, age 21+ 
Used linear and nonlinear regression 
methods to investigate the impact of four 
BMI groups on EQ-5D/EQ-VAS, Health 
Utilities Index (HUI2 & HUI3) and the SF-6D 
controlling for marital status, smoking 
status, work status, presence of chronic 
medical conditions and Family Functioning 
Measures scores 
Consistent with available 
studies, obese subjects 
reported worse HRQL 
than normal-weight 
subjects. 
Mond & Baune, 
Germany, 2009 
German Health 
Interview and 
Examination 
Survey (1997-
1999), n=4181, 
18-65 
Used linear regression to investigate the 
impact of BMI in three groups on SF-36 
scores. Controlled for age, social status and 
a range of medical conditions. 
Found relationship 
between physical 
functioning for mild 
obesity in women and 
moderate obesity in men. 
Found no association 
between weight status 
and psycho-social 
functioning, in women, 
whereas overweight was 
associated with better 
perceived psycho-social 
functioning in men. 
Lee et al., Wales, 
2005 
Used hospital 
treated patients 
in Wales (2002-
2003), n=30020, 
age 18+ 
Used linear regression techniques 
investigating the association between BMI 
as a linear variable on EQ-5D score 
controlling for age across individuals with 
and without diabetes.  
Found that BMI is 
negatively correlated 
with EQ-5D score in 
patients with and without 
diabetes.  
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3.2.2 Findings 
There is evidence that obesity is inversely associated with HRQL. Of the 21 identified 
studies that met the inclusion criteria and investigate the associations between obesity 
and HRQL, four were from the UK (Lee et al., 2005; Doll, Petersen, & Stewart-Brown, 
2000; Macran, 2004; Sach et al., 2007), and they all provide evidence of a negative 
association between obesity and HRQL. Some studies have investigated the association 
between obesity and HRQL separately on a physical and a mental scale (Wiczinski et 
al., 2009; Brown, Dobson, & Mishra, 1998; Le Pen, Levy, Loos, Banzet, & Basdevant, 
1998; Doll, Petersen, & Stewart-Brown, 2000; Larsson, Karlsson, & Sullivan, 2002; Yan 
et al., 2004; Laaksonen, Sarlio-Lahteenkorva, Leino-Arjas, Martikainen & Lahelma, 
2005; Mond & Baune, 2009). These studies demonstrate an association between 
obesity and HRQL on the physical but not the mental QOL scale. Five of the studies 
have used EQ-5D (Lee et al., 2005; Macran, 2004; Jia & Lubetkin, 2005; Sach et al., 
2007; Wee et al., 2008) and they all identify an inverse association between obesity 
and EQ-5D score. 
 
The most common method used is the ANOVA method to test for significant variation, 
and then present summary statistics of the HRQL variable for different BMI groups. A 
gender difference is commonly observed as the studies that fit separate models for 
men and women tend to find a more pronounced effect for women.  
 
In these studies there might be issues with omitted variables, which are other 
explanatory variables that have not been included in the model that are correlated 
with the dependent variable (HRQL) and the independent variables (BMI groups). One 
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such variable is longstanding illnesses. An illness (such as different cancers) might alter 
BMI status and HRQL. By controlling for illness variables one could avoid this potential 
bias. However, controlling for illness variables is also criticised. It has been argued that 
controlling for comorbidities is an overadjustment as these factors are part of the 
pathway between obesity and the output variable (See Zizza, 2004). Hence, it can be 
seen as controlling for the risk factor effect of obesity and by doing this one looks only 
at the direct health effects. 
 
A number of studies have identified a negative correlation between obesity and HRQL 
when they control for comorbidities (Fine et al., 1999; Heo, Allison, Faith, Zhu, & 
Fontaine, 2003; Jia & Lubetkin, 2005; Kortt, & Clarke, 2005; Sach et al., 2007; Wee et 
al., 2008). However, studies that fit regressions with and without illness variables find 
that controlling for illnesses reduce the negative association between obesity and 
HRQL. Macran (2004) and Mond & Baune (2009) found that most of the association 
between obesity and HRQL can be explained by the presence of longstanding illnesses. 
Especially in men, where they do not identify a relationship when longstanding 
illnesses are controlled for.  
 
We identified one study that investigates if the effect of obesity varies by SES 
measures. Laaksonen, Sarlio-Lahteenkorva, Leino-Arjas, Martikainen & Lahelma (2005) 
investigate if the association between BMI and HRQL varies by occupational status and 
working conditions (consisting of perceived job control and demand) using Finnish 
data. They show that the association between BMI and HRQL, measured using the 
physical function component of the SF-36, is modified by working conditions. This was 
 77 
 
not found for the mental health scale of the SF-36. Although they found that working 
conditions modified the relationship between BMI and HRQL they did not find any 
evidence for occupational class (managers and professionals, semiprofessionals, 
routine non-manual workers, and manual workers). They used linear regression 
methods and interacted BMI (as a continuous variable) with occupational class and 
working conditions. Laaksonen et al. might have found a different result if they had 
allowed a nonlinear impact of BMI on health. Furthermore, this study looks only at 
public sector workers between the ages of 40 – 60 yrs. Hence, this sample does not 
cover some socioeconomic groups, such as the unemployed and entrepreneurs. In 
addition, the age range is restricted which further reduce the variation in the 
population. Furthermore, morbidly obese individuals have higher unemployment rates 
and will not be included in this sample. This study was not undertaken in the UK, and 
results might vary between countries, socioeconomic status might have different 
consequences across countries. In addition, they use self-rated height and weight, 
which has been criticised as individuals have a tendency to underreport weight and 
over report height (Gorber, S. C., Tremblay, Moher, & Gorber, B., 2007). The following 
study overcomes these limitations by applying BMI categories allowing for the 
nonlinear impact of BMI on HRQL, using a representative population of the English 
population, and using nurse measured height and weight.  
 
Of the English studies only the study by Macran (2004) use a representative sample for 
the English population aged 18 and over. However, this study use a dataset from 1996, 
while there are similar data available for the years 2003-2004.  
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To conclude, there is evidence of a negative relationship between obesity on HRQL. 
This relationship persists after controlling for comorbidities. However, limited evidence 
exists on whether or not this effect varies across SES groups.   
 
3.3 Methods 
 
3.3.1 Data and variables 
The analysis is based on data from four rounds (2003-2006) of the Health Survey for 
England (HSE) (National Centre for Social Research & Department of Epidemiology and 
Public Health (UCL)). The HSE is a repeated cross-sectional nationally representative 
survey which draws a different sample every year of individuals living in England. The 
sample is selected every year using multi-stage stratified probability sampling design 
with postcode sectors selected at the first stage and household addresses selected at 
the second stage. Stratification is based on geographical areas and not on individual 
characteristics. Respondents are interviewed on a range of topics including their health 
(including obesity and EQ-5D score), and their socioeconomic status. Only participants 
aged 16 or above completed the EQ-5D questionnaire and are included in this study.  
 
Our measure of HRQL is the EQ-5D (The Euroqol Group, 1990), which is included in the 
HSE in 1996 and 2003–2006. This measure is commonly used in cost-effectiveness 
analyses to calculate quality-adjusted life years. The HSE includes other measures of 
HRQL like self-rated health; however EQ-5D is used in this chapter as it is the preferred 
measure of HRQL in adults in cost-effectiveness analyses considered by the National 
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Institute for Health and Clinical Excellence in England (NICE, 2008). The EQ-5D is a 
generic measure of HRQL. It is applicable to a wide range of health conditions and 
treatments, and provides a descriptive profile that is reducible to a single index value 
for health status. The EQ-5D descriptive system consists of five dimensions – mobility, 
self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension is 
scored at one of three levels, depending on whether the respondent has no problems 
(score=1), some problems (=2) or serious problems (=3) with each dimension. This 
descriptive system defines 243 EQ-5D health states, plus ‘unconscious’ and ‘dead’, 
giving 245 states in total. Each EQ-5D health state can be converted to a single 
summary index by applying a formula that attaches weights to each of the levels in 
each dimension. A number of such formula, or value sets, are available for different 
countries, based on the valuation of EQ-5D health states from general population 
samples. The HSE uses weights obtained from the UK population by the Measurement 
and Valuation of Health Group (The MVH Group, 1995; Dolan, 1997). After applying 
these weights, an EQ-5D index score of one represents full health, a score of zero is 
equivalent to death, and negative scores represent health states worse than death. 
 
Our obesity measure is based on body mass index (BMI), measured as weight in 
kilograms divided by height in metres squared (kg/m2). BMI is computed from the 
height and weight measures obtained during the interviewer visit in the HSE; it is not 
based on self reported height and weight, which means that the likelihood of 
systematic measurement error is reduced. Obesity is measured as a categorical 
variable based on four BMI categories, defined according to World Health Organization 
guidelines (WHO Expert Committee on Physical Status, 1995): normal weight, BMI 
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18.5-24.9 kg/m2; overweight, BMI 25-29.9 kg/m2; class I obesity, BMI 30-34.9 kg/m2; 
and, class II / III obesity BMI >35 kg/m2. In our data there are 171 men and 491 women 
in obesity class III (BMI >40 kg/m2); we combine obesity classes II and III to ensure an 
adequate number of observations in each cell when we interact SES and obesity 
category. Our data also has small number of respondents in the underweight group 
(BMI <18.5 kg/m2; 155 men, 305 women). We do not combine underweight and 
normal weight because there is some evidence that the underweight have lower HRQL 
than the normal weight (Jia & Lubetkin, 2005). We therefore include underweight as a 
separate category (interacted with SES where appropriate). Based on the discussion in 
chapter 1, we do not report the results for this group in the following analysis. 
 
Our SES variable is a composite measure, designed to capture multiple dimensions of 
SES (individual, household and area socioeconomic variables) rather than focusing on a 
single aspect (such as income). We use a regression-based approach to construct the 
SES measure and regress (using interval regression) total annual household income 
reported in 31 income bands (including an open-ended top category) against a set of 
socioeconomic variables. We calculate predicted values from this model, which are 
then equivalised using McClements household score provided in the HSE to account 
for household size and composition. The socioeconomic variables used as covariates in 
the interval regression are: education qualifications (measured in seven categories); 
social class of household reference person (HRP; six categories); cars owned by 
household (four categories); economic activity status for last week (11 categories); 
housing tenure (five categories); bedrooms in household (five categories); index of 
multiple deprivation quintile (SOA level) (five categories); and, whether or not the 
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person was an income support claimant (yes/no). The predicted SES measure is 
explained partly but not exclusively by the total annual household income variable. 
When we regress the predicted SES measure against the 30 income band indicators 
(excluding the lowest category) the model R2 is 0.2647. The predicted SES measure is 
then divided into quartiles for use in the EQ-5D models.  
 
In the EQ-5D models we also include covariates for: age (cubic function); ethnicity 
(nine categories); marital status (six categories); smoking status (four categories); 
Government Office Region of residence (nine categories); predicted equivalised total 
annual household income (continuous variable); and, survey year (four categories). We 
also run a model controlling for number (five categories) and type (fourteen 
categories) of longstanding illness; limiting longstanding illness (yes/no); and, acute ill 
health days the last two weeks (five categories). 
 
3.3.2 Statistical analysis  
We investigate differences in EQ-5D scores and individual and household 
characteristics by BMI category using one-way ANOVA models for continuous variables 
and χ2 tests for categorical variables. We then regress EQ-5D score (hi) against the BMI 
categories10 using OLS, with normal weight as the omitted category:  
 
ii
a
aii uZBMIh  

2
5
1
10         (3.2) 
 
                                                     
10
 As described above we include underweight and interact it with SES as appropriately. However, we do 
not report the results for this group and denote only the BMI groups of interest in the equations  
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Where Zi is other variables like age and smoking status and i indexes the individuals. 
The β’s are vectors of parameters to be estimated. 
 
We then rerun this model including interaction terms between the BMI categories and 
the SES quartiles, with normal weight/SES quartile 1 (most deprived) as the omitted 
category.  
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Three versions of each model were estimated: unadjusted models including the BMI 
categories or BMI/SES categories only; multivariate models that controlled for all the 
individual and household characteristics except for the longstanding and acute illness 
variables; and, multivariate models that controlled for all the individual and household 
characteristics including the longstanding and acute illness variables. We run separate 
models for men and women. After every regression we compute the predicted mean 
EQ-5D score for each BMI or BMI/SES category. In the multivariate models we do this 
by fixing the covariates at their whole-sample mean values. In this case, the variation 
in predicted mean EQ-5D scores is a function of the impact of obesity on EQ-5D scores 
and how this varies by SES, and is not affected by the values of the covariates and 
comorbidities. We also compute predicted mean EQ-5D scores for each BMI/SES 
category by setting the individual and household characteristics to the mean values of 
each SES category, and then to the mean values of each BMI category. In these cases 
the values of the covariates used in the predictions are more representative of the 
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individuals in each SES or obesity category, and variation in predicted mean EQ-5D 
scores reflects both differences in the impact of obesity on EQ-5D scores and how this 
varies by SES, but also differences in the values of the individual and household 
characteristics and between categories.  
 
Standard errors for the predicted mean values were computed using the standard 
error calculation based on Korn & Graubard (1999), which accounts for the variation in 
the covariates that would arise from repeated sampling, and is appropriate to use with 
a representative sample of the population when making inferences about the 
underlying population.  
 
We test for equality in predicted mean EQ-5D scores between BMI categories (across 
all SES groups combined and within SES groups) and between SES quartiles within BMI 
categories using Wald tests and F- tests. 
 
We test for statistically significant interactions between obesity and SES (i.e., whether 
or not the association between obesity and EQ-5D score depends on SES, and vice 
versa) for each gender in the adjusted and unadjusted models using two-way ANOVA.  
 
We apply survey individual-level selection weights reported in the HSE to each 
observation. This adjusts for the fact that different observations have different 
probabilities of selection and participation in the survey. It is also possible that, due to 
the sampling strategy used in the HSE, observations are independent across Primary 
Sampling Units (PSUs), but not within PSUs. If this is the case then if we use estimators 
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that assume independence within these clusters the standard errors on our regression 
coefficients will be too small and we will overestimate the statistical significance of the 
independent variables in our models. We therefore control for clustered sampling 
within PSUs using unique PSU/year identifiers that produce Huber/White/sandwich 
robust variance estimators that allow for within-group dependence (Kish & Frankel, 
1974).  
 
To maximise the sample size, we included individuals in the EQ-5D models with missing 
income data for whom we could compute a predicted SES value. In the EQ-5D models 
we included an indicator for missing income (yes/no), to control for the possibility that 
income may not be missing at random. To investigate the effect of imputing missing 
income values we repeated our analysis in individuals with non-missing income data 
only. 
 
P values below the 5% level (t statistics higher than ≈1.9) are regarded as statistically 
significant. Values between 5% and 10% (t statistics between ≈1.6 and ≈1.9) are 
regarded as weakly significant. Analyses were undertaken using Stata SE version 11. 
 
3.4 Results 
The total number of respondents in the HSE in 2003-2006 was 61,603. Forty five 
thousand nine hundred and eighty five were aged 16 or above and 42,002 had EQ-5D 
data. Thirty three thousand seven hundred and sixteen observations were included in 
the income regression and predicted SES values were computed for 42,825 
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observations. A total of 33,105 observations (15,142 men, 17,963 women) had EQ-5D 
scores and predicted income data and were used in the EQ-5D models. The numbers of 
observations in each BMI/SES category are in the Table 3.2.  
 
Table 3.2: Numbers of observations by BMI category, gender and SES quartile  
  Normal weight Overweight Class I obesity Class II/III obesity 
Men     
All 4,535 6,795 2,854 803 
SES quartile     
  1 (most deprived) 1,080 1,417 714 217 
  2 1,127 1,582 701 207 
  3 1,107 1,786 721 211 
  4 (least deprived) 1,221 2,010 718 168 
Women     
All 7,261 6,019 2,802 1576 
SES quartile     
  1 (most deprived) 1,545 1,645 923 607 
  2 1,777 1,559 764 400 
  3 1,908 1,492 626 330 
  4 (least deprived) 2,031 1,323 489 239 
Source: HSE 2003-2006 
 
Selected descriptive statistics across BMI categories are in Table 3.3, while full 
descriptive statistics are in Appendix 3.1. Thirty six percent of the sample were normal 
weight, 39% (the modal category) were overweight and 24% were obese (17% class I 
obesity, 7% class II/III obesity). The mean EQ-5D score across the whole sample was 
0.871, falling from a mean value of 0.900 in the normal weight category to 0.782 in the 
class II/III obesity category (P<0.01). The mean predicted SES measure was highest in 
the normal weight category and lowest in the class II/III obesity category; the modal 
SES quartile was quartile 4 (least deprived) in the normal weight category and quartile 
1 (most deprived) in the class I and II/III obesity categories. Forty six percent of the 
sample was men and the mean age was 48 years. There was significant variation 
between BMI categories with respect to gender, age, ethnicity, marital status, smoking 
status, education qualifications, social class of HRP, car ownership, economic activity, 
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housing tenure, bedrooms in household, area deprivation and claiming income support 
(all P<0.01).  
 
Table 3.3: Selected descriptive statistics by BMI category 
  
Whole 
sample 
Normal 
weight Overweight 
Class I 
obesity 
Class II / III 
Obesity P value 
Observations        
  Number 33,105 11,796 12,814 5,656 2379   
  % 100 36 39 17 7   
EQ-5D score 0.871 0.900 0.876 0.840 0.782 <0.01 
Predicted SES measure 29,652 30,914 30,159 27,831 25,821 <0.01 
Missing income 14 14 14 14 15 0.46 
SES quartile        
  1 (most deprived) 25 22 24 29 35 
<0.01 
  2 25 25 25 26 26 
  3 25 26 26 24 23 
  4 (least deprived) 25 28 26 21 17 
Gender        
  Men  46 38 53 50 34 
<0.01   Women 54 62 47 50 66 
Age (years)  48 43 50 52 50 <0.01 
Source: HSE 2003-2006 
 
Table 3.4 shows the results of the interval regression model of banded total annual 
household income against the individual, household and area socioeconomic variables. 
The coefficients show the predicted change in income if each of the dependent 
variables takes the value 1. Education, social class of HRP, number of cars and 
bedrooms in household are all positively correlated with income. Compared to being in 
paid employment all other types of economic activity are negatively associated with 
income. Claiming income support is negatively correlated with income, as is area 
deprivation. We used these coefficients to generate our predicted SES measure. 
Respondents were categorised into quartiles based on the predicted SES values. The 
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range of values for equivalised predicted income was -18,72011 to 146,702; the cut-
points used to set the quartiles were 17,542, 27,728 and 39,215.  
 
  
                                                     
11
 We convert the predicted income into quartiles and use these as our SES measure and do not use the 
actual income values in the further analysis. Hence, it is not a problem that we obtain negative 
predicted income values. 
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Table 3.4: Interval regression of total annual household income against SES 
indicators 
 Coef. Z 
Educational qualifications   
  Degree or equivalent Base category 
  Higher education below degree -9,799 -15.11 
  NVQ3/GCE A Level or equivalent -7,685 -10.53 
  NVQ2/GCE O Level or equivalent -10,231 -16.31 
  NVQ1/CSE other grade or equivalent -11,363 -14.11 
  Foreign/other -13,419 -17.25 
  No qualification -10,779 -16.44 
Social Class of HRP   
  Professional Base category 
  Managerial technical -4,809 -4.42 
  Skilled non-manual -13,251 -11.51 
  Skilled manual -13,268 -11.99 
  Semi-skilled manual -14,341 -12.61 
  Unskilled manual -14,652 -12.90 
Cars owned by household    
  Household has no car Base category 
  One 300 0.59 
  Two 7,561 10.79 
  Three or more 16,337 11.54 
Economic activity status for last week    
  In paid employment or self-employed Base category 
  Going to school or college full time -10,331 -4.51 
  On a government training scheme -15,454 -6.98 
  Doing unpaid work -2,156 -0.27 
  Waiting to take up paid work already obtained -3,446 -0.59 
  Looking for paid work or a government training scheme -14,299 -14.23 
  Intending to look for work but prevented by temporary sickness -14,720 -9.99 
  Permanently unable to work because of long-term sickness -11,422 -15.50 
  Retired from paid work -12,587 -23.01 
  Looking after home or family -10,348 -9.87 
  Doing something else -19,093 -10.11 
Housing tenure    
  Own outright Base category 
  Buying with help of a mortgage or loan 4,310 6.59 
  Pay part rent and part mortgage -1,130 -0.62 
  Rent  -928 -1.32 
  Live rent free and/or squatting -6,967 -4.74 
Bedrooms in household    
  One  Base category 
  Two  683 1.12 
  Three  3,034 4.55 
  Four  10,627 10.63 
  Five or more  25,708 12.88 
IMD quintile (SOA level)   
  1 (least deprived) Base category 
  2 -2,937 -3.87 
  3 -3,946 -5.00 
  4 -5,558 -7.20 
  5 (most deprived) -6,138 -7.96 
Income support claimant   
  No Base category 
  Yes -2,041 -2.49 
Constant 47,940 31.21 
Observations 33,716 
Adjusted R 
2 
0.077 
Notes 
HRP = household reference person. IMD = Index of Multiple Deprivation. SOA = super output area.  
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The unadjusted EQ-5D regressions are in Table 3.5. For all men combined and all 
women combined EQ-5D scores decreased significantly at higher levels of obesity 
(both P<0.01). The mean EQ-5D score among men of normal weight was 0.910, and for 
those in the overweight, class I obesity and class II / III obesity categories it was 0.894, 
0.866, and 0.821, respectively. In women analogous figures were 0.904, 0.866, 0.827, 
and 0.775, respectively; the negative correlation of overweight and obesity with EQ-5D 
score were greater for women than for men.  
 
We repeated the unadjusted analyses for all men combined and all women combined 
restricting the sample to individuals with non-missing income data only (28,374 
observations; 13,016 men, 15,358 women). We then compared the predicted mean 
EQ-5D scores produced by both models for each of the BMI categories in both men 
and women using t-tests. There were no significant differences for every BMI category 
in both genders (all tests P>0.23). In the remainder of this chapter we focus on the 
results for all individuals in whom we were able to compute predicted SES values. 
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Table 3.5: Association between obesity and EQ-5D score (unadjusted) 
 Normal weight Overweight Class I obesity Class II/III obesity Equal 
  Coef. t Mean SE Coef. t Mean SE Coef. t Mean SE Coef. t Mean SE means 
Men                      
All Base category 0.910 0.002 -0.017 -4.76 0.894 0.002 -0.044 -9.38 0.866 0.003 -0.089 -9.00 0.821 0.008 P<0.01 
SES quartile                   
  1 (most deprived) Base category 0.838 0.007 -0.038 -3.62 0.800 0.006 -0.072 -5.43 0.766 0.009 -0.160 -6.41 0.679 0.019 P<0.01 
  2 0.080 8.65 0.919 0.004 0.057 6.03 0.895 0.004 0.028 2.57 0.867 0.006 -0.019 -0.98 0.819 0.015 P<0.01 
  3 0.095 10.42 0.933 0.003 0.078 8.66 0.916 0.003 0.062 5.93 0.900 0.005 0.046 3.00 0.884 0.010 P<0.01 
  4 (least deprived) 0.107 12.25 0.946 0.003 0.097 11.25 0.936 0.002 0.087 9.07 0.925 0.004 0.079 5.74 0.918 0.009 P<0.01 
 Equal means P<0.01 P<0.01 P<0.01 P<0.01   
Women                   
All Base category 0.904 0.002 -0.038 -11.54 0.866 0.003 -0.078 -16.21 0.827 0.004 -0.130 -17.04 0.775 0.007 P<0.01 
SES quartile                   
  1 (most deprived) Base category 0.841 0.006 -0.048 -5.48 0.792 0.006 -0.083 -7.54 0.758 0.009 -0.152 -10.26 0.689 0.013 P<0.01 
  2 0.072 9.90 0.913 0.003 0.033 4.07 0.873 0.005 -0.004 -0.39 0.836 0.008 -0.039 -2.61 0.802 0.013 P<0.01 
  3 0.079 10.81 0.919 0.003 0.056 7.03 0.896 0.005 0.030 3.06 0.871 0.007 0.001 0.10 0.842 0.012 P<0.01 
  4 (least deprived) 0.091 12.87 0.931 0.003 0.073 9.54 0.914 0.004 0.045 4.49 0.885 0.007 0.009 0.63 0.850 0.012 P<0.01 
Equal means P<0.01 P<0.01 P<0.01 P<0.01   
Notes 
The dependent variable is EQ-5D score. The coefficients and t-statistics show the impact of the obesity variables on EQ-5D scores based on OLS. The mean and SE 
values are predicted mean EQ-5D scores, and their standard errors, for each BMI or BMI/SES category. 
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While the magnitude of the effect was reduced for all men combined and all women 
combined in the multivariate models, the negative correlation between obesity and 
EQ-5D scores remained significant for all men and all women after controlling for 
individual and household characteristics except for the longstanding and acute illness 
variables (Table 3.6; both P<0.01).  Compared with normal weight, class II/III obesity 
was associated with a mean difference in EQ-5D score of -0.067 (t=-7.2, P<0.01) in men 
and -0.100 (t=-14.06, P<0.01) in women. For all men combined, while overall there was 
a significant negative correlation between obesity and EQ-5D score, there were no 
significant differences between overweight and normal weight. 
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Table 3.6: Association between obesity and EQ-5D score (controlling for individual and household characteristics) 
  Normal weight Overweight Class I obesity Class II/III obesity Equal 
  Coef. t Mean SE Coef. t Mean SE Coef. t Mean SE Coef. t Mean SE means 
Men                   
All Base category 0.898 0.002 -0.002 -0.45 0.897 0.002 -0.020 -4.25 0.878 0.003 -0.067 -7.20 0.831 0.007 P<0.01 
SES quartile                  
  1 (most deprived) Base category 0.874 0.007 -0.012 -1.22 0.862 0.006 -0.044 -3.35 0.831 0.009 -0.139 -5.81 0.735 0.019 P<0.01 
  2 0.039 4.52 0.914 0.004 0.037 4.01 0.911 0.004 0.013 1.17 0.887 0.006 -0.036 -1.87 0.838 0.014 P<0.01 
  3 0.033 3.63 0.907 0.003 0.036 3.89 0.911 0.003 0.025 2.35 0.899 0.005 0.001 0.09 0.876 0.010 P=0.04 
  4 (least deprived) 0.021 2.00 0.895 0.004 0.023 2.13 0.897 0.004 0.017 1.48 0.891 0.005 0.004 0.27 0.879 0.010 P=0.35 
 Equal means P<0.01 P<0.01 P<0.01 P<0.01  
Women                  
All Base category 0.889 0.002 -0.014 -4.35 0.875 0.002 -0.044 -9.53 0.845 0.004 -0.100 -14.06 0.789 0.007 P<0.01 
SES quartile                  
  1 (most deprived) Base category 0.882 0.006 -0.028 -3.31 0.854 0.007 -0.061 -5.81 0.821 0.009 -0.141 -9.99 0.740 0.013 P<0.01 
  2 0.026 3.72 0.908 0.004 0.006 0.76 0.888 0.005 -0.03 -2.91 0.852 0.008 -0.074 -5.14 0.808 0.012 P<0.01 
  3 0.011 1.42 0.893 0.004 0.004 0.43 0.886 0.005 -0.018 -1.81 0.863 0.007 -0.054 -3.87 0.828 0.012 P<0.01 
  4 (least deprived) -0.007 -0.69 0.875 0.006 -0.011 -1.07 0.870 0.006 -0.033 -2.61 0.849 0.009 -0.064 -4.10 0.817 0.013 P<0.01 
Equal means P<0.01 P<0.01 P=0.01 P<0.01  
Notes 
The dependent variable is EQ-5D score. The coefficients and t-statistics show the impact of the obesity variables on EQ-5D scores based on OLS. The mean and SE 
values are predicted mean EQ-5D scores, and their standard errors, for each BMI or BMI/SES category computed by setting the individual and household 
characteristics to their whole-sample mean values. The individual and household characteristics are age, age squared and age cubed, predicted equivalised total 
annual household income, ethnicity, marital status, smoking status, Government Office Region of residence and survey year.  
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Similar results, although at reduced levels, were found controlling for longstanding and 
acute illnesses as well (Table 3.7; both P<0.01). Compared with normal weight, class II 
and class III obesity was associated with a mean difference in EQ-5D score of -0.028 
(t=-3.9, P<0.01) in men and -0.049 (t=-8.8, P<0.01) in women, after controlling for 
individual and household characteristics including the longstanding and acute illness 
variables.  
 
 94 
 
Table 3.7: Associations between obesity and EQ-5D scores (controlling for individual and household characteristics including the 
longstanding and acute illness variables) 
  Normal weight Overweight Class I obesity Class II/III obesity Equal 
  Coef. t Mean SE Coef. t Mean SE Coef. t Mean SE Coef. t Mean SE means 
Men                        
All Base category 0.893 0.002 0.000 0.080 0.893 0.002 -0.006 -1.650 0.886 0.003 -0.028 -3.920 0.865 0.006 P<0.01 
SES quartile                       
  1 (most deprived) Base category 0.881 0.006 -0.002 -0.260 0.878 0.006 -0.019 -1.910 0.861 0.009 -0.074 -4.050 0.807 0.017 P<0.01 
  2 0.019 2.700 0.899 0.004 0.017 2.370 0.898 0.004 0.007 0.790 0.887 0.006 -0.020 -1.250 0.861 0.014 P=0.03 
  3 0.016 2.220 0.897 0.004 0.020 2.640 0.900 0.003 0.020 2.260 0.900 0.005 0.019 1.550 0.900 0.010 P=0.9 
  4 (least deprived) 0.013 1.530 0.894 0.004 0.014 1.540 0.894 0.004 0.014 1.500 0.895 0.006 0.010 0.780 0.891 0.011 P=0.99 
 Equal means P=0.05 P<0.01 P<0.01 P<0.01   
Women                       
All Base category 0.879 0.002 -0.008 -3.220 0.871 0.002 -0.022 -5.710 0.857 0.003 -0.049 -8.780 0.830 0.005 P<0.01 
SES quartile                       
  1 (most deprived) Base category 0.877 0.005 -0.021 -3.170 0.856 0.006 -0.029 -3.460 0.848 0.008 -0.078 -6.910 0.799 0.011 P<0.01 
  2 0.010 1.730 0.886 0.003 0.002 0.420 0.879 0.004 -0.022 -2.660 0.855 0.007 -0.029 -2.590 0.848 0.010 P<0.01 
  3 0.004 0.660 0.881 0.003 -0.002 -0.320 0.874 0.004 -0.007 -0.840 0.870 0.006 -0.031 -2.730 0.846 0.010 P<0.01 
  4 (least deprived) -0.002 -0.290 0.874 0.005 -0.003 -0.380 0.873 0.005 -0.017 -1.670 0.859 0.008 -0.027 -2.140 0.849 0.011 P=0.02 
Equal means P=0.08 P<0.01 P=0.14 P<0.01   
Notes 
The dependent variable is EQ-5D score. The coefficients and t-statistics show the impact of the obesity variables on EQ-5D scores based on OLS. The ‘Mean’ values 
are predicted mean EQ-5D scores for each BMI or BMI/SES category computed by setting the age variables, the individual characteristics and the longstanding 
illnesses to their sample mean values. The individual and household characteristics are age, age squared and age cubed, predicted equivalised total annual 
household income, ethnicity, marital status, smoking status, Government Office Region of residence, survey year, the longstanding illness variables (the number and 
type of longstanding illnesses, limiting longstanding illness) and acute illness. 
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The analysis by SES quartile reveals socioeconomic variation in the relationship 
between obesity and HRQL. The relationship between obesity and EQ-5D score 
depends on SES: the interaction between obesity and SES was statistically significant 
for both genders in the unadjusted models, the models controlling for individual and 
household characteristics except for the longstanding and acute illness variables, and 
in the model controlling for longstanding and acute illnesses as well (all P<0.01).  
 
In the unadjusted models, in every SES quartile and in both men and women, mean 
EQ-5D scores were significantly decreased at higher levels of obesity (all P<0.01; Table 
3.5). In addition, in every BMI category mean EQ-5D scores were significantly lower in 
more deprived SES quartiles (all P<0.01). For example, the mean EQ-5D scores in men 
with class II/III obesity were 0.679 in SES quartile 1 (most deprived) and 0.819, 0.884 
and 0.918 in quartiles 2, 3 and 4 (least deprived), respectively.  In women analogous 
figures were 0.689, 0.802, 0.842 and 0.850, respectively. 
 
Similar trends were found when controlling for individual and household 
characteristics (Table 3.6). In every BMI category mean EQ-5D scores varied 
significantly by SES (all P≤0.01), and EQ-5D scores were lowest in the most deprived 
SES groups (the mean EQ-5D score of normal weight women in the least deprived 
quartile was not significantly different to that of normal weight women in the most 
deprived quartile). In men, mean EQ-5D scores declined significantly in SES quartiles 1, 
2 and 3 (all P<0.05), but not in quartile 4 (least deprived; P=0.35). In women, mean EQ-
5D scores declined significantly with obesity in every SES group (all P<0.01). In every 
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model, for both men and women, the BMI/SES category with the lowest mean EQ-5D 
score was class II/III obesity/SES quartile 1.  
 
Furthermore, similar results were obtained when we control for longstanding and 
acute illnesses (Table 3.7). In men, mean EQ-5D scores declined significantly in SES 
quartiles 1 and 2 (all P<0.05), but not in quartiles 3 and 4 (least deprived). In women, 
mean EQ-5D scores declined significantly with obesity in every SES group (all P<0.01).  
 
To further examine variation across BMI groups and across SES groups separately we 
repeated the adjusted analyses by setting the individual and household characteristics 
to the mean values of each SES category, and then to the mean values of each obesity 
category (see appendix 3.2 and appendix 3.3). In these cases the variation in predicted 
mean EQ-5D scores between BMI or BMI/SES categories becomes more pronounced, 
because it also reflects differences in the values of the individual and household 
characteristics between categories. 
 
3.5 Discussion 
The aims of this chapter were to investigate the association between obesity and 
HRQL, and whether or not any observed relationship varies by SES. Our main findings 
are that obesity and HRQL are negatively correlated, and that the relationship between 
obesity and HRQL is significantly more pronounced in the lower SES groups than in the 
higher SES groups.  
 
 97 
 
We provide evidence to show that overweight and obese men and women have 
significantly lower HRQL than those of normal weight. After controlling for individual 
and household characteristics, we obtain similar results, albeit at reduced levels. Our 
findings also show that the negative association between obesity and HRQL is greater 
in women than in men. 
 
These results are qualitatively similar to those in other studies, which have also shown 
that HRQL is negatively correlated with obesity, and that the negative impact of 
obesity is diminished but not eliminated after controlling for individual and household 
characteristics (Jia & Lubetkin, 2005; Sach et al., 2007). Our findings are also 
quantitatively similar to Sach et al., (2007) who investigate the association between 
obesity and HRQL in a UK general practice population. They report that overweight, 
class I obesity and class II obesity are associated with a mean reduction in EQ-5D score 
across both genders combined of -0.023, -0.099 and -0.121, respectively. Our figures 
are -0.017, -0.044 and -0.089 for men, and -0.038, -0.078 and -0.130 for women. Our 
results controlling for individual and household characteristics but not longstanding 
and acute illnesses are also consistent; Sach et al. report that being overweight has a 
non-significant relationship with EQ-5D score and that being obese (all classes 
combined) is associated with a mean reduction in EQ-5D score of -0.04. Our analysis 
shows that being overweight has a non-significant relationship with EQ-5D score in 
men and a small but significant negative relationship in women (mean reduction -
0.014). In men, class I obesity has a significant impact on EQ-5D score of -0.020, and 
class II/III obesity is associated with a mean reduction in EQ-5D score of -0.067. 
Comparable figures for women are -0.044, and -0.100, respectively. 
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This chapter also shows that the negative association between obesity and HRQL 
varies significantly by SES; the association is more negative in people from lower SES 
groups. Overweight and obese people in lower SES groups have lower HRQL than those 
of normal weight in the same SES group, and have lower HRQL than those in higher SES 
groups with the same weight. This trend is also observed after controlling for individual 
and household characteristics, although the statistical significance and magnitude of 
effects is diminished. While a number of studies have investigated the association 
between obesity and HRQL controlling for SES in multivariate analyses, we are not 
aware of any published studies that have stratified their analyses by SES groups and 
shown that the association between BMI groups and HRQL varies by SES. 
 
Is the magnitude of the variation in EQ-5D scores between BMI/SES categories 
reported in this chapter important? Walters & Brazier (2005) investigated the smallest 
change in EQ-5D score that can be regarded as significant, i.e., the minimally important 
difference (MID; defined as the smallest difference which patients would perceive as 
important). Across a range of conditions (leg ulcer, back pain, early rheumatoid 
arthritis, limb reconstruction, osteoarthritis, irritable bowel syndrome, and chronic 
obstructive lung disease) the mean MID (range) for the EQ-5D was 0.074 (-0.011 to 
0.140). Pickard, Neary & Cella (2007) investigated MIDs for the EQ-5D in the UK for 12 
types of cancer and calculated estimates in the range 0.070 to 0.120. Applying these 
MIDs to our results, compared with the base category (normal weight/SES quartile 1 
(most deprived)), the range of coefficients for men and women in our study was -0.160 
to +0.107 and –0.152 to +0.091, respectively, in the unadjusted models (Table 3.5) and 
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-0.139 to +0.039 and -0.141 to +0.026 after controlling for individual and household 
characteristics (Table 3.6), with the largest differences occurring between SES quartiles 
1 and 4 in the normal weight groups and between class II/III obesity and normal weight 
in SES quartile 1. Caution is required when drawing conclusions from these 
comparisons because the MIDs are derived from randomised controlled trials and 
longitudinal observational studies that were designed to assess the efficacy of 
treatment interventions, rather than evaluate differences in health input states. In 
addition, the MIDs vary by condition and none of the studies focused specifically on 
obesity; so MIDs for obesity are unknown, and may fall outside of the ranges given 
above. Nonetheless, these comparisons suggest that the variations in EQ-5D score 
reported in this study between BMI/SES categories are quantitatively important.  
 
In Chapter 2 we suggest that obesity reduces health by increasing the health 
depreciation rate. Furthermore we suggested that the health depreciation rate might 
vary by SES and presented three hypotheses for this relationship. The findings in this 
chapter support hypothesis (b) of a more pronounced negative impact of obesity on 
health in the lower SES group compared with higher SES groups. Birch, Jerret and Eyles 
(2000) suggest that given the economic resources and favourable social circumstances, 
high SES individuals are more capable of tackling the harm of unhealthy lifestyles. 
While low SES groups are already weak and are more likely to suffer the comorbidities 
of unhealthy lifestyles. We ran regressions controlling for longstanding and acute 
illness and find that the magnitude of the associations was considerably reduced, 
which emphasise the role of obesity-related comorbidities. Hence, in the following 
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Chapter 4 we will analyse further their part in the association between obesity and 
HRQL.   
 
The main implication of our findings is that more attention needs to be paid to 
accounting for heterogeneity in the pathways to health when undertaking research 
studies, in particular accounting for the modifying effect of SES when analysing the 
impact of obesity on health and interventions to reduce obesity. Given the common 
use of HRQL measures such as the EQ-5D in cost-effectiveness analyses, our findings 
also suggest that particular attention needs to be paid to the role of SES when 
undertaking economic evaluations of interventions to reduce obesity. The results show 
that obesity is associated more strongly with HRQL in lower SES groups compared with 
higher SES groups. Assuming that these associations are causal, it suggests that greater 
HRQL gains might be achieved by reducing obesity in lower SES groups. Such findings 
suggests that care is required when selecting HRQL estimates for BMI categories in 
cost-effectiveness analyses to ensure that the values used are appropriate to the SES 
group under investigation. It also suggests that the cost-effectiveness of programmes 
to reduce obesity may vary by SES group, and that sub-group analyses by SES may be 
warranted. 
 
This chapter has a number of potential limitations related to endogeneity, making it 
difficult to draw inferences about the causal impact of obesity on EQ-5D. First, there 
may be omitted variable bias: there may be unobserved factors that affect both 
obesity and HRQL. One such factor might be the discount rate – the rate of time 
preference – which affects the weight that individuals give to their future health and 
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also their BMI (Morris, 2007). Another factor might be health problems. For example, 
individuals may be obese because they have a health problem, which precludes them 
from undertaking physical activity. Conversely, individuals might lose weight due to a 
health problem. Hence, it is difficult to establish the direction of the bias. We ran 
models controlling for limiting longstanding and acute illnesses. Although the 
magnitude of the association is reduced the results demonstrate a similar trend. The 
effect of obesity is still significantly more negative in the lower SES groups. Second, 
there may be measurement error: if BMI is mis-measured, and if the level of mis-
measurement is associated with HRQL, the obesity coefficients may be biased (note 
that in our data height and weight were obtained during the interviewer visit and are 
not self-reported so the likelihood of this problem is reduced). Third, and related to 
this, there may be reporting bias with respect to HRQL: the EQ-5D, like any HRQL 
measure, is essentially subjective. It may therefore suffer from systematic reporting 
bias that is correlated with obesity and/or with SES. Fourth, our measure of obesity is 
BMI, which has been criticised, e.g., because it does not incorporate body fat, which is 
an independent predictor of ill health (Burkhauser & Cawley, 2008). Fifth, the HSE data 
are cross-sectional. We therefore model the impact of current obesity on current 
HRQL, when obesity in previous time periods might be more significant.  
 
Most previous studies also suffer from these limitations. Nonetheless, we believe that 
our dataset offers a number of advantages over previous studies. Our BMI measure is 
based on actual height and weight measurements obtained during the interviewer 
visit, not on self-reported values. Thus, the likelihood of systematic measurement error 
is reduced. The number of observations in our sample is sufficiently large to permit 
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analyses stratified by gender, SES and BMI; our findings show that the impact of 
obesity on HRQL varies by all these factors. Also, we have better information on 
individual and household characteristics and so can argue that it is less likely that the 
estimated effects of obesity on HRQL in our models are due to their correlation with 
omitted variables. 
 
To summarise, this chapter has shown that, as in previous studies, obesity is negatively 
correlated with HRQL. In addition, we have shown that the negative association 
between obesity and HRQL is greater in people from lower SES groups: overweight and 
obese people in lower SES groups have lower HRQL than those of normal weight in the 
same SES group, and have lower HRQL than those in higher SES groups of the same 
weight.  
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CHAPTER 4 
 
Socioeconomic variation in the relationship between 
obesity and health related quality of life in individuals 
with obesity-related comorbidities 
 
4.1 Introduction  
In Chapter 3 we compared models with and without controlling for longstanding and 
acute illnesses. We illustrate that the negative association between obesity and HRQL 
is substantially reduced when we control for illnesses. However, obesity is still 
significant negatively associated with HRQL. This means that the loss in HRQL due to 
obesity is predominantly due to increased prevalence of illnesses in the obese (the risk 
factor effect). In this chapter we want to investigate further the role of the risk factor 
effect of obesity. First, we investigate how obesity-related comorbidities modify the 
association between obesity and HRQL. Second, we investigate how socioeconomic 
status influences this. The analysis allows us to explore the relationship between 
obesity and HRQL in individuals with obesity-related comorbidities. In addition, this 
analysis allows us to explore possible causes of socioeconomic variation in the 
association between BMI and HRQL identified in Chapter 3.  
 
To approach the first aim we present a model where we have an obesity-related 
comorbidity (Ct) variable that can take on two values (no comorbidity=0, has 
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comorbidity=1). This obesity-related comorbidity could be diabetes, for example. In 
that case the Ct variable will take the value one if the person has diabetes and zero 
otherwise. We interact the obesity-related comorbidity with obesity (Ot). In this 
example we assume that the obesity variable can take on two values (normal 
weight=0, obese=1): 
 
tttttt uXCOCOH  43210 *       (4.1) 
 
Ht represents health, the Xt denotes all other covariates like age and other lifestyles 
(smoking), ut is the error term, t denotes the time period and the β’s are vectors of 
parameters to be estimated. To test if there is variation in the association between 
obesity and HRQL by obesity-related comorbidities we can test the hypothesis H0: 
β3=0. If β3≠0 it means that H0 is rejected and the association between obesity and 
HRQL is not equal in individuals with and without comorbidities. Hence, the association 
between obesity and HRQL varies by obesity-related comorbidities (or vice versa). 
 
The second aim of this chapter is to explore SES variation in the association between 
obesity-related comorbidities and HRQL. In Chapter 3 we found that the association 
between obesity and HRQL is more negative and more significant in lower SES 
individuals. One possible explanation for this is that obesity-related comorbidities are 
more negatively associated with HRQL in lower SES groups compared with higher SES 
groups. It might be that the favourable social circumstances that high SES individuals 
enjoy will act as a buffer against the negative consequences of comorbidities. For 
instance, favourable circumstances in higher SES individuals might increase their 
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diabetes control, which then again reduces the probability of suffering negative 
consequences of diabetes.  
 
To investigate this we need a method for looking at variation across SES groups in the 
effect of obesity-related comorbidities on HRQL. We use a model with a third level 
interaction between obesity, SES and the comorbidity. The motivation behind using 
such an approach is that we have two interactions that need to be taken account of 
and we want to test a third interaction. The first interaction we need to take account 
of is the interaction between obesity and SES indentified in Chapter 3 (O*SESt). The 
second is the interaction in equation 4.1 between obesity-related comorbidities and 
obesity (O*Ct). The third interaction, and the one we want to test, is between obesity-
related comorbidities and SES (C*SESt).  Hence, we run the model below: 
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       (4.2) 
 
In this example we assume that the SES variable (SESt) can take on two values (high 
SES= 0, low SES=1). In the equation above α1 represents the effect of obesity when 
both Ct=0 and SESt=0. α2 represents the effect of the comorbidity when Ot=0 and 
SESt=0. α3 represents the effect of SES when Ot=0 and Ct=0. The second level 
interactions α4 controls for the effect of obesity in individuals with comorbidities if 
SESt= 0, α5 controls for the effect of obesity when SESt=1 and Ct=0, and α6 controls for 
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the effect of comorbidities when SESt=1 and Ot=0. The third level interaction α7 
captures all variation in Ht due to obesity if an individual is low SES (SESt=1) and has a 
comorbidity (Ct=1). We want to test if there is variation in the association between 
obesity-related comorbidities and HRQL by SES group. Hence, we want to test the 
hypothesis H0: α6=0. However, this is not straight forward as we need to take into 
account the third level interaction (α7) and we will later discuss how to do this. If α6≠0 
across obesity groups it means that H0 is rejected and the association between 
obesity-related-comorbidities and HRQL is not equal across SES groups. Hence, the 
association between obesity-related comorbidities and HRQL varies by SES (or vice 
versa). 
 
Little is known about the associations between obesity and HRQL in individuals 
suffering from various comorbidities. We have found two papers that investigate the 
association between obesity and HRQL in individuals with diabetes. However, only one 
of these compares the results in patients with and without diabetes to investigate 
whether or not there are significant differences. Furthermore, both studies use a 
sample of patients recently discharged from hospital. Hence, they might not represent 
the general population as individuals who do not have diabetes have been to the 
hospital for some other reason than diabetes. The more recent of the two studies, by 
Lee et al. (2005), investigates the association between obesity and EQ-5D score in 
individuals with type 1 diabetes, type 2 diabetes and no diabetes in Wales controlling 
for age. They find that obesity is negatively correlated with EQ-5D score for individuals 
with and without diabetes. Furthermore they found that there were no differences in 
the association between obesity and HRQL between those with and without diabetes 
 107 
 
(non-significant interactions between obesity and diabetes status). Redekop et al. 
(2002) investigate the association between obesity and EQ-5D score in Dutch patients 
with type 2 diabetes. They find that obesity (BMI>30 kg/m2) is negatively associated 
with EQ-5D score compared with none obese patients (BMI<30 kg/m2) controlling for 
age, gender, diabetes related complications, and insulin therapy. However, this study 
limits their sample to individuals with diabetes and does not compare the results to 
individuals without diabetes. We are not aware of any studies investigating this effect 
across SES groups. 
 
To recap, first we investigate if the association between obesity and HRQL varies by 
obesity-related comorbidities. Second, we investigate if the association between 
obesity-related comorbidities and HRQL varies by SES.   
 
4.2 Methods 
 
4.2.1 Data and variables 
We use the same dataset as in Chapter 3 (HSE: 2003-2006). We focus on 4 of 42 
possible longstanding illnesses in HSE: diabetes; stroke; heart attack or angina; and, 
hypertension. 
 
There are numerous studies that link obesity to a number of comorbidities. The four 
comorbidities in this chapter are chosen based on two key reports: Foresight: Tackling 
Obesities: Future Choices Project Report (2nd Ed.) (Butland et al., 2007); and, Tackling 
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Obesity in England (National Audit Office, 2001). These reports have conducted 
extensive reviews of international literature with an aim of making the results relevant 
to the English population.  
 
In Table 4.1 we see the rationale for the chosen longstanding illnesses. The reports 
only describe comorbidities that are associated with obesity; hence we cannot draw 
any conclusions regarding causality. For a list of all the longstanding illness categories 
used in HSE see Appendix 4.1.  
 
Table 4.1: Longstanding illnesses categories in HSE that are related to obesity 
Longstanding illness Rationale, taken from: National Audit Office, 
Tackling obesity in England, 2001. The Foresight 
report, Tackling Obesities: Future Choices – Project 
Report 
Diabetes Obese men and women are 12.7 and 5.2 times 
more likely to have diabetes type 2, respectively. 
Stroke Obese men and women are 1.3 times more likely to 
have suffered a stroke. 
Heart attack or angina Obese men and women are 1.8 times more likely to 
have angina. 
Hypertension/high blood 
pressure  
Obese men and women are 4.2 and 2.6 times more 
likely to have hypertension, respectively. 
Note 
Obese and non obese groups vary between the groups used to estimate the relative risks. Hence, the 
risks are not comparable across illnesses. 
 
The reports identify additional obesity-related comorbidities like various cancers, 
osteoarthritis and digestive complaints. For example, obese men and women are 2.7 
and 3 times more likely to have cancer of the colon, respectively. However, in HSE for 
these diseases the categories are too wide and includes a number of longstanding 
illnesses that have not been associated with obesity, which will dilute the effect overall 
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and make the coefficients smaller and less significant. In Appendix 4.2 we provide a 
description of each illness category.  
 
Consistent with Chapter 3, EQ-5D is our measure of HRQL and BMI is divided into five 
BMI categories (but we do not report the results for the underweight category). 
Furthermore, we use the same predicted SES measure and cut points as in Chapter 3 
(see Table 3.4, Chapter 3). In addition, we run models controlling for: age (cubic 
function); ethnicity (nine categories); marital status (six categories); smoking status 
(four categories); Government Office Region of residence (nine categories); predicted 
equivalised total annual household income (continuous variable); and, survey year 
(four categories). We do not stratify by gender in this analysis because of the low 
number of individuals in each disease category. We control for gender by including a 
dummy variable taking the value of one if the individual is a man and zero otherwise12. 
 
4.2.2 Statistical analysis 
We explain the following methods in three parts. We start with the methods used to 
investigate whether or not the association between BMI and HRQL varies by obesity-
related comorbidities. We then explain the methods used to investigate 
socioeconomic variation in the association between obesity-related comorbidities and 
HRQL. Lastly, we explain the methods used to investigate the association between 
obesity and HRQL in individuals without any longstanding illnesses. Later the results 
will be explained under the same headings.  
                                                     
12
 We investigated if interacting gender and age as a cubic function improved model fit using a likelihood 
ratio test. The test did not indicate that interacting age and gender improved the model fit (P=0.2692) 
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4.2.2.1 Variation in the association between BMI and HRQL by obesity-related 
comorbidities: methods 
We regress EQ-5D score against BMI categories including interaction terms between 
BMI categories and obesity-related comorbidity (ORC). In equation 4.4 below the ORCi 
variable represents one of the obesity-related comorbidities (diabetes; stroke; heart 
attack or angina; and, hypertension). For example, in the case when it represents 
diabetes it is a dummy taking on the value of one if the person has diabetes and zero 
otherwise. The omitted categories are individuals not suffering from the comorbidity in 
question (ORCi=0) and normal weight (BMIi=1). Zi denotes the other covariates. We fit 
four models, one for each of the comorbidities.  
 
ii
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aii uZORCBMIORCBMIh  
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10 *      (4.4) 
 
β1 provides the impact of BMI categories in individuals without the comorbidity (note 
that individuals can have other comorbidities but the one that is analysed), β2 provides 
the impact of the comorbidity in individuals in the normal weight category. β3 is the 
interaction between BMI and the comorbidity in individuals who are either overweight 
or obese (i.e., whether or not the association between obesity and EQ-5D score 
depends on the obesity-related comorbidity, or vice versa).  We test if this interaction 
is statistically significant in models using two-way ANOVA.  
 
 111 
 
After every regression we compute the predicted mean EQ-5D score for each 
BMI/comorbidity category. We do this by fixing the covariates at their whole-sample 
mean values so that the variation in predicted mean EQ-5D scores is a function of BMI 
categories and how this varies by obesity-related comorbidities, and is not affected by 
the values of the other covariates. 
 
We test for equality in predicted mean EQ-5D scores between BMI categories (across 
each comorbidity and within each comorbidity) using Wald tests. 
 
As in Chapter 3 we apply survey weights reported in the HSE to each observation to 
adjust for the fact that different observations have different probabilities of being 
selected for participation in the survey. In addition, we control for clustered sampling 
within PSUs using unique PSU/year identifiers that produce Huber/White/sandwich 
robust variance estimators that allow for within-group dependence (Kish & Frankel, 
1974). 
 
4.2.2.2 Socioeconomic variation in the association between obesity-related 
comorbidities and HRQL: Methods 
We now introduce SES explicitly into this analysis and use a third level interaction 
approach as it allows us to jointly test the interaction between SES and comorbidity 
across all BMI groups to see if we get a significant interaction between the comorbidity 
and SES. 
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We rerun model 4.1 including triple categorical variable interaction terms between the 
BMI categories, comorbidities and the SES quartiles, with “normal weight/no 
comorbidity/SES quartile 1 (most deprived)” as the omitted category. As above we 
have four comorbidities and run one model for each.  
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This will provide EQ-5D values specific to each BMI/SES/comorbidity combination. 
Here β1 is the effect of BMIi when ORCi=0 (not having the comorbidity in question) and 
SESi=1, β2 is the effect of the comorbidity when BMIi=1 (normal weight) and SESi=1 and 
β3 is the effect of SES when BMIi= 1 and ORCi=0. β4 is the interaction between BMIi and 
ORCi when SESi=1, β5 is the interaction between BMIi and SESi when ORCi=0 and β6 is 
the interaction between SESi and ORCi when BMIi=1. β7 is the effect of the interaction 
when BMIi>1 (individuals are overweight or obese), SESi>1 (individuals are not in the 
lowest SES quartile) and ORCi=1 individuals have the comorbidity in question.  
 
We want to test the interaction between SES and BMI. To do this we follow the steps 
by UCLA Academic Technology Services (2011) for testing three-way interactions using 
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ANOVA models13. This means that we test the interaction SES*comorbidity for the 
normal weight, overweight, obese class I and obese class II/III and calculate a mean 
across these groups. 
 
We compute the predicted mean EQ-5D score for each BMI/SES/comorbidity category 
by fixing the covariates at their whole-sample mean values, so that the variation in 
predicted mean EQ-5D scores is a function of BMI categories and how this varies by 
obesity-related comorbidities and SES.  
 
Table 4.2 summarise the models used in this chapter. 
 
Table 4.2: Summary of models 
Model Comorbidity Interactions Covariates 
1 Diabetes BMI/comorbidity Individual and household 
characteristics 
2 Stroke BMI/comorbidity Individual and household 
characteristics 
3 Heart attack and angina  BMI/comorbidity Individual and household 
characteristics 
4 Hypertension BMI/comorbidity Individual and household 
characteristics 
5 Diabetes BMI/SES/comorbidity Individual and household 
characteristics 
6 Stroke BMI/SES/comorbidity Individual and household 
characteristics 
7 Heart attack and angina  BMI/SES/comorbidity Individual and household 
characteristics 
8 Hypertension BMI/SES/comorbidity Individual and household 
characteristics 
 
                                                     
13
 First, we run the ANOVA regression. Second, we generate predicted means based on the ANOVA. 
Third, we test the predicted means across SES and comorbidity groups for different values of the BMI 
variable. A significant value means that the association between the comorbidity and HRQL varies by SES 
groups across BMI groups. 
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4.3 Results 
The total number of respondents having each of the chosen illnesses can be found in 
Table 4.3. We see that for some of the illnesses caution is needed due to low numbers 
especially when stratified by SES. 
 
Table 4.3: Number of observations by BMI category, illness category and SES quartile 
 Total Normal weight Over-weight Class I obesity Class II/III obesity 
Diabetes      
All 1234 191 425 382 236 
SES quartile    
  1 (most deprived) 514 66 168 170 110 
  2 287 40 96 98 53 
  3 249 45 93 65 46 
  4 (least deprived) 184 40 68 49 27 
Stroke      
All 219 55 85 57 22 
SES quartile    
  1 (most deprived) 121 29 53 27 12 
  2 46 9 17 16 4 
  3 31 10 9 8 4 
  4 (least deprived) 21 7 6 6 2 
Hypertension 
All 2340 389 922 666 363 
SES quartile    
  1 (most deprived) 850 152 319 251 128 
  2 565 92 221 152 100 
  3 471 61 200 137 73 
  4 (least deprived) 454 84 182 126 62 
Heart attack and angina    
All 684 131 285 190 78 
SES quartile    
  1 (most deprived) 379 75 154 107 43 
  2 157 26 61 49 21 
  3 91 20 40 19 12 
  4 (least deprived) 57 10 30 15 2 
Source: HSE 2003-2006 
 
We see descriptive statistics of each illness across each BMI category in Table 4.4. 
Almost four percent of the individuals in the sample have diabetes (either type 1 or 
type 2), 0.7% of the individuals in the sample have had a stroke, 7.1% have 
hypertension and 2.1% have had a heart attack or angina. The percentage suffering 
from each of the illnesses was lowest in the normal weight categories and highest in 
the obesity class I and obesity class II/III categories across all illnesses. There were 
significant variations between BMI categories with respect to all of the illnesses. In 
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Appendix 4.3 we have stratified the statistics in Table 4.4 by SES groups. We see that a 
larger share of individuals suffer from comorbidities in the lower SES groups. Also the 
difference between the obese and the normal weight is larger in the lower SES groups 
than in the higher. This suggests that the prevalence of obesity related comorbidities is 
higher in the lower SES groups.  
 
Table 4.4: Descriptive statistics by BMI category  
  
Whole Normal 
Overweight 
Class I Class II/III 
P value 
sample weight Obesity obesity 
Diabetes       
  Yes 3.7 1.6 3.3 6.8 9.9  
  No 96.3 98.4 96.7 93.3 90.1 P<0.01 
Stroke       
  Yes 0.7 0.5 0.7 1.0 0.9  
  No 99.3 99.5 99.3 99.0 99.1 P<0.01 
Hypertension     
  Yes 7.1 3.3 7.2 11.8 15.3  
  No 92.9 96.7 92.8 88.2 84.7 P<0.01 
Heart attack and angina      
  Yes 2.1 1.1 2.2 3.4 3.3  
  No 97.9 98.9 97.8 96.6 96.7 P<0.01 
No illnesses       
  Yes 54.7 63.1 53.6 45.3 39.4  
  No 45.3 36.9 46.4 54.7 60.6 P<0.01 
Source: HSE 2003-2006 
Note 
All statistics are %.  
 
We will present the result of the analysis in two parts, similar to the methods section. 
First, we will present the results of variation in the association between obesity and 
HRQL by obesity-related comorbidities. Then we will present the findings on 
socioeconomic variation in the association between obesity-related comorbidities and 
HRQL. 
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4.3.1 Variation in the association between BMI and HRQL by obesity- related 
comorbidities: results 
The predictions based on the EQ-5D regressions controlling for individual and 
household characteristics across each illness category are in Table 4.5. EQ-5D score 
decreases significantly at higher levels of BMI across individuals in each comorbidity 
category: diabetes; hypertension; stroke; and, heart attack and angina. For example 
the mean EQ-5D score among normal weight individuals with diabetes was 0.834 and 
for those in the overweight, class I obesity and class II/III obesity categories it was 
0.864, 0.817, and 0.701, respectively.  
 
Across the four comorbidities the association between BMI groups and EQ-5D score is 
most pronounced in individuals suffering from heart attack or angina, where the mean 
in EQ-5D score falls from a mean of 0.782 in the normal weight category to 0.561 in 
the obese class II/III category. The association between BMI groups and EQ-5D score 
was least pronounced in individuals suffering from hypertension, where the mean EQ-
5D score falls from a mean of 0.888 in the normal weight category to 0.774 in the 
obese class II/III category. 
 
When we look at individuals with and without each of the four comorbidities, we find 
the largest disparities between individuals who have suffered a stroke and individuals 
who have not suffered a stroke14. In the normal weight category the mean EQ-5D score 
was 0.895 in individuals who have not suffered a stroke and 0.682 in individuals who 
have had a stroke. Conversely, we identify the smallest disparities between individuals 
                                                     
14
 Note that both individuals who have suffered a stroke and individuals who have not suffered a stroke 
can have other comorbidities 
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with and without hypertension, where the mean EQ-5D score across normal weight 
individuals was 0.888 and 0.895, respectively. 
 
The comparison between individuals with and without each comorbidity shows 
variation in the association between obesity and HRQL. The association between 
obesity and HRQL depends on obesity-related comorbidities. The interactions between 
obesity and: diabetes; heart attack or angina; and, stroke were statistically significant. 
The relationship between obesity and HRQL was more pronounced in individuals with 
each of these comorbidities than individuals without. E.g. in the diabetes group the 
predicted mean EQ-5D score falls from a value of 0.834 in the normal weight group to 
0.701 in the class II/III category. In the comparator group (diabetes: no) similar number 
were 0.895 to 0.819, respectively. 
 
The interaction between hypertension and BMI was not significant. This means that 
there were no significant variations in the associations between obesity and EQ-5D 
score between individuals with and without hypertension. However, a similar trend 
was identified. 
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Table 4.5: The relationship between obesity and HRQL by comorbidities 
  Normal Over- Obese Obese Equal 
  weight Weight Class I Class II/III means 
Diabetes  
  Yes 0.834 0.864 0.817 0.701 P<0.01 
  No 0.895 0.886 0.864 0.819 P<0.01 
Equal means P<0.01 P=0.03 P<0.01 P<0.01   
Significant interaction  P<0.01 
Hypertension  
  Yes 0.888 0.875 0.84 0.774 P<0.01 
  No 0.895 0.887 0.864 0.814 P<0.01 
Equal means P=0.54 P=0.08 P<0.01 P<0.01   
Significant interaction P=0.17 
Heart attack and angina  
  Yes 0.782 0.77 0.715 0.561 P<0.01 
  No 0.896 0.888 0.865 0.816 P<0.01 
Equal means P<0.01 P<0.01 P<0.01 P<0.01   
Significant interaction P<0.01 
Stroke  
  Yes 0.682 0.722 0.706 0.461 P<0.01 
  No 0.895 0.887 0.863 0.811 P<0.01 
Equal means P<0.01 P<0.01 P<0.01 P<0.01   
Significant interaction P<0.01 
Notes 
Individuals can have other longstanding illnesses in addition to the ones in each comorbidity group.   
The dependent variable is EQ-5D score. The values are predicted mean EQ-5D scores, for each BMI or 
BMI/SES category computed by setting the individual and household characteristics to their whole-
sample mean values. The individual and household characteristics are age, age squared and age cubed, 
predicted equivalised total annual household income, ethnicity, marital status, smoking status, 
Government Office Region of residence and survey year. The underlying model the predictions are 
based on is OLS. 
 
4.3.2 Socioeconomic variation in the association between obesity-related 
comorbidities and HRQL: results 
Table 4.6 shows the predicted mean EQ-5D score in each BMI category across the four 
obesity-related comorbidities by SES quartile. 
 
In each BMI category across each obesity-related comorbidity the mean EQ-5D score 
was lower in more deprived SES quartiles. For example, the mean EQ-5D score in 
diabetic individuals with type II/III obesity were 0.627 in SES quartile 1 (most deprived) 
and 0.712, 0.756 and 0.82 in quartiles 2, 3 and 4 (least deprived), respectively. 
 
 119 
 
In the introduction we stated that we aimed to investigate socioeconomic variation in 
the impact of obesity-related comorbidities on HRQL. Hence, we now look at the 
variation in EQ-5D score between individuals with and without the comorbidity within 
the same BMI group across SES groups. The analysis by SES quartile reveals 
socioeconomic variation in the relationship between obesity-related comorbidities and 
HRQL: the interaction between obesity-related comorbidities and SES was statistically 
significant for each comorbidity (diabetes; stroke; and, hypertension) (all: P<0.01). 
However, this was not found when the comorbidity in question was the ‘heart attack 
and angina’ category, where the interaction was not significant (P=0.2). We see that 
the association between obesity-related comorbidities and HRQL is more pronounced 
in the lower SES quartiles than in the higher SES quartiles. For example, obese class 
II/III individuals in SES quartile 1 (most deprived) with and without diabetes has a 
mean EQ-5D score of 0.627 and 0.759, respectively. This makes up a mean difference 
in EQ-5D score of 0.132 (0.759-0.627=0.132). Similar numbers for SES quartile 4 (least 
deprived) was 0.82 and 0.849, respectively. This makes up a mean difference in EQ-5D 
score of 0.028 (0.849-0.82=0.028). This trend persist in the obesity classes across all 
comorbidities, except for some groups with hypertension where the association was 
more negative in the higher SES groups. In the normal weight category we find similar 
trends of a more pronounced association between: diabetes; stroke and hypertension 
and HRQL in the lower SES quartiles. In general this trend shows that association 
between obesity-related comorbidities and HRQL is more pronounced in lower SES 
individuals.  
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These findings support the hypothesis of a more pronounced association between 
obesity-related comorbidities and HRQL in lower SES groups. This means that not only 
do lower SES individuals have a lower HRQL in general; they also have a larger 
reduction in EQ-5D score when they get obesity-related comorbidities.  
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Table 4.6: Impact of comorbidities on the relationship between obesity and HRQL 
across SES quartiles 
  Normal Over- Obese Obese Equal 
  weight Weight Class I Class II/III means 
Diabetes      
SES group 1 (most deprived)      
  Has diabetes 0.774 0.845 0.786 0.627 P<0.01 
  No diabetes 0.882 0.858 0.829 0.759 P<0.01 
Equal means P=0.01 P=0.50 P=0.04 P<0.01  
SES group 2      
  Has diabetes 0.806 0.847 0.828 0.712 P=0.05 
  No diabetes 0.914 0.901 0.871 0.832 P<0.01 
Equal means P=0.01 P=0.01 P=0.08 P=0.01  
SES group 3      
  Has diabetes 0.866 0.9 0.808 0.756 P<0.01 
  No diabetes 0.902 0.898 0.885 0.858 P<0.01 
Equal means P=0.28 P=0.93 P<0.01 P=0.01  
SES group 4 (least deprived)      
  Has diabetes 0.91 0.857 0.876 0.82 P=0.02 
  No diabetes 0.885 0.885 0.873 0.849 P<0.01 
Equal means P=0.07 P=0.16 P=0.873 P=0.34  
Test diabetes*SES = 0 P<0.01 
Heart attack and angina      
SES group 1 (most deprived)      
  Has heart attack or angina 0.77 0.724 0.677 0.491 P<0.01 
  No heart attack and angina 0.882 0.862 0.833 0.754 P<0.01 
Equal means P<0.01 P<0.01 P<0.01 P<0.01  
SES group 2      
  Has heart attack or angina 0.751 0.806 0.742 0.567 P<0.01 
  No heart attack and angina 0.914 0.901 0.873 0.831 P<0.01 
Equal means P=0.01 P<0.01 P<0.01 P<0.01  
SES group 3      
  Has heart attack or angina 0.802 0.77 0.753 0.688 P=0.63 
  No heart attack and angina 0.902 0.9 0.883 0.854 P<0.01 
Equal means P=0.06 P<0.01 P=0.01 P=0.02  
SES group 4 (least deprived)      
  Has heart attack or angina 0.796 0.871 0.761 0.794 P=0.11 
  No heart attack and angina 0.887 0.885 0.874 0.848 P<0.01 
Equal means P=0.01 P=0.54 P=0.03 P=0.60  
Test ‘heart attack and angina’*SES = 0 P=0.2 
Stroke      
SES group 1 (most deprived)      
  Has had a stroke 0.634 0.687 0.727 0.355 P<0.01 
  No stroke 0.882 0.86 0.827 0.748 P<0.01 
Equal means P<0.01 P<0.01 P=0.01 P<0.01  
SES group 2      
  Has had a stroke 0.755 0.777 0.746 0.421 P=0.08 
  No stroke 0.913 0.9 0.87 0.825 P<0.01 
Equal means P=0.1 P=0.03 P=0.09 P<0.01  
SES group 3      
  Has had a stroke 0.629 0.733 0.425 0.609 P=0.12 
  No stroke 0.902 0.899 0.884 0.852 P<0.01 
Equal means P<0.01 P=0.08 P<0.01 P=0.07  
SES group 4 (least deprived)      
  Has had a stroke 0.816 0.76 0.813 0.842 P=0.57 
  No stroke 0.885 0.885 0.873 0.847 P<0.01 
Equal means P=0.01 P<0.01 P=0.41 P=0.96  
Test stroke*SES = 0 P<0.01 
Hypertension      
SES group 1 (most deprived)      
  Has hypertension 0.841 0.833 0.832 0.715 P<0.01 
  No hypertension 0.882 0.861 0.824 0.747 P<0.01 
Equal means P=0.05 P=0.05 P=0.62 P=0.24  
SES group 2      
  Has hypertension 0.929 0.876 0.81 0.754 P<0.01 
  No hypertension 0.912 0.901 0.875 0.835 P<0.01 
Equal means P=0.28 P=0.09 P<0.01 P<0.01  
Table continues on the next page 
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Table continued 
SES group 3      
  Has hypertension 0.895 0.914 0.847 0.85 P<0.01 
  No hypertension 0.901 0.898 0.885 0.85 P<0.01 
Equal means P=0.79 P=0.15 P=0.04 P=0.99  
SES group 4 (least deprived)      
  Has hypertension 0.901 0.883 0.865 0.816 P<0.01 
  No hypertension 0.885 0.885 0.873 0.852 P<0.01 
Equal means P=0.30 P=0.90 P=0.53 P=0.08  
Test hypertension*SES = 0 P<0.01 
Notes 
The dependent variable is EQ-5D score. The values are predicted mean EQ-5D scores, for each BMI or 
BMI/SES category computed by setting the individual and household characteristics to their whole-
sample mean values. The individual and household characteristics are age, age squared and age cubed, 
predicted equivalised total annual household income, ethnicity, marital status, smoking status, 
Government Office Region of residence and survey year. The underlying regression model is OLS. 
 
4.4 Discussion 
The aim of this chapter was twofold. First, we investigate the association between 
obesity and HRQL in individuals with obesity-related comorbidities. Second, we explore 
whether or not there are socioeconomic variation in the association between obesity-
related comorbidities and HRQL.  
 
We provide evidence to show that people with obesity-related comorbidities have 
lower HRQL than those without obesity-related comorbidities in the same BMI group. 
Furthermore, overweight and obese people with: diabetes; hypertension; stroke; and, 
heart attack and angina, have significantly lower HRQL than those of normal weight. 
I.e. there is an association between obesity and HRQL in a population with obesity-
related comorbidities. Although, we would expect this result we are not aware of any 
studies that has investigated this, except for diabetes (See: Lee et al., 2005; Redekop et 
al., 2002). 
 
The association between obesity and HRQL was more negative in individuals with 
obesity-related comorbidities than in individuals without. The interactions between 
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BMI groups and obesity-related comorbidities (diabetes; heart attack or angina; and, 
stroke) were significant (P<0.01). Hence, the association between BMI groups and 
HRQL depends on obesity-related comorbidities (or vice versa). This means that the 
associations between obesity and HRQL are more negative in individuals with obesity-
related comorbidities than individuals without obesity-related comorbidities. However, 
this was not identified in individuals with hypertension as the interaction was not 
significant.  
 
This part of the analysis reveals a number of potential endogeneity issues. There may 
be omitted variable bias: one such variable might be disease severity. For example, 
imagine we have two types of stroke “severe” and “less severe”. Individuals who suffer 
a “severe” stroke may be more precluded from undertaking physical activity than 
individuals who have suffered a “less severe” stroke. Hence, individuals who suffer a 
more “severe” stroke will provide lower EQ-5D scores (because of the more severe 
stroke) and be more likely to be obese (because of the more severe stroke), which 
would mean that we overestimate the impact of obesity on HRQL. In the case of other 
diseases this effect might be opposite, so that individuals who have a more severe 
version of the illness lose weight and are less likely to be obese. In this case we would 
underestimate the impact of obesity on HRQL.  
 
These results are qualitatively similar to those in other studies, which have also shown 
that HRQL is negatively correlated with obesity for individuals suffering from diabetes. 
Lee et al. (2005) demonstrate a significant negative association between obesity and 
EQ-5D score across individuals with diabetes type 1, diabetes type 2 and without 
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diabetes controlling for age. They include individuals (six weeks) post discharged from 
an outpatient or inpatient clinic in Wales. They find that the age standardised EQ-5D 
score in normal weight (BMI: 18.5-24.9 kg/m2) individuals with Type 1 diabetes, Type 2 
diabetes and no diabetes were 0.706, 0.616 and 0.720, respectively. In this chapter 
values in individuals with and without diabetes were 0.834 and 0.895, respectively. 
Hence, we predict higher values in general, which might be because we look at the 
general population while they look at individuals who have had an inpatient stay or 
outpatient visits the last six weeks. Redekop et al. (2002) shows that being obese 
(BMI>30 kg/m2) compared to not being obese (BMI<30 kg/m2) reduce the EQ-5D score 
in diabetic individuals with -0.044 (P<0.01) controlling for age, gender, diabetes related 
complications, and insulin therapy. Our results show that, in diabetic individuals, the 
reduction in mean EQ-5D score going from normal weight to being obese class I or 
obese class II/III was -0.017 and -0.133, respectively. 
 
The result also contradicts the findings of Lee et al. (2005). They find an insignificant 
interaction term between BMI and diabetes status, and conclude that there is no 
variation in the association between obesity and HRQL by diabetes status. We find this 
interaction to be significant. We are not aware of any studies looking at this effect 
across other obesity-related comorbidities than diabetes.  
 
Our second analysis revealed that the negative association between obesity-related 
comorbidities and HRQL varies by SES. The association between obesity-related 
comorbidities and HRQL was more negative in individuals in lower SES quartiles than in 
higher SES quartiles. The interactions between SES and obesity-related comorbidities 
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(diabetes; hypertension; and, stroke) were significant (P<0.01). Hence, the association 
between obesity-related comorbidities and HRQL depends on SES (or vice versa). 
However, this was not found for the ‘heart attack and angina’ category, where the 
interaction was not significant (P=0.2), but the trend showed a more pronounced 
association in the lower SES groups. This could explain why we, in Chapter 3, found 
that lower SES individuals have more a more pronounced association between BMI 
and HRQL than higher SES individuals. Obesity increases the probability of obesity-
related comorbidities; however the comorbidities cause more problems in lower SES 
individuals. Note that this also depends on the prevalence of obesity-related 
comorbidities across obesity categories and SES. In Appendix 4.3 we illustrated that 
the prevalence of obesity-related comorbidities increased more in lower SES groups 
than in higher SES groups going from normal weight to obese. Hence, this is also a 
reason for our findings in Chapter 3.  
 
It is not clear why obesity-related comorbidities would cause more problems in lower 
SES groups. We offer some suggestions. It has been shown that lower SES is associated 
with lower adherence to medication treatments including lipid lower medication 
(Avorn et al., 1998). For instance for diabetes, it could be the case that favourable 
economic and social circumstances improve individuals’ ability to monitor and control 
glycemic status. Poor glycemic control is associated with development of diabetic 
complications (Golden et al., 2003) and therefore makes diabetes worse in lower SES 
groups. However, one must be aware that it is difficult to establish causality as this 
analysis might suffer from endogeneity issues. We can not exclude the possible reverse 
causality. For example, individuals who have more problems with controlling diabetes 
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have a tendency to become lower SES (e.g., loss in income due to poor health) as a 
result of the poorly controlled diabetes.  
 
There are several implications of the results in this chapter. They suggest, as earlier 
studies, that there is an association between obesity and HRQL in individuals with 
obesity-related comorbidities. Furthermore, this is the first study that we are aware of 
that suggests that this association is significantly different for individuals with and 
without obesity-related comorbidities. The association is more negative in individuals 
with obesity-related comorbidities. The implication is that attention needs to be paid 
to the role of comorbidities when undertaking economic evaluation of obesity 
interventions. Care is required when selecting HRQL estimates for BMI categories to 
ensure that the values used are appropriate to the prevalence of obesity-related 
comorbidities in the population of interest.  
 
We find that obesity-related comorbidities are associated with a more pronounced 
loss in HRQL in lower SES groups compared with higher SES groups. This could explain 
the results obtained in Chapter 3. However, as mentioned this also depends on the 
incidence and prevalence of comorbidities across SES groups. Nevertheless, it suggests 
that part of the reason why there is SES variation in the association between obesity 
and HRQL is that lower SES individuals have more problems with the obesity-related 
comorbidities.  
 
These findings can also be generalised to explain socioeconomic variation in the impact 
of other lifestyle-related risk factors on health. For example, Birch et al. (2000) and 
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Pampel and Rogers (2004) findings on socioeconomic heterogeneities in the impact of 
smoking on health. Smoking is associated with increased prevalence of comorbidities, 
which might have an increased burden in lower SES groups. There has been a focus on 
comorbidities as a reason for the variations in the associations between lifestyle and 
health. For example, Birch et al. (1997) suggest that high SES individuals might have a 
better ‘adaptive defence’ against smoking-related diseases. However, to our 
awareness it has never been tested. These findings suggest that it is related to the 
comorbidities.  
 
This study also draws attention to a potential weakness in studies investigating the 
impact of obesity on HRQL. That is that we do not know if it is obesity that decreases 
HRQL, or if it is the severity of the comorbidity that increase/reduce BMI and reduce 
HRQL. Hence, it is emphasised that we have investigated associations between obesity 
and HRQL and not the impact of obesity on HRQL. Nevertheless, this study is the first 
to investigate and show significant interactions between obesity and obesity-related 
comorbidities. In this way it suggests that more research is needed in this area to 
establish causal relationships.  
 
In addition to the endogeneity issues mentioned above, this study suffers from a 
number of potential limitations. There may be other omitted variables in addition to 
the ones mentioned above. One such factor might be the discount rate – the rate of 
time preference – which affects the weight that individuals give to their future health 
and also their BMI (Morris, 2007). There may be measurement error: if BMI is mis-
measured (e.g., if it is based on self-reported height and weight), and if the level of 
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mis-measurement is associated with HRQL, the obesity coefficients may be biased 
(note that in our data height and weight were obtained during the interviewer visit and 
are not self-reported so the likelihood of this problem is reduced). Related to this, 
there may be reporting bias with respect to HRQL: EQ-5D, like any HRQL measure, is 
essentially subjective. It may therefore suffer from systematic reporting bias that is 
correlated with obesity, SES and/or with the longstanding illness. In addition, the HSE 
data are cross-sectional. We therefore model the impact of current obesity on current 
HRQL, when obesity in previous time periods might be more significant. Furthermore, 
our measure of obesity is BMI, which has been criticised, e.g., because it does not 
incorporate body fat, which is an independent predictor of ill health (Burkhauser & 
Cawley, 2008). Also, we measure HRQL in a single measure (EQ-5D); previous studies 
have provided results using both this and alternative HRQL measures, such as the SF-
6D (Sach et al., 2007) and the SF-12 (Jia & Lubetkin, 2005). Previous studies 
investigating the impact of obesity on HRQL in a population with diabetes (Lee et al., 
(2005); and Redekop et al., 2002) also suffer from the limitations mentioned above. 
 
To summarise, we illustrate that the association between obesity and HRQL is more 
negative in individuals with obesity-related comorbidities than in individuals without 
these. Furthermore, we illustrate that obesity-related comorbidities are more 
negatively associated with HRQL in the lower SES groups. Hence, the reason for the 
SES variation identified in Chapter 3 is partly due to SES variation in the association 
between obesity-related comorbidities and HRQL.  
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CHAPTER 5 
 
Socioeconomic variation in the relationship between 
obesity and life expectancy 
 
5.1 Introduction  
Life expectancy has improved year-on-year over the past decade; however the 
socioeconomic gap continues to widen (Department of Health, 2008). As mentioned 
earlier, obesity levels have been rising over the last decade and there is compelling 
evidence showing a socioeconomic gradient in obesity.  Numerous theories have tried 
to explain how different factors contribute to the widening socioeconomic life 
expectancy gap, and lifestyle related risk factors like smoking and obesity are 
frequently identified as contributors (see, e.g., Marmot, 2010).  
 
In chapter 3 we found that the association between obesity and HRQL is more negative 
in lower SES individuals compared with higher SES individuals and suggested that the 
relationship between obesity (Ot) and HRQL should be modelled by including an 
interaction between obesity and SES:  
 
tttttt eXbSESObSESbObbH  43210 *      (5.1) 
 
 130 
 
The aims of this chapter are to investigate whether or not we find similar SES variation 
in the relationship between obesity and life expectancy. We start with a review of the 
literature investigating the relationship between obesity and life expectancy. We then 
undertake an analysis using data from an individual level health survey and its 
longitudinal follow up, which includes height and weight collected at nurse visit, plus a 
set of individual and household characteristics that allows us to control for 
confounding factors that affect the relationship between obesity and life expectancy.  
 
5.2 Literature review: the association between obesity and 
mortality/life expectancy 
The objective of the review was to identify studies that investigate the association 
between obesity and mortality/life expectancy in order to identify the appropriate 
econometric specification to use. In the following analysis we investigate the impact of 
obesity over a lifetime. We want the studies identified in this review to inform our 
analysis. Hence, we choose to focus on papers using duration/survival analysis 
methods that take lifetime into consideration. Thus we do not look at studies who 
investigate outcomes like “the probability of premature mortality” or “10 year 
mortality risk” using binary choice models.   
 
There are two main estimation techniques depending on the underlying survival time 
variable; continuous or discrete time models. In our data time is measured as a 
continuous variable, hence these models will be in focus in this review. Within 
continuous time models we have both; semi-parametric and parametric models. The 
advantage of the semi-parametric model is that it is less restricted by the underlying 
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parametric distribution. However, the parametric distributions allow one to predict 
median life expectancy and control for unobservable heterogeneity; this will be 
discussed in greater detail later.  
 
5.2.1 Search strategy 
We use similar methods to Chapter 2 and search the literature in three stages: First, 
we conduct a search in PubMed using controlled vocabulary:  
 
"Obesity"[Mesh] OR "Body Mass Index"[Mesh] AND "Mortality"[Mesh] OR "Life 
Expectancy"[Mesh] AND "Survival Analysis"[Mesh] 
 
The search gave 1096 hits. We screened the title and abstract of these to identify 
relevant papers. We ended up with 9 papers. The second stage was a reference search 
of the identified papers in the first stage. In the third stage we used the “cited by” 
option in Google scholar to identify papers that had referenced the papers identified in 
the first two stages. Based on the second and third stage we found 9 new papers and 
we ended up with a total of 18 papers. 
 
From each paper we extracted the publication year, country, baseline year and length 
of follow up, methods and results, see Table 5.1. 
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Table 5.1: Literature review of studies on obesity and life expectancy 
Authors, 
country, year 
Participant
s and age 
at baseline 
Baseline and 
follow up years 
Statistical methods Results 
Abell et al., 
USA, 2008 
n=27691,  
not given 
Values collected 
between 1960 
and 1980; follow 
up 15-30 years 
Cox model; BMI as categorical variable; 
control for age, smoking status, 
hypertension, cholesterol, and 
diabetes; separate models by gender 
and race 
Find that obesity is an 
independent predictor of 
cardiovascular disease 
mortality in white people. 
Adams et al., 
USA, 2006 
n=567265, 
age 50-71 
1995; follow up 
10 years 
Cox model; include BMI as a categorical 
variable; adjusted for race or ethnic 
group, level of education, smoking 
status, physical activity, and alcohol 
consumption; separate by race, age, 
smoking, chronic disease, and duration 
of follow-up 
The risk of death among 
obese (BMI> 30) subjects 
was two to at least three 
times that of participants 
with a BMI of 23.5 to 24.9. 
Allison et al., 
USA, 1999 
n varied by 
dataset, 
age 18+ 
Use six datasets. 
The dataset with 
the longest follow 
up was from 1971 
and had a follow 
up of 21 years 
Cox model; BMI as categorical variable; 
controlling for age, gender and smoking 
Apply six data sources and 
find hazard rates between 
1.33 – 1.60 of a BMI 
between 30-35 compared 
to a BMI between 23-25. 
Al Snih et al., 
USA, 2007 
n=12725, 
age 65+ 
1982; follow up 
for 7 years. 
Cox model: BMI as categorical variable. 
control for age, sex, marital status, 
smoking status, years of formal 
education, and selected obesity related 
medical conditions 
Looked at individuals 65 
and older. Found higher 
mortality in individuals 
who has had a BMI of 35 
and above.  
Batty et al., 
England, 2006 
N=18403, 
age 40-64, 
male only, 
only civil 
servants  
1967-1970: follow 
up maximum 35 
years 
Cox model: BMI as categorical variable. 
Control for age, employment grade, 
physical activity, smoking habit, marital 
status, disease at entry, weight loss in 
the previous year, BP lowering 
medication, height adjusted FEV1, 
systolic BP, diastolic BP, plasma 
cholesterol, blood glucose (in 
normoglycaemic patients), glucose 
intolerance, and diabetes status. 
Find a significant negative 
impact of obesity on 
mortality.   
Bender, 
Trautner, 
Spraul, & 
Berger, 
Germany , 
1998 
N=6193, 
age 18-75, 
include 
only 
individuals 
with a BMI 
over 25 
1961; follow up 
33 years 
Cox model; BMI as categorical variable; 
control for age, systolic blood pressure, 
cholesterol, diabetes, glucose tolerance 
and smoking; separate by gender 
Having a BMI of 36-40 is 
associated with a hazard 
ratio of 1.31 compared to 
having a BMI of 25-32  
Calle et al., 
USA, 1999 
N=1,184,65
7, age 30+ 
1982; follow up 
14 years 
Cox model; include BMI as a categorical 
variable; separated population by 
smoking status and disease history; 
control for age, education, physical 
activity, alcohol use, marital status, 
aspirin use, fat consumption, vegetable 
consumption, and (in women) use of 
estrogen-replacement therapy 
Find that the hazard rate of 
a BMI of 30-31.9 is 1.62 
compared to a BMI of 23.5-
24.9 in non smoking men 
aged 30-64 
Czernichow et 
al., UK, 2011 
N varied 
between 
the 
surveys, 
age not 
given 
Collected 
between 1994 
and 2003; mean 
follow up of 8.1 
years 
Cox model; BMI as a continuous 
variable; control for: age and sex, 
followed by socioeconomic status, 
cigarette smoking, systolic blood 
pressure, total blood cholesterol, 
diabetes status, physical activity and 
history of CVD 
Obesity increase mortality 
risk using Body Mass Index, 
waist circumference, and 
waist to hip ratio as 
measure of obesity.  
Flegal, 
Graubard, 
Williamson, & 
Gail, USA, 2005 
N=36859, 
Age 25+ 
1971; follow up 
21 years 
Cox model; BMI as categorical variable; 
controlled for sex, smoking status, race, 
and alcohol use; separated by age 
Calculate excess deaths 
from overweight and 
obesity combined (BMI 
>25) to be 25 814 in year 
2000 
Fontaine et al., 
USA, (2003) 
N varied by 
the survey, 
age18-85 
1971-75; follow 
up 17-21 years 
Cox model; include BMI as a quadratic 
term; separate by race and gender; 
control for age and smoking 
20 year old white male 
with a BMI of more than 45 
is estimated to lose 13 
years of life due to obesity. 
Freedman, 
Ron, Ballard-
N=83744, 
age 22+ 
1983-1989; follow 
up 11-17 years 
Cox model; BMI as categorical variable; 
control for education, race, smoking 
Calculate that the hazard 
rate of a BMI of 30-34.9 is 
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Barbash, 
Doody, & Linet, 
USA, 2006 
and alcohol use; separate by gender, 
race and age 
1.47 for a man above the 
age of 55 compared to a 
man with a BMI of 21-22.9  
Lawlor et al., 
Scotland, 2006 
Men: 
n=11033 
women: 
n=8327, 
age 45-64 
1972-1976; follow 
up 28 to 34 years 
Cox model: BMI as categorical variable. 
Control for age and smoking  
Obesity and overweight is 
associated with all cause 
mortality 
Mayhew, 
Richardson, & 
Rickayzen, UK 
2009 
N=7414, 
age 18+ 
1984-85; follow 
up 21 years 
Cox model; include BMI and waist to 
height as a quadratic term; separate by 
gender and smoking status; control for 
age 
A non-smoking 30-year old 
man with a BMI of 34 is 
expected to live 4 year less 
than a similar man with a 
BMI of 24. For women the 
equivalent loss is 2 years. 
Seidell, 
Verschuren, 
van Leer, & 
Kromhout, 
Netherlands, 
1996  
N=48287, 
age 30-54 
1974-1980; follow 
up 12 years 
Cox model; BMI as a categorical 
variable; control for smoking, 
hypertension, hypercholesterolemia, 
and diabetes mellitus 
Obesity (BMI>30) had a 
hazard rate of 1.5 
compared to normal 
weight (18.5<BMI<4.9) 
Stevens et al., 
USA, 1998 
Men: 
n=62116 
women: 
n=262019, 
age 30+ 
1959; follow up 
12 years 
Cox model; include BMI both as a 
continuous and categorical variable; 
exclude individuals with a smoking 
history; separate by age; control for 
age, education, physical activity and 
alcohol use 
The hazard ratio associated 
with an increment of 1 in 
BMI was 1.1 for men aged 
30-44. For women the 
corresponding estimate 
was 1.08 
Tsai et al., USA, 
2006 
N=7139, 
age not 
given, only 
workers at 
an oil plant 
1988; follow up 
20 years 
Cox model: BMI as categorical variable. 
Control for age, sex, and smoking 
status, cholesterol, hypertension, and 
fasting blood glucose 
Obesity was associated 
with increased mortality  
Vapattanawong 
et al., Thailand, 
2010 
N=15997, 
age 60+ 
2004; mean 
follow up:3.8 
years 
Cox model: BMI as categorical variable. 
control for marital status, urban/rural, 
education, living arrangement, 
diabetes, hypertension, smoking, and 
physical activity 
Focused on individuals 
aged 60 and above and did 
not find a negative impact 
of obesity on survival. 
Yan et al., USA, 
2006 
N=17643, 
age 31-64 
Values collected 
between 1967 
and 1973; mean 
follow up was 32 
years 
Cox model; BMI as categorical variable; 
control for age, sex, education, minor 
electrocardiographic abnormality, 
systolic blood pressure, and serum total 
cholesterol level. Stratified by smoking, 
blood pressure and cholesterol level 
For individuals with no 
cardiovascular risk factors 
as well as for those with 1 
or more risk factors, those 
who are obese in middle 
age have a higher risk of 
mortality from CHD, 
cardiovascular disease, and 
diabetes in older age than 
those who are normal 
weight 
Note 
Could not obtain the full version of the Seidell, Verschuren, van Leer, & Kromhout (1996) paper. The 
description is based on information in the abstract 
 
5.2.2 Findings 
We identified 18 studies and most of them support a negative association between 
obesity and life expectancy. They all use the Cox proportional hazard model and 
frequently test for proportional hazard of the covariates and fit models that do not 
violate the proportional hazard assumption. However, we are not aware of any studies 
that have applied other alternative parametric survival distributions.  
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In these studies there is a trade-off between how recent the data is (date for obesity 
measurement and other measures) and the length of the mortality follow-up. The 
longest follow up we have identified is a mean of 33 years in a German study by 
Bender, Trautner, Spraul, & Berger (1998) using data from 1961. None of the identified 
studies had repeated measures of BMI. 
 
Smoking receives a great deal of attention in these studies as it has been showed to 
modify the association between BMI and mortality (Stevens, Juhaeri, Cai, Thun, 2000). 
The reason being that people who smoke have a tendency to have a lower BMI but 
also a higher mortality; hence it reduces the association between obesity and 
mortality. This is controlled for either by stratifying by smoking status or controlling for 
it as a covariate in the model. 
 
Age has also received attention in some of the studies as two American studies found 
it to have an impact on the relationship between BMI and mortality. The relationship 
between BMI and mortality is characterised by a U or a J shape, however it has been 
found to flatten out as age increase (Freedman et al., 2006). BMI seems to have a 
protective effect in the oldest individuals (aged 75 and older) (Stevens at al., 1998).  
 
Survival models, which look at BMI, have issues with omitted variables. This is other 
explanatory variables that have not been included in the model that are correlated 
with the dependent variable (life expectancy) and the independent variables (BMI 
groups). Although we would expect obesity to reduce life expectancy it is possible that 
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it is actually health variables that influence both life expectancy and BMI. One way to 
control for this is to control for longstanding illnesses15. However, remember that 
when we do this we reduce the risk factor effect of obesity16. Six studies have 
controlled for illness variables and two stratify by this, although with conflicting 
results. However, the studies that control for illness variables have only controlled for 
illness variables that are related to obesity. For example, Abell et al. (2008) control for 
hypertension, cholesterol and diabetes. Hence, they do not sufficiently deal with the 
omitted variable issue mentioned above. There is a need for a study that investigates 
the consequences of controlling for all illnesses, not only those related to obesity. 
 
Although research from other countries is useful when assessing the impact of excess 
body fat on the UK population, research based on UK specific data would be more 
relevant when answering UK specific questions (Mayhew, Richardson, & Rickayzen, 
2009). The majority of research is based on US data; however we have identified four 
studies based in the UK.  Three studies using UK data have calculated hazard ratios due 
to obesity based on Cox models. Czernichow et al. (2011) conducted a study to 
investigate the association between three measures of body fat (BMI, waist 
circumference and waist-hip ratio) and CVD mortality risk using Health Survey for 
England data linked to mortality records. They find that BMI is a predictor of mortality 
controlling for age and sex, socioeconomic status, cigarette smoking, systolic blood 
pressure, total blood cholesterol, diabetes status, physical activity and history of CVD. 
Little difference was found between the measures of body fat (BMI, waist 
                                                     
15
 It has been argued that controlling for comorbidities is an overadjustment as these factors are part of 
the pathway between obesity and the output variable (See Zizza, 2004). 
16
 Although we do not completely remove the risk factor effect as individuals can get longstanding 
illnesses after the date of BMI measurement. 
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circumference and waist-hip ratio). The mean age at baseline ranged from 49-57 years, 
but there is a relatively short follow up of only 8.1 years. Lawlor et al. (2006) 
investigate the impact of obesity controlling for age and smoking using data from two 
Scottish towns. They account for heterogeneity bias by omitting individuals who die 
within two years after the physical measurement. They find that obese individuals 
have a significantly higher hazard rate for death than normal weight individuals. Batty 
et al. (2006) use the Whitehall study and investigate the hazard rate for death in obese 
individuals controlling for age, employment grade, physical activity, smoking habit, 
marital status, weight loss in the previous year, physical and illness variables related to 
obesity. These three studies all use the Cox proportional hazard model. The authors do 
not provide information about whether or not they have tested the proportional 
hazard assumption. If this assumption is violated their estimates may be invalid. 
Hence, although it is an advantage that these studies control for a number of 
covariates in terms of heterogeneity, the more covariates the more likely they are to 
violate the proportional hazard assumption. Hence, we will test for proportional 
hazard in our analysis. They also report their results as hazard ratios, but do not show 
the consequences of obesity for life expectancy in terms of life years lost. 
Furthermore, both the study by Lawlor et al. (2006) and Batty et al. (2006) use does 
not use data that is representable of the English population. Although Czernichow et 
al. (2011) use a the HSE the short follow up makes it problematic to estimate the 
consequences of obesity in the long run, in addition, the results are extra vulnerable to 
heterogeneity bias.    
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Mayhew, Richardson, & Rickayzen (2009) investigate the effect of obesity, measured 
by BMI and waist to height ratio (WTH), on life expectancy controlling for age and 
stratifying by smoking status and conclude that higher BMI and WTH reduce life 
expectancy. They test for proportional hazard and allow for interactions between 
BMI/WTH and age. They do not find an interaction between age and BMI; however 
they do find an interaction between age and WTH. To generate predictions of life 
expectancy they calculate age and BMI specific hazard ratios based on the Cox model. 
They then get the probability of death in each year of adult life from life tables. Then 
multiply the BMI specific hazard ratio with the probability of death in each year. To 
control for smoking the analysis was conducted on two datasets: non-smokers and all 
participants (smokers and non-smokers together). This study does not control for any 
other covariates like SES, ethnicity, marital status and comorbidities/longstanding 
illnesses, which can cause heterogeneity. For example, we know that obesity is related 
to socioeconomic status. Furthermore, longstanding illnesses might affect both obesity 
and life expectancy. Hence, we will control for these in our study. In addition, rather 
than stratifying by smoking status we will control for it in the analysis. 
 
Relatively little interest has been given to socioeconomic variables. Six studies have 
controlled for SES variables. Though, we have not found any studies that focus 
specifically on SES and analyse whether or not the impact of obesity varies by SES 
groups. 
 
To conclude, there is evidence of a relationship between obesity and mortality/life 
expectancy, in that obesity increases mortality and reduces life expectancy. Based on 
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the identified literature we argue that there are still issues yet to be resolved. None of 
the studies has controlled for all comorbidities, only comorbidities related to obesity. 
We will in the following look at the consequences of controlling for comorbidities. 
Except from the Cox model, no other alternative parametric distribution has been tried 
out so none have predicted life expectancy based on parametric distributions. None of 
the studies consider the influence of unobservable heterogeneity related to duration 
dependence on estimated mortality, which might produce incorrect results (Jones, 
2005). There is uncertainty regarding the effect of age, only one study has looked at 
this in England and the findings were inconsistent. In addition, there has been 
relatively little focus on how socioeconomic status influences this analysis and we have 
not been able to identify studies that investigate whether or not the impact of obesity 
on life expectancy varies by SES. We will account for these issues in the following 
chapter.  
 
5.3 Methods 
 
5.3.1 Data 
The analysis is based on data from the first wave of the Health and Lifestyle Survey 
(HALS1)17 (1984/1985; n=9003) and the longitudinal follow up in June 2009. HALS1 
surveys a representative sample of the population of Great Britain aged 18 years and 
                                                     
17
 There is also a follow up survey HALS2 1991/2. The benefit of using this second round would be that 
we could get repeated BMI measurement. However, this has not been used in this analysis due a 
relatively high dropout rate (41%) (n=5352). We analyse our data by BMI and SES groups and need a 
certain amount of individuals in each group for our analysis to be meaningful. This is even more 
important in survival analysis as only part of the individuals in the sample have died. In addition, with a 
high dropout rate there are problems with attrition bias.  
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over. Data for HALS1 were collected between autumn 1984 and summer 1985, in two 
home visits, the second by a research nurse during which a range of physiological 
measurements (including height and weight) were taken. In the longitudinal follow up 
in June 2009 the original participants in HALS1 were flagged on the NHS Central 
Register (NHSCR) (now part of “The NHS Information Centre for Health and Social 
Care”), which is a computerised record of everyone registered with a GP in Great 
Britain that also collects demographic information, including mortality 
(http://www.ic.nhs.uk/). The linkage between HALS1 and NHSCR meant that it was 
possible to assess whether or not participants in HALS1 had died by June 2009 and if 
so, their date of death. Ninety eight percent of participants in HALS1 were identified in 
the NHSCR.  
 
In our analysis we excluded pregnant women at the date when BMI was measured, 
because their BMI is temporarily increased, and individuals with missing BMI data; this 
reduced the sample from 8803 to 7,289. We also excluded individuals under the age of 
40 years at the time of HALS1. This was for two reasons. First, by 2009 low mortality 
rates were observed among those below 40 years of age, which meant that a high 
proportion of the survival data were censored in this group. Second, there is some 
uncertainty about the SES of those under 40 years of age; our SES measures are based 
on educational, occupation and social class, which may change over time, especially 
among younger groups. We are unable to account for such changes in our analysis, 
which means that the observed impact of SES on survival could be biased. A similar 
approach has been taken in previous analyses of HALS data (Balia & Jones, 2008). This 
reduced the sample from 7,289 to 4,062.  
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5.3.2 Variables and data handling 
Survival time is measured as the time to death or censoring in months from the date at 
which height and weight were measured in HALS1. Thus, the ‘entry date’ is the date of 
BMI measurement in HALS1 and the ‘exit date’ is either date of death or date last 
recorded alive (which is June 2009) if the respondent did not die during the follow-up 
period. Survival time is right censored because actual survival time is not observed for 
those who died beyond the censoring point. It is also left truncated because it is 
observed only for those individuals who survived up to the HALS1 interview date. 
 
Our obesity measure is based on body mass index (BMI), measured as weight in 
kilograms divided by height in metres squared (kg/m2). BMI is computed from the 
height and weight measurement obtained during the nurse visit; it is not based on self-
reported height and weight, which means that the likelihood of systematic 
measurement error is reduced. Obesity is measured as a categorical variable based on 
three BMI categories: normal weight 18.5-25 kg/m2; overweight 25-29.9 kg/m2; and, 
obese >30 kg/m2. Our data also has a small number of respondents in the underweight 
category. As earlier chapters we include this as a separate category, but do not report 
the results. 
 
To generate our measure of SES we follow the approach in earlier chapters and use a 
composite measure. The main reason being that it is designed to capture multiple 
dimensions of SES (individual and household variables) rather than focusing on a single 
aspect (e.g., income). We use interval regression methods (because the income 
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variable is banded) to construct the SES measure and regress total weekly household 
income reported in 12 income bands (including an open-ended top category) against a 
set of socioeconomic variables. In this interval regression we do not exclude individuals 
under the age of 40. I.e. we include all individuals over the age of 18 in this prediction 
and control for age. This is done to include the maximum amount of individuals in the 
model. The socioeconomic variables used as covariates in the interval regression are: 
education qualifications (measured in six categories); social class of household 
reference person (HRP; seven categories); individual economic activity status (seven 
categories); owning a house (yes/no); bedrooms in household (four categories); age (as 
a quadratic function); and, gender interacted with age. We calculate predicted values 
from this model. In case of the income variable in HALS there is a high non-response 
rate, so to maximise the sample size, we included individuals in the duration models 
with missing income data for whom we could compute a predicted value. In the 
duration models we included an indicator for missing income (yes/no), to control for 
the possibility that income may not be missing at random. By doing this we compute 
SES values for 1313 (over the age of 40) individuals with missing income values. The 
predicted SES measure is then divided into quartiles for use in the duration models.  
 
In the duration models we also control for a range of individual and household 
characteristics. Age was included as a quadratic function (based on likelihood ratio 
tests for functional form). We control for smoking status (three categories) as it has 
been showed to modify the association between BMI and mortality (Stevens, Juhaeri, 
Cai, Thun, 2000). In addition we control for marital status (five categories), 
geographical area (ten categories) and ethnicity (three categories) to reduce the risk of 
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heterogeneity bias. We also run a model controlling for number (five categories) and 
whether or not the longstanding illness limits activities in some way (yes/no). 
 
5.3.3 Econometric methods 
We start by describing the theory behind the econometric methods applied before we 
describe how they will be used in this analysis. 
 
5.3.3.1 Parametric vs. semi-parametric models  
The basic concepts of duration analysis are the survival function and the hazard rate. 
The survival function (S(t)) is the probability that someone survives to at least time t. 
The probability of survival is equal to 1 at the entry in the state of interest. In this 
analysis we follow the individuals from the time of height and weight measure 
(sometime between 1984-1985) until June 2009. At this point those who are not dead 
are censored. The hazard rate is the instantaneous rate of failure per unit of time, so it 
shows the probability that someone fails at time t, given that they have survived up to 
that point.  It can be written as: 
 
)(
)(
)(
tS
tf
th            (5.2) 
 
Where f(t) is the probability density function for the probability of failing at time t. The 
density function will capture uncensored observations, where we observe their actual 
time of failure, and the survival function is used for censored observations where we 
only know that they have survived to at least time t.  
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We follow our participants for up to 300 months (1984/85 - 2009). We consider these 
intervals (in months) to be sufficiently small so that it is reasonable to treat the 
observed times occurring on a continuous time scale; hence we apply continuous time 
models (Masyn, 2003). We focus on two approaches to duration analysis; parametric 
and semi-parametric approaches. Both of these can be expressed as: 
 
)exp(*)()( 0 ii xthth          (5.3) 
 
The dependent variable is the hazard function at a given time, for individual i. The first 
term on the right hand side ( )(0 th ) is the baseline hazard and corresponds to the 
probability of dying when all explanatory variables (xi) are equal to zero. The shape of 
the baseline hazard allows us to estimate how the hazard function changes with time. 
In the semi-parametric Cox model this term is left unspecified and treated as an 
unknown function of time. If this term is specified it yields a parametric model. A 
parametric model assumes particular functional forms for the survival function S(t) and 
the probability density function f(t) and then also the hazard function h(t). For a 
further description of each functional form for S(t) and f(t) available in Stata 11 see 
StataCorp (2009), table 1, p. 358. The second part of function 5.3 above ( )exp( jx ) 
allows us to estimate the proportional change that can be expected in the baseline 
hazard related to changes in the explanatory variables (the x’s).  
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The semi-parametric Cox proportional hazard18 model is more flexible and robust than 
the parametric models as it does not specify the baseline hazard but treats it as an 
unknown function of time.  However, “a parametric version, if adequate, would lead to 
more efficient estimates of survival probabilities and contribute to a better 
understanding of the survival/duration phenomenon under study” (Hjort, 1992). A 
further advantage of the parametric models is that they allow controlling for 
unobservable heterogeneity by including a frailty distribution, which we explain in 
more detail below. This cannot be done in Cox models without repeated 
measurements for each individual19. In addition, parametric models allow one to 
predict median life expectancy based on the survival function.   
 
Above we explained how we could calculate the impact of the coefficients ( )exp( jx ) 
on the baseline hazard, which is the instantaneous rate of failure per unit of time. This 
could also be seen as a multiplicative risk of dying in each time period and we refer to 
it as the relative mortality. The relative mortality between obese and normal weight is:
ttimeatweigthnormaltheindeathsofNumber
ttimeatobesetheindeathsofNumber
. Since the hazard ratio is relative 
similar hazard ratios can have unequal consequences in additive terms across groups 
depending on the baseline mortality in that group.  
 
                                                     
18
 The Cox model assumes that time is continuous and there are no tied survival failures. Tied failures 
are failures that fall within the same time period but that did not happen exactly at the same point in 
time. These do occur and the Cox model needs a method to handle these. We use the Breslow method 
for tied failures, which assumes that failures in the same period did actually happen in the same period. 
It has been shown to work well if the number of events is small relative to the sample size. 
 
19
 The stcox command for the Cox proportional hazard model includes an option for estimating models 
with shared frailty, assuming a Gamma mixture. However, in this data that we use, there is only a single 
record per person, and so the command is not applicable (Jenkins, 2008). 
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While the relative mortality risk can give an indication about relative severity of 
obesity it does not quantify the implications in terms of magnitude of difference (such 
as how much sooner an obese person will die). Hence, we also predict life expectancy, 
which can be considered more useful in terms of information. We describe this in 
more detail later. 
 
5.3.3.2 Unobservable heterogeneity 
Unobservable heterogeneity has received some attention in the literature on duration 
analysis (Jones, 2005). The potential problem can be explained by a scenario where the 
population is made up of two subpopulations: ‘frail’ individuals’ with a high hazard rate 
and ‘strong individuals’ with a low hazard rate. Whether or not one is considered to be 
in the frailty group is decided by unobserved variables. Over time the frailer individuals 
die first and the proportion of frail individuals in the population will decrease and the 
overall hazard will decrease.  
 
This can bias the results in two ways. First, if the frail individuals are equally distributed 
across the sample it can decrease all hazard ratios of each explanatory variable in the 
model (decreasing duration dependence). Second, if frailty is a confounder for some 
variables it could lead to false hazard ratios for these estimates (Masyn, 2003). For 
example, terminally ill individuals might lose weight and die early, which would 
underestimate the impact of obesity on life expectancy. 
 
To account for unobservable heterogeneity (frailty) we add an extra error term (v) to 
the parametric models as shown below.  
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)exp(*)(*)exp(*)()( 00 uxthvxthth iii        (5.4) 
 
Where h0(t) is the baseline hazard function and the ‘error’ term u = ln(v) is a random 
variable with a mean of zero. The random variable v, or equivalently u, can be 
interpreted as the impact of ‘omitted variables’ on the hazard rate. We must assume a 
distribution for the added error term (frailty distribution) and the Gamma distribution 
and Inverse Gaussian distribution have been most commonly used (Jenkins, 2008). We 
follow Forster & Jones (2001) and assume a gamma distribution for this error term 
(gamma frailty). 
 
5.3.3.3 The proportional hazard assumption 
A main assumption in a proportional hazard model is proportionality, which means 
that the hazard rate is independent of time t. In the Cox model we use Schoenfeld and 
scaled Schoenfeld residuals to test for proportional hazard, both as a whole and for 
each individual predictor. The null hypothesis is, effectively, that the log hazard ratio is 
constant over time; a rejection of the null hypothesis indicates that the proportional 
hazards assumption is violated. 
 
Note that proportional hazard does not mean that the BMI of individuals does not vary 
across time. It measures the average hazard rate for the individuals depending on their 
BMI category at the time of the survey. Hence, most individuals change their BMI 
status during follow up. So our model measures the impact of being obese at one point 
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in time and then it takes into account mean variations from this obesity status across 
all individuals in the sample. 
 
5.3.3.4 Predicting median life expectancy 
As mentioned above we aim to calculate life expectancy and see how this varies by 
BMI and SES. Life expectancy for an individual is a result of the hazard rate (probability 
of dying in each time period) for an individual across time. Hence, life expectancy is a 
useful and interpretable index. We focus on median life expectancy which is the time 
beyond which 50% of the subjects are expected to survive.  
 
Estimating median life expectancy consists of two stages. First, we plug in the mean 
covariate values and the parameter estimates into the survival function S(t), we 
denote this )(ˆ tS . The second stage is to set )(ˆ tS =1/2 to get the predicted value when 
50% of the subjects are alive.  
 
}2/1)(ˆ:{_  tSttMedian         (5.5) 
 
Hence, to predict the median survival time in this way the survival function must be 
specified. As mentioned earlier the semi-parametric Cox model leaves the baseline 
function unspecified so we do not have this option in semi-parametric models.  
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5.3.3.5 Choosing the parametric distribution 
There are several parametric distributions and we want to choose the parametric 
distribution that best fits the data. We test the following distributions of the survival 
function S(t) available in Stata 11: Weibull, generalised gamma, Gompertz, 
exponential, lognormal and loglogistic. We decide upon the parametric specification 
that best fit our data in two stages. First, we use plots of cumulative Cox-Snell residuals 
for the observed failures in the sample to assess the general fit of the model for those 
who fail. This compares the predictions of the hazard accumulated over time with the 
actual failures over time. A correctly fitted model should yield a straight line with a 
slope of 1. We pick out the distribution based on visual examination of the residuals. 
Hence, we might end up with more than one distribution and use the second stage to 
choose between these. In the second stage we compute Akaike’s Information Criterion 
(AIC). The AIC is a measure that rewards general goodness of fit of a model, which 
penalises overfitting. The preferred model is the one with the lowest AIC value (Forster 
& Jones, 2001).  
 
5.3.3.6 Estimation strategy 
We start by running all the diagnostic tests to identify the parametric distribution that 
best fits our data. To determine whether the results are sensitive to the parametric 
assumptions we follow an approach suggested by Newey, Powell & Walker (1990) and 
reanalyse the data using the semi-parametric Cox model. Relating to the Cox model we 
test for proportional hazard.  
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We regress the probability that someone fails (dies) at time t against BMI categories, 
SES quartiles, age and other control variables (Z) using both semi-parametric and 
parametric methods: 
 
)432
exp(*)()(
876543
210
iiiiiii
iii
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  (5.6) 
 
Where the omitted categories are normal weight and SES groups 1 (most deprived).  
 
We test for unobservable heterogeneity (frailty) by a likelihood ratio test of the null 
hypothesis that the variance in the heterogeneity parameter (ui) is zero. A significant 
test means that the frailty term accounts for unobservable heterogeneity in the model.   
 
The aim in this chapter was not only to investigate the impact of obesity on 
mortality/life expectancy, but also to investigate if this impact varies by SES. 
Furthermore, we want to investigate how age influences this. One can investigate if 
the impact of obesity on relative mortality varies by SES and age by investigating if 
there are interactions between these. We use the likelihood ratio test to compare 
larger models (with interactions) to more sparsely fitted models. We fit three models 
with interactions.  
 
First, a model interacting BMI groups with SES groups:  
)
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 (5.7) 
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Second, a model interacting BMI groups with age20: 
)**
432exp(*)()(
109876
543210
iiiiii
iiiiii
uZageobeseageoverweightagesquaredage
SESSESSESobeseoverweightthth




 (5.8) 
 
Third, we fit a model interacting BMI with both age and SES: 
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 (5.9)
 
 
As mentioned life expectancy is a prediction based on the underlying mortality model. 
We base the predictions of life expectancy on the models with the best fit based on 
the likelihood ratio tests. 
 
Care is required when interpreting the interactions in equation 5.7, 5.8 and 5.9. An 
interaction in a multiplicative survival model is neither sufficient nor necessary to 
meaningfully decide whether or not there are interactions in the predicted life years. 
Hence, we do not use the significance in the multiplicative interaction terms to decide 
whether or not there are interactions in the association between obesity and life 
expectancy, rather we look at the implications of the predicted values (Ai & Norton, 
2003; Greene, 2010; and Berry, DeMerit & Esarey, 2010).   
 
                                                     
20
 We interact BMI groups with age as a linear variable based on likelihood ratio tests. 
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We calculate predicted median survival in each BMI group across the SES groups for 
men and women setting the age to 65, 75 and 85 and the covariates to their mean 
value based on the preferred parametric model. Hence, the variation in predicted 
median life expectancy is a function of the impact of obesity on life expectancy and 
how this varies by SES, and is not affected by the values of the other covariates. 
 
We run each model twice using first semi-parametric and then parametric methods. 
We run separate models for men and women. And separate models with and without 
controlling for longstanding illnesses. Hence in total we run 8 models for each gender 
as shown in Table 5.2.  
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Table 5.2: summary of models 
Model BMI, SES and 
age 
Covariates Distribution 
1 Separate dummy 
variables 
Household and individual 
characteristics* 
Cox proportional 
hazard 
2 Separate dummy 
variables 
Household and individual 
characteristics* 
Parametric 
distribution 
3 Interacted 
models 
Household and individual 
characteristics* 
Cox proportional 
hazard 
4 Interacted 
models 
Household and individual 
characteristics* 
Parametric 
distribution 
5 Separate dummy 
variables 
Household, individual 
characteristics* and longstanding 
illness variables** 
Cox proportional 
hazard 
6 Separate dummy 
variables 
Household, individual 
characteristics* and longstanding 
illness variables** 
Parametric 
distribution 
7 Interacted 
models 
Household, individual 
characteristics* and longstanding 
illness variables** 
Cox proportional 
hazard 
8 Interacted 
models 
Household, individual 
characteristics* and longstanding 
illness variables** 
Parametric 
distribution 
* Smoking status, marital status, geographical area and ethnicity  
**Number of longstanding illnesses and whether or not the longstanding illness limits activities in some 
way  
 
P values for the hazard ratios below the 5% level (z scores higher than ≈1.9) are 
regarded as statistically significant. Values between 5% and 10% (z scores between 
≈1.6 and ≈1.9) are regarded as weakly significant.  
 
5.4 Results  
After exclusions, our estimation sample consisted of 1,832 men and 2,230 women of 
whom 1,052 (57%) and 1,023 (46%) respectively, were reported as deceased at the 
censoring point (Table 5.3). Comparable figures by BMI category for men were 463 of 
817 (57%) in the normal weight group, 445 of 807 (55%) in the overweight group, and 
107 of 167 (64%) in the obese group. For women these figures were 471 of, 1,150 
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(41%) in the normal weight group, 335 of 687 (49%) in the overweight group, and 172 
of 311 (55%) in the obese group. A higher percentage was reported deceased in lower 
SES quartiles compared with higher SES quartiles across each BMI group for both men 
and women. 
 
Table 5.3: Summary statistics of the individuals used in the duration model  
  Whole sample Normal weight Overweight Obese 
  Total N Failures (%) Total N Failures (%) Total N Failures (%) Total N Failures (%) 
Men         
N 1832 1052 (57) 817 463 (57) 807 445 (55) 167 107 (64) 
SES         
  1 (most deprived) 395 345 (87) 186 162 (87) 152 132 (87) 39 33 (85) 
  2 469 337 (72) 204 137 (67) 205 147 (72) 44 37 (84) 
  3 459 223 (49) 181 89 (49) 222 105 (47) 53 28 (53) 
  4 (least deprived) 509 147 (29) 246 75 (30) 228 61 (27) 31 9 (29) 
Women         
N 2230 1023 (46) 1150 471 (41) 687 335 (49) 311 172 (55) 
SES         
  1 (most deprived) 619 500 (81) 275 213 (77) 210 171 (81) 104 91 (88) 
  2 546 280 (51) 260 129 (50) 187 90 (48) 84 51 (61) 
  3 555 161 (29) 304 78 (26) 159 56 (35) 78 22 (28) 
  4 (least deprived) 510 82 (16) 311 51 (16) 131 18 (14) 45 8 (18) 
Source: HALS1 1984/1985 and the longitudinal follow up in June 2009 
Note 
These figures do not control for age at entry 
 
Selected descriptive statistics are in Table 5.4, while full summary statistics on each of 
covariates in our model across each BMI group can be found in Appendix 5.1. Forty 
eight percent of participants were normal weight at measurement, thirty seven 
percent were overweight and twelve percent were obese. The mean age at 
measurement was 58, the mean time to censoring (at date of measurement) was 291 
months and the mean unadjusted time to death was 149 months. The highest 
predicted income was in the normal weight category and the percentage obese was 
highest in SES quartile 1 (most deprived). 
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Table 5.4: Selected descriptive statistics by BMI category 
  
Whole 
sample 
Normal 
weight 
Overweight Obese 
Mean time to censoring at date of measurement (months)* 291 291 291 291 
Mean time to death at date of measurement (months)** 149 150 152 152 
Predicted income (Weekly) 136 141 135 123 
SES groups     
  1 (most deprived) 25 23 24 30 
  2 25 24 26 27 
  3 25 25 26 27 
  4 (least deprived) 25 28 24 16 
Missing income    
  Yes 17 17 17 17 
  No 83 83 83 83 
Age 58 57 59 58 
Gender     
  Male 46 42 54 35 
  Female 54 58 46 65 
Source: HALS1 1984/1985 and the longitudinal follow up in June 2009 
Notes: 
All statistics are either mean (for continuous variables) or % (categorical variables) 
* includes only individuals who had survived up until censoring 
** includes only individuals who died before censoring 
 
Table 5.5 shows the results of the interval regression model of banded total weekly 
household income against the individual, household and area socioeconomic variables. 
Education, social class of HRP, accommodation tenure and bedrooms in household are 
all positively correlated with income. Compared to being in paid employment all other 
types of economic activity are negatively correlated with income. We used these 
coefficients to predict income for each respondent. Respondents were categorised 
into quartiles based on the predicted income values. The range of values for predicted 
weekly income was 3 to 299; the cut-points used to set the quartiles were 91, 132 and 
178. 
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Table 5.5: Interval regression of weekly total household income against SES 
indicators 
  Coef. Z 
Educational qualifications   
  Degree or equivalent Base category 
  Higher education below degree -14.55 -3.3 
  NVQ3/GCE A Level or equivalent 0.60 0.1 
  NVQ2/GCE O Level or equivalent -13.11 -3.2 
  Other -19.00 -3.9 
  No qualification -29.13 -7.5 
Social Class of HRP   
  Professional Base category 
  Managerial technical -25.13 -4.9 
  Skilled non-manual -45.13 -8.0 
  Skilled manual -47.91 -9.1 
  Semi-skilled manual -56.97 -10.1 
  Unskilled manual -56.45 -8.2 
  Other -33.22 -3.2 
Economic activity status for last week   
  Working full time Base category 
  Working part time -18.05 -4.6 
  Unemployed -68.95 -13.5 
  Permanently sick or disabled -54.11 -7.3 
  Retired -48.93 -10.1 
  Keeping house -39.09 -10.1 
  Full time student -52.96 -4.1 
Bedrooms in household   
  One Base category 
  Two 7.52 1.6 
  Three 21.21 4.7 
  Four or more 70.17 13.1 
Housing tenure   
  Own accommodation 35.37 14.4 
  Rent Base category 
Gender    
  Male 55.70 3.2 
  Female Base category 
Age 2.33 4.3 
Age squared -0.03 -5.2 
Male*age -2.65 -3.5 
Male*age squared 0.03 3.7 
Constant 147.09 10.9 
Observations 5787 
Adjusted R
2 
0.08 
 
In Appendix 5.4 and Appendix 5.5 we see the Cox-Snell residuals for men and women 
for each parametric distribution. These indicate that our data fits models with 
monotonic hazard rates for both men and women. Appendix 5.4 and Appendix 5.5 also 
show the AIC for men and women for each parametric distribution. These show that 
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the Gompertz model has the best fit for both men and women. The Cox-Snell residuals 
for men and women in the Gompertz model with gamma frailty are showed in Figure 
5.1. We see that the fit is good as the residuals lie close to the 45 degree line. 
However, the fit is less good at higher values. It is common for models with censored 
data to have less good fit at large values of time; this is because fewer individuals have 
the highest hazard values due to prior failures (UCLA Academic Technology Services, 
2011).  
 
Figure 5.1: Cox-Snell residuals for men and women based on the Gompertz 
distribution with gamma frailty distribution 
Men 
 
Women 
 
Note: 
The dependent variable is survival time and the independent variables are age, SES, BMI, smoking, 
ethnicity, marital status, area and missing income 
 
Table 5.6 show the output of Gompertz model accounting for unobservable 
heterogeneity (gamma frailty distribution) for men and women with and without 
interactions. We also see the results of the Schoenfeld and scaled Schoenfeld residual 
test for proportional hazard for both men and women for all variables. We see that we 
fail to reject the “global test“ of proportional hazard in each of the models for both 
men and women. Although not shown, we also fail to reject proportional hazard for 
0
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each of the covariates (except from the dummy variable for East Midlands for men in 
the main effects model). Failing to reject the proportional hazard test means that we 
do not have any problems with our models not fulfilling the proportional hazard 
assumption; hence we can apply proportional hazard models. The upshot of this is that 
the preferred model is the Gompertz model, but we also rerun the analysis using a Cox 
model.  
 
The coefficients in the tables are hazard ratios. A value larger than 1 should be 
interpreted as an upward shift in the baseline hazard function, hence it increases the 
likelihood of dying in each time period. Conversely, a value smaller than 1 should be 
interpreted as a downward shift in the baseline hazard function, hence it decreases the 
likelihood of dying in each time period. 
 
The main effects models in Table 5.6 illustrate a significant correlation between 
obesity and mortality, in that obesity increases hazard rate in each time period, 
controlling for age and a range of other individual characteristics. This association is 
more pronounced in women where the hazard rate in the Gompertz model is 1.42 
versus 1.35 in men. In the main effects models we also find a significant positive 
relationship between SES and mortality controlling for age and a range of other 
individual characteristics. I.e. higher SES groups have lower mortality in each time 
period independently of other factors. The SES effect on mortality is similar for men 
and women; however the impact of SES group 2 is only significant in men. The hazard 
rates for SES groups 2, 3 and 4 (least deprived) in men are 0.82, 0.68 and 0.54, 
respectively. For women similar figures are 0.9, 0.73 and 0.54, respectively. Table 5.6 
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also shows that the unobservable heterogeneity parameter (frailty distribution) is 
significant in women but not in men in the main effects models.  
 
The likelihood ratio tests, which compare the fit of the models with interactions to the 
main effect model, were insignificant in men for: the BMI interacted with SES model 
(P=0.31), the BMI interacted with age model (P=0.44) and for the fully interacted 
model (P=0.43). Hence, the interactions do not do much to help explain variation in 
the dependent variable in men. 
 
In women, the likelihood ratio tests were insignificant comparing the main effects 
model with the BMI interacted with SES model (P=0.29) and the BMI interacted with 
age model (P=0.11), but significant in the fully interacted model (P=0.01). Furthermore, 
comparisons illustrate that the fully interacted model had a significantly better fit than: 
the BMI interacted with SES model (P<0.01) and the BMI interacted with age model 
(P=0.02). Hence, the fully interacted model has the best fit in women.  
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Table 5.6: Gompertz models controlling for age and additional household and individual characteristics   
  Main effects model BMI interacted with SES model BMI interacted with age model Fully interacted model 
  Men Women Men Women Men Women Men Women 
  
Haz. 
ratio z 
Haz. 
ratio z 
Haz. 
ratio z 
Haz. 
ratio z 
Haz. 
Ratio z 
Haz. 
ratio Z 
Haz. 
ratio z 
Haz. 
ratio z 
BMI 
                  Normal weight Base category Base category Base category Base category Base category Base category Base category Base category 
  Overweight 1.043 0.6 0.977 -0.3 0.993 -0.06 1.063 0.55 0.621 -1.1 1.295 0.54 0.672 -0.76 2.720 1.61 
  Obese 1.346 2.65 1.418 3.46 1.232 1.04 1.486 2.88 1.381 0.45 4.484 2.68 1.550 0.5 19.296 3.98 
SES 
                  1 (most deprived) Base category Base category Base category Base category Base category Base category Base category Base category 
  2 0.82 -2.4 0.904 -1.12 0.683 -3.11 1.009 0.07 0.793 -2.7 0.935 -0.77 0.677 -3.15 1.111 0.86 
  3 0.68 -3.82 0.718 -2.92 0.683 -2.64 0.752 -1.91 0.675 -3.81 0.745 -2.64 0.668 -2.7 0.882 -0.81 
  4 (least deprived) 0.543 -5.07 0.532 -4.29 0.612 -3.09 0.656 -2.36 0.541 -4.99 0.565 -3.86 0.594 -3.11 0.798 -1.22 
BMI*SES 
              Overweight*SES 2 
  
1.306 1.55 0.782 -1.36 
  
1.331 1.64 0.702 -1.87 
  Overweight*SES 3 
  
1.011 0.06 1.092 0.42 
  
1.064 0.31 0.918 -0.37 
  Overweight*SES 4 
  
0.801 -1.04 0.661 -1.39 
  
0.860 -0.65 0.533 -1.93 
  Obese*SES 2 
  
1.455 1.35 1.049 0.22 
  
1.437 1.28 0.749 -1.26 
  Obese*SES 3 
  
0.984 -0.05 0.756 -0.99 
  
0.972 -0.09 0.453 -2.54 
  Obese*SES 4 
  
0.864 -0.36 0.675 -0.96 
  
0.823 -0.44 0.358 -2.34 
Age 
                  Age  1.179 5.34 1.160 4.62 1.178 5.30 1.163 4.70 1.180 5.22 1.158 4.58 1.180 5.23 1.170 4.93 
  Age squared 0.999 -2.31 1.000 -1.47 1.000 -2.29 1.000 -1.55 0.999 -2.33 1.000 -1.38 0.999 -2.31 1.000 -1.6 
BMI*age 
              Overweight*age 
    
1.008 1.23 0.996 -0.62 1.006 0.77 0.987 -1.56 
  Obese*age 
    
1.000 -0.04 0.982 -2.11 0.996 -0.28 0.964 -3.49 
  
            LR-test compared with main effects model 
  
P=0.31 P=0.29 P=0.44 P=0.11 P=0.43 P=0.01 
LR-test compared with SES*BMI model 
            
P=0.65 P>0.01 
LR-test compared with age*BMI model 
            
P=0.39 P=0.02 
Test for unobservable heterogeneity  P=0.38 P=0.04 P=0.38 P=0.26 P=0.3 P=0.39 P=0.3 P=1.00 
Test for proportional hazard* P=0.94 P=0.36 P=0.73 P=0.57 P=0.97 P=0.5 P=0.82 P=0.66 
The dependent variable is survival time. Controlling for smoking, ethnicity, marital status, area and missing income. There are 1791 participants in the models for 
men and 2147 in the models for women. 
*Significant tests means that the proportional hazard assumption is violated 
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In Appendix 5.2 we see the output of the same regressions run in the Cox models. In 
general there are only minor differences in the output from the Gompertz and Cox 
models. However, the coefficients for obesity show a stronger impact in the Gompertz 
models for both genders. For example, the hazard rate of obesity for women in the 
main effect model is measured in the Cox model to be 1.37 while it is 1.42 in the 
Gompertz model. The differences between the models are more pronounced in 
women than in men.  
 
Table 5.7 show the output of the Gompertz models controlling for longstanding 
illnesses. We can see that we fail to reject the global tests across all models in both 
men and women. We also fail to reject the proportional hazard in the Schoenfeld and 
scaled Schoenfeld residual test for both men and women for all variables21 (except 
from the dummy variable for East Midlands for men and SES quartile 2 in women). This 
means that we can apply a proportional hazard model. 
 
The main effects models in Table 5.7 illustrate that obesity still has a significant 
negative impact on mortality. However, we can see that the impact is reduced going 
from 1.35 in the main effects model not controlling for illness to 1.31 in the main 
effects model controlling for illnesses in men. In women, corresponding figures were 
1.42 and 1.30, respectively. So controlling for illnesses reduces the hazard ratio 
relatively more in women and it is now slightly more pronounced in men. The positive 
impact of SES in the main effects models are also slightly reduced, however it is still 
                                                     
21
 Not shown in Table 5.7. 
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significant in SES quartile 3 and 4 (least deprived) in both men and women. We also 
find that the unobservable heterogeneity parameter (frailty distribution) is significant 
in women but not in men, in the main effects models. 
 
The comparisons of the models based on the likelihood ratio tests provide the same 
results as in the model not controlling for illnesses. Hence, the interactions do not 
improve the fit of the model in men. However, in women the fully interacted model 
has a significantly better fit than the other models. 
 
In Appendix 5.3 we see the output of the Cox models controlling for illnesses. We find 
also here that the mortality rates are weaker in the Cox model than in the Gompertz 
model, however the differences are small and the trend is similar in both models.  
 
 162 
 
Table 5.7: Gompertz models controlling for age and additional household and individual characteristics controlling for illnesses 
 
Main effects model BMI interacted with SES model BMI interacted with age model Fully interacted model 
 
Men Women Men Women Men Women Men Women 
  
Haz. 
ratio z 
Haz. 
ratio z 
Haz. 
ratio z 
Haz. 
Ratio Z 
Haz. 
Ratio z 
Haz. 
Ratio z 
Haz. 
ratio z 
Haz. 
ratio z 
BMI 
                  Normal weight Base category Base category Base category Base category Base category Base category Base category Base category 
  Overweight 1.045 0.62 0.95 -0.64 1.004 0.03 1.009 0.08 0.672 -0.92 1.219 0.41 0.760 -0.52 2.202 1.25 
  Obese 1.314 2.41 1.304 2.59 1.233 1.01 1.346 2.1 1.498 0.56 4.735 2.74 1.765 0.64 19.746 3.93 
SES 
                  1 (most deprived) Base category Base category Base category Base category Base category Base category Base category Base category 
  2 0.868 -1.68 0.958 -0.48 0.724 -2.59 1.031 0.25 0.835 -2.06 0.982 -0.2 0.721 -2.6 1.128 0.97 
  3 0.741 -2.91 0.757 -2.45 0.759 -1.87 0.786 -1.59 0.734 -2.96 0.784 -2.18 0.749 -1.9 0.914 -0.58 
  4 (least deprived) 0.596 -4.25 0.571 -3.79 0.67 -2.49 0.68 -2.15 0.595 -4.18 0.604 -3.4 0.659 -2.47 0.818 -1.08 
BMI*SES 
              Overweight*SES 2 
  
1.292 1.46 0.827 -1.04 
    
1.309 1.52 0.750 -1.49 
  Overweight*SES 3 
  
0.981 -0.1 1.138 0.6 
    
1.017 0.08 0.976 -0.1 
  Overweight*SES 4 
  
0.797 -1.05 0.686 -1.25 
   
0.838 -0.75 0.571 -1.71 
  Obese*SES 2 
  
1.418 1.23 1.115 0.48 
   
1.391 1.15 0.771 -1.1 
  Obese*SES 3 
  
0.912 -0.3 0.733 -1.09 
   
0.886 -0.38 0.436 -2.64 
  Obese*SES 4 
  
0.906 -0.24 0.756 -0.68 
   
0.839 -0.39 0.388 -2.13 
Age 
                Age  1.168 5.02 1.153 4.4 1.168 4.99 1.155 4.46 1.171 4.96 1.155 4.48 1.172 4.96 1.166 4.76 
  Age squared 1.000 -1.93 1.000 -1.28 1.000 -1.93 1.000 -1.35 1.000 -2 1.000 -1.31 1.000 -1.96 1.000 -1.47 
BMI*age 
              Overweight*age 
     
 
 
 1.007 1.04 0.996 -0.55 1.004 0.55 0.989 -1.27 
  Obese*age 
   
 
 
 0.998 -0.18 0.980 -2.33 0.995 -0.43 0.963 -3.59 
  
            LR-test compared with main effects model 
  
P=0.39 P=0.19 P=0.52 P=0.07 P=0.47 P=0.01 
LR-test compared with SES*BMI model 
            
P=0.71 P<0.01 
LR-test compared with age*BMI model 
            
P=0.39 P=0.03 
Test for unobservable heterogeneity  P=0.32 P=0.05 
    
P=0.3 P=0.42 
Test for proportional hazard* P=0.71 P=0.14 P=0.52 P=0.25 P=0.8 P=0.23 P=0.62 P=0.29 
The dependent variable is survival time. Controlling for smoking, ethnicity, marital status, area, missing income, number of longstanding illnesses and whether or not 
the illnesses is limiting. There are 1791 participants in the models for men and 2147 in the models for women. 
*Significant tests means that the proportional hazard assumption is violated 
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We now show the predicted life expectancy based on the hazard models. The model 
with the best fit in men was the main effects model while in women it was the fully 
interacted model; hence we base the predictions on these.  
 
The predicted life expectancy of individuals aged 55, 65 and 75 across the BMI groups 
for men and women are in Table 5.8. Across all men we see that obese individuals 
have a lower predicted life expectancy than normal weight individuals. The life 
expectancy among men of normal weight aged 55 was 25 years, and for those being 
overweight, and obese it were 24.6, and 22.1, respectively. In women we see that 
obesity reduce life expectancy for individuals aged 55 and 65. However, in women 
aged 75 obesity is associated with increased life expectancy.  
 
Table 5.8: Predicted survival time based on the Gompertz distribution with gamma 
frailty 
  Age 55 Age 65 Age 75 
  
Normal 
Overweight Obese 
Normal 
Overweight Obese 
Normal 
Overweight Obese weight weight weight 
Men 
  
  
  
  
  
  
All 25 24.6 22.1 15.9 15.6 13.5 9.5 9.2 7.7 
SES 
  
  
  
  
  
  
  1 (most deprived) 21.9 21.5 19.2 13.4 13.1 11.2 7.6 7.4 6.1 
  2 23.8 23.4 21 15 14.6 12.6 8.7 8.5 7.1 
  3 25.7 25.3 22.8 16.5 16.2 14.1 9.9 9.6 8.1 
  4 (least deprived) 28 27.5 25 18.5 18.1 15.9 11.4 11.1 9.4 
Women 
  
  
  
  
  
  
All 31 30.8 26.4 20.1 21.1 19.3 11.6 13.4 13.6 
SES 
           1 (most deprived) 30.5 27.7 21 19.6 18.3 14.5 11.2 11.1 9.6 
  2 29.4 30.2 22.7 18.7 20.6 16 10.5 12.9 10.8 
  3 31.8 29.8 30 20.8 20.2 22.6 12.1 12.6 16.5 
  4 (least deprived) 32.8 36.5 33.5 21.7 26.4 25.9 12.8 17.9 19.5 
Note 
The predictions are based on the models in Table 5.6 where we control for age, age squared, smoking 
status, marital status, geographical area and ethnicity. The predictions are in years, although they are 
based on models where the time variable is in months.  
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Table 5.8 also shows the results by SES groups. Less deprived SES groups had a higher 
predicted life expectancy in both men and women across all BMI groups. For example, 
normal weight men aged 55 have a predicted life expectancy of 21.9 years in SES 
quartile 1 (most deprived), and 23.8, 25.7 and 28 years in quartiles 2, 3 and 4 (least 
deprived), respectively. In normal weight women aged 55 the predicted life expectancy 
in SES quartile 1 (most deprived) was 30.5, in quartiles 2, 3 and 4 (least deprived) it 
was 29.4, 31.8 and 32.8 years, respectively.  
 
We did not find an interaction effect between obesity and SES in the latent variable 
model for men. This means that the relative impact of obesity on mortality does not 
vary by SES. Hence, obesity has an equally negative impact in each time period in men. 
Individuals who live longer will have a more negative impact of obesity. The reason is 
that the negative impact of obesity “works” for more time periods. Higher SES men live 
longer than lower SES men, so they will lose more life in absolute terms due to obesity. 
For example, a man aged 65 SES quartile 1 (most deprived), will on average lose 2.2 
years due to obesity, while and a man aged 65 in SES quartile 4 (least deprived) would 
on average lose 2.6 years due to obesity. 
 
The likelihood ratio tests supported the fully interacted models in women. The results 
of the predictions based on this model reveal an opposite effect of obesity in high and 
low SES groups. Our results show SES variation in the impact of obesity on life 
expectancy in women. The predictions illustrate that obesity reduces life expectancy 
for women in SES quartile 1 (most deprived) across women aged 55, 65 and 75. 
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However, in SES group 4 (least deprived) obesity is associated with increased life 
expectancy across women aged 55, 65 and 75.  
 
In Table 5.9 we see predictions based on the survival models controlling for 
longstanding illnesses. We see similar trends of a lower life expectancy in obese 
compared with normal weight in men and women (except in women aged 75 where 
the trend is positive). We also see that lower SES individuals have a lower life 
expectancy than higher SES individuals. In addition, we find a similar SES gradient in 
the impact of obesity on life expectancy. Hence, obesity has a negative impact on life 
expectancy in low SES women but positive impact on life expectancy in high SES 
women.  
 
Table 5.9: Predicted survival time based on the Gompertz distribution with gamma 
frailty: Controlling for longstanding illnesses 
  Age 55 Age 65 Age 75 
  
Normal 
Overweight Obese 
Normal 
Overweight Obese 
Normal 
Overweight Obese weight weight weight 
Men 
         All 25 24.6 22.4 16 15.6 13.8 9.4 9.1 7.8 
SES 
           1 (most deprived) 22.6 22.2 20.1 14 13.6 11.9 7.9 7.6 6.5 
  2 23.9 23.5 21.4 15.1 14.7 12.9 8.7 8.4 7.2 
  3 25.5 25 22.8 16.4 16 14.2 9.7 9.4 8 
  4 (least deprived) 27.6 27.2 24.9 18.2 17.9 15.9 11.1 10.8 9.3 
Women 
         All 30.5 30.7 26.6 20.1 21.2 20.0 11.8 13.5 14.5 
SES 
           1 (most deprived) 30.2 28.3 21.7 19.8 19.1 15.5 11.5 11.8 10.7 
  2 29.0 29.9 23.0 18.7 20.6 16.6 10.7 13.0 11.6 
  3 31.0 29.4 30.5 20.6 20.1 23.5 12.2 12.6 17.7 
  4 (least deprived) 32.1 35.9 32.7 21.6 26.1 25.7 13.0 17.7 19.7 
Note 
The predictions are based on the models in Table 5.7 where we control for age, age squared, smoking 
status, marital status, geographical area, ethnicity number of longstanding illnesses and whether or not 
the illnesses is limiting. The predictions are in years, although they are based on models where the time 
variable is in months.  
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5.5 Discussion  
In this chapter we use the Health and Lifestyle Survey from 1984/1985 and its 
longitudinal follow up in 2009 to investigate the relationship between obesity and 
mortality/life expectancy and whether or not this varies by SES. We have conducted a 
comprehensive analysis using semi-parametric and parametric methods to investigate 
this relationship, applying different combinations of covariates accounting for 
unobservable heterogeneity. To decide upon the correct parametric distribution we 
conduct extensive analysis and based on this choose a Gompertz distribution. We run 
both semi-parametric Cox models and parametric Gompertz models, which show 
similar results. 
 
In men, obesity is negatively associated with life expectancy across all ages. In women, 
obesity reduces life expectancy at the ages of 55 and 65; while it increases life 
expectancy in women aged 75. This is consistent with Stevens et al. (1998) who found 
that obesity increased mortality in American women aged 30 to 74, while the women 
over the age of 75 had a reduced risk of death22.  
 
We also investigate the impact of overweight as well as obesity on mortality/life 
expectancy. We do not find the hazard rate of overweight to be significant. This is 
consistent with the existing literature where some have found a positive effect (see, 
e.g., Peeters et al., 2003; Adams et al., 2006), but not others (see, e.g., Flegal et al., 
2005).   
 
                                                     
22
 They also found this in men. Hence, our study contradicts these results. 
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Our results illustrate a lower mortality rate and longer life expectancy in higher SES 
groups than in lower SES groups in both men and women. We run models with and 
without interactions between BMI and SES groups. The likelihood ratio tests support a 
model with no interactions in men. Hence, the impact of SES and obesity on mortality 
does not vary across SES groups in men. When we look at life expectancy we look at 
the consequences of mortality over a lifetime. Our models indicate that obesity leads 
to a greater loss in life years due to obesity in higher SES men than in lower SES men.  
 
We predict the number of years survived after the measurement date at age 55, 65 
and 75. A 55 year old obese man in the lowest SES group will on average live 19 years, 
while a 55 year old obese man in the highest SES group will on average live for 25 
years. An obese man in the highest SES group has a higher predicted life expectancy 
(25 years) than a normal weight man in the lowest SES group (22 years). Men in higher 
SES groups have a longer predicted life expectancy and will have a greater predicted 
absolute loss in life years due to obesity. The reason is that the negative impact of 
obesity will “work” for more time periods in these models. 
 
In women we find that models fitting separate interactions between age and BMI did 
not improve the fit compared with the main effects model. Neither did models that fit 
interactions between SES and BMI. However, when we fit a model with both 
interactions in one model they significantly improve the fit of the model. Hence, a fully 
interacted model with interactions between BMI and SES, and BMI and age was the 
model with the best fit in women. This means that the mortality rate due to obesity 
varies by both SES and age.  
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A 55 year old obese woman in the lowest SES group will on average live 21 years, while 
a 55 year old normal weight woman in the lowest SES group will on average live for 
30.5 years. Similar results for women in the highest SES group are 33.5 and 32.8, 
respectively. Hence, obesity reduces life expectancy in the low SES women aged 55 
and increase life expectancy in the high SES women aged 55. A similar SES gradient was 
found in women aged 65 and 75. 
  
We fit a model controlling for number of longstanding illnesses and whether or not 
these are limiting. The models show that the impact of obesity and SES is slightly 
reduced. When we control for longstanding illnesses we must keep in mind that we 
only control for longstanding illnesses at the time of obesity measurement and not 
between the time of measurement and death/censoring. Hence, longstanding illnesses 
can still have an impact on the hazard ratio, however this is after obesity measurement 
hence it follows the obesity status. In this way we control for endogeneity issues 
related to omitted illness/health variables.  
 
Mayhew, Richardson and Rickayzen (2009) have calculated expected life years lost 
from obesity by applying hazard ratios (based on Cox models) for obese individuals to 
life tables. They tested an interaction between BMI and age and found it to be 
insignificant in both men and women. We find an interaction between age and BMI in 
women. They found that for non smoking males, the expected years of life lost across 
all ages would be 4 to 16 years for individuals with BMI in excess of 35 compared to 
having a BMI of 24. For non smoking females this was 2 to 10 years compared to 
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having a BMI of 26. Hence, they have found a more pronounced effect of obesity in 
males. We find a more pronounced obesity effect in females in the model controlling 
for individual and household characteristics and a more pronounced obesity effect in 
males in the model that also control for longstanding illnesses. The main differences 
between our studies are as mentioned that we control for a range of covariates (e.g., 
ethnicity) and account for unobservable heterogeneity (frailty). We have a longer 
follow up period and do not stratify by smoking status (we control for it in the 
regression). Hence, we can argue that our study is less likely to be affected by omitted 
variables bias (e.g. unobserved health variables, discount factor or general frailty), 
decreasing duration dependence and sample selection bias. In addition, we 
demonstrate that the hazard rate varies by both age and SES in women. 
 
In this chapter we have presented both hazard ratios and life expectancy. The relative 
mortality or the absolute loss in predicted life years answers different questions and 
which of these one wants to focus on depends on the question that one wants to 
answer. The results in Chapter 3 showed that obesity leads to a greater loss in HRQL in 
lower SES groups than in higher SES groups. This supports the hypothesis of a more 
negative impact of obesity on health in lower SES groups compared with higher SES 
groups. If we view life expectancy as another dimension of health these results support 
this hypothesis in women, but not in men. Hence, a question arises regarding why we 
do not get these results in men. HRQL is a measure of perceived health status. It might 
be that lower SES men perceive the consequences of obesity to be worse as they have 
less favourable economic and social circumstances that will increase the burden of 
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obesity. But that the actual physical impact of obesity and its related comorbidities is 
similar across SES groups. 
 
The result in women serves to further emphasize the heterogeneous nature of obesity. 
Attention needs to be paid to the pathways in which obesity influences health and life 
expectancy. This has consequences for decision making in health and care is required 
when selecting estimates for BMI categories in simulation models.  
 
We are not aware of any studies that have used other alternative parametric 
distributions than the Cox proportional hazard model. We suggest more attention 
should be given to parametric distributions in this type of analysis as there are two 
advantages with this approach. First, one can predict life expectancy based on the 
parametric distribution. Second, one can control for unobservable heterogeneity in 
datasets without repeated measurements for the same individual. We find that the 
unobservable heterogeneity is significant in the main effects model in women even 
after controlling for a range of individuals characteristics including longstanding 
illnesses. The downside of using parametric distributions is that their validity relies on 
finding a distribution that fits the data.   
 
Our findings have a number of limitations. First, our obesity data are measured once 
for each individual; it would be preferable to have repeated measures over time as we 
do not capture obesity onset timing which might have an impact on survival. Second, 
the relatively small sample size at higher BMI levels does not allow us to divide our 
sample into additional obesity categories. It is likely that the effect of obesity class III 
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(BMI>40 kg/m2) on life expectancy differs from the effect of obesity class I (30 
kg/m2>BMI>35 kg/m2). Third, the data are based on measures from 1984/1985, when 
the prevalence of obesity was lower than it is today; the impact of obesity may change 
as population norms change. Fourth, our measure of obesity is BMI, which has been 
criticised, e.g., because it does not incorporate body fat, with body fat content being 
what is actually the independent predictor of ill health (Burkhauser & Cawley, 2008). 
Hence, measurement error might arise.   
 
Nonetheless, we believe this chapter has a number of advantages over previous 
studies. Our BMI measure is based on height and weight measurements obtained 
during the nurse visit, not on self-reported values. Thus, the likelihood of systematic 
measurement error is reduced. We are the first study to investigate the relationship 
between BMI and mortality/life expectancy in the UK by including BMI as a categorical 
variable. This allows us to conclude that there is significant difference in the mortality 
of obese individuals compared to normal weight individuals. We are the first to apply 
the HALS longitudinal follow up from June 2009, hence we have a longer follow up 
period. We are the first to apply both semi-parametric and parametric models in our 
estimation. This makes our results more robust as the semi-parametric models are not 
constrained by a parametric distribution. Earlier studies have important limitations in 
terms of endogeneity. The most important is omitted variable bias23: for example 
there might be health variables that reduce/decrease weight and increase mortality. 
We account for the issue by including a frailty distribution. Furthermore, we fit models 
                                                     
23
 Reverse causality is not an issue as the dependent variable and the independent variable are 
determined at different points in time. 
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both with and without controlling for longstanding illnesses and show that obesity has 
an impact in both. Also, we have information on individual and household 
characteristics so we can argue that it is less likely that the estimated effects of obesity 
on life expectancy in our models are due to their correlation with other omitted 
variables. Controlling for unobservable heterogeneity also ensures that our results do 
not suffer from decreasing duration dependence. 
 
To summarise, this chapter has shown that, as in previous studies, obesity is negatively 
correlated with life expectancy in men and younger women. In older women obesity is 
associated with increased life expectancy. We have found that these results are robust 
across semi-parametric and parametric distributions controlling for a range of different 
covariates both with and without controlling for unobservable heterogeneity. In 
addition, we find that the impact of obesity on life expectancy depends on SES and 
that the impact is more negative in lower SES women than in higher SES women. 
However, this was not found in men.  
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CHAPTER 6 
 
Socioeconomic variation in the relationship between 
obesity and health service use 
 
6.1 Introduction 
It has been shown that there is a socioeconomic gradient in obesity (see, e.g., Wardle, 
2002) and socioeconomic status (SES) has been showed to have an impact on how the 
health service are used (Allin, Masseria & Mossialos, 2010; Benzeval & Judge, 1994; 
Morris, Sutton & Gravelle, 2005; Saez, Saurina, Coenders & Gonzalez-Raya, 2006; 
Vallejo-Torres & Morris, 2010; Veugelers & Yip, 2003). For example, lower SES 
individuals have been shown to use more primary care and higher SES individuals use 
more secondary care (See, e.g., Morris, Sutton, & Gravelle, 2005).  In this chapter we 
develop the current approach to allow for interactions between obesity and SES. We 
look at if the association between a current health risk factor (obesity) and health 
service use differs across SES groups.  
 
Based on the theoretical model in Chapter 2 we presented the following empirical 
model for health service use: 
 
ttttttt eSaXaSESLaSESaLaam  543210 *     (6.1) 
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Where health service use (mt) is determined by lifestyle (Lt), SES, other non-need 
variables (such as ethnicity) and supply. The a’s are parameters to be estimated and 
the et is the error term. We have also included an interaction between lifestyle and 
SES, which allows the association between obesity and use to vary by SES or vice versa. 
The aims of this chapter are to investigate the relationship between obesity and health 
service use, and to investigate whether or not this relationship varies by SES. We start 
with a review of the literature of the relationship between obesity and health service 
use. We then undertake the analysis using one panel dataset and one pooled cross 
sectional dataset. Both include height and weight, plus a comprehensive set of 
individual and household characteristics that allows us to control for factors that affect 
the relationship between obesity and health service use. It is an advantage to use a 
panel dataset as it allows us to account for time invariant heterogeneity. In addition, 
this dataset has good geographical identifiers. However, the cross sectional dataset 
has objectively measured height and weight, which is less likely to be biased compared 
to the self-reported height and weight in the panel dataset. 
 
6.2 Literature review of the association between obesity and 
health service use 
The objective of the review was to identify studies that investigate the 
impact/association between obesity and health service use. We have restricted this 
search to studies presenting statistics on health service use; hence we exclude cost of 
illness studies. 
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6.2.1 Search strategy 
We followed similar strategies as in Chapter 3 and searched the literature in three 
stages: First, we search the journals24: Obesity Reviews; Health Economics; Journal of 
Health Economics; and, Social Science & Medicine25. The search term was:  
 
obesity OR obese OR overweight OR weight loss AND GP OR physicians OR specialist OR 
outpatient OR inpatient OR hospital OR length of stay OR medication OR drugs OR 
preventive services OR nurse OR primary care OR secondary care  
 
From the first stage we identified a total of 6 studies. The second stage was a 
reference search of the identified papers in the first stage. In the third stage we used 
the “cited by” option in Google scholar to identify papers that had referenced the 
papers identified in the two first stages. In total we identified 27 studies. 
 
From each paper we extract data on year, country, type of health service use studied, 
methods and results. This is shown in Table 6.1. We restricted the search to papers 
written in English. 
 
 
  
                                                     
24
 Tried to conduct a search in MEDLINE using the search term: ((((("Obesity"[Mesh]) OR "Body Mass 
Index"[Mesh]) AND "Inpatients"[Mesh]) OR "Outpatients"[Mesh]) OR "Health Personnel"[Mesh]) OR 
"Preventive Health Services"[Mesh]. However, this gave 676990 hits so we decided to use this second 
best solution. 
25
 Obesity Reviews is the highest ranked obesity journal by impact factor (Thompson ISI, 2010). Health 
Economics and Journal of Health Economics were chosen as they are the two top ranked journals in the 
field of health economics in the Thomson Reuters Journal Citation Reports. Social Science & Medicine is 
the world most cited social science journal (Thomson ISI, 2010) and it has a focus on health economics. 
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Table 6.1: Literature review of studies examining the associations between obesity 
and health service use 
Authors, 
country, year 
Dataset Statistical methods Type of use Results 
Bertakis, Azari, 
USA, 2005 
Patients at a 
primary care clinic 
(year not given), 
n= 509, age not 
given 
Used log-transformed utilisation 
variables to investigate the impact 
of a dummy for obesity (BMI > 30) 
controlling for health status, 
depression, age, education, 
income, and sex.  
Primary care 
visits, specialty 
clinic visits, 
emergency 
department 
visits, 
hospitalisations, 
and laboratory, 
diagnostic, 
and radiological 
tests 
Obesity was significantly 
related to the use of 
primary care and 
diagnostic services 
Chen, Jiang, 
Mao, Canada, 
2007 
National survey 
(2003), n=113603, 
age 20+ 
Used logistic regressions methods 
to investigate the impact of four 
BMI groups controlling for age, 
marital status, household size, 
number of bedrooms, income 
adequacy, educational level, 
immigrant status, visible minority, 
marital status, smoking status, 
alcohol use, exercise and allergy 
history 
Hospital 
admissions and 
length of stay 
Obese individuals have 
more hospital 
admissions and longer 
length of stay 
Chu, Wang, MS, 
Chang, and Wu, 
Taiwan, 2010 
Cross sectional 
national survey 
(2001), n=12283,  
age 20-85 
Use a two-stage approach with 
linear regression and tobit models 
to investigate the effect of four BMI 
groups on use controlling for age, 
smoking, drinking and co 
morbidities 
Outpatient visits 
and 
hospitalization 
Medical utilization was 
found to increase with 
higher BMI  
Counterweight 
project team, 
UK, 2005 
Patients at 80 
general practises 
around in the UK 
(2000-2003), 
n=7300, age 18-75 
Logistic regression comparing 
normal weight (BMI 18.5–<25) and 
obese (BMI>30) controlling for age, 
sex, deprivation category, country, 
and the presence of a comorbidity 
Medication Obesity increased 
prescribing in most 
categories 
Counterweight 
Project Team, 
UK, 2005 
Patients at 80 
general practises 
around in the UK 
(2000-2003), 
n=7300, age 18-75 
Used logistic regression methods to 
investigate the correlation between 
health service use and obesity 
(BMI>30) compared with normal 
weight (18.5<BMI<24.9). Controlled 
for age, sex, social deprivation 
category, country, and group and 
additionally for the presence of 
comorbidities. 
GP visits, practice 
nurse visits, 
inpatient and 
outpatient visits 
Found a significant 
relationship between 
obesity and; GP visits, 
practice nurse visits, 
inpatient and outpatient 
visit 
Dzien et al., 
Austria, 2003 
Outpatients (year 
of measurement 
not given), 
n=3360, only 
mean age given, 
which was 57  
Provided mean and standard 
deviations of BMI categories across 
medication categories. Used 
significant tests to test for variation 
in the means. 
Medication Found that more 
medication was given to 
individuals who were 
overweight or obese 
Folmann et al., 
Denmark, 2006 
Two subsamples, 
one with 
measured  WC, 
n=5151 and one 
with measured 
BMI, n=4048 
(1999-2001), age 
30-60 
Used two-part models and Poisson 
regression investigating the impact 
on use  
Hospital contacts Obese men and women 
had an increased 
number of hospital 
contacts compared with 
normal weight 
individuals 
Guallar-
Castillon et al., 
Spain, 2002 
Cross sectional 
Spanish National 
Health Survey 
(1993), n=13244, 
age 16+ 
Logistic regression models were 
used to calculate the impact of 
three BMI groups on use 
controlling for age, education level, 
occupation, civil status, social 
support, tobacco use, alcohol 
consumption, physical activity at 
work and during leisure time, job 
status and town of residence. Does 
also investigate an interaction 
Hospitalisations, 
medical visits, 
utilisation of 
hospital 
emergency 
services, and 
medication use 
Overweight and obese 
women visited the 
physician, used hospital 
emergency services and 
took medication with 
greater frequency than 
did women of normal 
weight. They do not find 
the interaction terms 
between education and 
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between BMI as a linear term and 
education. 
BMI to be significant.   
Gupta & Greve, 
Denmark, 2011 
National health 
survey combined 
with register data 
(2000 and 2005), 
n=10013, age 25-
60 
Use a finite mixture model to 
investigate the impact of three BMI 
groups on use controlling for 
gender, education, marriage, age, 
and smoking 
GP use, 
Hospitalisation 
and Bed days,  
Estimated bodyweight 
effects vary across 
latent classes and 
show that being obese 
or overweight does not 
increase the utilization 
of GP services among 
infrequent users but 
does so among frequent 
users 
Han, Truesdale, 
Taber, Cai, 
Juhaeri and 
Stevens, USA, 
2009 
Cross sectional  
study from four 
US communities 
(1987-1989), 
n=15792, age 45-
64 
Used negative binomial models to 
investigate the impact of three BMI 
groups adjusted for race, gender, 
field centre, age, physical activity, 
education level, smoking status, 
alcoholic beverage consumption 
and health insurance. Adjusted 
numbers of hospitalizations were 
calculated after setting covariates 
to the mean value.  
Hospitalisations Obese men and women 
had more 
hospitalisations than 
non obese men and 
women. Found no race 
differences.  
Hauck & 
Hollingsworth, 
Australia, 2010 
Data from 122 
Australian 
hospitals (2005/6), 
episodes=435 147, 
age 17+ 
Quantile Regression analysis is used 
to generate 19 estimates of the 
difference between severely obese 
and other patients across the 
whole range of length of stay,  
Hospital length of 
stay across 
specialities 
There are significant 
differences in average 
length of stay for almost 
all specialties. 
Luchsinger, 
Lee, 
Carrasquillo, 
Rabinowitz, 
Shea, USA, 
2003 
Medicare 
Beneficiary Survey 
(1992-94), 
n=8754, age 65-
100 
Poisson regression was used for 
multivariate analyses relating five 
BMI groups and BMI as a 
continuous variable to number of 
hospitalizations, adjusting for sex, 
age, smoking status, and heart 
disease. Only in individuals aged 75 
and older. 
Hospitalisations Does not find a 
significant association 
between BMI and 
hospitalizations 
 
Pearson, Bhat-
Schelbert, Ford 
and Mokdad, 
USA, 2009 
National 
Ambulatory 
Medical Care 
survey (2006), 
n=9280, age 18+ 
Used logistic regression models to 
investigate the impact of  two BMI 
groups (exclude underweight) 
controlling for age, sex, race, 
payment source, major reason for 
the visit, and the total number of 
co-morbid chronic conditions 
Duration of 
outpatient visit 
and prescribed 
medication 
Time spent with the 
provider was found to 
be greater among visits 
with obese patients, but 
not significantly 
different from visits with 
non-obese patients. The 
number of medications 
for each visit was found 
to be significantly 
greater for visits where 
the patient was 
considered to be obese. 
Peytremann-
Bridevaux & 
Santos-
Eggimann, 
Europe, 2007a 
Data from 10 
European 
countries (SHARE 
survey) (2004), 
n=16695, age 50-
79 
Used logistic regression to 
investigate the impact of three BMI 
groups (excluded underweight) on 
use controlling for age, 
socioeconomic status, smoking, 
physical activity, alcohol, country of 
residence, and chronic conditions 
Ambulatory care, 
high use of a GP, 
visits to 
specialists, high 
use of 
medication, 
hospitalization, 
high number of 
times hospitalized 
and nights spent 
in the hospital, 
surgery, home 
healthcare and 
domestic help 
Demonstrated an 
increased risk of using 
ambulatory care and 
visiting general 
practitioners, as well as 
taking ≥2 medication 
categories.  
 
Peytremann-
Bridevaux & 
Santos-
Eggimann, 
Europe, 2007b 
Data from 10 
European 
countries (SHARE 
survey) (2004), 
n=16695, age 50-
79 
Used logistic regressions to 
investigate the impact of three BMI 
groups controlling for age, sex, 
education, income, smoking, 
alcohol, physical activity, and 
country 
Influenza 
immunization, 
colorectal 
and breast cancer 
screening, 
discussion and 
recommendation 
about physical 
activity, and 
Overweight and obesity 
were associated with 
higher odds of receiving 
influenza immunization 
but not with receipt of 
breast or colorectal 
cancer screening. 
Overweight and obese 
individuals mentioned 
 178 
 
weight 
measurement 
more frequently that 
their general 
practitioner  discussed 
physical activity or 
checked their weigh 
Popoola, UK, 
2004 
Health Survey for 
England (1998), 
n=4102 , age 50-
69 
Used logistic regression methods to 
investigate the correlations 
between health service use and 
across three BMI groups in a 
population between 50 and 69. 
Controlling for age, gender, 
ethnicity, SES, education, alcohol 
and smoking.  
GP visits, 
medication use, 
outpatient visits 
and inpatients 
stays 
Significant association 
between BMI and 
outpatient services and 
medication use but not 
inpatient services and 
GP visits 
Quesenberry, 
Caan, Jacobson, 
USA, 1998 
Members of an 
health 
maintenance 
organisation 
(1993), n=17118, 
age 20+ 
Used Poisson regression to 
investigate the impact of four BMI 
groups (excluding underweight) on 
use controlling for age sex, 
smoking, alcohol consumption, 
educational level, and race    
hospitalisations, 
laboratory 
services, 
outpatient visits, 
outpatient 
pharmacy and 
radiology services 
There was an 
association between 
BMI and annual 
rates of inpatient days, 
number and costs of 
outpatient visits, costs 
of outpatient pharmacy 
and laboratory services, 
Reidpath et al. 
Australia, 2002 
Cross sectional 
Australian health 
survey (1995), 
men: n=17033 
women: n=17174, 
age 20+ 
Fit separate logistic models using 
continuous and categorical BMI 
(four groups) as the dependent 
variable controlling for age and 
income.  
Medication use, 
hospitalization, 
emergency room 
visits, outpatient 
clinic visits, doctor 
visits, other 
health 
professional visits,  
and in women 
only regular pap 
smear tests, 
regular breast 
examinations, 
regular 
mammograms 
Found a positive 
relationship with 
medication use, 
outpatient and doctor 
visits for men and 
women in Australia. In 
addition, they found a 
significant relationship 
for women for other 
health professionals. 
They also looked at the 
relationship between 
BMI and preventive 
service for women, and 
found that this 
relationship was 
negative. 
Saez, Saurina, 
Coenders & 
Gonzalez-Raya, 
Spain, 2006 
Using a survey of 
the population in 
one regian in 
Spain (2002), 
n=734,  all ages 
Three BMI groups.  Use a regional 
multilevel model with random 
effects. Controls for age, gender, 
marital status, co morbidities, 
smoking, medical insurance 
tenancy, income, labour status and 
profession, place of birth, people in 
household, number of cars, 
number of owned dwellings. Fit 
separate models across income 
groups. 
GP and specialist 
visits 
Find that obese 
individuals have a higher 
probability of having GP 
visit, however a lower 
probability of a 
specialist visit.  
Sansone RA, 
Sansone LA, 
Wiederman, 
USA, 1998 
Women in one 
health 
maintenance 
organisation (year 
not given), n=194, 
age 17-52 
Used linear regression and logistic 
models to investigate the impact of 
five BMI groups on use controlling 
for age, race, family income, 
education, smoking status, and 
health insurance status 
Mammography, 
clinical breast 
examination, 
gynaecologic 
examination, and 
Papanicolaou 
smear and the 
number of 
physician visits 
Among women, an 
increased BMI is 
associated with 
decreased preventive 
health care services, 
however increased 
physician visits 
Schafer & 
Ferraro, USA, 
2007 
Hospital records 
(1971-1975), 
n=4574, age 40-77 
Use various methods including 
interval regression and duration 
models to investigate the impact of 
the duration of obesity on use 
controlling for age, gender, race, 
education, income, live alone, 
health insurance, drinking, 
smoking, sedentary lifestyle, place 
of residence, morbidity and 
hospitalisation history 
Hospitalisation 
and length of stay 
Results reveal that 
obesity increased 
hospital admissions and 
length of stay over the 
20 years studied. 
Trakas, 
Lawrence, 
Shear, Canada, 
Canadian cross 
sectional survey 
(1994), n=17626, 
Used logistic regression to 
investigate the impact of obesity 
(BMI > 27) on use controlling for 
Physician visits, 
disability days, 
admissions to 
Obese respondents 
were more likely to 
consult with physicians, 
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1999 age 12+ age, sex, level of physical activity 
and education 
hospital and 
medication use 
be prescribed a number 
of medications and to 
require excess disability 
days 
Van Dijk, Otters 
and Schuit, The 
Netherlands, 
2006 
Patients in a Dutch 
general practice 
(2001), n=8944, 
age 18+ 
Used bivariate and multilevel 
analysis to investigate the impact of 
BMI (in two or three groups) on use 
controlling for age, sex, educational 
level, type of health insurance, 
residence, smoking, alcohol 
consumption and exercising 
GP use and 
prescriptions 
Obesity increases the 
workload of Dutch 
general practitioners 
and the use of 
prescribed medication. 
Von Lengerke 
et al., Germany, 
2005 
Cross sectional 
German survey, 
n=947, age 25-74 
Use a two-part model approach for 
the two utilization parameters. The 
first part is a logistic model and the 
second part is a zero-truncated 
negative binomial model. 
Controlling for sex, age, social class, 
public vs. private health insurance, 
and rural vs. urban place of 
residence Use 5 BMI groups but 
exclude underweight. 
GP visits and 
inpatient stays 
Found a relationship 
between obesity and GP 
use. Regarding days in 
hospital, only the 
extremely obese 
reported significantly 
more utilization than 
those normal weight 
Wildenschild, 
Kjøller, Sabroe, 
Erlandsen, and 
Heitmann, 
Denmark, 2011 
Cross sectional 
Danish Health 
Survey (1987, 
1994, 2000 and 
2005), men: 
n=19142, women: 
n=18335, age16+ 
Used logistic regression to 
investigate the impact of  four BMI 
groups controlling for age, marital 
status, educational level, 
employment, and smoking status 
GP, physician 
from the 
emergency 
service, medical 
specialist, 
industrial medical 
officer, 
emergency ward, 
outpatient clinic, 
hospitalization, 
and other 
physician 
Computed a composite 
measure for all types of 
care and found a 
significant positive 
association for both 
men and women 
Yan et al., USA, 
2006 
Participants 
recruited in the 
Chicago area 
(1967-1963), 
n=17643, age 31-
64. Followed up 
the individuals 
and recorded 
hospital stays until 
2002 
Used logistic regression models to 
investigate the impact of three BMI 
groups on hospitalisations 
controlling for sex, race, age, 
education, minor 
lectrocardiographic abnormality, 
SBP and serum total cholesterol 
Hospitalisation  Those who are obese in 
middle age have a 
higher risk of 
hospitalization and 
mortality from CHD, 
cardiovascular disease, 
and diabetes in older 
age than those who are 
normal weight 
Zizza , Herring, 
Stevens, 
Popkin, USA, 
2004 
Used national US 
longitudinal 
survey sectional 
survey (1971-
1992), n=14407, 
age 25+ 
Used Poisson regression to 
investigate the impact of five BMI 
groups on length of stay controlling 
for age, gender, race, marital 
status, whether respondents had 
children, smoking status, 
socioeconomic status, region of 
residence, and urban-rural 
residence in our models 
Inpatient days Obese individuals have 
longer hospital stays 
 
6.2.2 Findings 
We start with an overview of the studies, methods and results. We then discuss in 
more detail the UK specific studies and studies that measure socioeconomic variation 
in the impact of obesity on health service use.  
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We identified 27 studies and there were wide variations in the origins of the data, 
however many of the studies were from North America (11 studies). We also found 
three studies from the UK (Counterweight Project Team, 2005a; Counterweight Project 
Team, 2005b; Popoola, 2004).  
 
The literature covers a variety of services including; GP visits, specialist visit, 
emergency services, preventive services, medication use, inpatient and outpatient 
visits. Although, countries, populations, age range and other control variables differ 
across studies it has been shown that obesity is generally associated with increased 
use of health services. Table 6.2 shows summary statistics of selected results of the 
review. Of the ten studies looking at GP visits, nine find that obesity increases the 
frequency of visits. The evidence for a relationship for outpatient visits is also quite 
robust, with six identified studies all showing a positive relationship. The evidence for 
hospitalisations however is more mixed and of the 18 identified studies 12 
demonstrate a positive relationship between obesity and hospital admittance, while 
the rest shows no relationship. However, there appears to be a positive association 
between inpatient stays and those in obesity class III (BMI>40 kg/m2).  
 
The literature review also identified ten studies investigating the association between 
obesity and medication use. These studies all provide evidence of a positive 
relationship between obesity and medication use. We have found two studies that 
investigate the effect of obesity on medication use disaggregated into therapeutic 
classifications (van Dijk, Otters and Schuit, 2006; Counterweight Project Team, 2005b). 
The Counterweight Project Team (2005b) demonstrate that obese (BMI>30 kg/m2) 
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individuals compared with normal weight (18.5<BMI<25 kg/m2) individuals have a 
significantly increased use of medications for the cardiovascular system; central 
nervous system; endocrine system; musculoskeletal and joint disease; infections; 
gastrointestinal; and  skin and respiratory system controlling for age, sex, deprivation 
category, and country (England/Scotland). In addition, van Dijk, Otters and Schuit 
(2006) show a significantly higher odds of using medicines for; alimentary tract and 
metabolism, cardiovascular system, dermatological, systemic hormonal preparations, 
anti-infective for systemic use, musculoskeletal system and the respiratory system for 
obese (BMI>30 kg/m2) compared normal weight (BMI<25 kg/m2) men and women in 
the Netherlands. 
 
Table 6.2: Summary of identified studies examining the evidence on the association 
between obesity and health service use 
Type of use Evidence of relationship between obesity and use of obesity 
 Obesity increase use Obesity decrease use No association 
GP visit 9 0 1 
Practice nurse 1 0 0 
Hospitalisations 12 0 6 
Outpatient 6 0 0 
Medication 10 0 0 
 
A range of different econometric methods have been applied and the most common 
method is a standard binary choice model (usually a logistic regression model) looking 
at the relative odds of utilising the health service P(HSU=1), where HSU denotes health 
service use. However, two part models are becoming more popular in more recent 
studies. The two part model investigates the decision process regarding use in two 
parts where the first is a standard binary choice model modelling the probability of use 
P(HSU=1), and the second step equation models the level of utilisation among users 
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E(HSU|HSU>0). In this way they capture not only the binary decision to use the health 
service but also the intensity of use.  
 
Most of the studies have presented their results in odds ratios or relative risk (RR). The 
relative risk is the risk of health service use for obese (O) vs. non obese is: 
 
)01(
)11(



OHSUP
OHSUP
RR         (6.2) 
 
Few have calculated the absolute difference, which is the difference in risk: 
 
)01()11(  OHSUPOHSUPME       (6.3) 
 
We will discuss the implications of these different interpretations later in this chapter.  
 
6.2.2.1 UK evidence 
The function and the structure of the health care system vary across countries and this 
may influence people’s opportunities and choice of health service use. For example, in 
some countries GP’s act as gatekeepers while in other countries patients can go 
straight to a specialist. Hence, country specific evidence is important. The 
Counterweight project (2005a) team looks at obese and normal weight individuals who 
have had their height and weight registered at 80 practices spread across England and 
Scotland. They found that obese patients made significantly more visits to the general 
practitioner, practice nurse, and hospital outpatient units than normal weight patients, 
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and they were admitted to the hospital more often. For both GP and practice nurse 
visits, the relationship remained after adjusting for age, sex, social deprivation 
category, country, and number of comorbidities. As described above the 
Counterweight Project Team (2005b) also conducted a study to investigate the impact 
of obesity on prescribing in primary care. They find that obese individuals are 
prescribed more drugs than normal weight individuals in primary care.  Furthermore, a 
study has been conducted using the Health Survey for England (1998) to examine the 
association between obesity and health service use in the population between 50 and 
69 in England (Popoola, 2004). Popoola found that obese (BMI>30 kg/m2) individuals 
had a significantly higher relative odds of using outpatient services and using two or 
more prescription drugs compared with normal weight (BMI: 18.5 - 25 kg/m2). 
However, no significant relationship was found between the use of inpatient services 
and GP visits for this group.  
 
Our study will differ from these studies in a number of respects. They include only one 
category for obesity. We will include more categories as it is likely that the effect of 
obesity class II/III (BMI>35 kg/m2) on health service use differs from the effect of 
obesity class I (30 kg/m2>BMI>35 kg/m2). These studies do not take account of supply 
variables and it has been indicated that supply has significant effects on health service 
utilisation (Morris, Sutton & Gravelle, 2005). Hence, we will take account of this in our 
analysis. They use cross-sectional data; hence they cannot exclude the influence of 
time invariant heterogeneities, which we to some extent address with panel data. They 
do not focus on the gender difference by stratifying by gender. Instead they control for 
it in the analysis. We illustrated in earlier chapters there may be a separate gender 
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effect of BMI on health. Hence, it is interesting to see if this effect materialises itself in 
this analysis as well. They use binary regression models to investigate relative odds of 
positive outcomes. Hence, they do not look at the number of visits/drugs used. They 
present their results in odds ratios and it would be useful with a study that uses 
absolute values rather than relative. Furthermore, none of these studies have stratified 
the results by SES groups. Hence, this is an area that has not received enough 
attention. 
  
6.2.2.2 Socioeconomic variation in the association between obesity and health service 
use 
We have identified two studies that investigate SES variation in the association 
between obesity and health service use. The first by Saez, Saurina, Coenders & 
Gonzalez-Raya (2006) use Spanish data to look at relative risks of GP and specialist 
visits. They find that obese individuals have a higher relative risk of having a GP visit, 
however a lower probability of a specialist visit. They also look at the relative risk of GP 
and specialist visits across income groups. They find that relative risk of GP use 
decreased with income and that the relative risk of specialist services increased with 
income. Then they stratify income across BMI groups. They state that they identify the 
same income-use trend in the obesity and overweight groups.  
 
The second is another Spanish study by Guallar-Casillon et al. (2002) that looks at the 
association between BMI and health service use (Hospitalisations, medical visits, 
utilisation of hospital emergency services, and medication use) in women interacting 
BMI and education. The interaction was non-significant. They use a binary choice 
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model and therefore look at if the health service is used or not. They do not investigate 
the number of contacts.  
 
The aim of both these studies was to present their results in relative terms (odds ratios 
and relative risks), hence they do not analyse, e.g., the number of visits and drugs used 
or the percentage increase in the number of visits in absolute terms. As will be 
explained later they might have reached a different conclusion if this was their aim. 
Also, neither of these studies was undertaken in the UK, and results might vary 
between countries, for example, Spain has relatively high involvement of the private 
sector in their health care system.  
 
To conclude, there is evidence of an association between obesity and a wide range of 
services. Although UK specific evidence exists we will apply a number of new methods 
and use a range of new utilisation and control variables. Furthermore, limited research 
has been done on socioeconomic variation in the association between obesity and 
health service use. 
 
6.3 Methods 
This chapter uses data from the Health Survey for England (HSE) and the British 
Household Panel Survey (BHPS). These have been chosen as they are British nationally 
representative surveys that provide data on obesity, SES and health service use. In the 
following sections we will present the data and variables separately for HSE and then 
BHPS. We then present the econometric methods.  
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6.3.1 Health Survey for England: Data and variables 
From the HSE we include data for individuals over the age of 16 for four different 
combinations of the datasets depending on the health service utilisation variable. We 
apply the following health service use variables from HSE: GP visits, practice nurse 
visits, inpatient stays, outpatient visits and a range of medication use categories. 
 
Information on GP visits for all causes is available for four rounds (1999-2002, N=60 
091), practice nurse visit data are available for two rounds (2001-2002, N=38 038) and 
inpatient visits and outpatient visits data are available for two rounds (1999-2000, 
N=22 053). Lastly, medication use data are available for ten rounds (1999-2008, N=158 
703). 
 
Respondents were asked about the number of visits to the GP in the last two weeks. 
However, less than 3% had more than one visit in the last two weeks. Hence, we look 
at whether or not the individual had a GP visit as a binary dependent variable taking 
the value 1 if the person has had GP visits in the last two weeks and 0 otherwise(<16% 
had one or more visits). This is similar for practice nurse visits (less than 1% had more 
than one visit and 6% one or more visits) and therefore this variable is also only 
included as a binary variable.  
 
For inpatient stays and outpatient visits respondents were asked if they had an 
inpatient stay/outpatient visit in the last year. However, in this case the HSE only 
provides information on whether or not the individual used inpatient/outpatient 
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services and not the number of visits. Therefore we include these as binary variables 
taking the value 1 if the person has made use of inpatient/outpatient services the last 
year and 0 otherwise.  
 
We also look at current medication use. Information about current medication use was 
only obtained for individuals who were visited by a nurse during the survey. The years 
included in this analysis was 1999-2008. HSE has information on type of medication 
and has categorised them by 12 medication categories (+ other medication taken) 
based on therapeutic classifications in the British National Formula (BNF), see 
Appendix 6.1. In addition, HSE records the number of prescribed medications taken.  
 
The obesity measure is based on height and weight obtained during the interviewer 
visit; it is not self-reported. Obesity is measured as a categorical variable based on four 
BMI categories, defined according to World Health Organization guidelines (WHO 
Expert Committee on Physical Status, 1995): normal weight, BMI 18.5-24.9 kg/m2; 
overweight, BMI 25-29.9 kg/m2; class I obesity, BMI 30-34.9 kg/m2; and, class II/III 
obesity BMI >35 kg/m2. As in previous chapters, we combine obesity classes II and III to 
ensure an adequate number of observations in each cell when we interact BMI and 
SES. Also we do not combine underweight (BMI <18.5 kg/m2) and normal weight and 
include underweight as a separate category, but do not report the results for this 
group. 
 
SES is a composite measure, and measured in quartiles of a continuous variable based 
on the linear prediction from an interval regression model of total annual household 
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income reported in 31 income bands (including an open-ended top category), against a 
set of individual and household characteristics. The predicted values were equivalised 
using the McClements household score provided in the HSE to account for household 
size and composition, and then divided into quartiles. The individual and household 
characteristics used in the interval regression were: year (ten categories), education 
qualifications (measured in seven categories); social class of household reference 
person (HRP; seven categories); cars or van owned by household (four categories); 
housing tenure (five categories); bedrooms in household (five categories); economic 
activity (eleven categories); and, whether or not the person was an income support 
claimant (yes/no). We predict income based on all individuals in the years 1999-2008 
and divide this into quartiles. As we use data over the year 1999-2008 it is likely that 
individuals in the earlier years have a lower income because of general income growth 
over time. To control for this we recode every individual in the sample to the most 
recent year before we make the prediction. 
 
To capture regional differences in supply we control for District Health Authority (95 
categories) in the health service use regressions. By controlling extensively for health 
area we capture differences in supply of health services in the area, such as GPs per 
head, other medical staff per head, distance to hospital or GP practice. There is 
evidence of PCT level variation in obesity (Moon, Quarendon, Bernard, Twigg & Blyth, 
2007). Hence, when we control for health area level data we possibly reduce some of 
the effect of both obesity and SES on health service use. We have fitted regressions 
without these variables, finding that the positive impact of obesity and the negative 
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impact of SES is slightly stronger. However, it does not have an impact on the 
conclusion of the analysis.  
 
The District Health Authority variable is only available for the years 1999-2002. Hence, 
it is not available for all the years included in the medication analysis. In this analysis 
we control for area with the broader area level variable Government Office Region of 
residence (nine categories). This variable might also pick up regional variation in 
obesity and SES, we discuss this further below.  
 
In the health service use equations we also include the following covariates: age (as a 
cubic function); survey year (one dummy for each year depending on the dataset); 
marital status (six categories); smoking status (four categories); ethnicity (ten 
categories); and, missing income (yes/no). We also stratify by gender.  
 
6.3.2 British Household Panel Survey: Data and variables  
The BHPS is a longitudinal cohort survey of adult members of a nationally 
representative sample of British households. Respondents are interviewed on a range 
of topics including their age, socio-economic indicators, health status and a range of 
health service use indicators. The latest wave with available obesity data was wave 16 
collected from 1 September 2006 to April 2007. The survey collects data from adult 
members of the household. Those in the initial sample are followed until they refuse to 
participate, die or are lost to follow-up. The present study includes everyone over the 
age of 16 from wave 14 (1st September 2004 to 11th May 2005) and wave 16 (1st 
September 2006 to 3rd April 2007), which are the only waves measuring height and 
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weight. We included respondents who are not observed at every wave (unbalanced 
panel). The total number of respondents in both waves are 13 194. In addition, there 
were 2552 individuals who were only included in wave 14 and 1486 individuals who 
were only included in wave 16. This constitutes a total of 30 426 observations.  
 
From the BHPS we apply the following health service use variables: GP visits, hospital 
outpatient use, hospital inpatient use, seen a chiropodist, had x-ray of lungs and chest, 
checked blood pressure, had a cholesterol test and had a blood test. For GP visits and 
outpatient use the health services use variable was measured by the following 
question: ‘how many times have you made use of a health service since the 1st of 
September the previous year?’. The answers were grouped into 5 groups (none, 1-2, 3-
5, 6-10, more than 10). For the remaining health service use variables the use was 
measured by a binary response to the following question ‘have you made use of a 
health service since the 1st of September the previous year?’.  
 
The participants were interviewed in a period from the 1st of September to six to seven 
months after. This means that the time period differs across the population. We 
controlled for this by including a time elapsed variable. This variable controls for the 
time period in days from the 1st of September to the interview date.  
 
BMI is calculated by dividing each respondent’s weight in kilograms by their height in 
meters squared. We constructed a measure of BMI based on the self-reported 
measures on height and weight obtained during the interview. We divide BMI into the 
same four categories (+ underweight) as in the HSE data.  
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SES is based on a continuous variable from a linear prediction from a random effects 
linear regression model of total annual household income26, against a set of 
socioeconomic variables. The predicted values were equivalised using McClements 
household score provided in the BHPS to account for household size and composition 
and then divided into quartiles. The variables used in the regression were: year (two 
waves), education qualifications (six categories); social class of household reference 
person (HRP; seven categories); car or van owned by household (yes/no); housing 
tenure (five categories); bedrooms in household (five categories); economic activity 
status (9 categories); and, whether or not the person was an income support claimant 
(yes/no).   
 
To capture regional differences in supply we include indicators for Primary Care Trusts 
(PCT) in England, Local Health Boards (LHB) in Wales, Community Health Partnerships 
(CHP) in Scotland, and an indicator for individuals who live in Northern Ireland, Chanel 
Islands, and Isle of Man (216 categories). As mentioned earlier, when we control for 
health area level data we possibly reduce some of the effect of both obesity and SES 
on health service use. As in HSE we fit regressions with and without these variables. 
Generally we find a reduced effect of obesity and a slightly reduced effect of SES across 
the different types of use when we include them. However, as in HSE it does not alter 
the conclusion of the analysis. 
                                                     
26 We use the total household income variable provided in the BHPS. This has been imputed using a 
regression based imputation technique; see Taylor, 2004 for further information. Hence, we do not have 
any missing income values.  
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In the health service use regressions as well as obesity and SES we also included 
covariates for: age (as a cubic function), survey year, marital status (7 categories), 
smoking status (yes/no) and ethnicity (9 categories).  
 
6.3.3 Econometric methods 
The HSE is a repeated cross-sectional dataset while the BHPS is a panel dataset. Hence, 
in the following analysis we use both cross-sectional methods and panel data methods. 
We start by describing the regression models and the estimation strategy, followed by 
an explanation of the adjustments that have been made to these methods when we 
conduct the analysis in the BHPS.  
 
6.3.3.1 Regression models 
As mentioned above we have three types of dependent variables: binary, banded-
count and count variables. When we have binary dependent variables we use 
nonlinear binary dependent variable models instead of the Linear Probability Model 
(LPM) due to the well known shortcomings of the LPM27. We chose the probit model 
over the logit28 model as economists have a tendency to prefer the normality 
assumption of the error term in the probit model (see, e.g., Wooldrige, 2002; Greene, 
2010). 
 
                                                     
27
 Most importantly the LPM does not restrict its predicted probabilities to a value between 0 and 1. In 
addition, and related to the previous problem, the partial effects are constant, which can provide 
unlikely values at extreme values of continuous variables. 
28
 The main difference between the logit and probit models lies in the distribution of the errors; 
however they tend to provide very similar predicted probabilities. 
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For some types of use (medication use in the HSE; GP and outpatient visits in the BHPS) 
we have count data on the number of visits/drugs used. In the BHPS the variables are 
grouped count data and to account for this we use interval regression methods. In the 
HSE the variables are not grouped and we use a negative binomial (negbin) count 
model. The negbin model is chosen over the more common Poisson count model as we 
have a large proportion of zeros, which could cause the conditional mean variance of 
the dependent variable to differ from the conditional variance. The negbin model 
accounts for this potential problem by allowing for a variance that is greater than its 
mean (Jones, 2005). 
 
What follows is a two-part model. “The decision to contact a physician and the 
decision about how often to contact a physician are determined by different decision 
makers” (Pohlmeier & Ulrich, 1995). Hence, in the case of GP/outpatient visits, but not 
medication use, we treat the decision process as consisting of two separate probability 
functions. We analyse the decision to use or not to use the health service by a binary 
probit model as above, P(GP=1). We fit a model for the subsample of individuals who 
have used the type of health service at least once, E(GP|GP>0). This model investigates 
the number of GP/outpatient visits.  
 
We do not treat the number of medications used as a decision consisting of two parts. 
In this case we do not see the decision about use and frequency of medications to 
consist of different decision makers.  
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6.3.3.2 Interpretation of the output 
In this chapter we use both linear and nonlinear models. As we discussed in the 
literature review, the outputs of nonlinear models are often interpreted in two ways. 
The first is the absolute effect and is the effect of the independent variables on E(y). 
The second is the relative effect, which is reported in the form of risk ratios or relative 
difference.  
 
Whether one should focus on absolute or relative effects depends on the question the 
researcher wants to answer. In this research we want to quantify the consequences of 
the findings and focus on absolute values. The absolute effect is the coefficient in a 
linear regression model. However, the interpretation of the coefficient change when 
one uses a nonlinear model. This has consequences for the interpretation of the 
interaction terms, which we explain below. 
 
Assuming we have two SES groups high and low and we want to measure 
heterogeneities in the impact of obesity on a dependent variable (mi). We can 
estimate the following linear model: 
 
iiiii uOyyOm  3210         (6.4) 
 
Where yi is a dummy taking the value of one if the individual is high SES, Oi is a dummy 
taking the value one if the individual is obese and the Oyi is an interaction between 
high SES and obese. The β’s are parameters to be estimated and ui is the error term. If 
the model is linear the hypothesis test of the interaction term (β3=0) would be a test of 
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whether or not there are absolute differences in the impact of obesity on health and 
health service use. If the models are nonlinear the hypothesis tests of the interaction 
term (β3=0) would be a test of whether or not there are interactions in the impact of O 
and Y on the latent variable m*. The latent variables are unbound unobserved 
variables and the hypotheses about these latent variables are about whether or not 
there are relative interactions in the models. The marginal effect of each variable in a 
nonlinear model is the cross partial derivative. In contrast to the linear model the 
marginal effect changes depending on the values of the other covariates, even in 
models without interaction terms.  
 
Clarity about whether one focuses on absolute or the relative effects is especially 
relevant in our case where we seek to compare the effect of obesity across subgroups. 
One could end up in a situation where the relative interaction effect and the absolute 
interaction effect tell different stories and have different signs. See, e.g., Ai & Norton 
(2003); Greene (2010); and Berry, DeMerit & Esarey (2010) for further discussions. 
 
Hence, in a linear model we focus on the interaction term. While in a nonlinear model 
we need an alternative method for establishing whether or not there are different 
consequences of obesity across SES groups. There has been much debate around how 
to interpret interactions in nonlinear models when one wants to interpret the 
interactions as marginal effects (Ai & Norton, 2003; Norton et al., 2004; Greene, 2010; 
Kolasinski and Siegel, 2010; Huang & Shields, 2000; Karaca-Mandic, Norton & Dowd, 
2011; Berry, DeMerit & Esarey, 2010). We follow an approach by Greene (2010) who 
argues that hypothesis tests about interactions and other effects in nonlinear models 
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should be about the model coefficients and about the structural aspects of the model 
specifications. Marginal effects are neither coefficients nor elements of specification of 
the model they are implications of the specified model. Greene (2010) suggests 
investigating interactions in nonlinear models in two steps:  
 
1. Build the latent variable model based on appropriate statistical procedures. 
Conduct hypothesis testing about the model coefficients and interactions at 
this stage. Hypothesis tests are about the model coefficients and the structural 
aspects of the model specifications. 
2. Use the model to inform the reader about partial effects using graphical 
presentations, with no need for any testing in stage two.  
 
We follow these steps although we do not provide graphical interpretations. Instead 
we provide tables of predicted means across groups.  
 
6.3.3.3 Estimation strategy 
We regress the health service use variables against the BMI categories and SES 
quartiles using probit/count/interval regression models for cross sectional data 
including interaction terms between BMI and SES categories, with normal weight and 
SES quartile 1 (most deprived) as the omitted categories. Hence, we fit the following 
latent variable model: 
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Where health service use (mi) is a function of SES, the BMI groups, interactions 
between BMI and SES, and other variables (Zi), ui is the error term and i indexes the 
individuals. The β’s are vectors of coefficients to be estimated 
 
When we follow the approach suggested by Greene (2010) we conduct our analysis in 
two steps. We start with step one where we decide upon the functional form that best 
fits our data. To decide upon the variable specification we follow previous research by 
Birch, Jerret & Eyles (1997 & 2000) and Birch et al., 2005 and use a stepwise backward 
elimination process, which is a process where one starts with a full model including all 
variables and interactions and then remove variables until we are left with a model 
that only includes significant variables. We use the likelihood ratio29 test as criteria for 
removal. We run separate models for each gender controlling for individual and 
household characteristics.  
 
When we have specified the model we move on to the second step, which is to 
estimate predicted mean health service use across SES and BMI groups, based on the 
specified model.  
 
When we have binary dependent variables we want to estimate the predicted 
probability of use of the health services P(m=1) and compute predicted mean health 
service use for each BMI or BMI/SES category after every regression based on specified 
                                                     
29
 The likelihood in a clustered analysis is not a true likelihood, i.e. it is not the distribution of the sample. 
When clustering is used individual observations are no longer independent, thus the likelihood-ratio test 
should not be used, and Wald tests should be used instead (Sribney, 2005). Hence, in the analysis where 
we clustering by PSU we base our selection of the variables on Wald tests only.  
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latent variable models. We fix the other covariates at the whole sample mean values. 
Hence, the variation in the predicted mean health service use is a function of the 
impact of obesity on probability of health service use and how this varies by SES, and is 
not affected by the values of the covariates, which vary between individuals. 
 
In the interval regression models and negbin models we compute predicted mean 
number of consultations (E(m)) fixing the covariates at the whole-sample mean values 
in the same way as explained for the probit models above. 
 
To maximise the sample size, we included individuals in the models with missing 
income data for whom we could compute a predicted income value. In the models we 
included an indicator for missing income (yes/no), to control for the possibility that 
income may not be missing at random. 
 
We apply survey weights reported in the HSE to each observation. This adjusts for the 
fact that different observations have different probabilities of selection and 
participation in the survey. Medication use data was obtained only for those who were 
visited by a nurse during the survey; hence we apply nurse weights reported in the 
HSE. This adjusts for the non response bias to the nurse section of the survey. It is also 
possible that, due to the sampling strategy used in the HSE, observations are 
independent across Primary Sampling Units (PSUs), but not within PSUs. If this is the 
case then if we use estimators that assume independence within these clusters the 
standard errors on our regression coefficients will be too small and we will 
overestimate the statistical significance of the independent variables in our models. 
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We control for clustered sampling within PSUs using unique PSU/year identifiers that 
produce Huber/White/sandwich robust variance estimators that allow for within-
group dependence (Kish & Frankel, 1974). 
 
P values below the 5% level (t statistics higher than ≈1.9) are regarded as statistically 
significant.  
 
6.3.3.4 Panel data adjustment in BHPS 
In the following part we explain the changes made to account for the BHPS being a 
panel dataset. There are essentially two panel data methods: fixed effects and random 
effects. In cases where key variables do not vary sufficiently over time we are forced to 
use random effects30 (Wooldrige, 2002). In our case we have explanatory variables like 
SES groups and BMI groups that do not vary sufficiently over time, the reason being 
that we only have two time periods. Alternatively, we could use a pooled panel model. 
However, not only does the pooled panel model have problems with the error terms 
being serially correlated, the random effects model removes a fraction of the time 
invariant heterogeneity (Wooldrige, 2002).   
 
We ran the models in the previous paragraph using random effects binary probit and 
random effects interval regression models: 
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30
 We also recognise that there are more advanced random effects models like Mundlak and 
Chamberlain. However, these models do also need sufficient variation in the dependent variables over 
time. 
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Where t = 1, 2 denotes the time period for individual i. Wt is a dummy variable taking 
the value 1 if t=2 and zero otherwise. It does not change across individuals so it does 
not have an i subscript. The error term in a random effects model (vit) consists of ai, 
which captures unobservable individual heterogeneity that does not vary over time, 
hence it does not have a t subscript. uit is a random error that captures time variant 
errors. In random effects probit models one assumes that uit is ),0(
2
uIN  . To be able 
to compute marginal effects and predicted means one must make an assumption 
about the distribution of the unobserved effect ai. We follow Wooldrige (2002) & 
Arulampalam (1999) and assume that the ai’s are ),0(
2
aIN   
31. Further, one needs to 
make an assumption about the distribution of the error term vit. We follow 
Arulampalam (1999) who showed that to calculate the predicted probabilities one 
must calculate the marginal effect on the latent variable and multiply this with the 
variance in the error term 1 .  
 
Table 6.3 shows a summary of the 14 models we run using BHPS and HSE. Each of 
these models is fitted separately for men and women.  
 
  
                                                     
31
 Based on this; the correlation between error terms for the same individual across time is: 
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Table 6.3: Summary of regression models for analysing the association between 
obesity and health service use  
Number Dataset Dependent variables Regression 
method 
With or without 
interactions 
between BMI and 
SES groups 
Covariates 
1 BHPS 
(2004/5 
and 
2006/7) 
Binary: 
GP visits; outpatient visit; 
inpatient stay; chiropodist; 
x-ray of chest and lungs; 
had blood pressure taken; 
had a cholesterol test; Had 
a blood test 
Random effects 
probit models 
No interactions Individual and household 
characteristics including 
health area variables  
2 BHPS 
(2004/5 
and 
2006/7) 
Binary: 
GP visits; outpatient visit; 
inpatient stay; chiropodist; 
x-ray of chest and lungs; 
had blood pressure taken; 
had a cholesterol test; Had 
a blood test 
Random effects 
probit models 
BMI groups 
interacted with 
SES groups 
Individual and household 
characteristics including 
health area variables  
3 BHPS 
(2004/5 
and 
2006/7) 
Banded: 
Number of GP visit; number 
of outpatient 
Random effects 
interval 
regression 
models 
No interactions Individual and household 
characteristics including 
health area variables  
4 BHPS 
(2004/5 
and 
2006/7) 
Banded: 
Number of GP visit; number 
of outpatient 
Random effects 
interval 
regression 
models 
BMI groups 
interacted with 
SES groups 
Individual and household 
characteristics including 
health area variables  
5 HSE 
(1999-
2002) 
Binary: 
GP visits 
Probit models 
for cross 
sectional data 
No interactions Individual and household 
characteristics including 
health area variables 
6 HSE 
(1999-
2002) 
Binary: 
GP visits 
Probit models 
for cross 
sectional data 
BMI groups 
interacted with 
SES groups 
Individual and household 
characteristics including 
health area variables 
7 HSE 
2001-
2002) 
Binary: 
Practice nurse visits 
Probit models 
for cross 
sectional data 
No interactions Individual and household 
characteristics including 
health area variables 
8 HSE 
(2001-
2002) 
Binary: 
Practice nurse visits 
Probit models 
for cross 
sectional data 
BMI groups 
interacted with 
SES groups 
Individual and household 
characteristics including 
health area variables 
9 HSE 
(1999-
2000) 
Binary: 
Inpatient stays and 
outpatient visits 
Probit models 
for cross 
sectional data 
No interactions Individual and household 
characteristics including 
health area variables 
10 HSE 
(1999-
2000) 
Binary: 
Inpatient stays and 
outpatient visits 
Probit models 
for cross 
sectional data 
BMI groups 
interacted with 
SES groups 
Individual and household 
characteristics including 
health area variables 
11 HSE 
(1999-
2008) 
Binary: 
12 medication categories 
Probit models 
for cross 
sectional data 
No interactions Individual and household 
characteristics 
12 HSE 
(1999-
2008) 
Binary: 
12 medication categories 
Probit models 
for cross 
sectional data 
BMI groups 
interacted with 
SES groups 
Individual and household 
characteristics 
13 HSE 
(1999-
2008) 
Count: 
Number of prescribed 
medications 
Negative 
binomial count 
model 
No interactions Individual and household 
characteristics 
14 HSE 
(1999-
2008) 
Count: 
Number of prescribed 
medications  
Negative 
binomial count 
model 
BMI groups 
interacted with 
SES groups 
Individual and household 
characteristics 
 
As mentioned earlier, the advantage of the analysis in BHPS is that we apply panel 
models hence it can to some extent account for time invariant heterogeneity bias and 
serial correlation of the error terms. In addition, the data is more recent (in all cases 
 202 
 
except for medication use) and we have good data on health area variables. However, 
in HSE we have nurse measured height and weight, which is less likely to be biased 
compared to the self-reported height and weight in BHPS. 
 
6.4 Results 
We present the results in two parts first the results of the cross-sectional models in the 
HSE and then of the panel models in BHPS. We then compare the results across the 
datasets. 
 
6.4.1 Health Survey for England: Results 
Table 6.4 summarises the HSE data and shows the total number of individuals who 
were over the age of 16, had valid health service use data and BMI values across the 
three versions of the dataset. For data used for the GP visits analysis (years: 1999-
2002) 36 766 individuals had valid data, while 22 645 had valid data for the practice 
nurse analysis (years: 2001-2002) and 17 834 were included in the outpatient and 
inpatient use (years: 1999-2000) analysis. The mean share of individuals who had a GP 
visit in the last two weeks across the whole sample was 16% increasing from a mean of 
15% in the normal weight category to 22% in the class II/III obesity category. Similar 
trends were found for practice nurse visits with 5% in the normal weight category and 
9% in the class II/III obesity category. For outpatient visits the last year equivalent 
numbers were 30% and 39%, respectively. For the inpatient stays the last year similar 
numbers were 7% and 8%, respectively.  
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Table 6.4: summary statistics for the three versions of the HSE 
 
Whole Normal 
Overweight 
Class I Class II/III 
sample weight Obesity obesity 
GP visit last two weeks (1999-2002)      
Observations     
Number (%) 36766 (100) 14649 (40) 13762 (37) 5489 (15) 2198 (6) 
GP visit % 16 15 16 18 22 
Practice nurse visit  last two weeks 
(2001-2002)     
Observations     
Number 22645 (100) 9059 (40) 8349 (37) 3386 (15) 1410 (6) 
Practice nurse visit % 6 5 7 8 9 
Inpatient and outpatient visits last 
year (1999-2000) 
 
   
Observations     
Number 17834 (100) 6835 (38) 6770 (38) 2810 (16) 1123 (6) 
Outpatient % 32 30 32 35 39 
Inpatient % 8 7 8 9 8 
Note 
The years from the HSE included in each analysis varies by the dependent variable. Other than for 
“Observations” all statistics are percentages 
 
In Appendix 6.2 we present summary statistics of all the variables for the years 1999-
2002 across the BMI groups. We see that as in previous chapters the mean predicted 
SES measure was highest in the overweight category and lowest in class II/III obesity 
category; the modal SES quartile was 4 (least deprived) in the normal weight category 
and quartile 1 (most deprived) in the obese class II/III category. Forty six percent of the 
sample was men and the mean age was 46 years. 
 
In the medication use analysis we pool ten years and the total number of respondents 
was 158 703, of these 67 041 were over the age of 16, had valid medication use data 
(had a nurse visit), and BMI values. The numbers of observations in each BMI category 
are in Table 6.5. Summary statistics of the variables are in Appendix 6.3. Thirty seven 
percent of the individuals in the sample were normal weight, 38% (the modal category) 
were overweight and 24% were obese (17% in class I and 7% in class II/III). The mean 
number of medications used per person across the whole sample was 1.43, increasing 
from a mean number of 0.99 in the normal weight category to 2.45 in the class II/III 
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obesity. The mean share of individuals who use medication across the whole sample 
was 46% increasing from a mean of 37% in the normal weight category to 63% in the 
class II/III obesity. The mean predicted SES measure was highest in the overweight 
category and lowest in class II/III obesity category; the modal SES quartile was 4 (least 
deprived) in the normal weight category and quartile 1 (most deprived) in the obese 
class II/III category. Forty six percent of the sample was men and the mean age was 48 
years.  
 
Table 6.5: Summary statistics of medication use across each BMI category (HSE: 
1999-2008) 
  Whole 
sample 
Normal 
Weight 
Overweight 
Class I 
obesity 
Class II/III 
Obesity  
Medication (1999-2008)      
Observations     
  Number (%) 66435 (100) 24313 (37) 25489 (38) 11040 (17) 4626 (7) 
Medication categories      
  Cardio-vascular 22 13 24 33 38 
  Gastrointestinal 9 6 9 12 13 
  Respiratory 10 9 9 10 14 
  CNS 15 11 15 20 26 
  Endocrine 11 8 11 14 19 
  Musculoskeletal 7 4 6 10 13 
  Medication excluding contraceptives 46 37 48 56 63 
  Number of medications 1.4 1 1.5 2 2.5 
Note 
Other than for “Observations” all statistics are either mean (for number of medications) or % (all other 
variables). Number of medications are total number of medications not only the number of categories. 
 
Table 6.6 shows the results of the interval regression of total annual household income 
against the SES indicators using HSE data. The variables have the expected signs. 
Higher education, higher social class of HRP, owning a car or van and bedrooms in 
household are all positively correlated with income. Compared to being in paid 
employment all other types of economic activity have a negative effect on income. 
Claiming income support is negatively correlated with income. We used these 
coefficients to generate our predicted SES measures. Respondents were categorised 
into quartiles based on the predicted SES values. The range of values for equivalised 
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predicted income were -94,80532 to 16,2396; the cut-points used to set the quartiles 
were: 18,692; 28,243; and, 39,655. 
                                                     
32
 We convert the predicted income into quartiles and use these as our SES measure and do not use the 
actual income values in the further analysis. Hence, it is not a problem that we obtain negative 
predicted income values 
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Table 6.6: Interval regression of total annual household income against SES 
indicators in HSE (HSE: 1999-2008) 
  Coef. Z 
Educational qualifications  
  Degree or equivalent Base category 
  Higher education below degree -9629.7 -24.5 
  NVQ3/GCE A Level or equivalent -8095.01 -20.25 
  NVQ2/GCE O Level or equivalent -10075.4 -27.18 
  NVQ1/CSE other grade or equivalent -11708.5 -25.71 
  Foreign/other -10792.8 -20.93 
  No qualification -11416.1 -29.97 
Social Class of HRP  
  Professional Base category 
  Managerial technical -4278.77 -7.89 
  Skilled non-manual -9578.07 -17.28 
  Skilled manual -11772.2 -21.32 
  Manual unskilled -12141.6 -20.34 
  Not described SES -9611.56 -4.83 
  Missing SES -9598.16 -14.04 
Cars owned by household  
  Household has no car Base category 
  One car 1273.366 4.77 
  Two cars 9716.553 25.73 
  Three or more cars 19546.32 25.6 
Economic activity status for last week 
  In paid employment or self-employed Base category 
  Going to school or college full time -12474.6 -11.59 
  On a government training scheme -15741.4 -11.81 
  Doing unpaid work -5255.6 -1.4 
  Waiting to take up paid work already obtained -8964.46 -3.72 
  Looking for paid work or a government training scheme -15227.8 -29.35 
  Intending to look for work but prevented by temporary sickness -14834.2 -11.64 
  Permanently unable to work because of long-term sickness -11953.9 -29.01 
  Retired from paid work -11211.2 -33.83 
  Looking after home or family -10718.8 -21.48 
  Doing something else -16765.5 -14 
Housing tenure  
  Own outright Base category 
  Buying with help of a mortgage or loan 4178.557 11.63 
  Pay part rent and part mortgage -2922.75 -2.99 
  Rent  -1910.84 -5.47 
  Live rent free and/or squatting -5286.34 -5.6 
Bedrooms in household  
  One  Base category 
  Two  510.8716 1.63 
  Three  2263.775 6.86 
  Four  11496.58 23.13 
  Five or more  25732.5 24.49 
Income support claimant  
  No Base category 
  Yes -2347.2 -7.06 
Percent within each year   
  1999 -8052.89 -16.03 
  2000 -7142.33 -13.65 
  2001 -6125.48 -13.02 
  2002 -4814.98 -8.96 
  2003 -4034.08 -7.91 
  2004 -3292.6 -4.71 
  2005 -2685.33 -4.37 
  2006 -2014.44 -3.84 
  2007 -629.859 -0.93 
  2008 Base category 
Constant 45347.65 53.5 
Observations 84414 
Adjusted R 2 0.076 
Notes 
HRP = household reference person 
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Appendix 6.5 shows the latent variable models before we have excluded any variables 
for GP visit, practice nurse visits, inpatient and outpatient visits in HSE. The tables 
show the coefficients, the z values and joint tests for interactions. In general, across 
the models the effects of BMI and SES are significant; however the joint tests for the 
interactions are not. In appendix 6.6 we see the refitted models after we have 
conducted the stepwise backward elimination procedure. These are the models we 
base the predictions on. 
 
The predicted probabilities of health service use across each BMI category can be 
found in Table 6.7. We find that obesity increases the probability of having a GP visit 
for both men and women. Furthermore, we find that obese and overweight men have 
an increased probability of a practice nurse visit; however, there is no variation in 
outpatient visits across BMI groups for men. For overweight and obese women, there 
is no increase in use of practice nurses, however we see an increased probability of an 
outpatient visit and inpatient stays. The variation in probability of use is more 
pronounced in women than in men.  
 
Table 6.7: Predicted probability of health service use across BMI categories 
  Men Women 
  
Normal Over- Obese Obese Normal Over- Obese Obese 
weight weight Class I Class II/III Weight weight Class I Class II/III 
GP visit 0.127 0.130 0.141 0.187 0.169 0.190 0.200 0.232 
Practice nurse visit 0.037 0.042 0.048 0.082 0.069 " " " 
Outpatient visit 0.318 " " " 0.288 0.297 0.351 0.392 
Inpatient stay 0.066 " " " 0.078 0.092 0.124 0.098 
Note 
" Predicted probability equal to the normal weight category  
The predictions are based on probit models using the HSE. The dependent variables are the health 
service use variables. The mean values are predicted probability of health service use for each BMI or 
BMI/SES category computed by setting the individual and household characteristics to their whole-
sample mean values. The individual and household characteristics are age, age squared and age cubed, 
ethnicity, marital status, smoking status, health area variables, survey year, time elapsed and missing 
income.  
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Table 6.8 also shows the predicted probabilities of using health services across each 
SES quartile. Across all health services for both men and women lower SES groups use 
the health service more than higher SES groups. There is one exception for practice 
nurse visits for women, where we do not find any SES variation. In general, the SES 
gradient in use seems to be somewhat more pronounced in men. We see similar 
trends within each of the quartiles, in that higher levels of obesity is associated with 
higher predicted probability of use.  
 
There were no clear SES variation in the association between obesity and health 
service use. However, in women, the increase in GP visits in the last two weeks for 
overweight and obese were somewhat more pronounced in the lower SES groups 
compared with the higher SES groups. For example, the predicted mean share of 
individuals who have had a GP visit in the lowest SES quartile 1 in women increased 
from a predicted mean of 20% in the normal weight category to 26% in the class II/III 
obesity, which is a discrete difference of 6%. For the least deprived SES quartile 4 in 
women similar numbers were 15% and 20%, which constitutes a discrete difference of 
5%. For GP visits in men there was no clear gradient however the increase in visits was 
more pronounced in least deprived SES quartile 4 than in the most deprived SES 
quartile 1. 
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Table 6.8: Predicted probability of health service use across BMI and SES categories 
  Men Women 
  
Normal Over- Obese Obese Normal Over- Obese Obese 
weight Weight Class I Class II/III weight weight Class I Class II/III 
GP visit         
  1 (most deprived) 0.180 0.180 0.183 0.236 0.203 0.224 0.231 0.263 
  2 0.136 0.136 0.138 0.183 0.169 0.187 0.194 0.222 
  3 0.125 0.125 0.127 0.169 0.160 0.178 0.184 0.212 
  4 (least deprived) 0.092 0.114 0.142 0.171 0.151 0.168 0.175 0.201 
Practice nurse visit         
  1 (most deprived) 0.042 0.048 0.054 0.091 0.085 " " " 
  2 0.044 0.049 0.056 0.093 0.063 " " " 
  3 0.034 0.039 0.044 0.076 0.063 " " " 
  4 (least deprived) 0.029 0.033 0.038 0.066 0.068 " " " 
Outpatient visit         
  1 (most deprived) 0.370 " " " 0.288 0.297 0.351 0.392 
  2 0.324 " " " " " " " 
  3 0.312 " " " " " " " 
  4 (least deprived) 0.268 " " " " " " " 
Inpatient stay         
  1 (most deprived) 0.092 " " " 0.097 0.112 0.146 0.115 
  2 0.067 " " " 0.065 0.077 0.103 0.079 
  3 0.056 " " " 0.079 0.093 0.122 0.095 
  4 (least deprived) 0.053 " " " 0.072 0.084 0.112 0.087 
Note 
The predictions are based on probit models using the HSE. The dependent variables are the health 
service use variables. The mean values are predicted probability of health service use for each BMI or 
BMI/SES category computed by setting the individual and household characteristics to their whole-
sample mean values. The individual and household characteristics are age, age squared and age cubed, 
ethnicity, marital status, smoking status, health area variables, survey year, time elapsed and missing 
income.  
 
Appendix 6.7 shows the latent variable models before we have excluded any variables 
for medication use visits in HSE. The tables show the coefficients the, z values and joint 
tests for interactions. In appendix 6.8 we see the refitted models after backward 
elimination procedure. These are the models we base the predictions on. 
 
The predicted probabilities of medication use across each BMI group can be found in 
Table 6.9. The probability of using cardio-vascular medicine, gastrointestinal medicine, 
respiratory medicine, CNS medicine, endocrine medicine, musculoskeletal medicine 
increased for overweight and obese men and women compared with normal weight. 
For both genders CNS medicine was the modal type of medication in the normal 
weight group, while cardio vascular medicine was the modal type of medicine in the 
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obese class II/III category. On average normal weight men used 0.65 medications while 
the in the overweight, obese class I and obese class II/III categories the mean number 
of medications used were 0.74, 1.01 and 1.46, respectively. In women, analogous 
figures were 0.89, 1.06, 1.38 and 1.85.  
 
Table 6.9: Predicted probability of medication use across BMI categories 
  Men Women 
  Normal Over- Obese Obese Normal Over- Obese Obese 
  weight weight Class I 
Class II 
and III 
weight weight Class I 
Class II 
and III 
Cardio-vascular medicine 0.057 0.096 0.157 0.257 0.071 0.105 0.169 0.254 
Gastrointestinal medicine 0.046 0.049 0.057 0.071 0.049 0.058 0.083 0.093 
Respiratory medicine 0.083 0.082 0.085 0.108 0.082 0.090 0.107 0.142 
CNS medicine 0.073 0.084 0.106 0.154 0.121 0.151 0.184 0.240 
Endocrine medicine 0.022 0.030 0.051 0.097 0.092 0.102 0.115 0.151 
Musculoskeletal medicine 0.026 0.033 0.057 0.073 0.035 0.045 0.070 0.095 
Average number of prescribed medicines taken 0.649 0.739 1.013 1.457 0.889 1.063 1.377 1.853 
Note 
The predictions are based on negbin and probit models using the HSE. The dependent variables are the 
medication categories. The mean values are predicted probability of medication use for each BMI or 
BMI/SES category computed by setting the individual and household characteristics to their whole-
sample mean values. The individual and household characteristics are age, age squared and age cubed, 
ethnicity, marital status, smoking status, area variables, survey year, time elapsed and missing income.  
 
In Table 6.10 we see that similar trends were found in every SES quartile for both men 
and women, where the predicted probability of using medication was higher in the 
obesity categories than in the normal weight category 
  
More deprived SES groups have higher probability of using each of the medication 
types across all BMI categories for both men and women. Except for endocrine 
medicine for women where there was no variation in use across SES groups. When we 
look at the variable for all types of medication except from contraceptives we see that 
both men and women have a significantly higher predicted mean number of 
medications prescribed across all BMI categories.  
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For medication use we identify a SES gradient in the association between obesity and 
use in both men and women. Compared with normal weight overweight and obese 
men and women in the lower SES groups had a more pronounced effect on number of 
medications used than in the higher SES groups. For example, the predicted mean 
number of medications used in the lowest SES quartile 1 in men increased from a 
predicted mean of mean of 0.91 in the normal weight category to 1.97 in the class II/III 
obesity, which is a discrete difference of 1.06. For the least deprived SES quartile 4 in 
men similar numbers were 0.5 and 1.08, which constitutes a discrete difference of 
0.58. For women, although the difference is less pronounced, we identify the same 
gradient, in which lower SES women have a more pronounced association between 
obesity and number of medications used than higher SES women.  
 
We discussed how the absolute and the relative interaction effects could differ. We 
see that there is no SES variation in the relative difference in the use of medications. 
For example, the relative difference in medications used in the lowest SES quartile 1 
between normal weight and obesity class II/III obesity is 1.967/0.912=2.16. For the 
least deprived SES quartile 4 in men similar numbers were 1.076/0.499=2.16. The 
interpretation of these results is that low SES individuals use more medications than 
high SES individuals when they are normal weight. When they become obese the 
difference in number of medications used increases. Hence obesity costs more in 
terms of medications used in the lower SES group. However, the relative difference 
between the SES groups does not differ.  
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Table 6.10: Predicted probability of medication use across BMI and SES categories 
  Men Women 
  Normal Over- Obese Obese Normal Over- Obese Obese 
  weight weight Class I 
Class II and 
III 
weight weight Class I 
Class II and 
III 
Cardio-vascular medicine         
All 0.057 0.096 0.157 0.257 0.071 0.105 0.169 0.254 
  1 (most deprived) 0.078 0.127 0.199 0.311 0.098 0.145 0.189 0.270 
  2 0.060 0.101 0.163 0.265 0.082 0.109 0.186 0.280 
  3 0.050 0.085 0.141 0.235 0.063 0.091 0.178 0.249 
  4 (least deprived) 0.045 0.078 0.130 0.220 0.047 0.078 0.125 0.221 
Gastrointestinal medicine         
All 0.046 0.049 0.057 0.071 0.049 0.058 0.083 0.093 
  1 (most deprived) 0.068 0.071 0.081 0.099 0.065 0.076 0.105 0.116 
  2 0.049 0.052 0.060 0.074 0.050 0.059 0.083 0.092 
  3 0.041 0.044 0.051 0.063 0.045 0.053 0.076 0.084 
  4 (least deprived) 0.034 0.036 0.042 0.053 0.038 0.045 0.065 0.073 
Respiratory medicine         
All 0.083 0.082 0.085 0.108 0.082 0.090 0.107 0.142 
  1 (most deprived) 0.099 0.101 0.127 0.180 0.100 0.109 0.128 0.167 
  2 0.084 0.085 0.077 0.117 0.084 0.092 0.109 0.143 
  3 0.075 0.075 0.074 0.063 0.075 0.082 0.098 0.130 
  4 (least deprived) 0.077 0.071 0.069 0.078 0.073 0.080 0.095 0.126 
CNS medicine         
All 0.073 0.084 0.106 0.154 0.121 0.151 0.184 0.240 
  1 (most deprived) 0.147 0.166 0.200 0.266 0.198 0.222 0.264 0.328 
  2 0.077 0.089 0.112 0.158 0.154 0.175 0.213 0.270 
  3 0.058 0.068 0.086 0.125 0.122 0.161 0.164 0.233 
  4 (least deprived) 0.041 0.049 0.063 0.094 0.094 0.124 0.170 0.183 
Endocrine medicine         
All 0.022 0.030 0.051 0.097 0.092 0.102 0.115 0.151 
  1 (most deprived) 0.027 0.037 0.061 0.115 " " " " 
  2 0.025 0.034 0.057 0.108 " " " " 
  3 0.020 0.027 0.046 0.089 " " " " 
  4 (least deprived) 0.017 0.024 0.041 0.081 " " " " 
Musculoskeletal medicine         
All 0.026 0.033 0.057 0.073 0.035 0.045 0.070 0.095 
  1 (most deprived) 0.037 0.047 0.077 0.097 0.042 0.054 0.082 0.109 
  2 0.028 0.036 0.061 0.078 0.038 0.050 0.076 0.101 
  3 0.024 0.031 0.053 0.069 0.033 0.044 0.067 0.091 
  4 (least deprived) 0.018 0.023 0.041 0.053 0.026 0.034 0.054 0.074 
Average number of  
  
   
  
   prescribed medicines taken 
All 0.649 0.739 1.013 1.457 0.889 1.063 1.377 1.853 
  1 (most deprived) 0.912 1.050 1.410 1.967 1.113 1.312 1.664 2.192 
  2 0.675 0.777 1.043 1.456 0.935 1.102 1.398 1.841 
3 0.562 0.647 0.869 1.212 0.808 0.952 1.207 1.591 
  4 (least deprived) 0.499 0.575 0.771 1.076 0.753 0.887 1.125 1.482 
Note 
The predictions are based on negbin and probit models using the HSE. The dependent variables are the 
medication categories. The mean values are predicted probability of medication use for each BMI or 
BMI/SES category computed by setting the individual and household characteristics to their whole-
sample mean values. The individual and household characteristics are age, age squared and age cubed, 
ethnicity, marital status, smoking status, area variables, survey year, time elapsed and missing income.  
 
Due to low use of some of the services the results would be sensitive to outliers and 
other random variations. We exclude the results for the services for which the 
predicted probability of use was below 10% for all BMI/SES groups. This meant that we 
 213 
 
excluded the results for: gynae/urinary medicine; cytotoxic medicine; medicine for 
nutrition/blood; eye/ear etc.; infection; medicine for skin; other medicine; and, day 
case visits.  
 
6.4.2 British Household Panel Survey: Results 
The total number of observations in BHPS across the two periods was 30 426, of these 
20 824 had valid health service use data, were over the age of 16 and had valid BMI 
data.  
 
Descriptive statistics of the utilisation variables are in Table 6.11 and for the rest of the 
variables in Appendix 6.4. Forty one percent of the sample were normal weight (the 
modal category), 38% were overweight and 19% were obese (14% class I obesity, 5% 
class II/III obesity). Across the whole sample 74% had a GP visit, 41% had an outpatient 
visit, 10% had an inpatient stay, 10% had seen a chiropodist, 14% had x-ray of chest 
and lungs, 52% had their blood pressure checked, 23% had a cholesterol test, and 41% 
had a blood test. The percentage having used the different health services increased 
for overweight and obese individuals across all health services. The mean share of 
individuals who had outpatient and inpatient visits in HSE were 32% and 8%, 
respectively, which is lower than in the BHPS where it was 41% and 10%, respectively. 
Note that the year of measurement differed between the surveys. The mean predicted 
SES measure was highest in the overweight category and lowest in the class II/III 
obesity category; the modal SES quartile was quartile 4 (least deprived) in the normal 
weight category and quartile 1 (most deprived) in class I and II/III obesity categories. 
Forty seven percent of the sample was men and the mean age was 47 years.  
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Table 6.11: Summary statistics of health service use across each BMI category in 
BHPS (Waves: 2004/5 and 2006/7) 
  Whole Normal Overweight Class I Class II/III 
 sample weight  obesity obesity 
Health service use BHPS      
Observations      
  Number 20776 (100) 8515 (41) 7844 (38) 2900 (14) 1086 (5) 
Health service use variables      
  GP visit 74 71 74 78 82 
  Outpatient visit 41 39 42 45 53 
  Inpatient stay 10 10 10 11 14 
  Chiropodist 10 8 10 14 17 
  X-ray of chest and lungs 14 12 15 15 18 
  Blood pressure 52 45 54 60 65 
  Cholesterol test 23 16 27 31 35 
  Blood test 41 34 43 48 55 
Note 
Other than for “Observations” all statistics are % (categorical variables) 
 
Table 6.12 shows the results for the regression model of total household income 
against the individual and household socioeconomic variables. Education, social class 
of HRP, owning a car, and number of bedrooms in household are all positively 
correlated with income. Compared to being employed other types of economic activity 
have a negative effect on income, except for maternity leave which is not significant. 
Claiming income support is negatively correlated with income. We used these 
coefficients to generate our predicted SES measure. Respondents were categorised 
into quartiles based on the predicted SES values. The range of the values for the 
equivalised predicted income were -3,38733 to 86,065; the cut points used to set the 
quartiles were 19,823, 26,847 and 34,774.  
 
  
                                                     
33
 As earlier we convert the predicted income into quartiles and use these as our SES measure and do 
not use the actual income values in the further analysis. Hence, it is not a problem that we obtain 
negative predicted income values. 
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Table 6.12: Random effects regression of total annual household income against SES 
indicators in the BHPS 
  Coef. z 
Degree or equivalent Base category 
  NVQ3/GCE A Level or equivalent -1485.67 -2.44 
  NVQ2/GCE O Level or equivalent -3356.48 -6.7 
  NVQ1/CSE other grade or equivalent -4868.89 -11.25 
  No qualification -5012.46 -8.85 
Social Class of HRP   
  Professional Base category 
   Managerial technical -3540.44 -4.24 
  Non manual labour -7347.77 -8.12 
  Manual skilled -8334.93 -9.84 
  Partly skilled -8846.56 -9.38 
  Manual unskilled -9251.66 -10.35 
  Never had a job -8874.88 -7.58 
  Missing social class -7318.11 -8.48 
Car owned by household   
  Owns car Base category 
  No car -1267 -4.16 
Housing tenure   
  Own outright Base category 
  Shared -2947.66 -1.33 
  Rent -7473.69 -11.66 
  Live rent free and/or squatting -7425 -6.28 
  Other accommodation -6751.6 -2.79 
Bedrooms in household   
  One Base category 
  Two 2652.567 1.86 
  Three 4608.093 3.2 
  Four 7256.092 4.88 
  Five or more 13838.63 8.8 
Income support   
  Yes -1394.22 -3.33 
  No Base category 
Economic activity   
  Employed Base category 
  Unemployed -5584.63 -9.44 
  Retired -14690.2 -27.09 
  Maternity leave 846.0586 0.6 
  Family care -6494.85 -9.75 
  FT studt, school -2640.05 -4.03 
  LT sick, disabld -9440.1 -20.06 
  Gvt trng scheme  -5478.29 -3.48 
  Other economic activity (omitted)  
Wave   
  Wave 16 -1638.37 -5.31 
_cons 38661.22 24.06 
Observations 28494 
Test for random effects: Var(u) = 0 0.0000 
Note 
The test for random effect is a Breusch and Pagan Lagrangian multiplier test for random effects a 
significant results show that u is not zero and a pooled OLS will provide biased estimates. 
 
Appendix 6.9 shows the coefficients and z values of the probit and interval regression 
models fitted with interactions between BMI groups and SES groups in BHPS. Based on 
the test for joint significance of the interactions we refit the models with or without 
interactions. There were significant interactions between BMI and SES in the interval 
regression model for GP visits for women. The interval regression model is a linear 
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model hence the significant interactions mean that there is a significant difference in 
the predicted mean utilisation and that the impact of obesity is more pronounced in 
lower SES women than in higher SES women. In Appendix 6.10 we see the models after 
the backwards elimination procedure, these are the models we base the predictions 
on. 
 
The predicted probabilities of health service use across each BMI category can be 
found in Table 6.13. We find that overweight and obese men and women have an 
increased probability of having a GP visit and have an increased number of GP visits. 
Similarly, for all men and all women the predicted probability of having an outpatient 
visit increases at higher levels of obesity. The predicted number of outpatient visits 
increases at higher levels of obesity for women, but not in men. Furthermore, 
compared with normal weight, overweight and obese men and women have increased 
predicted probability of inpatient stays, having seen a chiropodist, had blood pressure 
taken, had a cholesterol test and having had a blood test at higher levels of obesity.  In 
addition, we find an increased predicted probability of having an x-ray of the chest and 
lungs for overweight and obese women compared with normal weight women, we do 
not find this in men. The predicted probability of using most types of the health service 
was higher in women than in men, except from having a cholesterol test where men 
have a higher predicted probability.  
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Table 6.13: Predicted probability of health service use across BMI categories in BHPS 
(Waves: 2004/5 and 2006/7) 
  Men Women 
  
Normal Over- Obese Obese Normal Over- Obese Obese 
weight weight Class I Class II/III weight weight Class I 
Class 
II/III 
GP visit 0.656 0.690 0.712 0.763 0.809 0.839 0.866 0.907 
Number of GP visit if number of visits>0 3.542 3.689 4.098 4.804 4.094 4.566 5.004 5.741 
Outpatient visit 0.355 0.370 0.387 0.457 0.417 0.437 0.478 0.563 
Number of outpatient visit if number of visits>0 3.176 " " " 3.540 3.419 3.830 3.885 
Inpatient stay 0.035 0.040 0.044 0.070 0.085 0.095 0.106 0.124 
Chiropodist 0.029 0.041 0.077 0.113 0.055 0.068 0.088 0.111 
X-ray of chest and lungs 0.113 " " " 0.098 0.108 0.107 0.155 
Had blood pressure taken 0.387 0.467 0.515 0.603 0.539 0.591 0.646 0.698 
Had a cholesterol test 0.133 0.186 0.224 0.313 0.122 0.157 0.188 0.221 
Had a blood test 0.299 0.353 0.389 0.479 0.389 0.453 0.512 0.581 
Note 
" Predicted mean equal to the normal weight category 
Predictions based on random effects probit and interval regression models. The dependent variables are 
the health service use variables. The mean values are predicted probability of health service use for each 
BMI or BMI/SES category computed by setting the individual and household characteristics to their 
whole-sample mean values. The individual and household characteristics are age, age squared and age 
cubed, ethnicity, marital status, smoking status, health area variables, survey year and time elapsed.  
 
Table 6.14 shows the predicted probability of using the health service across each SES 
quartile. We see similar trends within each of the quartiles, in that higher levels of 
obesity are associated with higher predicted probability of use. Lower SES men and 
women have a higher utilisation of GP, outpatient, inpatient, X-ray and blood test 
services than higher SES men and women. We also find a social gradient in the percent 
having had a cholesterol test in women but not in men. 
 
Although, a higher percentage of the low SES individuals have had a GP visit, the 
impact of obesity and overweight on percentage share of individuals who have had a 
GP visit is relatively similar across the SES groups. However, as mentioned we 
identified an interaction in the number of GP visits for women. The predicted mean 
number of visits increases more in the lower SES women than in the higher SES 
women. For example, the predicted mean number of GP visit in the lowest SES quartile 
1 women increased from a predicted mean of 4.8 in the normal weight category to 5.5 
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in the class II/III obesity, which is a discrete difference of 1.7. For the least deprived SES 
women quartile 4 similar numbers were 3.9 and 4.6, which constitutes a discrete 
difference of 0.7.  
 
We also identify an SES gradient in inpatient visits, where the impact of obesity on the 
predicted share of individuals who have had an inpatient stay increased more for both 
men and women in the lower SES groups than in the higher SES groups. The predicted 
mean share of individuals who have had an inpatient stay in the lowest SES quartile 1 
men increased from a predicted mean of 5% in the normal weight category to 10% in 
the class II/III obesity, which is a discrete difference of 5%. For the least deprived SES 
men quartile 4 similar numbers were 3% and 6 %, which constitutes a discrete 
difference of 3%. Similar numbers were found for women. 
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Table 6.14: Predicted probability of health service use across BMI and SES categories 
in BHPS (Waves: 2004/5 and 2006/7) 
  Men Women 
  
Normal Over- Obese Obese Normal Over- Obese Obese 
weight weight Class I Class II/III weight weight Class I Class II/III 
GP visit         
  1 (most deprived) 0.703 0.737 0.755 0.800 0.823 0.850 0.875 0.913 
  2 0.647 0.683 0.703 0.753 0.817 0.845 0.870 0.910 
  3 0.645 0.681 0.701 0.751 0.786 0.817 0.845 0.891 
  4 (least deprived) 0.634 0.671 0.691 0.742 0.808 0.837 0.863 0.905 
Number of GP visit if number of visits > 0         
  1 (most deprived) 4.321 4.487 4.838 5.499 4.779 5.195 5.921 6.512 
  2 3.607 3.773 4.124 4.786 3.967 4.465 5.248 5.629 
  3 3.182 3.347 3.698 4.360 3.810 4.223 4.147 5.230 
  4 (least deprived) 3.109 3.275 3.626 4.287 3.873 4.226 4.196 4.606 
Outpatient visit         
  1 (most deprived) 0.395 0.412 0.426 0.494 0.417 0.437 0.478 0.563 
  2 0.361 0.378 0.392 0.458 " " " " 
  3 0.336 0.352 0.366 0.431 " " " " 
  4 (least deprived) 0.336 0.353 0.367 0.432 " " " " 
Number of outpatient visit if 
number of visits > 0         
  1 (most deprived) 3.425 " " " 3.829 3.690 4.085 4.117 
  2 3.158 " " " 3.575 3.435 3.830 3.862 
  3 3.031 " " " 3.320 3.181 3.575 3.608 
  4 (least deprived) 3.069 " " " 3.438 3.299 3.693 3.726 
Inpatient stay         
  1 (most deprived) 0.054 0.063 0.066 0.097 0.104 0.117 0.127 0.146 
  2 0.041 0.049 0.051 0.077 0.073 0.084 0.092 0.106 
  3 0.027 0.032 0.034 0.053 0.077 0.087 0.096 0.111 
  4 (least deprived) 0.029 0.034 0.036 0.056 0.078 0.089 0.097 0.112 
Chiropodist         
  1 (most deprived) 0.029 0.041 0.077 0.113 0.055 0.068 0.088 0.111 
  2 " " " " " " " " 
  3 " " " " " " " " 
  4 (least deprived) " " " " " " " " 
X-ray of chest and lungs         
  1 (most deprived) 0.150 " " " 0.119 0.130 0.127 0.177 
  2 0.122 " " " 0.101 0.110 0.108 0.153 
  3 0.101 " " " 0.080 0.088 0.086 0.125 
  4 (least deprived) 0.092 " " " 0.089 0.098 0.095 0.137 
Had blood pressure taken         
  1 (most deprived) 0.387 0.467 0.515 0.603 0.539 0.591 0.646 0.698 
  2 " " " " " " " " 
  3 " " " " " " " " 
  4 (least deprived) " " " " " " " " 
Had a cholesterol test         
  1 (most deprived) 0.133 0.186 0.224 0.313 0.119 0.112 0.164 0.180 
  2 " " " " 0.124 0.117 0.168 0.210 
  3 " " " " 0.121 0.122 0.160 0.161 
  4 (least deprived) " " " " 0.122 0.090 0.132 0.207 
Had a blood test         
  1 (most deprived) 0.331 0.389 0.423 0.511 0.419 0.483 0.540 0.605 
  2 0.307 0.365 0.398 0.486 0.392 0.455 0.512 0.578 
  3 0.275 0.329 0.361 0.448 0.370 0.432 0.489 0.555 
  4 (least deprived) 0.289 0.345 0.377 0.464 0.379 0.442 0.498 0.565 
Note 
The predictions are based on random effects probit and interval regression models. The dependent 
variables are the health service use variables. The mean values are predicted probability of health 
service use for each BMI or BMI/SES category computed by setting the individual and household 
characteristics to their whole-sample mean values. The individual and household characteristics are age, 
age squared and age cubed, ethnicity, marital status, smoking status, health area variables, survey year 
and time elapsed.  
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Similarly to the analysis in HSE we exclude results where the utilisation across all 
BMI/SES groups is below 10% for both men and women separately.  Hence, we exclude 
physiotherapist use, cervical smear tests (in women) and breast cancer screens (in 
women). 
 
6.4.3 Comparison of the results in HSE and BHPS 
In general the findings are consistent across both datasets, where we find that 
overweight and obese individuals utilise the health service more than normal weight 
and that lower SES individuals utilise more than higher SES groups. However, where 
direct comparison is possible the associations between obesity and use are more 
positive in BHPS than in HSE. This could possibly be due to BHPS being panel data and 
therefore partly controls for heterogeneity from time invariant variables. Such 
variables could include discount rate (the weight individuals put on future benefits) or 
impact of increased health service use on obesity (reverse causality). Another, 
possibility is that the BHPS data is more recent (except in the medication use analysis). 
It could also be due to different time periods across the datasets and different 
populations. However, this will be discussed further for each dependent variable in the 
conclusion of this chapter.  
 
The actual predicted probability of a GP visit differs for the HSE and BHPS. The reason 
is that the dependent variable in the HSE measures GP visits in the last two weeks 
while BHPS measures it since the 1st of September last year. In both HSE and BHPS we 
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find that the predicted probability of GP visits increases when BMI increase. 
Furthermore we find that the predicted mean number of visits increases when BMI 
increases for both men and women in BHPS. We also find a higher GP utilisation in 
more deprived SES quartiles than in less deprived SES quartiles in both men and 
women across all BMI groups in both datasets. Furthermore there are indications of a 
more pronounced association between obesity and mean share of individuals who 
have had a GP visit in the lower SES groups in women in HSE. These findings are 
supported by a significantly more pronounced association between BMI and number 
of GP visits in women in the BHPS. In men an opposite result was found of a somewhat 
more pronounced association in higher SES men across both datasets.  
 
We find that obesity increases the use of outpatient services in women across both 
datasets. In men we only find that obesity increases use in the BHPS, but not in the 
HSE. In both datasets lower SES men use significantly more outpatient services than 
higher SES men. In women we do not detect an SES gradient in the probability of 
having an outpatient visit in either the HSE or the BHPS. However, we find that lower 
SES women who have had at least one outpatient visit have a higher number of visits 
than higher SES women.   
 
For inpatient visits we find conflicting results in men as we do not find variation in 
predicted probability of a visit across BMI groups in the HSE, however we do find this 
in the BHPS. In women we find variation in the predicted share of users across BMI 
groups in both datasets. In both men and women we find that lower SES individuals 
use inpatient services more than higher SES individuals. In addition, we observe a more 
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pronounced association between obesity and inpatient stays in the lower SES groups 
across both datasets in women; we also find this in the BHPS in men.  
 
Table 6.15: Summary of findings 
Utilisation 
variable 
Gender Association 
between BMI and 
use 
Association between 
SES and use 
SES variation in the impact of 
obesity (absolute) 
GP visits Men Positive Negative Variation across SES groups, but no 
clear trend 
Women Positive Negative More pronounced in lower SES 
women than in higher SES women. 
Outpatient 
visits 
Men Positive association 
in BHPS no 
association in HSE 
Negative No variation 
 
Women Positive No association in HSE. 
Negative association 
for number of visits in 
BHPS. 
No variation 
 
Inpatient visits Men No association in 
HSE. Positive 
association in BHPS  
Negative More pronounced in lower SES than 
in higher SES groups. 
Women Positive Negative More pronounced in lower SES than 
in higher SES groups. 
 
Practice nurse 
visits 
Men Positive Negative More pronounced association in 
lower SES than in higher SES groups 
Women No association Negative No variation 
Chiropodist Men Positive No association  No variation 
Women Positive No association No variation 
X-ray of chest 
and lungs 
Men No association Negative No variation 
Women Positive Negative More pronounced association in 
lower SES than in higher SES groups 
Had blood 
pressure taken 
Men Positive No association  No variation 
Women Positive No association No variation 
Had a 
cholesterol 
test 
Men Positive No association No variation 
Women Positive Negative Variation across SES groups, but no 
clear trend. 
Had a blood 
test 
Men Positive Negative More pronounced association in 
lower SES than in higher SES groups 
Women Positive Negative No variation 
Medication use Men Positive Negative More pronounced in lower SES than 
in higher SES 
Women Positive Negative More pronounced in lower SES than 
in higher SES groups 
 
6.5 Discussion 
The aims of this chapter were to investigate the relationship between obesity and 
health service use, and whether or not any observed relationship varies by SES. Our 
main finding is that obesity and health service use are positively correlated. However, 
the SES stratified results are mixed. The relationship between obesity and use is more 
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pronounced in the lower SES groups than in the higher SES groups for some types of 
use, but not all.  
 
Using the BHPS we find that, controlling for individual and household characteristics 
and a set of comprehensive area level variables, obesity is associated with increased 
probability of: GP visits, outpatient visits, inpatient stays, chiropodist visits, blood 
pressure tests, cholesterol tests and blood tests. In addition, we find that obesity will 
increase the use of x-ray of chest and lungs for women but not for men.  
 
We rerun the analysis in HSE for GP visits; inpatient stays; and, outpatient visits and 
find that the results were consistent across the datasets except from inpatient visits in 
men, where we only found a significant result in the BHPS but not in HSE. In HSE we 
also investigate the relationship between obesity and practice nurse visits and find that 
this is positive and significant in men, but not in women.  
 
We provide evidence to show that overweight and obese men and women have a 
greater predicted mean number of medications used than those of normal weight 
after controlling for a range of individual and household characteristics. Our findings 
are also disaggregated by therapeutic classification and show that obesity is associated 
with higher utilisation of cardio-vascular medicine, gastrointestinal medicine, 
respiratory medicine, CNS medicine, endocrine medicine, and musculoskeletal 
medicine for both men and women. It is to be expected that obesity increases the use 
of medication for cardiovascular disease and the endocrine system since obese have a 
higher risk of comorbidities like stroke, CHD and diabetes. We would also expect to 
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find an increase in the use of central nervous system medication as this is the category 
of drugs for treatment of obesity. The NICE guidelines states that drugs aimed at 
weight reduction (Orlistat or Sibutramine34) should be considered treatment in 
overweight and obese individuals if comorbidities are present. In addition, drugs 
should be considered to all individuals in obesity class II and III even when 
comorbidities are not present (NICE, 2006). The musculoskeletal medicine category 
includes medication for soft tissue inflammation which might be more of a problem in 
obese. In addition, obesity is possibly related to respiratory diseases like asthma (Shore 
& Johnston, 2006) which could explain why our analysis shows an association with 
respiratory medicine.  
 
BHPS has an advantage over HSE as it is a panel dataset one can use panel models to 
some extent to control for unobserved time invariant heterogeneity. In addition, a 
further advantage of the BHPS is that we have controlled for extensive PCT level area 
variables, which reduces the likelihood that supply will have an influence on the 
results. We have only been able to control extensively for health area in the part of the 
HSE analysis that looks at GP visits, practice nurse visits, inpatient and outpatient visits, 
but not in the part that investigate medication use. In the medication analysis part of 
the impact of supply will be picked up by clustering at the primary sampling unit; 
however this will only affect the variance and therefore only the significance of the 
variables and not the coefficients. However, part of the variation might also be picked 
up by the broad area level variables Government Office Region of residence (nine 
                                                     
34
 Although Sibutramine have later been withdrawn from market in September 2010 
 225 
 
categories). Nevertheless, an advantage of the HSE dataset is that we have nurse 
measured height and weight. Thus, the likelihood of systematic measurement error is 
reduced. Although, the results are consistent across the datasets the association 
between obesity and use is generally more pronounced in BHPS. This result might arise 
as HSE might be more vulnerable to reversed causality bias (if this bias is time 
invariant). For example, some types of health service might make individuals less 
obese, hence individuals who have frequent health service visits might be less likely to 
be obese. Furthermore, it might be because the BHPS data is more recent (except from 
the medication analysis), and that more interventions to handle obesity and obesity 
related comorbidities are available. However, it could also be a bias in BHPS as we use 
self reported height and weight compared with nurse measured values in HSE. 
 
We provide evidence to show that overweight and obese men and women use more 
health services than those of normal weight. Our findings also show that women use 
the health services more than men. These results are qualitatively similar to those of 
other studies, which have also shown that health service use is positively associated 
with obesity (see, e.g., Reidpath et al., 2002). However, most of the studies in our 
literature review have presented their results in terms of relative odds ratios and it is 
difficult to directly compare them with our predicted probabilities. Hence, to enable 
comparison we have calculated odds ratios.  We have chosen to compare our results 
with the results by Reidpath et al., (2002). The reason is that this study investigates the 
association between obesity and health service use separately for men and women. 
They find that compared with normal weight men (20 kg/m2>BMI>25 kg/m2) the odds 
ratio of having had a doctor visit in overweight men (25 kg/m2>BMI>30 kg/m2) was 
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1.06 and obese (BMI>30 kg/m2) was 1.2 using Australian data controlling for age and 
income. In women comparable figures were 1.15 and 1.3. In HSE we find that the odds 
ratio of having had a GP visit the last two weeks in men was 1.03 in the overweight, 
1.13 in the obese class I group and 1.58 in the obese class II/III. In women comparable 
odds ratios were 1.15, 1.22 and 1.48, respectively. In the BHPS we find that 
comparable odds ratios in men were 1.2, 1.43 and 2.04, and in women 1.31, 1.74 and 
2.96, respectively. As we can see the results in the HSE are comparable to the results 
obtained by Reidpath et al., while the results in BHPS are more pronounced. This might 
be due to both HSE and the Reidpath study using cross sectional data, which might 
suffer from omitted variables bias to a greater extent than the BHPS analysis. Another 
explanation could be that the BHPS data (years: 2004/5-2006/7) is more recent than 
the data from the HSE (years: 1999-2002) and Reidpath (year: 1995) and that more 
treatments to tackle obesity related complications have been developed.  
 
Conflicting results has been found regarding inpatient visits, for example Reidpath et 
al., (2002) do not find a significant effect in either men or women. Our results support 
a positive impact of obesity on inpatient stays in women in both datasets. In men we 
find variation across BMI groups on the probability of inpatient stays only in BHPS and 
not in HSE. These conflicting results in men might arise for similar reasons as 
mentioned above.  
 
We are not aware of any studies that have investigated the association between 
obesity and chiropodist visits, blood pressure tests, cholesterol tests, blood tests and x-
ray of chest and lungs. We find that obesity is positively related to use of these services 
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(x-ray in women only). Obesity is associated with hypertension and increased risk of 
having high cholesterol levels (National Audit Office, 2001). Hence, obese individuals 
should have more frequent blood pressure tests and cholesterol tests and this study 
shows that they do. In addition, obese individuals are likely to have more problems 
with their lower limbs, which could explain the significant increase in chiropodist visits. 
Increased blood tests can stem from increased liver problems in the obese, which can 
be detected by blood tests. However, there is no apparent direct link that would 
explain why obese women have an increased use of x-ray of chest and lungs compared 
with normal weight women.    
 
As mentioned in the literature review we have identified two studies that investigate 
the effect of obesity on medication use disaggregated into therapeutic classifications 
(van Dijk, Otters and Schuit, 2006; Counterweight Project Team, 2004). Our results 
support the results of the Counterweight Project Team (2004) that show a significantly 
increased relative log odds of using medications for the cardiovascular system; central 
nervous system; endocrine system; musculoskeletal and joint disease; Infections; 
gastrointestinal; and  skin and respiratory system controlling for age, sex, deprivation 
category, and country (England/Scotland). Reidpath et al., (2002) find that the 
compared with normal weight the relative odds ratio of having used medication in the 
last two weeks in men for the overweight was 1.13 and for the obese it was 1.46, 
respectively. Similar figures in women were in the overweight 1.32 and in the obese 
1.68. Comparable figures in our study in men were (showing odds ratios) 1.17 in the 
overweight group, 1.58 in the obese class I group, and 2.27 in the obese class II/III 
group. In women, they were 1.24, 1.67 and 2.53, respectively. As we can see from 
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these numbers our study shows a more pronounced association between obesity and 
medication use. This might be because our data is more recent, hence more drugs 
have been developed to counteract obesity and the related comorbidities. It might 
also be that in general obese individuals are prescribed more medication in the 
England than in Australia.     
 
Across both datasets we find that lower SES individuals have higher health service 
utilisation than higher SES individuals across all BMI groups. This is expected as we 
have showed in earlier studies that in general individuals in lower SES groups have a 
lower health related quality of life and lower life expectancy within each BMI group, 
see Chapter 3, 4 and 5. 
 
The second aim of this chapter was to investigate SES variations in the relationship 
between obesity and health service use. We find a greater positive relationship 
between obesity and number of GP visits in the lower SES groups than in higher SES 
groups in women in the BHPS. Obese women in the lower SES group have on average 
1.7 more GP visits per year than in the normal weight group. Obese women in the 
higher SES group have on average 0.7 more GP visits per year than in the normal 
weight group. Hence, the absolute difference in GP visits is more than double in the 
lowest SES group compared with the highest SES group. Furthermore, in HSE the 
predictions based on the probit models show a more pronounced positive relationship 
between obesity and GP visits in lower SES groups than higher SES groups in women. 
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Hence, in the case of women both analyses support the same hypothesis although the 
dependent GP visit variable differs across the datasets35.  
 
We find in the BHPS a more pronounced association between obesity and the 
probability of an inpatient visit in the last year in the less deprived SES groups in men 
and women. The results are consistent in the HSE for women, but not in men where 
we did not find variation in use across BMI groups. Furthermore, we find that the 
association between obesity and use is stronger in lower SES groups than in higher for: 
chiropodist and blood test in men, and x-ray in women. 
 
For medication use we find that overweight and obese individuals use more 
medication than those of normal weight in the same SES group, and use more 
medications than those in higher SES groups within the same BMI group. Our analyses 
also illustrate a more positive association between obesity and medication use in 
lower SES groups compared to higher SES groups. Obese men in the lowest SES groups 
use on average 1.08 drugs more than normal weight men in the lowest SES group. 
Obese men in the highest SES group use on average 0.56 more drugs than normal 
weight men in the highest SES group. Hence, the association between obesity and 
medications use in the lowest SES group is nearly double that of the highest SES group. 
Similar trends, although less pronounced, where found in women. 
 
                                                     
35
 In the BHPS the variable is number of visits the last year while in the HSE it is a binary variable taking 
the value one if a person has had a visit in the last two weeks and zero otherwise. 
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This means not only is there a health service use gap between high and low SES 
individuals, this gap increases for overweight and obese individuals compared to 
normal weight individuals. These results support hypothesis (b) in Chapter 2 of a more 
pronounced impact of obesity in the lower SES groups. Our results are different to 
those found by Guallar-Castillon et al. (2002) who investigate health service use 
(hospitalisations, medical visits, hospital emergency services and medication) and do 
not find any interaction effect between BMI and education in Spanish women. 
However, our studies are not directly comparable as we look at predicted mean 
utilisation while they look at relative odds of use.  
 
In this chapter we have focused on the absolute effect of obesity on use and not the 
relative. We illustrated with an example how absolute and relative interactions have 
different interpretations and clarity is needed in what one wants to express with the 
results. The results in this chapter illustrate that in some cases there is no interaction 
term between BMI and SES in the relative effects, but there is still SES variation in the 
absolute consequences of obesity on use. For example, in the medication use analysis 
we found no relative interaction effect however, the number of medications used 
increased more in lower SES groups.  
 
These results have consequences for health service planning. Other studies have 
showed that obesity is related to SES, in which lower SES groups are over-represented 
in the higher BMI groups (Butland et al., 2007; Marmot, 2010). The results of this 
chapter suggests that obesity in lower SES groups leads to greater resource utilisation 
than in higher SES groups, for some types of use. This means that not only do lower 
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SES groups have a higher prevalence of obesity, but obesity also demands more health 
care resources in these groups. This provides an argument for paying particular 
attention to counteracting obesity in lower SES groups. In addition, this suggests that 
attention needs to be paid to the role of SES when undertaking predictions of future 
utilisation and costs. If one fails to take into consideration the interface between SES 
and obesity one might fail to reflect the actual relationship between obesity and health 
service use.  
 
A number of studies have investigated horizontal inequity in health service use (See, 
e.g., Morris, Sutton & Gravelle, 2005) and found that lower SES groups use more 
primary care services and less secondary care services. Our study finds more use of 
both primary and secondary care services. However, we have not fully controlled for 
need variables (as this was not the aim of our study). 
 
Our study has some potential limitations. First, obesity might be endogenous making it 
difficult to draw inferences about the impact of obesity on health service use. 
Endogeneity might arise for the following reasons. There might be reverse causality: 
for example, the GP might tell obese individuals to exercise more and eat less energy 
dense food. Hence, obesity is then a function of health service use. This would mean 
that we have underestimated the impact of obesity on use. There might be omitted 
variable bias, i.e., variables that affect both health service use and obesity. One such 
variable might be health status. Health status may increase health service use and, as 
discussed in Chapter 3, it may reduce physical activity which will increase weight. 
Conversely, reduced health status in terms of diseases may also reduce weight. Hence, 
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it is difficult to establish the direction of this causality. Another omitted variable might 
be supply of health services. We have not been able to control for supply factors as 
extensively in the medication analysis as in the two other analyses. However, we argue 
that clustering by PSU and controlling for the broad area level variables to some extent 
can control for this. There may be measurement error: BMI in itself might be mis-
measured when it is based on self-reported height and weight. If the level of mis-
measurement is associated with the dependent variable the obesity coefficients might 
be biased. This is an issue in the BHPS but not in the HSE where BMI is based on nurse 
measured height and weight. Another potential measurement error is related to using 
BMI as a measure of obesity. This measure can be considered an imperfect measure, 
and it has been criticised, e.g., because it does not incorporate body fat, which is an 
independent predictor of ill health (Burkhauser & Cawley, 2008).  
 
This chapter has a number of advantages compared with earlier studies. The number 
of observations in our sample is sufficiently large to permit analyses stratified by both 
gender and SES; our findings show that the impact of obesity on health service use 
varies by both these factors. BHPS is a panel dataset, which makes our results less 
vulnerable to time invariant heterogeneity bias. Also, we have rich information on 
individual and household characteristics and so can argue that it is less likely that the 
estimated effects of obesity on health service use in our models are due to their 
correlation with omitted variables. Our extensive health area variables (216 groups in 
the BHPS and 95 categories in the HSE) let us control for area variation in supply. This 
has not been done in previous studies. 
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To summarise, first this chapter has shown that obesity is positively correlated with 
health service use. Second, we have analysed how SES influences this relationship and 
found mixed results. Individuals in lower SES groups use more health care than 
individuals in higher SES groups across all obesity categories. In addition, the 
association between obesity and GP visits (in women), inpatient stays (in women) and 
medication use (for both men and women) is more pronounced in lower SES groups 
compared with higher SES groups.  
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CHAPTER 7 
 
Conclusion and implications 
 
7.1 Introduction 
The two general aims of this thesis were: 
 
1. Examine the relationships between obesity and health outcome; and obesity 
and health service use in Great Britain  
2. Investigate whether or not there are socioeconomic variations in these 
relationships 
 
To meet the general aims the preceding chapters we have provided a comprehensive 
analysis of socioeconomic variation in the consequences of obesity. In Chapter 2, we 
outlined the relationship between socioeconomic status, lifestyle and health in light of 
a theoretical model, an economic model and a literature review. We also mapped the 
relationship between socioeconomic status, obesity and health service use. Based on 
the economic models we generated econometric models for testing. Chapters 3, 4 and 
5 provided extensive analysis of the association between obesity and health and how 
this varies by SES. We measured health in terms of Health Related Quality of Life 
(HRQL) and life expectancy. Chapter 6 examined the association between obesity on a 
range of health services and medications and how these varied by SES. 
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In this final chapter we summarise and discuss policy implications of the findings. We 
then discuss some limitations of these studies and offer some suggestions for further 
research.  
 
7.2 Main findings 
Chapter 2 provided a framework for examining socioeconomic variation in the 
relationships between: obesity and health; and, obesity and health service use. We 
show by what means the CSDH framework use to illustrate the pathways and 
mechanism through which social determinants of health influences health. We present 
a human capital model for health (the Grossman model) and use this model to analyse 
how the impact of risk factors on health might vary by SES. The models predict that 
individuals who are obese will have a lower equilibrium level of health. We further 
include SES and predict that higher SES groups have a higher equilibrium health than 
lower SES groups. We then take into account SES variation in the impact of obesity and 
its consequences for equilibrium health. We develop econometric models suitable for 
empirical testing based on these models. We conduct a literature review and find that 
limited information exists on this topic. Most of the evidence is on smoking and few 
studies have looked at obesity. We develop hypotheses to analyse SES variation in the 
impact of obesity on health service use, using a model based on the concept of need 
and non-need factors.  
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We will now discuss the empirical findings in this thesis under the heading of each of 
the general aims, starting by the first aim followed by the second aim.  
 
7.2.1 The associations between; obesity and health, and obesity and health 
service use 
In Chapter 3 we examined the relationship between HRQL and obesity and found that 
obesity and HRQL are negatively correlated. After controlling for individual and 
household characteristics, we obtain similar results, albeit at reduced levels. Our 
findings also show that the negative association between obesity and HRQL is greater 
in women than in men. These findings are consistent with previous findings using 
British data (see, e.g., Macran, 2004; Sach et al., 2007).  
 
In Chapter 4 we further analyse the relationship between HRQL and obesity in 
individuals with obesity-related comorbidities. We look at four longstanding illness 
categories related to obesity: diabetes; hypertension; stroke; and, heart attack and 
angina. We find that there is a significant negative association between obesity and 
HRQL in individuals with each of these four comorbidities. Furthermore, the 
relationship between obesity and HRQL varies by these obesity-related comorbidities. 
These results contradict the findings by Lee et al., (2005) who investigate the 
association between BMI and HRQL and find insignificant interaction terms between 
BMI and diabetes status. Except from diabetes we are not aware of any studies that 
investigate if the association between obesity and HRQL varies by other obesity-
related comorbidities.  
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In Chapter 5 we investigated the relationship between obesity and mortality/life 
expectancy controlling for a number of covariates. Obesity increased mortality and 
reduced life expectancy for men and younger women. In older women we found 
obesity to increase life expectancy. We also investigated the impact of overweight as 
well as obesity on life expectancy. We did not find a clear trend and could not conclude 
upon how overweight affects mortality. Furthermore, we fitted models controlling for 
a number of longstanding illnesses and whether or not these were limiting. These 
models showed that the impacts of obesity and SES are still significant and the 
magnitudes were only slightly reduced. In general, our findings support earlier findings 
on the relationship between obesity and life expectancy. However, this is the first 
study we are aware of that has: identified the parametric distribution that best fits the 
data; controlled for unobservable heterogeneity; predicted median life expectancy 
based on a parametric survival function; and, identified significant interactions 
between obesity as a category and age in women. In addition, this is the first study to 
control for all types of longstanding illnesses and whether or not they are limiting and 
we still show that there is an effect.   
 
In Chapter 6 we analysed the relationship between health service use and obesity, and 
whether or not this relationship varied by SES. We found that obesity was associated 
with increased probability of; GP visits, outpatient visits, inpatient stays, chiropodist 
visits, blood pressure tests, cholesterol tests and blood tests, using the BHPS (wave 14 
(1st September 2004 to 11th May 2005) and wave 16 (1st September 2006 to 3rd April 
2007)) controlling for individual and household characteristics and a set of 
comprehensive area level variables. In addition, we found that obesity increases the 
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use of x-ray of chest and lungs for women but not for men. Although numerous studies 
have investigated the associations between obesity and several types of health service 
use, we are not aware of any studies that have investigated the association between 
obesity and; chiropodist visits, blood pressure tests, cholesterol tests, blood tests and 
x-ray of chest and lungs. We found that obesity is positively related to use of these 
services. This serves to further explain the burden obesity puts on the health service 
and suggests that leaving out these services in studies of the cost of obesity will lead to 
an underestimate of the costs.  
 
We also investigated the relationship between obesity and practice nurse visits and 
found a positive association in men but not in women. We provided evidence to show 
that overweight and obese men and women have a greater predicted mean number of 
medications used than those of normal weight after controlling for a range of 
individual and household characteristics. Our findings were also disaggregated by 
therapeutic classification and showed that obesity was associated with a significantly 
higher utilisation of cardio-vascular medicine, gastrointestinal medicine, respiratory 
medicine, CNS medicine, endocrine medicine, musculoskeletal medicine for both men 
and women. This supports the current literature on obesity and medication use.  
 
Although a number of studies have investigated the association between obesity and 
health service use, our study has numerous advantages over earlier British studies. We 
are the first to apply count and linear models to investigate number of 
visits/medications used, while the others have used binary models. By doing this we 
capture more of the consequences of obesity. We are the first to control for supply 
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variables which has been showed to affect use. We are the first to use panel data 
methods hence we do to some extent control for unobservable heterogeneity. In 
addition, we are not aware of any British studies that have generated predicted 
probabilities (instead of odds ratios) to investigate the absolute (quantitative) increase 
in health service use and number of medications used.  
 
In Table 7.1 and Table 7.2 below we see a summary of some of the findings of the 
relationships between; obesity and health, and obesity and health service use. 
 
Table 7.1: Extracts of some of the findings of the relationship between obesity and 
health outcome 
 Men who are obese class II / III have a mean EQ-5D score of 0.831 compared 
with 0.893 in normal weight men 
o In women similar numbers were 0.882 and 0.740, respectively 
 Obese class II / III individuals with diabetes had a mean EQ-5D score of 0.701, 
falling from a mean of 0.834 in the normal weight group 
o For individuals with stroke similar numbers were 0.461 to 0.682, 
respectively 
o For individuals with hypertension similar numbers were 0.774 to 0.888, 
respectively 
o For individuals who have had heart attack or who has angina similar 
numbers were 0.561 to 0.782, respectively 
 Obese (BMI>30kg/m2)  men aged 55 will on average life 22.1 years while 
normal weight men aged 55 will on average live for another 25 years.  
o Similar numbers for women were 26.4 and 31.0, respectively.  
 
  
 240 
 
Table 7.2: Extracts of some of the findings of the relationship between obesity and 
health service use 
 Obese class II / III men will on average have 1.4 more GP visits per year than 
normal weight men  
o 0.5 more outpatient visits per year 
o 3.5% more likely to have an inpatient stay each year 
o 4% more likely to have a chiropodist visit each year 
o 21.4% more likely to have blood pressure taken each year 
o 17.7% more likely to have a cholesterol test each year 
o 18% more likely to have a blood test each year 
o Use 0.81 more types of medication per year 
 Obese class II / III women will on average have 1.9 more GP visits per year than 
normal weight women 
o 0.7 more outpatient visits per year 
o 3.9% more likely to have an inpatient stay each year 
o 5.5% more likely to have a chiropodist visit each year 
o 15.8% more likely to have blood pressure taken each year 
o 9.9% more likely to have a cholesterol test each year 
o 19.2% more likely to have a blood test each year 
o Use 0.96 more types of medication per year 
 
7.2.2 Socioeconomic variation in the associations between; obesity and health, 
and obesity and health service use 
The second aim of this thesis was to investigate if there is socioeconomic variation in 
the associations between: obesity and health, and obesity and health service use. 
Furthermore we wanted to establish the direction of these relationships and quantify 
them.  
 
Rather than focusing on a single SES indicator we developed a composite measure 
based on a prediction of income from a range of SES indicators. We use this measure 
of SES in Chapter 3 to examine whether or not the association between obesity and 
HRQL varies by SES. We find that the negative association between obesity and HRQL 
differs significantly across SES groups; the association is more negative in people from 
lower SES groups compared with individuals from higher SES groups. This is also 
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observed after controlling for individual and household characteristics, although the 
statistical significance and magnitude of the effects is diminished. A number of studies 
have investigated the impact of obesity on HRQL controlling for SES in multivariate 
analyses. In addition, the study by Laaksonen et al., (2005) found the association 
between obesity and SF-36 score to vary by working conditions (self evaluated job 
control and job demand). However, we are not aware of any published studies that 
have stratified their analyses by SES groups and showed that the association between 
BMI groups and HRQL varies by SES. 
 
In Chapter 4 we focus on obesity-related comorbidities and conduct an analysis of SES 
variation in the association between obesity-related comorbidities and HRQL. We find 
that the association between the obesity-related comorbidities on HRQL is more 
negative in lower SES groups compared with higher SES groups; this could explain why 
we identify the gradient in Chapter 3.  
 
In Chapter 5 we investigated whether or not the association between obesity and 
mortality/life expectancy varies by SES. We found that higher SES groups had a lower 
mortality and a longer predicted life expectancy than individuals in lower SES groups in 
both men and women. The hazard rate from obesity did not vary across SES groups in 
men. However, the predicted loss in life years due to obesity was greater in higher SES 
men than in lower SES men. In women, the hazard rate varies by both age and SES. We 
found that obesity had a negative impact on life expectancy in lower SES women (aged 
55, 65 and 75) and a positive impact on life expectancy in higher SES women (aged 55, 
65 and 75).   
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In Chapter 6 we investigated SES variation in the association between obesity and 
health service use. We found that the relationship between obesity and GP visits was 
more positive in the lower SES groups in women. In addition, we found a trend of a 
more pronounced association between obesity and the probability an inpatient stay in 
the lower SES groups. Our analyses also showed a more pronounced association 
between obesity and medication use in lower SES groups compared to higher SES 
groups in both men and women. This trend was more pronounced in men. 
Furthermore, the analysis shows a tendency for a more pronounce association in the 
lower SES groups between obesity and; having had a blood test in men, having had a 
practice nurse visit in men and having x-ray of chest and lungs in women. However, we 
also investigated a range of services where we did not identify this trend.  
 
7.3 Policy implications 
There are two main messages resulting from this research. First, in this thesis we have 
provided evidence of associations between obesity and health related quality of life, 
life expectancy and health service use in Great Britain. Not only do our findings show 
that obesity is related to all of these, we also quantify the consequences. This serves to 
further explain the burden that obesity puts on the individual and the health care 
system. Hence, it emphasises that effort is needed to avoid the current trend of 
increasing obesity rates in Great Britain.  
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The second main message is that the consequences of obesity are likely to vary by SES. 
Hence, more attention needs to be paid to analysing heterogeneities in pathways to 
health and health service use. Socioeconomic context is an element in understanding 
the production of health across populations.  
 
In the introduction we illustrated that there has been a focus on public health 
interventions aimed at vulnerable groups and that there is a call for interventions 
targeted at lower SES groups. The Department of Health’s White paper (2010) has 
suggested “a radical new approach” in counteracting health inequalities, where the 
government should consider different approaches for different groups. Furthermore, 
the Foresight Project Report suggested targeted interventions as a strategy to 
counteract obesity (in itself and not related to counteracting inequalities in health) 
(Butland et al., 2007). Hence, obesity interventions may be seen as being particularly 
important in deprived groups. However, to be able to measure the effectiveness and 
cost-effectiveness of targeted interventions information about SES specific outcomes 
are needed. Therefore this research suggests that to evaluate interventions across SES 
groups one would need to use estimates of costs and effects specific to the groups in 
question. Failure to do so might lead to misallocation of resources. The intervention 
being most cost-effective across the whole population may not be the most cost-
effective intervention for any of the SES groups when we stratify by SES.   
 
There is a focus on identifying factors that explain socioeconomic inequalities in 
health. Inspired by frameworks like the Commission for Social Determinants of Health 
(CSDH) framework, the focus has mainly been on identifying prevalence of risk factors 
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across SES groups. The impression has been that higher prevalence of a lifestyle 
related risk factor in lower SES groups contributes to inequalities in health. Hence, 
obesity will contribute to inequalities in health simply based on it being more 
prevalent in lower SES groups than in higher SES groups. This view has lead a number 
of government reports to suggest specifically counteracting lifestyle related risk factors 
in lower SES groups as means of preventing socioeconomic health inequalities (See, 
e.g., Department of Health, 2010; and, Marmot, 2010). However, this is based on an 
assumption that lifestyle related risk factors have a relatively similar impact on health 
across socioeconomic groups. This thesis challenges this assumption, and we suggest 
that information specific to the SES group in question is needed. 
  
The Acheson Report (1998) highlighted as one of its key recommendations “that as 
part of health impact assessment, all policies likely to have a direct or indirect effect on 
health should be evaluated in terms of their impact on health inequalities, and should 
be formulated in such a way that by favouring the less well-off they will, wherever 
possible, reduce such inequalities”. A policy maker who wants to assess how a public 
health intervention will influence the social gradient in health will need two pieces of 
information. First, one must know if there are variations across SES groups in the effect 
of the intervention on the prevalence of the risk factor. Second, one must know the 
relationship between the risk factor and health across SES groups. If one focuses only 
on the first part one might fail to identify variations in outcomes within populations 
and risk misinterpreting the consequences of the intervention and misallocate 
resources.  
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To recap, failure to identify heterogeneities could lead to inappropriate policy 
responses by inappropriate use of resources and increases in inequalities in health 
within populations. However, care is needed when we interpret the findings as we 
have not established causality.  
 
7.4 Research implications 
The aim of this thesis was not to develop new methods, but to apply existing methods 
investigating new hypotheses. However, we still have some implications for further 
research.  
 
The vast majority of obesity research investigates the relationship between obesity 
and an outcome variable (health or health service use) by controlling for SES factors. 
Our analysis serves to illustrate that by using this approach one risks representing only 
partially the relationship between obesity and the outcome variable. The prevalence of 
obesity has a socioeconomic gradient and researchers must take care to ensure that 
they in their research on pathways to health in fact represent the real relationship 
between the determinants of health and health/health service use. Hence, the main 
implication is that researchers must allow for possible interactions between obesity 
and SES. Below we briefly discuss a number of other implications for future research. 
 
Predicted SES 
Throughout this thesis we have based the measure of SES on a prediction of income. In 
this way we capture the multidimensional aspects of SES rather than focusing on a 
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single aspect like education or income. SES is a summary measure consisting of many 
factors and an advantage of our approach is that we can allow for a range of factors to 
influence in which group an individual is placed. Hence, we suggest using combined 
measures of SES when investigating this concept.  
 
Parametric survival distributions 
In Chapter 5 we have used fully parametric survival distributions alongside the 
commonly used semi-parametric distribution. We noted that this had a number of 
advantages. First, it allows for an easy interpretation of the consequences of the 
results in terms of predicting life expectancy. Second, one can control for unobservable 
(duration) heterogeneity by adding a frailty term. The downside of the parametric 
approach is that the results might be sensitive to the underlying parametric 
distribution. To investigate this we suggest reanalysing the data using a Cox model.  
 
To decide upon the “correct” parametric distribution we suggest using plots of 
cumulative Cox-Snell residuals and the Aikake’s information criterion. We also suggest 
to use the Cox proportional hazard model to run tests of proportional hazard of the 
coefficients using Schoenfeld and scaled Schoenfeld residuals.  
 
Using the BHPS and the HSE to model associations between obesity and use 
We have used both the BHPS and the HSE to model the associations between obesity 
and use. One advantages of the HSE is that the height and weight measurements are 
conducted by a nurse. Hence, it does not have the bias of self-reported height and 
weight measurement. In addition, the HSE has detailed information about medication 
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use. However, there is less information about other types of use. In the BHPS there is 
more detailed information about a range of health service use categories. In addition, 
there is more information about number of visits. Another advantage with the BHPS is 
that we have repeated measurements of the same individuals. This provides 
opportunities for a number of methods to eliminate the influence of omitted variables.  
 
Generating predicted absolute values 
In this thesis we have generated predictions of variation in health outcomes and health 
service use based on variation in BMI and SES. We have used a number of different 
approaches to quantify the findings depending on the dependent variable. When using 
interactions it can be difficult to understand the implications of the estimated 
coefficients, especially when applying to nonlinear models. Hence, we recommend 
that one provides predicted values to show the implications of the findings.  
 
Testing for heterogeneity 
In this thesis we have used a number of methods to test for socioeconomic 
heterogeneity across linear and nonlinear models. We discussed reasons for including 
interactions in linear and nonlinear models as well as the interpretation of those. In a 
linear model an interaction term can be interpreted directly as an absolute effect. In a 
nonlinear model the coefficients have a different interpretation and so has the 
interaction term.  
 
There has been much debate around how to interpret interactions in nonlinear models 
when one wants to interpret them as absolute effects. The reason is as illustrated by Ai 
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& Norton (2003) that the interaction term in the latent variable model cannot be used 
to say whether or not there are significant interactions in the absolute effects. We 
recommend following the approach suggested by Greene (2010), where one focuses 
on what the predicted values reveal about the problem in context, instead of the 
coefficients in the latent variable models.   
 
7.5 Some limitations and issues 
In each chapter it is acknowledged that there are a number of limitations. These arise 
mainly from restrictions in available data. We now discuss these in the context of 
offering some suggestions for further research. 
 
Endogeneity  
An independent variable is endogenous if it is correlated with the error term and this 
can arise for three reasons (Wooldrige, 2002). The first is omitted variables. Omitted 
variables occur when there are variables that affect both the dependent and the 
independent variable but, because of data availability, we can not include them in the 
regression. The second type of endogeneity is simultaneity or reverse causality. This is 
when the independent variable is determined partly by the dependent variable. Third 
there may be measurement error, which is when we can only observe an imperfect 
measure of one or more of the variables in the regression.  
 
In this thesis we have essentially used three types of dependent variables; health 
related quality of life, survival time and health service use. For each analysis it is 
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possible that there are different versions of the endogeneity issues mentioned above. 
In the following we will discuss in more detail why there might be endogeneity issues 
and how these might have influenced the results for each dependent variable.  
 
We start with the relationship between obesity and HRQL. While obesity may affect 
HRQL, the reverse may also be true and/or there may be omitted variables that affect 
both obesity and HRQL. One such variable might be functional status. Individuals may 
be obese because they have a reduced functional status. This reduced functional 
status might also be the cause of the reduced HRQL. The result of this would be that 
we overestimate the impact of obesity on HRQL. Conversely, we might have 
underestimated the impact of obesity on HRQL if, for example, an illness which reduce 
HRQL also reduce appetite. Hence, the bias might go both directions and it is difficult 
to establish whether we over- or underestimate the impact.  
 
Omitted variables can be mitigated if a proxy variable is available. Hence, to mitigate 
the issues above we run a separate analysis where we control extensively for 
longstanding and acute illnesses, in addition to the analysis where we only control for 
individual and household characteristics. The downside of this approach is that it is an 
overadjustment as health factors are part of the pathway between obesity and the 
output variable (See Zizza, 2004). Hence, when we use this approach we 
underestimate the impact of obesity on HRQL. It would be preferable to use an 
approach where one can look at causal impact of obesity accounting for the complex 
interface between obesity and its comorbidities. It is a general weakness in these 
studies, including our own, that this is not properly accounted for.  
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The second dependent variable is survival time. Newman et al. (2001) illustrated that 
weight loss is a predictor of mortality. If individuals loose weight shortly before they 
die one will underestimate the impact of obesity on mortality. Hence, this is a potential 
omitted variable issue. Furthermore, there might be other omitted variables that can 
affect both mortality and BMI. One such variable is health status. However, in our 
analysis we have accounted for this issue. First, we control for a range of variables and 
fit regressions both with and with out controlling for illness variables. Second, we add 
a frailty term to account for unobservable factors affecting the relationship between 
obesity and mortality. Hence, we argue that omitted variables are not an issue in our 
analysis. Furthermore, this analysis does not suffer from reverse causality as the 
dependent and the independent variables are measured at a different point in time. 
 
The third dependent variable discussed is health service use, which may suffer from 
omitted variable bias. For example, this association is an overestimate of the causal 
effect of obesity on use if some individuals becomes obese because of functional 
limitations, and have higher health service use because of these functional limitations. 
On the contrary, the causal effect might be an underestimate if, for example, 
individuals with a lower propensity to use the health service also are more likely to be 
obese (Cawley & Meyerhoefer, 2011). In addition, this analysis may suffer from reverse 
causality, i.e., health service use might reduce BMI. For example, a GP might motivate 
an obese person to loose weight, which would lead to an underestimate of the causal 
impact. Based on this it is difficult to establish the direction of the bias. Nevertheless, 
we limit the bias by controlling for a range of individual and household characteristics.  
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I each chapter there might be measurement error. Our measure of obesity is BMI, 
which can be considered to be an imperfect measure of obesity. For example, BMI has 
been criticised because it does not distinguish body fat from fat-free mass such as 
muscle and bone (Burkhauser & Cawley, 2008). This means that we include some 
individuals in the higher BMI categories which have a high BMI due to a high muscle 
mass. This would mean that we underestimate the negative consequences of higher 
BMI and reduce the significance of the BMI variables. Although we recognise this issue 
we have chosen to use BMI as it is the most commonly used measure of obesity, which 
enabled us to compare our results to those of other studies. Furthermore, it is more 
often available than other measures of obesity. 
 
BMI might also be mis-measured (e.g., if it is based on self-reported height and 
weight). If the level of mis-measurement is associated with the dependent variables, 
the obesity coefficients may be biased. In BHPS the values are self-reported. However, 
the HSE and HALS obtained their height and weight measurement during the 
interviewer visit and it is not self-reported so the likelihood of this problem is reduced.  
 
It is also likely that the dependent variables suffer from measurement error. For 
example, there may be reporting bias with respect to HRQL and health service use. It 
may be systematic reporting bias that is correlated with obesity and/or with SES in the 
HRQL measurement or the health service utilisation.  
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Little attention has been provided to these issues in earlier literature. However, some 
researchers have used an instrumental variable approach. This will be discussed in 
more detail below. 
 
Missing data 
We might have issues with missing data. For the covariates the missing values are 
included as a part of the excluded category. To allow for those values not missing at 
random we included dummy variables to indicate non-response. However, we have 
not done this for missing BMI. These values may be missing for a number of reasons 
which might not be random. This means that the data which is missing is correlated 
with a number of variables and our results fail to take these observations into account. 
There are a number of methods available for handling missing data. Some have for 
example imputed the missing variables. However, there are issues with this approach. 
If there is a unique set of values attached to the missing data it is difficult to argue that 
one can capture these based on predictions of non-missing individuals.    
 
Utilisation measures 
There are issues related to the measures of health service use. When we measure the 
probability of having a GP visits per year we do not capture the full extent of the 
implications of obesity for GP use. When we look at the number of visits per year our 
measure improves. However, we still do not capture how much time and resources are 
used on each defined group. For example, it might be that obese individuals get more 
treatment every time they go to the GP than normal weight individuals. If this was the 
case we would underestimate the impact of obesity on health service use.    
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Obesity onset and long versus short term consequences of obesity 
We have not been able to measure obesity onset which might have an impact on the 
consequences of obesity in terms of health. Furthermore, we have not been able to 
distinguish between long and short term consequences of obesity. It might take a 
number of years in the obesity state before the negative consequences of obesity 
emerge.  
 
7.6 Suggestions for future research 
 
Instrumental variable approach 
To address the endogeneity issues some researchers have used an instrumental 
variable approach. In this approach one use variables that are good predictors of 
obesity but are not independently related to the outcome variable (health or health 
service use). The validity in the instrumental variable approach relies in finding the 
appropriate instruments and these could often be hard to find. 
 
There are essentially two types of variables that have been used as instruments for 
obesity and we discuss each in the following.  
 
Some have applied are area level measures e.g. mean BMI and percentage obesity by 
area (see Vallejo-Torres & Morris, 2010; Morris, 2007). These have showed to be good 
predictors of obesity. However, there are issues with using this as an instrument. The 
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reason being that this instrument also suffers from similar endogeneity issues to the 
obesity variable. Imagine we look at the impact of obesity on health and want to 
remove the possible reverse causality in that health might affect obesity, and to do this 
we apply area level BMI as instruments. An issue with this is that area level health 
might affect obesity status in the area; hence we would not fully remove the reverse 
causality problem. One could control for area level health in the regressions, however 
this might then again be correlated with individual health. Hence, we remove part of 
the pathway between obesity and HRQL.  
 
Another approach is to exploit genetic variation in weight. This is to use the weight of a 
biological relative as an instrument for weight of the respondent. This has been 
showed to be a powerful predictor of the weight of the respondent (Cawley & 
Meyerhoefer, 2011). However, the instrument must also be uncorrelated with the 
respondents health or health service use. This means that a common environment 
must be uncorrelated with health and health care expenditures, which is difficult to 
prove. 
 
The validity of both instruments above is threatened as both are based on quite strong 
assumptions. In addition it has in general proved to be difficult to find other 
instruments for obesity. Hence, rather than going into this discussion in this PhD we 
have chosen to completely ignore this approach and we see it as a question for further 
research.  
 
Panel data methods 
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Panel data methods gives the opportunity to control for unobservable individual 
effects which remain constant over time. Hence, this might deal with the omitted 
variable bias and measurement error. However, due to limited time periods with 
obesity measurement in the BHPS and limited variation in the dependent variables we 
were forced to use random effects methods.  
 
If more time periods with BMI values in BHPS become available it would be interesting 
to redo the studies using a fixed effects model or a more advanced random effect 
model, which strictly looks at deviations from the mean. This would allow us to be 
confident that we have fully omitted time invariant heterogeneity.  
 
Using other measures of obesity 
To avoid the biases related to BMI one could use other measures of obesity. 
Candidates include: total body fat; percent body fat, which is total body fat divided by 
total mass; waist circumference; and waist-to-hip ratio. However, one must note that 
these measures also have weaknesses (Burkhauser & Cawley, 2008). The main reason 
why these have not been applied in this research is that they are less frequently 
available and literally all studies that investigate obesity use BMI and we aimed to 
compare our results with other studies.  
 
In addition, it would be interesting to measure the consequences of more extreme 
obesity categories. In our research we merged obesity class II and obesity class III to 
assure an adequate number of individuals in each category. However, the 
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consequences across these groups might differ and it would be interesting to 
investigate this further.  
 
Reason for SES variation 
It would be interesting to investigate reasons for why we get SES variation. We have to 
some extent investigated this in Chapter 4 by investigating SES variation in the 
association between obesity-related comorbidities and HRQL. Another related 
question is: Does the prevalence of obesity-related comorbidities vary by SES? Another 
interesting question could be; is obesity across SES groups caused by similar 
behaviour? This is interesting because it would give an indication on how to develop 
obesity interventions targeted at specific SES groups.  
 
Cost-effectiveness analysis of an obesity intervention across SES groups 
The Foresight report mentions as one of their “top five policy responses to obesity” 
targeting health interventions for those at increased risk, such as low income groups 
(Butland et al., 2007). However, little is known about the cost effectiveness of targeted 
interventions. It would be interesting to investigate whether or not this would yield 
good value for money.  
 
7.7 What does this thesis add? 
This thesis serves to increase focus on heterogeneous consequences of a homogenous 
condition. To inform a decision making process the evidence used must be designed 
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around the context of the problem. By failing to do so one risks misinforming policy 
makers and misallocating resources.   
 
In meeting the aims of this thesis we have made original contributions to the literature 
in a number of respects. In Chapter 3 we show that there is socioeconomic variation in 
the association between obesity and HRQL, this is the first time this has been shown. 
In Chapter 4, we identify a significantly more pronounced association between obesity 
and HRQL in individuals suffering from a range of obesity-related comorbidities. To our 
knowledge, this is the first time this has been shown. Furthermore, we demonstrate 
that the association between obesity-related comorbidities and HRQL is more 
pronounced in lower SES groups compared with higher SES groups. This is the first 
time this has been show. In Chapter 5 we investigate socioeconomic variation in the 
association between obesity and life expectancy. This is the first time this has been 
done. In addition, it is the first time the relationship between obesity and life 
expectancy has been investigated using a parametric distribution controlling for 
unobservable heterogeneity. Furthermore, it is the first time the predicted loss in life 
expectancy due to obesity has been predicted based on a parametric distribution. In 
Chapter 6 we analyse socioeconomic variation in the relationship between obesity and 
health service use. We are the first to show that obesity has a more pronounced 
association with health service use in lower SES groups than in higher SES groups. 
Furthermore, this is the first time the relationship between obesity and health service 
use has been analysed controlling for extensive health area variables. It is also the first 
study in Great Britain to provide “additive” (quantitative) estimates of the association 
between obesity and health service use. Lastly, we have discussed and provided a 
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framework for interactions in linear and nonlinear models in health economics 
research. 
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Appendices 
Appendices to Chapter 2 
Appendix 2.1: Search terms and number of identified studies  
Ovid MEDLINE(R) Daily Update, Ovid OLDMEDLINE(R) 1946 to 1965, Ovid MEDLINE(R) 
In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 1948 to Present 
Search Query Results 
#1 "Health Status Indicators"[Mesh] 151880 
#2 "Life Expectancy"[Mesh] 12027 
#3 "Mortality"[Mesh] 232329 
#4 #1 OR #2 OR #3 383415 
#5 "Socioeconomic Factors"[Mesh] 284754 
#6 #1 OR #2 OR #3 AND #5 17942 
#7 "Obesity"[Mesh] 107834 
#8 #1 OR #2 OR #3 AND #5 AND #7 224 
 
Ovid MEDLINE(R) Daily Update, Ovid OLDMEDLINE(R) 1946 to 1965, Ovid MEDLINE(R) 
In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 1948 to Present 
Search Query Results 
#1 "Health Status Indicators"[Mesh] 151880 
#2 "Life Expectancy"[Mesh] 12027 
#3 "Mortality"[Mesh] 232329 
#4 #1 OR #2 OR #3 383415 
#5 "Socioeconomic Factors"[Mesh] 284754 
#6 #1 OR #2 OR #3 AND #5 17942 
#7 "Smoking"[Mesh] 102909 
#8 #1 OR #2 OR #3 AND #5 AND #7 693 
 
Ovid MEDLINE(R) Daily Update, Ovid OLDMEDLINE(R) 1946 to 1965, Ovid MEDLINE(R) 
In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 1948 to Present 
Search Query Results 
#1 "Health Status Indicators"[Mesh] 151880 
#2 "Life Expectancy"[Mesh] 12027 
#3 "Mortality"[Mesh] 232329 
#4 #1 OR #2 OR #3 383415 
#5 "Socioeconomic Factors"[Mesh] 284754 
#6 #1 OR #2 OR #3 AND #5 17942 
#7 "Alcohol Drinking"[Mesh] 42601 
#8 #1 OR #2 OR #3 AND #5 AND #7 263 
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Ovid MEDLINE(R) Daily Update, Ovid OLDMEDLINE(R) 1946 to 1965, Ovid MEDLINE(R) 
In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 1948 to Present 
Search Query Results 
#1 "Health Status Indicators"[Mesh] 151880 
#2 "Life Expectancy"[Mesh] 12027 
#3 "Mortality"[Mesh] 232329 
#4 #1 OR #2 OR #3 383415 
#5 "Socioeconomic Factors"[Mesh] 284754 
#6 #1 OR #2 OR #3 AND #5 17942 
#7 "Drug Users"[Mesh] 538 
#8 #1 OR #2 OR #3 AND #5 AND #7 3 
 
EMBASE 1980 to 2011 Week 25  
Search Query Results 
#1 exp health status/ 94565 
#2 exp survival/ 386229 
#3 #1 OR #2  475718 
#4 exp socioeconomics/ 131838 
#5 #1 OR #2 AND #4 11649 
#6 exp obesity/ 187472 
#7 #1 OR #2 AND #4 AND #6 544 
 
EMBASE 1980 to 2011 Week 25  
Search Query Results 
#1 exp health status/ 94565 
#2 exp survival/ 386229 
#3 #1 OR #2  475718 
#4 exp socioeconomics/ 131838 
#5 #1 OR #2 AND #4 11649 
#6 exp smoking/ 163264 
#7 #1 OR #2 AND #4 AND #6 846 
 
EMBASE 1980 to 2011 Week 25  
Search Query Results 
#1 exp health status/ 94565 
#2 exp survival/ 386229 
#3 #1 OR #2  475718 
#4 exp socioeconomics/ 131838 
#5 #1 OR #2 AND #4 11649 
#6 exp drinking behaviour/ 27439 
#7 #1 OR #2 AND #4 AND #6 114 
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EMBASE 1980 to 2011 Week 25  
Search Query Results 
#1 exp health status/ 94565 
#2 exp survival/ 386229 
#3 #1 OR #2  475718 
#4 exp socioeconomics/ 131838 
#5 #1 OR #2 AND #4 11649 
#6 exp drug abuse/ 51597  
#7 #1 OR #2 AND #4 AND #6 83 
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Appendices to Chapter 3 
Appendix 3.1: Descriptive statistics by BMI category 
  
Whole Normal  
Overweight 
Class I 
Class II 
/ III P 
value sample weight obesity obesity 
Observations        
  Number 33,105 11,796 12,814 5,656 2379   
  % 100 36 39 17 7   
EQ-5D score 0.871 0.9 0.876 0.84 0.782 <0.01 
Predicted SES measure 29,652 30,914 30,159 27,831 25,821 <0.01 
Missing income 14 14 14 14 15 0.46 
SES quartile        
  1 (most deprived) 25 22 24 29 35 
<0.01 
  2 25 25 25 26 26 
  3 25 26 26 24 23 
  4 (least deprived) 25 28 26 21 17 
Gender        
  Men  46 38 53 50 34 
<0.01   Women 54 62 47 50 66 
Age (years)  48 43 50 52 50 <0.01 
Ethnicity        
  White 94 93 94 95 95 
<0.01 
  Black Caribbean 1 1 1 1 1 
  Black African 1 1 1 1 1 
  Indian 2 2 2 1 1 
  Pakistani 1 1 1 1 1 
  Bangladeshi <1 <1 <1 <1 <1 
  Chinese <1 <1 <1 <1 <1 
  Other ethnic group 2 2 1 1 1 
  Missing ethnicity <1 <1 <1 <1 <1 
Marital status        
  Married 57 48 62 65 61 
<0.01 
  Single 17 25 13 10 14 
  Separated 2 2 2 2 2 
  Divorced 6 6 6 6 6 
  Widowed 7 6 7 7 8 
  Cohabiting 11 12 10 10 9 
Smoking status        
  Never smoked 44 47 44 42 44 
<0.01 
  Ex occasional  smoker 6 6 6 5 5 
  Ex regular smoker 26 19 29 33 32 
  Current cigarette smoker 24 28 22 20 19 
GOR of residence       
  North East 6 6 6 7 7 
<0.01 
  North West 14 14 14 14 14 
  Yorkshire and The Humber   10 10 10 11 11 
  East Midlands  10 9 10 10 12 
  West Midlands  11 10 11 12 13 
  East of England  12 11 12 12 11 
  London 10 12 9 8 8 
  South West 10 10 10 10 10 
  South East 17 18 17 16 14 
Survey year        
  2003 35 36 35 35 32 
0.03 
  2004 15 15 16 15 15 
  2005 17 17 17 17 18 
  2006 32 32 32 33 34 
Educational qualifications       
  Degree or equivalent 19 23 19 15 12 
<0.01 
  Higher education below degree 12 11 13 12 12 
  NVQ3/GCE A Level or equiv. 13 15 12 11 11 
  NVQ2/GCE O Level or equiv. 24 25 23 23 25 
  NVQ1/CSE other grade or equiv. 5 7 5 5 6 
  Foreign/other 3 3 3 3 3 
  No qualification 25 21 25 31 32 
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Table continued  
Social Class of HRP       
  Professional 8 9 8 6 5 
<0.01 
  Managerial technical 36 38 37 33 30 
  Skilled non-manual 15 16 15 15 14 
  Skilled manual 24 21 24 27 28 
  Semi-skilled manual 13 13 13 15 17 
  Unskilled manual 4 4 4 4 5 
Cars owned by household       
  Household has no car 16 17 14 15 19 
<0.01 
  One 43 41 43 44 44 
  Two 33 33 34 32 28 
  Three or more 9 9 9 9 9 
Economic activity status last week      
  In paid employment/self-employed 67 71 66 63 62 
<0.01 
  Going to school or college full time 1 2 1 1 1 
  On a government training scheme <1 <1 <1 <1 <1 
  Doing unpaid work  <1 <1 <1 <1 <1 
  Waiting to take up paid work <1 <1 <1 <1 <1 
  Looking for paid work 1 1 1 1 1 
  Temporary sickness <1 <1 <1 <1 1 
  Long-term sickness 4 3 3 5 7 
  Retired from paid work 23 18 26 27 23 
  Looking after home or family 4 4 3 3 5 
  Doing something else <1 <1 <1 <1 <1 
Housing tenure        
  Own outright 32 29 34 34 27 
<0.01 
  Buying with mortgage or loan 46 48 46 43 43 
  Pay part rent part mortgage <1 <1 <1 <1 1 
  Rent  21 22 18 21 27 
  Live rent free and/or squatting 1 1 1 1 1 
Bedrooms in household       
  One  6 6 5 5 7 
<0.01 
  Two  21 21 21 21 23 
  Three  50 48 51 54 53 
  Four  18 19 18 16 14 
  Five or more  5 6 5 4 3 
IMD quintile (SOA level)       
  1 (least deprived) 23 23 24 20 17 
<0.01 
  2 22 22 23 22 20 
  3 20 20 21 21 20 
  4 20 20 18 21 23 
  5 (most deprived) 15 15 14 16 20 
Income support claimant       
  No 95 95 95 94 92 
<0.01   Yes 5 5 5 6 8 
No. longstanding illnesses        
  None 55 62 54 45 39  
  One 28 24 29 31 29  
  Two 12 9 12 15 18  
  Three 4 3 4 6 10  
  Four or more  2 1 2 3 4 <0.01 
Limiting longstanding illness 24 23 24 30 37 <0.01 
Type of longstanding illness       
  Neoplasms and benign growths 2 2 2 2 2 0.144 
  Endocrine and metabolic 5 1 7 11 15 <0.01 
  Mental disorders 3 5 3 4 6 <0.01 
  Nervous system 4 4 4 4 4 0.256 
  Eye complaints 1 2 2 2 2 0.039 
  Ear complaints 2 2 3 2 2 <0.01 
  Heart and circulatory system 14 7 13 19 22 <0.01 
  Respiratory system 12 12 9 9 13 <0.01 
  Digestive system 7 5 5 6 6 <0.01 
  Genito-urinary system 3 2 2 3 3 <0.01 
  Skin complaints 3 1 2 2 3 <0.01 
  Musculoskeletal system 42 13 20 25 30 <0.01 
  Infectious disease <1 <1 <1 <1 <1 0.338 
  Blood and related organs 2 1 1 1 1 0.544 
Acute illnesses days the last two weeks       
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Table continued  
  One to three 5 5 5 5 5 0.324 
  Four to six  3 2 2 3 4 <0.01 
  Seven to thirteen 3 2 3 3 4 <0.01 
  Fourteen 6 5 5 7 10 <0.01 
Source: HSE 2003-2004 
Notes 
Other than for “Observations” all statistics are either mean (for continuous variables) or % (categorical 
variables). “<1” indicates non-zero values less than one; “0” indicates zero values.  
GOR = Government Office Region. HRP = household reference person. IMD = Index of Multiple 
Deprivation. SOA = super output area. 
 
  
 
Appendix 3.2: Association between obesity and EQ-5D score (controlling for individual and household characteristics); predicted 
EQ-5D scores are computed by setting the individual and household characteristics to the mean values of their SES group 
  Normal weight Overweight Class I obesity Class II / III obesity Equal 
  Coef. t Mean SE Coef. t Mean SE Coef. t Mean SE Coef. t Mean SE means 
Men                   
All Base category 0.898 0.002 -0.002 -0.45 0.897 0.002 -0.02 -4.25 0.878 0.003 -0.067 -7.2 0.831 0.007 P<0.01 
SES quartile                  
  1 (most deprived) Base category 0.822 0.006 -0.012 -1.22 0.810 0.006 -0.044 -3.35 0.779 0.009 -0.139 -5.81 0.683 0.019 P<0.01 
  2 0.039 4.52 0.904 0.004 0.037 4.01 0.902 0.004 0.013 1.17 0.878 0.006 -0.036 -1.87 0.829 0.014 P<0.01 
  3 0.033 3.63 0.919 0.003 0.036 3.89 0.923 0.003 0.025 2.35 0.911 0.005 0.001 0.09 0.888 0.010 P=0.04 
  4 (least deprived) 0.021 2.00 0.937 0.003 0.023 2.13 0.939 0.002 0.017 1.48 0.933 0.004 0.004 0.27 0.920 0.009 P=0.35 
 Equal means P<0.01 P<0.01 P<0.01 P<0.01  
Women                  
All Base category 0.889 0.002 -0.014 -4.35 0.875 0.002 -0.044 -9.53 0.845 0.004 -0.100 -14.06 0.789 0.007 P<0.01 
SES quartile                  
  1 (most deprived) Base category 0.829 0.006 -0.028 -3.31 0.801 0.006 -0.061 -5.81 0.768 0.009 -0.141 -9.99 0.687 0.012 P<0.01 
  2 0.026 3.72 0.903 0.003 0.006 0.76 0.882 0.005 -0.03 -2.91 0.846 0.008 -0.074 -5.14 0.802 0.012 P<0.01 
  3 0.011 1.42 0.911 0.003 0.004 0.43 0.903 0.005 -0.018 -1.81 0.881 0.007 -0.054 -3.87 0.845 0.012 P<0.01 
  4 (least deprived) -0.007 -0.69 0.924 0.003 -0.011 -1.07 0.919 0.004 -0.033 -2.61 0.898 0.007 -0.064 -4.10 0.866 0.012 P<0.01 
Equal means P<0.01 P<0.01 P<0.01 P<0.01  
Notes 
The dependent variable is EQ-5D score. The coefficients and t-statistics show the impact of the obesity variables on EQ-5D scores based on OLS. The mean and SE values 
are predicted mean EQ-5D scores, and their standard errors, for each BMI or BMI/SES category computed by setting the individual and household characteristics to the 
mean values of their SES group. The individual and household characteristics are age, age squared and age cubed, predicted equivalised total annual household income, 
ethnicity, marital status, smoking status, Government Office Region of residence and survey year. 
  
 
 Appendix 3.3: Association between obesity and EQ-5D score (controlling for individual and household characteristics); predicted 
EQ-5D scores are computed by setting the individual and household characteristics to the mean values of their obesity group 
  Normal weight Overweight Class I obesity Class II / III obesity Equal 
  Coef. t Mean SE Coef. t Mean SE Coef. T Mean SE Coef. t Mean SE means 
Men                   
All Base category 0.910 0.002 -0.002 -0.45 0.894 0.002 -0.02 -4.25 0.866 0.003 -0.067 -7.20 0.821 0.008 P<0.01 
SES quartile                  
  1 (most deprived) Base category 0.887 0.006 -0.012 -1.22 0.858 0.007 -0.044 -3.35 0.819 0.009 -0.139 -5.81 0.726 0.019 P<0.01 
  2 0.039 4.52 0.926 0.004 0.037 4.01 0.908 0.004 0.013 1.17 0.875 0.006 -0.036 -1.87 0.829 0.039 P<0.01 
  3 0.033 3.63 0.919 0.003 0.036 3.89 0.907 0.003 0.025 2.35 0.887 0.005 0.001 0.09 0.867 0.033 P<0.01 
  4 (least deprived) 0.021 2.00 0.908 0.004 0.023 2.13 0.894 0.004 0.017 1.48 0.879 0.005 0.004 0.27 0.869 0.021 P<0.01 
 Equal means P<0.01 P<0.01 P<0.01 P<0.01  
Women                  
All Base category 0.904 0.002 -0.014 -4.35 0.866 0.003 -0.044 -9.53 0.827 0.004 -0.1 -14.06 0.775 0.007 P<0.01 
SES quartile                  
  1 (most deprived) Base category 0.897 0.007 -0.028 -3.31 0.846 0.007 -0.061 -5.81 0.804 0.009 -0.141 -9.99 0.727 0.013 P<0.01 
  2 0.026 3.72 0.923 0.004 0.006 0.76 0.880 0.005 -0.03 -2.91 0.835 0.008 -0.074 -5.14 0.795 0.012 P<0.01 
  3 0.011 1.42 0.908 0.003 0.004 0.43 0.877 0.005 -0.018 -1.81 0.847 0.007 -0.054 -3.87 0.815 0.012 P<0.01 
  4 (least deprived) -0.007 -0.69 0.890 0.005 -0.011 -1.07 0.862 0.006 -0.033 -2.61 0.832 0.009 -0.064 -4.10 0.804 0.013 P<0.01 
Equal means P<0.01 P<0.01 P=0.01 P<0.01  
Notes 
The dependent variable is EQ-5D score. The coefficients and t-statistics show the impact of the obesity variables on EQ-5D scores based on OLS. The mean and SE values 
are predicted mean EQ-5D scores, and their standard errors, for each BMI or BMI/SES category computed by setting the individual and household characteristics to the 
mean values of their obesity group. The individual and household characteristics are age, age squared and age cubed, predicted equivalised total annual household income, 
ethnicity, marital status, smoking status, Government Office Region of residence and survey year. 
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Appendices Chapter 4 
Appendix 4.1:  Longstanding illnesses in the HSE 
1. Cancer (neoplasm)  
2. Diabetes  
3. Other endocrine/metabolic  
4. Mental 
illness/anxiety/depression/nerves  
5. Mental handicap  
6. Epilepsy/fits/convulsions  
7. Migraine/headaches 
8. Other problems of nervous system 
9. Cataract/poor eye sight/blindness  
10. Other eye complaints  
11. Poor hearing/deafness 
12. Tinnitus/noises in the ear 
13. Menieres disease/ear complaints 
causing balance problems 
14. Other ear complaints  
15. Stroke/cerebral 
haemorrhage/cerebral thrombosis 
16. Heart attack/angina 
17. Hypertension/high blood 
pressure/blood pressure 
18. Other heart problems 
19. Piles/haemorrhoids including 
Varicose Veins in anus 
20. Varicose veins/phlebitis in lower 
extremities 
21. Other blood vessels/embolic 
22. Bronchitis/emphysema 
23. Asthma  
24. Hayfever 
25. Other respiratory complaints 
26. Stomach ulcer/ulcer/abdominal 
hernia/rupture 
27. Other digestive complaints 
28. Complaints of bowel/colon 
29. Complaints of teeth/mouth/tongue 
30. Kidney complaint 
31. Urinary tract infection 
32. Other bladder 
problems/incontinence  
33. Reproductive system disorders 
34. Arthritis/rheumatism/fibrositis 
35. Back problems/slipped 
disc/spine/neck  
36. Other problems of 
bones/joints/muscles 
37. Infectious and parasitic disease  
38. Disorders of blood and blood 
forming organs and immunity 
disorders 
39. Skin complaints 
40. Other complaints 
41. Unclassifiable (no other codable 
complaint) 
42. Complaint no longer present 
 
Appendix 4.2: Description of illness categories 
Longstanding illness Description based on HSE user guide 
Diabetes Incl. Hyperglycaemia 
Stroke Incl. stroke victim - partially paralysed and speech, Difficulty 
Hemiplegia, apoplexy, cerebral embolism, Cerebro - vascular 
accident 
Heart attack or angina Incl. coronary thrombosis, myocardial infarction 
Hypertension/high 
blood pressure/blood 
pressure 
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Appendix 4.3: Share of individuals with comorbidities by SES group 
  
Normal 
weight Over-weight Class I obesity 
Class II/III 
obesity 
Diabetes 
    SES quartile 
      1 (most deprived) 
       Yes 2.5% 5.5% 10.4% 13.3% 
   No 97.5% 94.5% 89.6% 86.7% 
  2 
       Yes 1.4% 3.1% 6.7% 8.7% 
   No 98.6% 96.9% 93.3% 91.3% 
  3 
       Yes 1.5% 2.8% 4.8% 8.5% 
   No 98.5% 97.2% 95.2% 91.5% 
  4 (least deprived) 
       Yes 1.2% 2.0% 4.1% 6.6% 
   No 98.8% 98.0% 95.9% 93.4% 
Stroke 
    SES quartile 
      1 (most deprived) 
    Yes 1.1% 1.7% 1.6% 1.5% 
No 98.9% 98.3% 98.4% 98.5% 
  2 
       Yes 0.3% 0.5% 1.1% 0.7% 
   No 99.7% 99.5% 98.9% 99.3% 
  3 
       Yes 0.3% 0.3% 0.6% 0.7% 
   No 99.7% 99.7% 99.4% 99.3% 
  4 (least deprived) 
       Yes 0.2% 0.2% 0.5% 0.5% 
   No 99.8% 99.8% 99.5% 99.5% 
Hypertension 
   SES quartile 
      1 (most deprived) 
       Yes 5.8% 10.4% 15.3% 15.5% 
   No 94.2% 89.6% 84.7% 84.5% 
  2 
       Yes 3.2% 7.0% 10.4% 16.5% 
   No 96.8% 93.0% 89.6% 83.5% 
  3 
       Yes 2.0% 6.1% 10.2% 13.5% 
   No 98.0% 93.9% 89.8% 86.5% 
  4 (least deprived) 
       Yes 2.6% 5.5% 10.4% 15.2% 
   No 97.4% 94.5% 89.6% 84.8% 
Heart attack and angina 
  SES quartile 
      1 (most deprived) 
       Yes 2.9% 5.0% 6.5% 5.2% 
   No 97.1% 95.0% 93.5% 94.8% 
  2 
       Yes 0.9% 1.9% 3.3% 3.5% 
   No 99.1% 98.1% 96.7% 96.5% 
  3 
       Yes 0.7% 1.2% 1.4% 2.2% 
   No 99.3% 98.8% 98.6% 97.8% 
  4 (least deprived) 
       Yes 0.3% 0.9% 1.2% 0.5% 
   No 99.7% 99.1% 98.8% 99.5% 
Source: HSE 2003-2006 
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Appendices Chapter 5 
Appendix 5.1: Summary statistics for individuals used in the duration studies 
  
Whole 
sample 
Normal 
weight 
Overweight Obese 
Predicted income 136 141 135 123 
SES groups     
  1 (most deprived) 25 23 24 30 
  2 25 24 26 27 
  3 25 25 26 27 
  4 (least deprived) 25 28 24 16 
Missing income    
  Yes 17 17 17 17 
  No 83 83 83 83 
Age 58 57 59 58 
Gender     
  Male 46 42 54 35 
  Female 54 58 46 65 
Ethnicity     
  White European 97 98 97 97 
  Other 2 2 2 2 
  Not answered  1 1 1 0 
Regular smoker    
  Yes 29 35 24 22 
  No  71 65 76 78 
Ex-smoker     
  Yes 2 2 2 1 
  No 98 98 98 99 
Marital status    
  Married 75 75 77 70 
  Single 6 6 4 5 
  Separated 2 2 2 1 
  Divorced 4 4 3 5 
  Widowed 14 12 14 18 
Area     
  London 10 10 9 7 
  Wales 5 5 5 8 
  North 6 6 7 7 
  North West 13 13 13 12 
  Yorks/Humber 9 9 9 10 
  West Midlands 8 8 8 8 
  East Midlands 8 9 7 8 
  East Anglia 4 4 4 4 
  South West 9 9 9 10 
  South East 18 20 18 14 
  Scotland 10 8 10 13 
Educational qualifications   
  Degree or equivalent 12 14 10 7 
  Higher education below degree 8 9 8 8 
  NVQ3/GCE A Level or equivalent 4 4 3 3 
  NVQ2/GCE O Level or equivalent 9 9 9 8 
  Other 62 58 65 70 
  No qualification 5 5 5 4 
Social Class of HRP    
  Professional 6 7 5 2 
  Managerial technical 25 26 25 20 
  Skilled non-manual 11 12 11 10 
  Skilled manual 36 33 37 42 
  Semi-skilled manual 17 16 17 18 
  Unskilled manual 5 6 5 7 
  Other 1 1 1 0 
Economic activity status for last week  
  Working full time 36 35 39 28 
  Working part time 13 15 10 13 
  Unemployed 3 3 3 3 
  Permanently sick or disabled 3 3 3 4 
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Table continued 
  Retired 35 33 37 37 
  Keeping house 0 0 0 0 
  Full time student 10 11 7 15 
Bedrooms in household   
  One 7 8 7 8 
  Two 26 25 28 25 
  Three 51 51 50 56 
  Four or more 15 16 14 11 
Housing tenure    
  Own accommodation 65 67 65 57 
  Rent 35 33 35 43 
No. longstanding illnesses    
  One illness 29 29 28 31 
  Two illnesses 10 9 10 14 
  Three illnesses 3 2 3 4 
  Four or more illnesses 0 0 0 1 
Limiting longstanding illness 23 21 22 29 
Source: HALS1 1984/1985 and the longitudinal follow up in June 2009 
Notes: 
All statistics are either mean (for continuous variables) or % (categorical variables) 
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Appendix 5.2: Cox model controlling for individual and household characteristics 
  Main effects model BMI interacted with SES model BMI interacted with age model Fully interacted model 
  Men Women Men Women Men Women Men Women 
  Haz. ratio z Haz. ratio z Haz. ratio z Haz. ratio z Haz. ratio z Haz. ratio z Haz. ratio z Haz. ratio z 
BMI 
                  Normal weight Base category Base category Base category Base category Base category Base category Base category Base category 
  Overweight 1.043 0.61 0.974 -0.36 0.988 -0.1 1.054 0.5 0.647 -1.03 1.316 0.59 0.693 -0.71 2.677 1.58 
  Obese 1.337 2.63 1.365 3.42 1.225 1.03 1.452 2.9 1.350 0.43 4.514 2.73 1.511 0.48 18.961 3.96 
SES 
                  1 (most deprived) Base category Base category Base category Base category Base category Base category Base category Base category 
  2 0.823 -2.42 0.901 -1.25 0.684 -3.17 1.015 0.13 0.796 -2.76 0.938 -0.75 0.680 -3.19 1.113 0.87 
  3 0.688 -3.89 0.73 -2.96 0.688 -2.67 0.757 -1.92 0.687 -3.88 0.749 -2.65 0.675 -2.71 0.882 -0.81 
  4 (least deprived) 0.55 -5.22 0.543 -4.33 0.615 -3.15 0.650 -2.44 0.552 -5.13 0.563 -3.96 0.599 -3.15 0.783 -1.32 
BMI*SES 
               Overweight*SES 2 
  
1.306 1.58 0.785 -1.38 
  
1.328 1.66 0.700 -1.88 
  Overweight*SES 3 
  
1.018 0.1 1.101 0.47 
  
1.067 0.33 0.919 -0.36 
  Overweight*SES 4 
  
0.812 -0.99 0.679 -1.31 
  
0.866 -0.63 0.544 -1.86 
  Obese*SES 2 
  
1.440 1.34 1.041 0.19 
  
1.424 1.28 0.750 -1.25 
  Obese*SES 3 
  
0.987 -0.05 0.768 -0.96 
  
0.976 -0.08 0.456 -2.52 
  Obese*SES 4 
  
0.867 -0.35 0.697 -0.9 
  
0.830 -0.42 0.367 -2.28 
Age 
                Age  1.169 5.11 1.162 4.91 1.170 5.05 1.164 4.93 1.169 5.02 1.155 4.55 1.170 5.01 1.166 4.82 
  Age squared 1.000 -2.08 1.000 -1.85 1.000 -2.03 1.000 -1.85 0.999 -2.13 1.000 -1.38 0.999 -2.08 1.000 -1.51 
BMI*age 
              Overweight*age 
    
1.007 1.15 0.995 -0.67 1.005 0.71 0.987 -1.53 
  Obese*age 
    
1.000 -0.02 0.982 -2.17 0.997 -0.26 0.965 -3.47 
Note 
The dependent variable is survival time. Controlling for smoking, ethnicity, marital status, area and missing income. 
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Appendix 5.3: Cox model controlling for individual, household characteristics and illness variables 
  Main effects model BMI interacted with SES model BMI interacted with age model Fully interacted model 
  Men Women Men Women Men Women Men Women 
  Haz. ratio z Haz. ratio z Haz. ratio z Haz. ratio z Haz. ratio z Haz. ratio z Haz. ratio z Haz. ratio z 
BMI 
                  Normal weight Base category Base category Base category Base category Base category Base category Base category Base category 
  Overweight 1.045 0.64 0.948 -0.73 0.999 -0.01 1.000 0 0.698 -0.85 1.241 0.46 0.780 -0.48 2.183 1.25 
  Obese 1.302 2.38 1.254 2.47 1.229 1.04 1.306 2.06 1.448 0.52 4.736 2.79 1.713 0.62 19.133 3.94 
SES 
                  1 (most deprived) Base category Base category Base category Base category Base category Base category Base category Base category 
  2 0.873 -1.66 0.949 -0.63 0.729 -2.62 1.036 0.3 0.840 -2.09 0.984 -0.19 0.726 -2.63 1.130 0.99 
  3 0.754 -2.89 0.764 -2.54 0.770 -1.84 0.789 -1.63 0.750 -2.92 0.789 -2.18 0.762 -1.85 0.915 -0.58 
  4 (least deprived) 0.607 -4.29 0.578 -3.87 0.677 -2.5 0.674 -2.24 0.609 -4.21 0.602 -3.48 0.667 -2.46 0.804 -1.17 
BMI*SES 
                Overweight*SES 2 
  
1.291 1.51 0.828 -1.07 
    
1.306 1.55 0.750 -1.5 
  Overweight*SES 3 
  
0.989 -0.06 1.149 0.67 
   
1.021 0.1 0.979 -0.09 
  Overweight*SES 4 
  
0.811 -0.99 0.707 -1.17 
  
0.848 -0.72 0.584 -1.64 
  Obese*SES 2 
  
1.391 1.2 1.095 0.43 
  
1.367 1.13 0.773 -1.11 
  Obese*SES 3 
  
0.907 -0.33 0.754 -1.03 
  
0.883 -0.4 0.441 -2.63 
  Obese*SES 4 
  
0.905 -0.24 0.785 -0.6 
  
0.844 -0.38 0.400 -2.07 
Age 
              Age  1.156 4.75 1.152 4.63 1.16 4.7 1.153 4.64 1.158 4.71 1.152 4.46 1.159 4.69 1.162 4.68 
  Age squared 1.000 -1.67 1.000 -1.58 1.000 -1.64 1.000 -1.57 1.000 -1.75 1.000 -1.32 1.000 -1.7 1.000 -1.42 
BMI*age 
     
 
 
 
          Overweight*age 
    
1.006 0.97 0.996 -0.6 1.004 0.5 0.989 -1.27 
  Obese*age 
    
0.998 -0.15 0.980 -2.39 0.995 -0.4 0.963 -3.6 
Note 
The dependent variable is survival time. Controlling for smoking, ethnicity, marital status, area, missing income, number of longstanding illnesses and whether or not the 
illness is limiting. 
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Appendix 5.4: Cox-Snell and AIC residuals for men 
Weibull (AIC = 3433.77) 
 
Generalised gamma (AIC= 3427.088) 
 
Gompertz (AIC= 3404.631) 
 
Exponential (AIC= 3709.575) 
 
Loglogistic (AIC= 3549.274) 
 
Lognormal (AIC= 3661.926) 
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Appendix 5.5: Cox-Snell residuals and AIC for women 
Weibull (AIC= 3671.249) 
 
Generalised gamma (AIC= 3666.321) 
 
Gompertz (AIC= 3618.839) 
 
Exponential (AIC= 3932.148) 
 
Loglogistic (AIC= 3765.378) 
 
Lognormal (AIC= 3879.428) 
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Appendices Chapter 6 
Appendix 6.1: Prescribed medication categories  
1: Cardio-vascular medicine  
2: Gastrointestinal medicine  
3: Respiratory medicine  
4: CNS medicine  
5: Medicine for infection  
6: Endocrine medicine  
7: Gynae/Urinary medicine  
8: Cytotoxic medicine  
9: Medicine for nutrition/blood  
10: Musculoskeletal medicine  
11: Eye/Ear etc medicine 
12: Medicine for skin  
13: Other medicine  
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Appendix 6.2: Descriptive statistics by BMI category of the HSE variables for the 
years 1999-2002 
  
Whole Normal 
Overweight 
Class I Class II/III 
sample weight obesity obesity 
Observations     
  Number 36766 14649 13762 5489 2198 
  % 100 40 37 15 6 
Predicted SES measure 25704 26071 26408 24715 23203 
Missing income 18 19 18 17 14 
SES quartile      
  1 (most deprived) 25 24 23 28 33 
  2 25 25 25 25 23 
  3 25 25 25 24 24 
  4 (least deprived) 25 26 27 23 20 
Gender      
  Men  46 40 53 49 31 
  Women 54 60 47 51 69 
Age (years)  45 40 49 50 47 
Ethnicity      
  White 93 92 94 94 94 
  Mixed 0 0 0 0 0 
  Caribbean 1 1 1 1 2 
  African 1 1 1 1 1 
  Indian 2 2 2 1 1 
  Pakistani 1 1 1 1 1 
  Bangladeshi 0 1 0 0 0 
  Chinese 0 1 0 0 0 
  Asian other 0 0 0 0 0 
  Other ethnicity 1 1 1 1 1 
Marital status     
  Married 52 43 60 62 57 
  Single 23 34 16 13 16 
  Separated 2 2 2 2 3 
  Divorced 5 5 5 6 7 
  Widowed 7 5 8 8 8 
  Cohabiting 10 11 9 9 9 
Smoking status     
  Never smoked 44 45 42 42 45 
  Ex occasional  smoker 6 6 6 5 5 
  Ex regular smoker 24 17 28 30 28 
  Current cigarette smoker 27 31 24 22 21 
GOR of residence     
  North East 6 6 6 7 8 
  North West 14 14 15 14 14 
  Yorkshire and The Humber   11 11 11 12 11 
  East Midlands  10 9 10 11 12 
  West Midlands  10 10 10 11 12 
  East of England  12 12 12 11 12 
  London 11 12 10 10 10 
  South West 11 11 11 10 9 
  South East 15 16 15 14 13 
Survey year      
  1999 19 19 19 18 17 
  2000 20 19 20 20 19 
  2001 37 34 39 40 39 
  2002 25 28 22 22 25 
Educational qualifications     
  Degree or equivalent 15 17 15 12 9 
  Higher education below degree 11 10 12 10 11 
  NVQ3/GCE A Level or equiv. 14 16 12 11 11 
  NVQ2/GCE O Level or equiv. 24 26 22 23 24 
  NVQ1/CSE other grade or equiv. 6 5 6 6 6 
  Foreign/other 4 4 5 5 4 
  No qualification 27 21 28 34 35 
Social Class of HRP     
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Table continued 
  Professional 30 29 32 28 26 
  Managerial technical 24 27 23 22 24 
  Skilled non-manual 35 32 37 39 38 
  Skilled manual 5 5 5 7 8 
  Semi-skilled manual 0 0 0 0 0 
  Unskilled manual 5 7 3 4 4 
Cars owned by household     
  Household has no car 20 21 18 20 23 
  Household has car 80 79 82 80 77 
Economic activity status last week    
  In paid employment/self-employed 65 68 64 61 60 
  Going to school or college full time 2 4 2 1 1 
  On a government training scheme 0 0 0 0 0 
  Doing unpaid work  0 0 0 0 0 
  Waiting to take up paid work 0 0 0 0 0 
  Looking for paid work 1 2 1 2 2 
  Temporary sickness 0 0 0 0 0 
  Long-term sickness 4 3 4 5 9 
  Retired from paid work 20 15 24 25 21 
  Looking after home or family 5 6 4 5 6 
  Doing something else 0 0 0 0 0 
Housing tenure     
  Own outright 27 23 30 31 24 
  Buying with mortgage or loan 46 48 47 43 42 
  Pay part rent part mortgage 0 1 0 0 0 
  Rent  25 26 21 25 33 
  Live rent free and/or squatting 1 1 1 1 1 
Bedrooms in household     
  One  6 6 6 6 7 
  Two  21 21 21 23 24 
  Three  50 48 51 52 53 
  Four  17 18 17 14 12 
  Five or more  5 6 5 4 3 
Income support claimant     
  No 93 93 94 93 88 
  Yes 7 7 6 7 12 
Notes 
Other than for “Observations” all statistics are either mean (for continuous variables) or % (categorical variables). 
“<1” indicates non-zero values less than one; “0” indicates zero values. HRP = household reference person.  
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Appendix 6.3. Descriptive statistics by BMI category in HSE (1999-2008) 
  
Whole Normal 
Overweight 
Class I Class II/III 
sample weight obesity obesity 
Observations     
  Number 66435 24313 25489 11040 4626 
  % 100 37 38 17 7 
Predicted SES measure 30796 31378 31543 29625 27748 
Missing income 17 18 17 16 16 
SES quartile      
  1 (most deprived) 25 23 23 28 33 
  2 25 25 25 25 25 
  3 25 25 25 24 24 
  4 (least deprived) 25 27 26 23 19 
Gender      
  Men  46 39 53 49 33 
  Women 54 61 47 51 67 
Age (years)  48 43 51 52 50 
Ethnicity      
  White 93 92 93 94 93 
  Mixed 1 1 1 0 1 
  Caribbean 1 1 1 1 2 
  African 1 1 1 1 1 
  Indian 2 2 2 1 1 
  Pakistani 1 1 1 1 1 
  Bangladeshi 0 1 0 0 0 
  Chinese 0 0 0 0 0 
  Asian other 0 1 0 0 0 
  Other ethnicity 1 1 1 1 1 
Marital status      
  Married 55 46 61 63 59 
  Single 19 28 13 11 14 
  Separated 2 2 2 2 2 
  Divorced 6 6 6 6 7 
  Widowed 7 6 8 8 8 
  Cohabiting 10 11 9 9 9 
Smoking status     
  Never smoked 45 47 44 42 45 
  Ex occasional  smoker 6 6 6 5 6 
  Ex regular smoker 26 19 29 33 31 
  Current cigarette smoker 23 28 21 19 19 
GOR of residence     
  North East 6 6 6 7 7 
  North West 14 14 15 14 14 
  Yorkshire and The Humber   11 11 11 12 11 
  East Midlands  10 9 10 10 11 
  West Midlands  10 9 10 11 12 
  East of England  12 11 12 11 12 
  London 10 12 9 9 8 
  South West 11 11 11 10 10 
  South East 16 17 16 16 15 
Survey year      
  1999 1 1 1 1 1 
  2000 9 9 9 8 8 
  2001 17 17 18 17 15 
  2002 11 13 10 9 10 
  2003 16 15 16 16 15 
  2004 1 1 1 1 1 
  2005 10 9 10 11 11 
  2006 14 14 14 15 16 
  2007 7 7 7 7 7 
  2008 15 14 14 16 17 
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Table continued  
Educational qualifications     
  Degree or equivalent 17 20 18 14 11 
  Higher education below degree 11 11 13 11 11 
  NVQ3/GCE A Level or equiv. 13 16 13 11 10 
  NVQ2/GCE O Level or equiv. 24 25 22 23 24 
  NVQ1/CSE other grade or equiv. 5 5 5 5 6 
  Foreign/other 3 3 3 4 3 
  No qualification 26 21 27 32 35 
Social Class of HRP     
  Professional 33 33 36 32 28 
  Managerial technical 23 26 22 21 22 
  Skilled non-manual 34 30 35 38 38 
  Skilled manual 5 5 5 6 7 
  Semi-skilled manual 0 0 0 0 0 
  Unskilled manual 5 7 3 3 4 
Cars owned by household     
  Household has no car 17 18 16 17 20 
  Household has car 83 82 84 83 80 
Economic activity status last week    
  In paid employment/self-
employed 
64 68 63 59 59 
  Going to school or college full 
time 
2 3 1 1 1 
  On a government training 
scheme 
0 0 0 0 0 
  Doing unpaid work  0 0 0 0 0 
  Waiting to take up paid work 0 0 0 0 0 
  Looking for paid work 1 1 1 1 1 
  Temporary sickness 0 0 0 0 0 
  Long-term sickness 4 3 3 5 7 
  Retired from paid work 24 19 28 29 25 
  Looking after home or family 4 5 4 4 5 
  Doing something else 0 0 0 0 0 
Housing tenure     
  Own outright 32 28 35 36 28 
  Buying with mortgage or loan 44 46 44 41 40 
  Pay part rent part mortgage 0 0 0 0 0 
  Rent  23 25 20 22 31 
  Live rent free and/or squatting 1 1 1 1 1 
Bedrooms in household     
  One  6 6 6 6 8 
  Two  21 21 21 22 24 
  Three  49 47 50 52 52 
  Four  18 19 18 16 14 
  Five or more  5 6 5 4 3 
Income support claimant     
  No 94 94 95 94 90 
  Yes 6 6 5 6 10 
Medication      
  Cardio-vascular 22 13 24 33 38 
  Gastrointestinal 9 6 9 12 13 
  Respiratory 10 9 9 10 14 
  CNS 15 11 15 20 26 
  Infection 2 2 2 2 3 
  Endocrine 11 8 11 14 19 
  Musculoskeletal 7 4 6 10 13 
  Medication excluding  
  contraceptives 
46 37 48 56 63 
  Number of medications 1 1 1 2 2 
Notes 
Other than for “Observations” all statistics are either mean (for continuous variables) or % (categorical 
variables).  
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Appendix 6.4: descriptive statistics by BMI category in the BHPS (2004/5 and 
2006/7) 
  
Whole Normal 
Overweight 
Class I Class II/III 
sample weight obesity obesity 
Observations     
  Number 20776 8515 7844 2900 1086 
  % 
100 41 38 14 5 
Predicted SES measure 28350 28642 28959 27491 25890 
SES quartile      
  1 (most deprived) 25 25 23 27 33 
  2 25 25 24 26 25 
  3 25 24 27 25 24 
  4 (least deprived) 25 26 26 23 18 
Gender      
  Men  47 46 53 45 35 
  Women 53 54 48 55 65 
Age (years)  47 44 49 50 48 
Ethnicity      
  White 97 97 98 98 96 
  Black Caribbean 0 0 0 0 0 
  Black African 0 0 0 0 0 
  Black other 0 0 0 0 0 
  Indian 1 1 1 1 2 
  Pakistani 0 0 0 0 0 
  Bangladeshi 0 0 0 0 0 
  Chinese 0 0 0 0 0 
  Other ethnic group 1 1 1 0 2 
Marital status      
  Married 54 47 59 61 58 
  Couple 12 13 11 11 10 
  Widowed 7 7 8 8 7 
  Divorced 6 5 6 6 8 
  Separated 2 2 2 2 2 
  Never married 20 27 14 12 14 
  Civil partnership 0 0 0 0 0 
Smoking status     
  Yes 25 28 23 20 22 
  No 75 72 77 80 78 
Wave (overall)      
2004/2005 62 70 58 55 53 
2006/2007 38 30 42 45 47 
Educational qualifications     
  Degree or equivalent 41 44 41 40 34 
  NVQ3/GCE A Level or equivalent 12 14 11 9 12 
  NVQ2/GCE O Level or equivalent 18 18 18 16 17 
  NVQ1/CSE other grade or equivalent 8 7 8 9 9 
  No qualification 20 17 21 25 28 
  Still in school 1 1 0 0 0 
Social Class of HRP     
  Professional and managerial technical 17 17 18 17 14 
  Non manual labour 42 46 39 39 40 
  Manual skilled 23 21 24 25 24 
  Manual unskilled 5 5 4 5 6 
  Missing social class 2 2 2 2 4 
  Never had a job 11 9 12 11 12 
Cars owned by household     
  Household has no car 29 32 24 26 36 
  Household has car 71 68 76 74 64 
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Table continued 
Economic activity status last week    
  Employed 58 59 60 57 53 
  Unemployed 3 4 2 3 3 
  Retired 22 19 25 25 20 
  Maternity leave 1 0 1 1 0 
  Family care 6 6 5 6 10 
  FT studt, school 5 8 3 1 2 
  LT sick, disabld 5 3 4 7 11 
  Gvt trng scheme  0 0 0 0 0 
  Other economic activity      
Housing tenure     
  Own outright 77 76 80 75 68 
  Shared 1 1 0 1 1 
  Rent 21 22 18 23 30 
  Live rent free and/or squatting 1 1 1 1 1 
  Other accommodation 0 0 0 0 0 
Bedrooms in household     
  One  1 1 0 0 0 
  Two  4 4 4 5 4 
  Three  15 15 15 16 19 
  Four  27 26 28 29 30 
  Five or more  53 54 54 50 46 
Income support claimant     
  No 95 95 95 93 90 
  Yes 5 5 5 7 10 
Health service use variables      
  GP visit 74 71 74 78 82 
  Outpatient visit 41 39 42 45 53 
  Inpatient stay 10 10 10 11 14 
  Chiropodist 10 8 10 14 17 
  X-ray of chest and lungs 14 12 15 15 18 
  Blood pressure 52 45 54 60 65 
  Cholesterol test 23 16 27 31 35 
  Blood test 41 34 43 48 55 
Notes 
Other than for “Observations” all statistics are either mean (for continuous variables) or % (categorical 
variables). “<1” indicates non-zero values less than one; “0” indicates zero values. HRP = household 
reference person.  
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Appendix 6.5: Output of probit models with interactions between BMI groups and SES in HSE (1999-2002) 
  GP Practice nurse Inpatient Outpatient 
  Men Women Men Women Men Women Men Women 
  Coef. z Coef. z Coef. z Coef. z Coef. z Coef. Z Coef. z Coef. z 
BMI                 
  Normal weight Base category Base category Base category Base category Base category Base category Base category Base category 
  Overweight 0.020 0.34 0.076 1.53 0.139 1.28 0.089 1.06 -0.034 -0.37 0.083 1 0.176 2.37 -0.079 -1.16 
  Obese class I 0.015 0.20 0.123 2.07 0.059 0.44 0.047 0.48 -0.155 -1.23 0.234 2.34 0.013 0.14 0.094 1.12 
  Obese class II/III 0.386 3.34 0.206 2.87 0.715 4.02 0.277 2.53 -0.030 -0.15 0.131 1.03 0.383 2.37 0.290 2.83 
                  
SES                 
  1 (most deprived) Base category Base category Base category Base category Base category Base category Base category Base category 
  2 -0.148 -2.41 -0.111 -2.29 0.146 1.24 -0.082 -0.98 -0.218 -2.10 -0.247 -2.67 -0.007 -0.09 -0.058 -0.84 
  3 -0.216 -3.30 -0.167 -3.4 -0.057 -0.44 -0.138 -1.57 -0.282 -2.50 -0.022 -0.25 -0.059 -0.74 -0.011 -0.16 
  4 (least deprived) -0.407 -5.91 -0.186 -3.59 -0.158 -1.18 -0.011 -0.13 -0.428 -3.49 -0.243 -2.46 -0.304 -3.52 -0.043 -0.59 
BMI*SES           
  Overweight*SES 2 -0.045 -0.55 -0.009 -0.13 -0.228 -1.52 -0.110 -0.94 0.008 0.06 0.047 0.37 -0.256 -2.48 0.181 1.87 
  Overweight*SES 3 -0.021 -0.24 -0.005 -0.07 -0.093 -0.59 0.021 0.18 -0.030 -0.20 -0.133 -1.06 -0.229 -2.17 0.072 0.74 
  Overweight*SES 4 0.111 1.30 -0.003 -0.05 0.005 0.03 -0.210 -1.66 0.126 0.83 0.136 1 -0.060 -0.55 0.198 1.92 
  Obese class I*SES 2 -0.013 -0.12 -0.133 -1.51 0.096 0.52 -0.027 -0.18 0.266 1.43 0.060 0.38 -0.062 -0.46 0.107 0.88 
  Obese class I*SES 3 0.000 0.00 0.033 0.37 0.056 0.29 0.103 0.68 0.225 1.17 -0.162 -1.02 0.068 0.49 0.173 1.37 
  Obese class I*SES 4 0.251 2.29 0.001 0.01 0.073 0.36 0.053 0.33 0.379 1.90 0.230 1.28 0.175 1.23 0.074 0.52 
  Obese class II/III*SES 2 -0.363 -2.04 0.058 0.54 -0.846 -2.70 -0.315 -1.80 0.092 0.29 0.146 0.71 -0.330 -1.37 0.144 0.91 
  Obese class  II/III*SES 3 -0.269 -1.53 -0.040 -0.35 -0.175 -0.66 -0.095 -0.52 -0.016 -0.04 -0.483 -2.06 -0.304 -1.24 -0.198 -1.19 
  Obese class  II/III*SES 4 0.006 0.03 -0.114 -0.9 -0.586 -1.81 -0.195 -0.93 0.398 1.20 0.143 0.62 -0.098 -0.39 -0.016 -0.09 
  Joint prob > chi2 0.1701 0.6612 0.1163 0.5332 0.7646 0.2508 0.1557 0.2975 
Note 
Controlling for age, age squared and age cubed, ethnicity, marital status, smoking status, area variables, survey year, and missing income. 
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Appendix 6.6: Output of probit models after exclusion of insignificant variables between BMI groups and SES in HSE (1999-2002) 
  GP Practice nurse Inpatient Outpatient 
  Men Women Men Women Men Women Men Women 
  Coef. z Coef. z Coef. Z Coef. z Coef. z Coef. z Coef. z Coef. z 
BMI                 
  Normal weight Base category Base category Base category   Base category  Base category 
  Overweight -0.001 -0.02 0.071 2.71 0.059 1.04     0.085 1.77   0.027 0.75 
  Obese class I 0.012 0.25 0.095 2.81 0.118 1.66     0.245 4.02   0.176 3.68 
  Obese class II/III 0.200 2.73 0.195 4.63 0.388 3.74     0.101 1.25   0.286 4.7 
                  
SES                 
  1 (most deprived) Base category Base category Base category Base category Base category Base category Base category Base category 
  2 -0.190 -5.06 -0.129 -4.22 0.014 0.22 -0.159 -3.19 -0.169 -2.67 -0.210 -3.65 -0.124 -2.61   
  3 -0.243 -6.13 -0.164 -5.07 -0.099 -1.43 -0.152 -2.82 -0.266 -3.83 -0.108 -1.83 -0.158 -3.16   
  4 (least deprived) -0.426 -6.71 -0.201 -5.7 -0.171 -2.29 -0.119 -2.06 -0.291 -4.05 -0.161 -2.41 -0.288 -5.49   
BMI*SES            
  Overweight*SES 2                 
  Overweight*SES 3                 
  Overweight*SES 4 0.130 1.78               
  Obese class I*SES 2                 
  Obese class I*SES 3                 
  Obese class I*SES 4 0.252 2.7               
  Obese class II/III*SES 2                 
  Obese class  II/III*SES 3                 
  Obese class  II/III*SES 4 0.190 1.21               
Note 
Controlling for age, age squared and age cubed, ethnicity, marital status, smoking status, area variables, survey year, and missing income. 
 
 
 
 
  
 304 
 
Appendix 6.7: Output of probit and negbin models with interactions between BMI groups and SES for individuals having had a 
nurse visit in HSE (1999-2008) 
Part 1 of 2 
  Cardio-vascular medicine Gastrointestinal medicine Respiratory medicine CNS medicine 
  Men Women Men Women Men Women Men Women 
  Coef. z Coef. z Coef. z Coef. z Coef. z Coef. z Coef. z Coef. z 
BMI                 
  Normal weight Base category Base category Base category Base category Base category Base category Base category Base category 
  Overweight 0.364 6.72 0.235 5.13 0.005 0.09 0.028 0.55 0.008 0.15 0.015 0.30 0.101 2.07 0.070 1.70 
  Obese class I 0.665 10.50 0.412 7.85 0.072 1.09 0.173 3.07 0.147 2.21 0.091 1.60 0.239 4.16 0.236 4.99 
  Obese class II/III 1.167 12.50 0.682 11.36 0.285 2.79 0.274 4.26 0.369 4.12 0.285 4.60 0.512 6.54 0.403 7.43 
                  
SES                 
  1 (most deprived) Base category Base category Base category Base category Base category Base category Base category Base category 
  2 -0.008 -0.12 -0.100 -1.95 -0.118 -1.81 -0.239 -4.40 -0.091 -1.53 -0.147 -2.95 -0.405 -6.71 -0.211 -4.90 
  3 -0.114 -1.68 -0.236 -4.60 -0.306 -4.32 -0.216 -3.88 -0.153 -2.54 -0.182 -3.72 -0.450 -7.16 -0.348 -7.97 
  4 (least deprived) -0.198 -3.06 -0.379 -7.01 -0.350 -5.11 -0.321 -5.74 -0.142 -2.35 -0.225 -4.46 -0.633 -10.77 -0.508 -11.18 
BMI*SES           
  Overweight*SES 2 -0.140 -1.78 -0.073 -1.11 -0.020 -0.25 0.136 1.91 -0.004 -0.05 0.082 1.22 0.057 0.75 0.050 0.85 
  Overweight*SES 3 -0.137 -1.72 -0.038 -0.57 0.103 1.18 0.021 0.27 -0.006 -0.08 -0.011 -0.16 -0.063 -0.82 0.116 1.95 
  Overweight*SES 4 -0.095 -1.26 0.020 0.29 0.025 0.29 0.073 0.95 -0.046 -0.61 0.059 0.85 -0.094 -1.27 0.101 1.66 
  Obese class I*SES 2 -0.190 -2.06 0.091 1.19 -0.098 -1.01 0.201 2.46 -0.193 -2.05 0.058 0.72 0.013 0.15 0.006 0.09 
  Obese class I*SES 3 -0.102 -1.11 0.197 2.57 0.117 1.13 0.062 0.72 -0.153 -1.62 0.100 1.25 -0.115 -1.28 -0.036 -0.50 
  Obese class I*SES 4 -0.108 -1.24 0.114 1.39 0.103 1.04 0.128 1.40 -0.204 -2.13 0.077 0.89 -0.041 -0.47 0.149 1.97 
  Obese class II/III*SES 2 -0.318 -2.33 0.129 1.45 -0.096 -0.63 0.074 0.74 -0.185 -1.38 0.026 0.28 -0.045 -0.33 0.076 0.94 
  Obese class  II/III*SES 3 -0.424 -3.19 0.170 1.88 -0.097 -0.66 0.057 0.54 -0.459 -3.23 -0.016 -0.17 -0.281 -2.25 0.062 0.73 
  Obese class  II/III*SES 4 -0.237 -1.80 0.223 2.24 -0.174 -1.07 0.071 0.62 -0.360 -2.44 0.127 1.25 -0.062 -0.48 0.035 0.38 
  Joint prob > chi2 0.1284 0.0248 0.4286 0.5488 0.0311 0.6895 0.359 0.1764 
 
 
 
 
 
 
 
 305 
 
Part 2 of 2 
  Endocrine medicine Musculoskeletal medicine 
Average number of prescribed 
medicines taken 
  Men Women Men Women Men Women 
  Coef. z Coef. z Coef. z Coef. z Coef. z Coef. z 
BMI             
  Normal weight Base category Base category Base category Base category Base category Base category 
  Overweight 0.241 3.29 -0.018 -0.36 0.161 2.37 0.058 1.02 0.155 3.02 0.135 3.62 
  Obese class I 0.451 5.77 0.110 2.05 0.377 4.88 0.240 3.97 0.446 7.61 0.314 7.53 
  Obese class II/III 0.798 8.24 0.293 4.62 0.524 5.38 0.452 6.79 0.810 10.09 0.574 12.81 
              
SES             
  1 (most deprived) Base category Base category Base category Base category Base category Base category 
  2 0.047 0.57 -0.084 -1.68 -0.091 -1.05 -0.164 -2.70 -0.303 -4.99 -0.250 -6.11 
  3 -0.069 -0.79 -0.017 -0.33 -0.145 -1.55 -0.133 -2.19 -0.433 -6.73 -0.363 -8.74 
  4 (least deprived) -0.040 -0.49 0.016 0.33 -0.251 -2.87 -0.271 -4.34 -0.601 -10.12 -0.459 -10.35 
BMI*SES       
  Overweight*SES 2 -0.164 -1.57 0.162 2.45 -0.096 -0.94 0.165 2.07 0.032 0.43 0.052 0.95 
  Overweight*SES 3 -0.051 -0.48 0.025 0.38 -0.044 -0.40 0.019 0.23 -0.064 -0.85 -0.004 -0.07 
  Overweight*SES 4 -0.241 -2.37 0.111 1.74 -0.077 -0.76 0.084 0.97 -0.026 -0.37 0.072 1.22 
  Obese class I*SES 2 -0.011 -0.09 0.137 1.84 0.047 0.41 0.176 1.96 -0.029 -0.34 0.160 2.62 
  Obese class I*SES 3 -0.171 -1.46 -0.056 -0.73 -0.045 -0.38 0.114 1.26 -0.062 -0.71 0.112 1.77 
  Obese class I*SES 4 -0.158 -1.40 -0.018 -0.24 -0.091 -0.80 0.136 1.40 0.043 0.52 0.084 1.21 
  Obese class II/III*SES 2 -0.102 -0.69 0.059 0.65 -0.004 -0.03 0.175 1.76 -0.044 -0.36 0.157 2.23 
  Obese class  II/III*SES 3 -0.116 -0.81 0.014 0.15 -0.099 -0.65 -0.032 -0.30 -0.125 -1.01 0.112 1.6 
  Obese class  II/III*SES 4 -0.108 -0.73 -0.098 -1.02 -0.062 -0.40 -0.006 -0.05 -0.003 -0.02 0.199 2.31 
  Joint prob > chi2 0.1232 0.056 0.8379 0.386 0.8435 0.0979 
Note 
Controlling for age, age squared and age cubed, ethnicity, marital status, smoking status, area variables, survey year, and missing income. 
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Appendix 6.8: Output of refitted probit and negbin models with interactions between BMI groups and SES for individuals having 
had a nurse visit in HSE (1999-2008) 
Part 1 of 2 
  Cardio-vascular medicine Gastrointestinal medicine Respiratory medicine CNS medicine 
  Men Women Men Women Men Women Men Women 
  Coef. z Coef. z Coef. Z Coef. z Coef. z Coef. z Coef. z Coef. z 
BMI                 
  Normal weight Base category Base category Base category Base category Base category Base category Base category Base category 
  Overweight 0.162 7.69 0.235 5.13 0.006 0.24 0.060 2.93 0.008 0.15 0.042 2.07 0.045 1.98 0.094 3.7 
  Obese class I 0.403 15.32 0.412 7.85 0.069 2.38 0.195 7.56 0.147 2.21 0.119 4.53 0.153 5.46 0.210 6.71 
  Obese class II/III 0.689 16.82 0.682 11.36 0.133 2.82 0.249 7.81 0.369 4.12 0.266 8.52 0.331 7.71 0.405 10.79 
                  
SES                 
  1 (most deprived) Base category Base category Base category Base category Base category Base category Base category Base category 
  2 -0.092 -3.45 -0.100 -1.95 -0.109 -3.88 -0.097 -4.03 -0.091 -1.53 -0.081 -3.39 -0.306 -11.47 -0.150 -6.83 
  3 -0.178 -6.6 -0.236 -4.6 -0.191 -6.57 -0.146 -5.75 -0.153 -2.54 -0.142 -5.64 -0.432 -15.66 -0.258 -8.02 
  4 (least deprived) -0.196 -7.29 -0.379 -7.01 -0.231 -7.8 -0.183 -6.78 -0.142 -2.35 -0.147 -5.48 -0.532 -18.93 -0.367 -10.91 
BMI*SES           
  Overweight*SES 2   -0.073 -1.11     -0.004 -0.05       
  Overweight*SES 3   -0.038 -0.57     -0.006 -0.08     0.040 0.93 
  Overweight*SES 4   0.020 0.29     -0.046 -0.61     -0.004 -0.09 
  Obese class I*SES 2   0.091 1.19     -0.193 -2.05       
  Obese class I*SES 3   0.197 2.57     -0.153 -1.62     -0.080 -1.47 
  Obese class I*SES 4   0.114 1.39     -0.204 -2.13     0.112 1.9 
  Obese class II/III*SES 2   0.129 1.45     -0.185 -1.38       
  Obese class  II/III*SES 3   0.170 1.88     -0.459 -3.23     -0.024 -0.34 
  Obese class  II/III*SES 4   0.223 2.24     -0.360 -2.44     -0.074 -0.99 
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Part 2 of 2 
  Endocrine medicine Musculoskeletal medicine 
Average number of prescribed medicines 
taken 
  Men Women Men Women Men Women 
  Coef. z Coef. z Coef. z Coef. z Coef. z Coef. z 
BMI             
  Normal weight Base category Base category Base category Base category Base category Base category 
  Overweight 0.051 2.04 0.044 2.38 0.048 1.97 0.074 3.47 0.141 5.15 0.164 8.03 
  Obese class I 0.228 7.54 0.108 4.6 0.235 7.88 0.231 8.61 0.436 13.33 0.402 17.23 
  Obese class II/III 0.486 10.58 0.255 8.56 0.322 7.06 0.370 11.34 0.769 16.66 0.677 24.25 
              
SES             
  1 (most deprived) Base category Base category Base category Base category Base category Base category 
  2 -0.028 -0.94   -0.085 -2.86 -0.038 -1.49 -0.301 -9.91 -0.174 -7.94 
  3 -0.117 -3.85   -0.151 -4.9 -0.095 -3.63 -0.484 -15.17 -0.320 -13.47 
  4 (least deprived) -0.124 -3.94   -0.204 -6.44 -0.144 -5.16 -0.603 -18.91 -0.391 -15.18 
BMI*SES       
  Overweight*SES 2                   
  Overweight*SES 3                   
  Overweight*SES 4                   
  Obese class I*SES 2                   
  Obese class I*SES 3                   
  Obese class I*SES 4                   
  Obese class II/III*SES 2                   
  Obese class  II/III*SES 3                   
  Obese class  II/III*SES 4                   
Note 
Controlling for age, age squared and age cubed, ethnicity, marital status, smoking status, area variables, survey year, and missing income. 
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Appendix 6.9: Output of probit models and interval regression models with interactions between BMI groups and SES for 
individuals in the BHPS 
Part 1 of 2 
  GP visits Number of GP visits Outpatient visits Number of outpatient visits Inpatient stay 
  Men Women Men Women Men Women Men Women Men Women 
BMI                     
  Normal weight Base category Base category Base category Base category Base category Base category Base category Base category Base category Base category 
  Overweight 0.166 1.80 0.188 2.02 0.021 0.11 0.416 2.27 -0.022 -0.26 0.126 1.76 -0.226 -1.06 -0.352 -1.70 -0.149 -1.43 -0.056 -0.67 
  Obese class I 0.236 1.76 0.396 3.24 1.007 3.83 1.142 5.01 0.114 0.95 0.276 3.07 0.099 0.34 0.142 0.57 0.077 0.55 0.129 1.28 
  Obese class II/III 0.475 2.23 0.665 3.95 1.144 2.86 1.733 5.86 0.551 2.98 0.435 3.72 0.277 0.67 0.089 0.29 0.224 1.09 0.143 1.11 
                      
SES                     
  1 (most deprived) Base category Base category Base category Base category Base category Base category Base category Base category Base category Base category 
  2 -0.261 -3.14 0.038 0.45 -0.659 -3.55 -0.812 -4.65 -0.199 -2.47 -0.068 -1.00 -0.385 -1.76 -0.657 -3.16 -0.280 -2.65 -0.293 -3.53 
  3 -0.162 -1.89 -0.138 -1.59 -1.084 -5.75 -0.969 -5.30 -0.164 -1.99 -0.012 -0.18 -0.726 -3.29 -0.705 -3.34 -0.589 -4.95 -0.333 -3.84 
  4 (least deprived) -0.177 -2.01 -0.051 -0.58 -1.297 -6.62 -0.906 -4.95 -0.236 -2.76 -0.015 -0.21 -0.398 -1.71 -0.482 -2.28 -0.514 -4.27 -0.218 -2.58 
BMI*SES            
  Overweight*SES 2 0.132 1.09 -0.074 -0.59 0.057 0.22 0.082 0.33 0.228 2.01 -0.043 -0.43 0.098 0.33 0.720 2.45 0.300 2.03 0.209 1.74 
  Overweight*SES 3 -0.074 -0.62 -0.080 -0.64 0.147 0.58 -0.002 -0.01 0.000 0.00 -0.120 -1.20 0.608 2.02 0.184 0.62 0.408 2.58 0.258 2.11 
  Overweight*SES 4 -0.160 -1.34 0.011 0.08 0.346 1.35 -0.064 -0.25 0.093 0.82 -0.080 -0.79 0.250 0.83 0.172 0.58 0.325 2.09 0.116 0.94 
  Obese class I*SES 2 -0.005 -0.03 -0.266 -1.58 -0.753 -2.11 0.139 0.43 0.020 0.13 -0.190 -1.48 0.343 0.83 0.762 2.05 0.010 0.05 -0.026 -0.17 
  Obese class I*SES 3 -0.052 -0.30 0.019 0.11 -0.666 -1.84 -0.805 -2.46 -0.089 -0.55 -0.021 -0.16 0.606 1.43 0.116 0.32 0.069 0.31 0.102 0.66 
  Obese class I*SES 4 -0.042 -0.24 -0.132 -0.73 -0.513 -1.41 -0.819 -2.39 0.049 0.30 -0.141 -1.04 -0.368 -0.88 0.061 0.16 0.143 0.67 -0.050 -0.30 
  Obese class II/III*SES 2 0.015 0.05 0.011 0.04 0.766 1.33 -0.071 -0.17 -0.253 -0.98 0.084 0.49 0.461 0.73 0.489 1.06 0.199 0.65 0.010 0.05 
  Obese class  II/III*SES 3 -0.376 -1.32 -0.245 -1.00 -0.703 -1.19 -0.313 -0.68 -0.533 -2.02 -0.003 -0.02 -0.092 -0.14 0.907 1.89 0.410 1.27 0.441 2.18 
  Obese class  II/III*SES 4 0.151 0.50 -0.036 -0.13 0.078 0.14 -1.000 -1.98 -0.121 -0.46 0.011 0.05 0.293 0.47 -0.592 -1.09 0.086 0.26 -0.123 -0.49 
  Joint prob > chi2 0.20 0.70 0.07 0.04 0.27 0.77 0.22 0.06 0.37 0.25 
  Likelihood-ratio test* 0.19 0.70 - - 0.26 0.77 - - 0.35 0.25 
* Likelihood-ratio test of restricted model with no interactions vs. less restrictive model with interactions. The models for “number of GP visits” and “number of 
    outpatient visits” are linear models hence we do not run likelihood ratio tests for these models.  
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Part 2 of 2 
  Chiropodist X-ray of chest and lungs Blood pressure Cholesterol test Blood test 
  Men Women Men Women Men Women Men Women Men Women 
BMI 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
  Normal weight Base category Base category Base category Base category Base category Base category Base category Base category Base category Base category 
  Overweight 0.327 1.65 0.171 1 -0.075 -0.81 -0.077 -0.87 0.114 1.21 0.198 2.38 0.256 2.14 0.291 2.82 0.279 2.84 0.085 1.09 
  Obese class I 0.832 3.19 0.527 2.59 0.034 0.27 -0.041 -0.37 0.333 2.48 0.407 3.81 0.563 3.51 0.376 3.03 0.4 2.87 0.256 2.6 
  Obese class II/III 1.496 4.19 0.724 2.73 0.116 0.6 0.217 1.58 0.565 2.79 0.605 4.29 0.74 3.13 0.917 5.91 0.644 3.05 0.626 4.79 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
SES 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
  1 (most deprived) Base category Base category Base category Base category Base category Base category Base category Base category Base category Base category 
  2 0.017 0.08 0.039 0.22 -0.252 -2.75 -0.232 -2.6 -0.239 -2.65 -0.033 -0.43 -0.15 -1.19 0.041 0.39 -0.098 -1.03 -0.269 -3.58 
  3 -0.325 -1.39 0.079 0.44 -0.375 -3.92 -0.467 -4.83 -0.203 -2.22 0.058 0.72 -0.119 -0.96 0.015 0.14 -0.143 -1.46 -0.221 -2.86 
  4 (least deprived) -0.234 -0.95 -0.155 -0.83 -0.454 -4.51 -0.251 -2.72 -0.194 -2.06 0.112 1.38 -0.16 -1.25 0.022 0.2 -0.161 -1.59 -0.203 -2.63 
BMI*SES       
 
  
 
  
 
  
 
  
 
      
  Overweight*SES 2 -0.111 -0.4 -0.001 0 0.244 1.91 0.16 1.26 0.288 2.28 0.003 0.03 0.111 0.68 -0.017 -0.12 0.018 0.14 0.285 2.63 
  Overweight*SES 3 0.11 0.37 0.097 0.41 0.186 1.44 0.334 2.5 0.176 1.42 -0.048 -0.41 0.12 0.75 -0.038 -0.26 -0.151 -1.15 0.12 1.09 
  Overweight*SES 4 -0.008 -0.03 0.152 0.61 0.231 1.76 0.12 0.91 0.183 1.47 0.027 0.23 0.092 0.57 -0.22 -1.5 -0.058 -0.44 0.122 1.1 
  Obese class I*SES 2 0.003 0.01 -0.09 -0.31 -0.023 -0.13 0.146 0.9 0.15 0.85 0.102 0.68 0.104 0.48 0.122 0.7 -0.039 -0.21 0.339 2.42 
  Obese class I*SES 3 0.138 0.36 -0.028 -0.1 -0.022 -0.12 0.316 1.85 0.129 0.72 -0.064 -0.42 -0.104 -0.47 -0.116 -0.65 -0.109 -0.58 0.114 0.8 
  Obese class I*SES 4 0.241 0.63 0.055 0.17 0.059 0.32 -0.115 -0.64 0.151 0.84 -0.078 -0.49 -0.073 -0.33 0.125 0.68 -0.028 -0.15 0.184 1.25 
  Obese class II/III*SES 2 -0.314 -0.59 0.264 0.7 0.028 0.1 0.329 1.6 0.25 0.9 0.201 0.97 0.337 1.02 -0.34 -1.49 -0.029 -0.1 0.324 1.68 
  Obese class  II/III*SES 3 -0.321 -0.55 0.071 0.18 0.156 0.54 0.047 0.21 0.031 0.11 -0.058 -0.27 0.013 0.04 -0.891 -3.6 -0.229 -0.75 -0.216 -1.09 
  Obese class  II/III*SES 4 0.239 0.44 -0.138 -0.3 -0.178 -0.56 0.013 0.05 0.452 1.56 -0.196 -0.81 0.541 1.62 -0.477 -1.76 0.391 1.3 -0.213 -0.95 
  Joint prob > chi2 0.98 0.99 0.65 0.17 0.53 0.86 0.72 0.01 0.67 0.06 
  Likelihood-ratio test* 0.98 0.99 0.64 0.16 0.52 0.86 0.72 0.01 0.66 0.06 
Note 
Controlling for age, age squared and age cubed, ethnicity, marital status, smoking status, area variables, survey year, and missing income. 
* Likelihood-ratio test of restricted model with no interactions vs. less restrictive model with interactions 
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Appendix 6.10: output of refitted probit models and interval regression models in the BHPS 
Part 1 of 2 
  GP visits Number of GP visits Outpatient visits Number of outpatient visits Inpatient stay 
  Men Women Men Women Men Women Men Women Men Women 
BMI 
 
  
   
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
  Normal weight Base category Base category Base category Base category Base category Base category   Base category Base category Base category 
  Overweight 0.132 3.08 0.15 3.17 0.166 1.74 0.416 2.27 0.059 1.43 0.068 1.82 
  
-0.089 -0.81 0.094 1.65 0.081 1.77 
  Obese class I 0.205 3.31 0.304 4.63 0.517 3.82 1.142 5.01 0.106 1.79 0.197 3.96 
  
0.368 2.59 0.122 1.52 0.141 2.35 
  Obese class II/III 0.405 3.86 0.596 5.96 1.179 5.41 1.733 5.86 0.326 3.37 0.46 6.56 
  
0.34 1.83 0.378 3.12 0.239 2.95 
  
     
  
 
  
 
  
 
  
   
  
 
  
 
  
SES 
     
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
  1 (most deprived) Base category Base category Base category Base category Base category   Base category Base category Base category Base category 
  2 -0.207 -3.61 -0.028 -0.48 -0.714 -5.92 -0.812 -4.65 -0.116 -2.17 
 
  -0.267 -1.94 -0.232 -1.79 -0.156 -2.29 -0.221 -4.12 
  3 -0.215 -3.65 -0.181 -3.03 -1.139 -9.12 -0.969 -5.3 -0.205 -3.7 
 
  -0.394 -2.76 -0.536 -4.05 -0.39 -5.21 -0.191 -3.45 
  4 (least deprived) -0.252 -4.13 -0.072 -1.15 -1.212 -9.33 -0.906 -4.95 -0.201 -3.53 
 
  -0.356 -2.39 -0.414 -2.99 -0.358 -4.69 -0.184 -3.17 
BMI*SES   
  
  
 
        
 
  
 
  
  Overweight*SES 2 
     
  0.082 0.33 
 
  
 
  
 
  
 
  
 
  
 
  
  Overweight*SES 3 
     
  -0.002 -0.01 
 
  
 
  
 
  
 
  
 
  
 
  
  Overweight*SES 4 
     
  -0.064 -0.25 
 
  
 
  
 
  
 
  
 
  
 
  
  Obese class I*SES 2 
     
  0.139 0.43 
 
  
 
  
 
  
 
  
 
  
 
  
  Obese class I*SES 3 
     
  -0.805 -2.46 
 
  
 
  
 
  
 
  
 
  
 
  
  Obese class I*SES 4 
     
  -0.819 -2.39 
 
  
 
  
 
  
 
  
 
  
 
  
  Obese class II/III*SES 2 
     
  -0.071 -0.17 
 
  
 
  
 
  
 
  
 
  
 
  
  Obese class  II/III*SES 3 
     
  -0.313 -0.68 
 
  
 
  
 
  
 
  
 
  
 
  
  Obese class  II/III*SES 4             -1 -1.98                         
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Part 2 of 2 
  Chiropodist X-ray of chest and lungs Blood pressure Cholesterol test Blood test 
  Men Women Men Women Men Women Men Women Men Women 
BMI                     
  Normal weight Base category Base category  Base category Base category Base category Base category Base category Base category Base category 
  Overweight 0.335 2.94 0.229 2.42   0.063 1.28 0.278 6.14 0.189 4.35 0.338 5.69 0.291 2.82 0.227 4.68 0.217 5.23 
  Obese class I 0.981 6.07 0.515 4.26   0.045 0.7 0.443 6.86 0.392 6.64 0.548 6.73 0.376 3.03 0.353 5.13 0.409 7.4 
  Obese class II/III 1.431 6.24 0.802 4.87   0.319 3.72 0.751 7.07 0.599 7.04 0.967 7.51 0.917 5.91 0.677 6.03 0.634 8.04 
                      
SES                     
  1 (most deprived)   Base category Base category    Base category Base category Base category 
  2     -0.162 -2.73 -0.123 -2.18       0.041 0.39 -0.094 -1.51 -0.094 -1.93 
  3     -0.300 -4.82 -0.286 -4.73       0.015 0.14 -0.232 -3.58 -0.171 -3.35 
  4 (least deprived)     -0.360 -5.54 -0.213 -3.39       0.022 0.2 -0.171 -2.55 -0.139 -2.6 
BMI*SES                
  Overweight*SES 2               -0.017 -0.12     
  Overweight*SES 3               -0.038 -0.26     
  Overweight*SES 4               -0.22 -1.5     
  Obese class I*SES 2               0.122 0.7     
  Obese class I*SES 3               -0.116 -0.65     
  Obese class I*SES 4               0.125 0.68     
  Obese class II/III*SES 2               -0.34 -1.49     
  Obese class  II/III*SES 3               -0.891 -3.6     
  Obese class  II/III*SES 4               -0.477 -1.76     
Note 
Controlling for age, age squared and age cubed, ethnicity, marital status, smoking status, area variables, survey year, and missing income. 
 
 
 
